Drug monographs A–Z
One monograph for each of 243 medicines, arranged A–Z, in a standard layout: Mechanism, Uses, Dosing, Side effects, Interactions and Special advice, then the chapters that discuss the drug and the BNF link.
Educational summaries, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Always check dose, indication, interactions and monitoring in the BNF and local guidelines before prescribing.
A
Abatacept
BNF entry for Abatacept · Stand-alone drug page
Mechanism
Fusion protein that blocks CD28 co-stimulation of T cells (selective T-cell co-stimulation modulator).
Uses
Rheumatoid arthritis and psoriatic or juvenile idiopathic arthritis after inadequate response to DMARDs.
Dosing
- Treatment: Stop the checkpoint inhibitor; IV methylprednisolone 500–1000 mg daily for 3–5 days, then oral steroid taper; second-line agents (e.g. abatacept, mycophenolate, ruxolitinib) for steroid-refractory disease.
Cardiology: Cardiomyopathies › 3.37 Immune Checkpoint Inhibitor Myocarditis
Side effects
Infections (including respiratory), headache, nausea; rarely serious infection, malignancy, infusion reactions.
Interactions
Avoid with other biologics (TNF inhibitors); live vaccines contraindicated.
Special advice
Screen for TB and hepatitis B before starting; avoid live vaccines; interrupt in serious infection.
More from the textbook: uses, cautions and other points
- T-cell co-stimulation | Abatacept | RA
Rheumatology Anatomy Physiology Pharmacology - T-cell costimulation | Abatacept | RA | Infections; fewer serious infections than some others
Rheumatology: assessment, investigations and drugs - Anti-TNF, abatacept, tocilizumab or sarilumab, JAK inhibitors - usually with methotrexate.
Rheumatology: Inflammatory arthritis - Clinically suspect arthralgia - joint pain with features suggesting early RA (anti-CCP positive) but no swelling yet; watch; trials of early abatacept and methotrexate are exploring prevention.
Rheumatology: Inflammatory arthritis - Drugs acting on T cells - calcineurin inhibitors (tacrolimus, ciclosporin - block IL-2), corticosteroids, abatacept (blocks co-stimulation), anti-thymocyte globulin.
Clinical Immunology: Immune system basics and immunological investigations - CTLA4 haploinsufficiency and LRBA deficiency - CVID-like antibody deficiency with autoimmunity, enteropathy and lymphocytic infiltration - abatacept (CTLA-4–Ig) is targeted therapy.
Clinical Immunology: Primary immunodeficiency
Where it is discussed
- Cardiology: Cardiomyopathies (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (1 mention)
- Rheumatology: Inflammatory arthritis (3 mentions)
- Clinical Immunology: Immune system basics and immunological investigations (1 mention)
- Clinical Immunology: Primary immunodeficiency (1 mention)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (3 mentions)
- Integrated cardiology chapter (1 mention)
Abiraterone
BNF entry for Abiraterone · Stand-alone drug page
Mechanism
Irreversible inhibitor of CYP17, blocking androgen synthesis in testes, adrenals and tumour.
Uses
Metastatic castration-resistant or high-risk hormone-sensitive prostate cancer, with prednisolone.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hypertension, hypokalaemia, fluid retention, liver enzyme rise, fatigue.
Interactions
CYP2D6 substrates (e.g. metoprolol) levels rise; strong CYP3A4 inducers lower levels.
Special advice
Always given with a corticosteroid to limit mineralocorticoid excess; monitor BP, potassium, fluid status and LFTs.
More from the textbook: uses, cautions and other points
- Abiraterone (with prednisolone) - hypertension, low potassium, fluid retention, liver toxicity.
Oncology: Principles - Abiraterone (with prednisolone) | Hypertension, low potassium, liver toxicity.
Oncology: Principles - Plus a newer hormonal drug (abiraterone, enzalutamide, apalutamide or darolutamide), with or without docetaxel .
Oncology: Urology and Genital cancers - Abiraterone (with prednisolone) | Metastatic prostate cancer; hypertension, low potassium, liver toxicity.
Oncology: Urology and Genital cancers
Where it is discussed
- Oncology: Principles (2 mentions)
- Oncology: Urology and Genital cancers (2 mentions)
Acarbose
BNF entry for Acarbose · Stand-alone drug page
Mechanism
Alpha-glucosidase inhibitor that slows intestinal carbohydrate digestion and post-meal glucose rise.
Uses
Type 2 diabetes as an add-on.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Flatulence, abdominal bloating, diarrhoea; rarely raised liver enzymes.
Interactions
Hypoglycaemia from other agents must be treated with glucose, not sucrose.
Special advice
Take with the first mouthful of food; treat hypoglycaemia with glucose; avoid in inflammatory bowel disease or intestinal obstruction.
More from the textbook: uses, cautions and other points
- Other oral options (rarely used) - acarbose (slows carbohydrate absorption - flatulence).
Endocrine: Anatomy Physiology and Pharmacology - Acarbose Post-bariatric hypoglycaemia | Slows carbohydrate absorption; first-line drug after dietary change.
Endocrinology: NETS and Hypoglycaemia - Treatment: Small frequent meals, fewer simple sugars, fluids between (not with) meals. Specialist options include acarbose or octreotide.
Gastroenterology: Oesophagus and Stomach - Drug triggers: PPIs (especially lansoprazole), NSAIDs, SSRIs (e.g. sertraline) , statins, beta-blockers, acarbose.
Gastroenterology: Inflammatory Bowel Disease - Management - small frequent meals, avoid sugary foods and drinks, more protein and fibre, drink fluids between rather than with meals; acarbose or octreotide in severe cases.
Surgery: Upper GI, hepatobiliary and bariatric surgery
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: NETS and Hypoglycaemia (1 mention)
- Gastroenterology: Oesophagus and Stomach (1 mention)
- Gastroenterology: Inflammatory Bowel Disease (1 mention)
- Surgery: Upper GI, hepatobiliary and bariatric surgery (1 mention)
Acetazolamide
BNF entry for Acetazolamide · Stand-alone drug page
Mechanism
Carbonic anhydrase inhibitor: reduces bicarbonate reabsorption (diuresis, metabolic acidosis) and aqueous and CSF production.
Uses
Glaucoma, idiopathic intracranial hypertension, altitude sickness, some epilepsies, oedema.
Dosing
- IV acetazolamide (500 mg) then oral.
Ophthalmology: Anatomy Physiology and Pharmacology - Emergency ophthalmology; IV acetazolamide 500 mg , topical timolol, apraclonidine and steroid; pilocarpine once IOP starts to fall; analgesia and antiemetic; lie supine.
Ophthalmology: Anatomy Physiology and Pharmacology - Acetazolamide 500 mg IV (or orally if IV not possible) - reduces aqueous production. Avoid in sulfonamide allergy; caution in kidney disease and sickle cell.
Ophthalmology: Red emergencies - Acetazolamide 500 mg IV | Acute angle closure. Avoid in sulfonamide allergy; caution in kidney disease and sickle cell.
Ophthalmology: Red emergencies
1 more dose entries from the chapters
- Acetazolamide (e.g. 125 mg twice daily) — carbonic anhydrase inhibitor (causes a metabolic acidosis that stimulates breathing) — for rapid ascent or previous AMS; side effects — tingling, polyuria, altered taste of fizzy drinks; avoid in sulfonamide allergy.
Emergency Medicine: Environmental emergencies
Side effects
Paraesthesia, tinnitus, polyuria, metabolic acidosis, hypokalaemia, renal stones, drowsiness.
Interactions
Salicylates increase toxicity; lithium levels may fall; carbamazepine and phenytoin levels may rise.
Special advice
Sulfonamide-related, so caution in sulfonamide allergy; monitor electrolytes and acid-base on long-term use.
More from the textbook: uses, cautions and other points
- Acetazolamide (carbonic anhydrase inhibitor) - causes a mild metabolic acidosis that stimulates breathing (used for altitude sickness).
Respiratory: Anatomy, Physiology and Pharmacology - Respiratory stimulants - doxapram (rarely used now; NIV is preferred); acetazolamide (altitude, some central sleep apnoea).
Respiratory: Anatomy, Physiology and Pharmacology - Acetazolamide for people at risk or with rapid ascent planned.
Respiratory: Sleep and Breathing (Complete) - Acetazolamide | Prevention of acute mountain sickness; tingling, frequent urination; avoid in sulfonamide allergy (caution).
Respiratory: Sleep and Breathing (Complete) - Idiopathic intracranial hypertension - usually young women with obesity; headache, papilloedema, visual loss, sixth nerve palsy; normal imaging with a high opening pressure; weight loss, acetazolamide; urgent ophthalmology if vision is threatened.
Neurology: Anatomy, Physiology and Pharmacology - Acetazolamide - lowers CSF production (side effects: tingling, fatigue, taste change, kidney stones).
Neurology: Headache and Facial Pain
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (3 mentions)
- Respiratory: Sleep and Breathing (Complete) (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Headache and Facial Pain (4 mentions)
- Neurology: Movement Disorders (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (5 mentions)
- Renal: Tubular Inherited Stones (3 mentions)
- Paediatrics: Neurology, bones and joints in children (1 mention)
- Ophthalmology: Anatomy Physiology and Pharmacology (5 mentions)
- Ophthalmology: Red emergencies (4 mentions)
- Ophthalmology: Retinal Visual Loss (2 mentions)
- ID: Tropical and travel medicine (1 mention)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
- Emergency Medicine: Environmental emergencies (2 mentions)
- Acute Medicine: Electrolytes, acid–base, AKI and metabolic emergencies (1 mention)
- Critical care: Admission and organ support (2 mentions)
- Integrated respiratory chapter (2 mentions)
- Integrated paediatrics chapter (1 mention)
- Physiology: Cells, tissues, homeostasis, fluids and acid–base balance (3 mentions)
Acetylcysteine
BNF entry for Acetylcysteine · Stand-alone drug page
Mechanism
Replenishes glutathione and supplies cysteine to detoxify the paracetamol metabolite NAPQI.
Uses
Paracetamol overdose; also used as a mucolytic.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Paracetamol overdose | 150 mg/kg → 50 mg/kg → 100 mg/kg IV | Recheck ALT, INR and paracetamol level at the end. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
This drug is not covered by a dedicated section of the textbook chapters.
Side effects
Anaphylactoid reactions (rash, bronchospasm, hypotension), nausea, flushing, vomiting.
Interactions
No major interactions in standard use.
Special advice
Give by IV infusion on a protocol; anaphylactoid reactions are rate-related; treat by pausing infusion, not stopping permanently; recheck INR, ALT and paracetamol level.
Aciclovir
BNF entry for Aciclovir · Stand-alone drug page
Mechanism
Guanosine analogue phosphorylated by viral thymidine kinase; inhibits viral DNA polymerase.
Uses
Herpes simplex (including encephalitis), varicella-zoster, prophylaxis in immunosuppression.
Dosing
- Encephalitis | IV aciclovir 10 mg/kg 8-hourly within 6 hours; MRI; LP
Neurology: Emergencies - IV aciclovir 10 mg/kg every 8 hours , started within 6 hours of arrival if encephalitis is suspected and results are not available. Use ideal body weight in obesity. Keep the patient well hydrated (it can cause kidney injury).
Neurology: Emergencies - First episode - aciclovir 400 mg three times daily for 5 days (or valaciclovir 500 mg twice daily), started within 5 days or while new lesions are forming; saline bathing, analgesia, topical lidocaine; catheter (suprapubic) for retention.
Gynaecology: Sexual health - Recurrences - self-care; short "episodic" courses (e.g. aciclovir 800 mg three times daily for 2 days).
Gynaecology: Sexual health
4 more dose entries from the chapters
- Oral antiviral within 72 hours of rash onset - aciclovir 800 mg five times a day , valaciclovir or famciclovir for 7 days - for people over 50 , immunocompromised, non-truncal involvement (face, neck, limbs, genitals), moderate or severe pain or rash, or eczema. Ophthalmic and immunocompromised patients - treat even after 72 …
Dermatology: Skin infections and infestations - Aciclovir / valaciclovir / famciclovir | Shingles within 72 hours (aciclovir 800 mg five times daily, 7 days); severe HSV; eczema herpeticum.
Dermatology: Skin infections and infestations - Oral antiviral within 72 hours of rash onset (or later if new lesions are still appearing) - aciclovir 800 mg five times daily or valaciclovir 1 g three times daily for 7 days.
Ophthalmology: Red emergencies - Aciclovir 800 mg five times daily or valaciclovir 1 g three times daily | Herpes zoster ophthalmicus for 7 days, within 72 hours.
Ophthalmology: Red emergencies
Side effects
Nausea, headache; IV: phlebitis, renal impairment (crystal nephropathy), neurological effects.
Interactions
Nephrotoxic drugs and probenecid increase levels; mycophenolate levels may rise.
Special advice
Hydrate well with IV use; dose-adjust in renal impairment; give early in suspected herpes encephalitis.
More from the textbook: uses, cautions and other points
- Look for the cause - missed or stopped antiseizure drugs, alcohol or drug withdrawal, infection (meningitis, encephalitis - aciclovir), stroke or bleed, low sodium, calcium or glucose, overdose (TCAs, isoniazid - pyridoxine), non-epileptic attacks (avoid repeated benzodiazepines if suspected - get senior help).
Neurology: Anatomy, Physiology and Pharmacology - Viral encephalitis - IV aciclovir started immediately on suspicion (kidney toxicity - hydrate, adjust for eGFR).
Neurology: Anatomy, Physiology and Pharmacology - Consider aciclovir if encephalitis is possible.
Neurology: Emergencies - Encephalitis: IV aciclovir within 6 hours.
Neurology: Emergencies - Aciclovir or valaciclovir plus prednisolone .
Neurology: Neuromuscular disease - Aciclovir / valaciclovir | Ramsay Hunt syndrome (with prednisolone).
Neurology: Neuromuscular disease
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Emergencies (5 mentions)
- Neurology: Neuromuscular disease (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Emergencies (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Haematology: Myeloma and Lymphoma (3 mentions)
- Palliative: Symptoms Management (1 mention)
- Paediatrics: Neonatology (2 mentions)
- Paediatrics: Infections in children (12 mentions)
- Obstetrics: Medical Problems (10 mentions)
- Gynaecology: Sexual health (5 mentions)
- Dermatology: Skin basics, eczema and psoriasis (5 mentions)
- Dermatology: Skin infections and infestations (11 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Nose and Throat disorders (1 mention)
- ENT: Emergencies (2 mentions)
- Ophthalmology: Anatomy Physiology and Pharmacology (2 mentions)
- Ophthalmology Basics Cataract Glaucoma (1 mention)
- Ophthalmology: Red emergencies (6 mentions)
- ID: How Infection Happens (5 mentions)
- ID: Sepsis, fever and serious bacterial infections (5 mentions)
- ID: Viral, fungal and parasitic infections (19 mentions)
Activated charcoal
BNF entry for Activated charcoal · Stand-alone drug page
Mechanism
Adsorbs ingested toxins in the gut to reduce absorption.
Uses
Selected recent overdoses of adsorbable agents.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Selected recent overdose | 50 g PO once | Avoid if aspiration risk, corrosives, iron or lithium. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
This drug is not covered by a dedicated section of the textbook chapters.
Side effects
Vomiting, constipation, black stools; aspiration if airway not protected.
Interactions
May reduce absorption of other oral drugs given at the same time.
Special advice
Only if the airway is protected and the agent is adsorbed; ineffective for iron, lithium, alcohols and corrosives; take toxicology advice.
Adalimumab
BNF entry for Adalimumab · Stand-alone drug page
Mechanism
Monoclonal antibody that binds and neutralises TNF-alpha.
Uses
Rheumatoid, psoriatic and juvenile arthritis, ankylosing spondylitis, Crohn disease, ulcerative colitis, psoriasis, uveitis.
Dosing
- Infliximab (IV 5 mg/kg at weeks 0, 2 and 6, then every 8 weeks; subcutaneous versions are available) and adalimumab (subcutaneous).
Gastroenterology: Inflammatory Bowel Disease
Side effects
Infections, injection-site reactions, headache; reactivated TB, demyelination, lupus-like syndrome, heart failure worsening.
Interactions
Avoid with other biologics; live vaccines contraindicated; methotrexate reduces antibody formation.
Special advice
Screen for TB and hepatitis B; check varicella status; stop and seek advice during serious infection; avoid in moderate to severe heart failure.
More from the textbook: uses, cautions and other points
- Infliximab (IV), adalimumab (SC), golimumab (UC) | TNF-alpha | Moderate to severe Crohn's and UC, perianal fistulas; TB reactivation , serious infections, worsens heart failure, demyelination, drug-induced lupus, paradoxical psoriasis, lymphoma (especially with thiopurines); infusion reactions; antibody formation - check drug …
Gastroenterology: Anatomy Physiology Pharmacology - Biosimilars - cheaper versions of infliximab and adalimumab; switching is usually safe.
Gastroenterology: Anatomy Physiology Pharmacology - Adalimumab Subcutaneous | Anti-TNF; self-injected.
Gastroenterology: Inflammatory Bowel Disease - Crohn's - exclusive enteral nutrition (liquid formula only for 6–8 weeks) is first-line induction (as effective as steroids, better for growth); steroids if not suitable; maintenance with azathioprine or methotrexate; anti-TNF (infliximab, adalimumab) for moderate to severe disease; surgery for complications.
Paediatrics: Gastroenterology and surgery in children - Infliximab / adalimumab | Moderate to severe IBD; TB screening first.
Paediatrics: Gastroenterology and surgery in children - Biologics - etanercept, adalimumab (also for uveitis), tocilizumab and anakinra (systemic JIA).
Paediatrics: Neurology, bones and joints in children
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Inflammatory Bowel Disease (2 mentions)
- Paediatrics: Gastroenterology and surgery in children (2 mentions)
- Paediatrics: Neurology, bones and joints in children (2 mentions)
- Dermatology: Skin basics, eczema and psoriasis (2 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (3 mentions)
- Rheumatology: Inflammatory arthritis (4 mentions)
- Rheumatology: Vasculitis, GCA and PMR (2 mentions)
- Ophthalmology: Anatomy Physiology and Pharmacology (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (2 mentions)
- Clinical Immunology: Immune system basics and immunological investigations (2 mentions)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (6 mentions)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (8 mentions)
- Integrated paediatrics chapter (4 mentions)
- Cell Biology: Cell cycle, signalling, cell death and stem cells (2 mentions)
Adenosine
BNF entry for Adenosine · Stand-alone drug page
Mechanism
Activates A1 receptors, causing transient AV nodal block and interrupting re-entrant tachycardia.
Uses
Regular narrow-complex (AV re-entrant) SVT; diagnostic aid in flutter or broad-complex tachycardia.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Regular narrow-complex SVT | 6 mg rapid IV → 12 mg → 18 mg | Avoid in irregular wide-complex tachycardia; flush immediately. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
This drug is not covered by a dedicated section of the textbook chapters.
Side effects
Flushing, chest tightness, dyspnoea, transient asystole or bradycardia, sense of doom.
Interactions
Dipyridamole and theophylline interact (potentiate or antagonise); carbamazepine prolongs block.
Special advice
Give by rapid bolus with a fast flush, with ECG recording; avoid in asthma, high-grade block and pre-excited AF; warn the patient of brief unpleasant symptoms.
Adrenaline
BNF entry for Adrenaline · Stand-alone drug page
Mechanism
Agonist at alpha and beta adrenoceptors: vasoconstriction, bronchodilation, increased cardiac output, mast-cell stabilisation.
Uses
Anaphylaxis, cardiac arrest, severe croup and asthma adjunct, shock (infusion), local anaesthetic additive.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Anaphylaxis / cardiac arrest | Anaphylaxis: 500 microg IM. Arrest: 1 mg IV | Do not confuse 1:1,000 IM with 1:10,000 IV. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
- Shockable rhythms — VF and pulseless VT — defibrillate, CPR for 2 minutes; adrenaline 1 mg and amiodarone 300 mg after the 3rd shock.
Cardiology: Presentations - Non-shockable rhythms — PEA and asystole — CPR, adrenaline 1 mg as soon as possible, then every 3–5 minutes.
Cardiology: Presentations - Cardiac arrest - VF/pulseless VT | CPR; shock; 2 minutes CPR between shocks; adrenaline 1 mg and amiodarone 300 mg after the 3rd shock
Cardiology: Cardiology Emergencies - Cardiac arrest - PEA/asystole | CPR; adrenaline 1 mg as soon as possible, then every 3–5 minutes; find a reversible cause
Cardiology: Cardiology Emergencies
4 more dose entries from the chapters
- Immediate defibrillation and ALS: adrenaline 1 mg and amiodarone 300 mg after the third shock.
Cardiology: Ischaemic Heart Disease (ACS) › 1.26 Arrhythmias After MI - Asystole: CPR and the non-shockable ALS pathway, with adrenaline 1 mg IV as soon as possible and every 3–5 minutes; treat the 4 Hs and 4 Ts. Consider pacing if P waves are present (ventricular standstill).
Cardiology: Ischaemic Heart Disease (ACS) › 1.26 Arrhythmias After MI - Adrenaline: 1 mg IV/IO after the third shock for shockable arrest, then every 3–5 min.
Cardiology: Cardiac Arrhythmias › 5.23 Ventricular Fibrillation and Pulseless VT - Treatment: CPR, oxygenation/ventilation, IV/IO access and adrenaline 1 mg as soon as possible then every 3–5 min.
Cardiology: Cardiac Arrhythmias › 5.24 PEA and Asystole
Side effects
Tachycardia, hypertension, arrhythmias, anxiety, tremor, hyperglycaemia, hypokalaemia.
Interactions
Beta-blockers may blunt effect and cause hypertension; tricyclics and MAOIs potentiate pressor effect.
Special advice
Anaphylaxis is IM into the anterolateral thigh; do not mix 1 in 1000 and 1 in 10,000 strengths; repeat as the protocol says.
More from the textbook: uses, cautions and other points
- Contractility (inotropy) - the strength of contraction at a given preload; increased by sympathetic stimulation and inotropes (dobutamine, adrenaline, milrinone, digoxin); reduced by beta-blockers, rate-limiting calcium channel blockers, ischaemia, acidosis and hypoxia.
Cardiology: Anatomy Physiology and Pharmacology - Adrenaline | Beta-1, beta-2 and alpha-1 - rate, contractility and vasoconstriction | Cardiac arrest, anaphylaxis, refractory shock
Cardiology: Anatomy Physiology and Pharmacology - Distributive | Vasodilatation — sepsis, anaphylaxis, neurogenic | Treat the cause (antibiotics, adrenaline), fluids, vasopressors
Cardiology: Presentations - Arrest | VF/pVT — shock; PEA/asystole — adrenaline; 4 Hs and 4 Ts
Cardiology: Presentations - Below 30°C: Up to 3 shocks only, and withhold adrenaline , until warmer.
Cardiology: Cardiology Emergencies - 30–35°C: Double the interval between adrenaline doses (every 6–10 minutes).
Cardiology: Cardiology Emergencies
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Presentations (6 mentions)
- Cardiology: Cardiology Emergencies (16 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (3 mentions)
- Cardiology: Cardiac Arrhythmias (5 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Respiratory: Emergencies (15 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (5 mentions)
- Endocrinology: Diabetes (1 mention)
- Endocrinology: Emergencies (2 mentions)
- Endocrinology: Adrenal Disease (4 mentions)
- Endocrinology: Thyroid disease (2 mentions)
- Endocrinology: NETS and Hypoglycaemia (1 mention)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Haematology: Emergencies (1 mention)
- Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia (1 mention)
- Haematology: Haemoglobinopathies and Transfusion (2 mentions)
- Oncology: Emergencies (2 mentions)
- Palliative: Symptoms Management (1 mention)
- Paediatrics: Respiratory and heart problems in children (5 mentions)
- Paediatrics: Growth, development and nutrition (2 mentions)
- Paediatrics: Neonatology (2 mentions)
- Obstetrics: Obstetrics: Emergencies (2 mentions)
- Dermatology: Skin lesions and skin cancer (1 mention)
Alendronic acid
BNF entry for Alendronic acid · Stand-alone drug page
Mechanism
Bisphosphonate that binds bone and inhibits osteoclast-mediated resorption.
Uses
Osteoporosis prevention and treatment, including glucocorticoid-induced.
Dosing
- Treat bone pain from active Paget's with a bisphosphonate. Zoledronic acid 5 mg IV as a single infusion is most effective, often giving years of remission. Ensure vitamin D is replete beforehand. Alternatives are oral risedronate or alendronate.
Endocrinology: Bone Medicine - Alendronic acid (osteoporosis) | 70 mg orally once weekly. Take fasting with a full glass of water and stay upright for 30 minutes. Avoid if CrCl is below 35 mL/min or with oesophageal disease.
Endocrinology: Bone Medicine
Side effects
Oesophagitis, dyspepsia, abdominal pain, musculoskeletal pain; rarely osteonecrosis of the jaw and atypical femoral fracture.
Interactions
Calcium, antacids and food reduce absorption; NSAIDs increase GI irritation.
Special advice
Take fasting with a full glass of water, upright for at least 30 minutes; correct calcium and vitamin D; dental check; avoid if oesophageal disorder or low eGFR below threshold.
More from the textbook: uses, cautions and other points
- Avoid if eGFR is under 35 (alendronate). Review the need after 5 years (consider a drug holiday).
Endocrine: Anatomy Physiology and Pharmacology - Alendronic acid | Upright 30 min with water; oesophagitis, jaw osteonecrosis, atypical femoral fractures.
Endocrine: Anatomy Physiology and Pharmacology - High risk: Oral bisphosphonate (alendronic acid or risedronate) first-line. If not tolerated, unsuitable or ineffective: IV zoledronic acid or denosumab. HRT is an option in younger postmenopausal women.
Endocrinology: Bone Medicine - 💡 Clinical Pearl: Many "treatment failures" on alendronate are actually taking it wrongly - with breakfast, tea or calcium. Check how the patient takes it before switching.
Endocrinology: Bone Medicine - Bisphosphonates — alendronic acid (weekly), risedronate, IV zoledronic acid (yearly) | Bind hydroxyapatite; taken up by osteoclasts → inhibit farnesyl pyrophosphate synthase → osteoclast apoptosis — anti-resorptive | Oral — take fasting with a full glass of water, sit upright 30 minutes ( oesophagitis ); avoid if eGFR under 35; …
Rheumatology Anatomy Physiology Pharmacology - Thigh pain and transverse femoral fracture after 8 years of alendronate | Atypical femoral fracture
Rheumatology Anatomy Physiology Pharmacology
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (3 mentions)
- Endocrinology: Bone Medicine (12 mentions)
- Rheumatology Anatomy Physiology Pharmacology (2 mentions)
- Rheumatology: assessment, investigations and drugs (1 mention)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (3 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)
Alfuzosin
BNF entry for Alfuzosin · Stand-alone drug page
Mechanism
Selective alpha-1 blocker relaxing prostatic and bladder-neck smooth muscle.
Uses
Lower urinary tract symptoms of benign prostatic hyperplasia.
Dosing
- Medicines : Drug Use Side effects Alpha-blocker (tamsulosin, alfuzosin) First-line for moderate to severe voiding symptoms; works in days Postural hypotension , dizziness, retrograde ejaculation, floppy iris syndrome (tell the eye surgeon before cataract surgery) 5-alpha reductase inhibitor (finasteride, dutasteride) Enlarged …
Surgey: Urology
Side effects
Dizziness, postural hypotension, headache, fatigue; intraoperative floppy iris syndrome.
Interactions
Additive hypotension with other antihypertensives and PDE5 inhibitors; avoid with strong CYP3A4 inhibitors.
Special advice
First-dose hypotension, so take at night; tell eye surgeon before cataract surgery.
More from the textbook: uses, cautions and other points
- Alpha-blockers (tamsulosin, alfuzosin, doxazosin) - relax prostate and bladder-neck muscle; work in days; postural hypotension (first dose, falls), dizziness, retrograde ejaculation , floppy iris syndrome during cataract surgery (tell the eye surgeon).
Renal: Anatomy, Physiology and Pharmacology - Alpha-blocker (tamsulosin, alfuzosin) | First-line for moderate to severe voiding symptoms; works in days | Postural hypotension , dizziness, retrograde ejaculation, floppy iris syndrome (tell the eye surgeon before cataract surgery)
Surgey: Urology
Where it is discussed
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Surgey: Urology (2 mentions)
Allopurinol
BNF entry for Allopurinol · Stand-alone drug page
Mechanism
Xanthine oxidase inhibitor reducing uric acid production.
Uses
Gout prevention, tumour lysis prophylaxis, recurrent urate stones.
Dosing
- Azathioprine 2–2.5 mg/kg/day | Maintenance; check TPMT first; FBC and LFT monitoring; pancreatitis, marrow suppression, skin cancer; avoid allopurinol.
Gastroenterology: Inflammatory Bowel Disease - Allopurinol — xanthine oxidase inhibitor — start low (100 mg daily, lower in CKD) and titrate monthly to a target urate under 360 µmol/L (under 300 if tophi or frequent flares); risks — rash, severe cutaneous reactions (SJS/TEN, DRESS — HLA-B*58:01 in Han Chinese, Thai and Korean ancestry); azathioprine and mercaptopurine …
Rheumatology Anatomy Physiology Pharmacology - Allopurinol starting low (e.g. 50–100 mg daily given CKD) and titrating monthly to urate under 360 µmol/L .
Rheumatology Anatomy Physiology Pharmacology - Allopurinol (xanthine oxidase inhibitor) - first-line ; start low (100 mg daily, or lower in CKD) and increase monthly (by 100 mg) according to urate until at target (often 300–600 mg or more; up to 900 mg); check urate monthly while titrating.
Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain
2 more dose entries from the chapters
- Start allopurinol 100 mg daily, increasing by 100 mg every month according to urate (checked monthly) to a target below 360 µmol/L .
Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain - 2. A 62-year-old man started allopurinol 300 mg daily 3 weeks ago for gout. He now has fever, sore red eyes, painful mouth ulcers and dusky skin lesions that are starting to blister on his trunk. Answer: Stevens–Johnson syndrome / toxic epidermal necrolysis.
Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy
Side effects
Rash, GI upset; rarely severe hypersensitivity (HLA-B*58:01), hepatitis, marrow suppression.
Interactions
Azathioprine and mercaptopurine toxicity rises (reduce doses); ampicillin rash more likely.
Special advice
Do not start in an acute attack; start low and titrate with serum urate; cover with colchicine or NSAID when starting; stop at first rash.
More from the textbook: uses, cautions and other points
- Allopurinol blocks xanthine oxidase, which breaks down thiopurines → dangerous toxicity - avoid, or use only with a specialist dose reduction (about a quarter of the dose).
Gastroenterology: Anatomy Physiology Pharmacology - Azathioprine / mercaptopurine | Check TPMT; marrow suppression, pancreatitis, skin cancer; avoid allopurinol.
Gastroenterology: Anatomy Physiology Pharmacology - Interaction: Allopurinol raises thiopurine levels dangerously. It is sometimes used deliberately with a quarter-dose thiopurine, under specialist care only.
Gastroenterology: Inflammatory Bowel Disease - Check TPMT before thiopurines; never combine with allopurinol without specialist dose reduction.
Gastroenterology: Inflammatory Bowel Disease - Mixed | Carbamazepine, phenytoin, sulfonamides, allopurinol
Gastroenterology: Liver disease - Aciclovir (confusion, crystals), baclofen (encephalopathy), colchicine, allopurinol (start low), methotrexate, sotalol, spironolactone (potassium), nitrofurantoin, bisphosphonates.
Renal: Anatomy, Physiology and Pharmacology
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (7 mentions)
- Gastroenterology: Inflammatory Bowel Disease (3 mentions)
- Gastroenterology: Liver disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (4 mentions)
- Renal: Chronic Kidney Disease (2 mentions)
- Renal: Tubular Inherited Stones (2 mentions)
- Renal: Dialysis and Transplant (5 mentions)
- Haematology: Anatomy Physiology and Pharmacology (5 mentions)
- Haematology: Emergencies (1 mention)
- Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia (3 mentions)
- Haematology: Myeloma and Lymphoma (3 mentions)
- Oncology: Emergencies (2 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (10 mentions)
- Rheumatology Anatomy Physiology Pharmacology (7 mentions)
- Rheumatology: assessment, investigations and drugs (4 mentions)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (16 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (4 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (4 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (9 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Clinical Immunology: Immune system basics and immunological investigations (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (2 mentions)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (4 mentions)
- Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics (1 mention)
Alteplase
BNF entry for Alteplase · Stand-alone drug page
Mechanism
Recombinant tissue plasminogen activator converting plasminogen to plasmin to lyse fibrin.
Uses
Acute ischaemic stroke, STEMI where PCI unavailable, massive PE with haemodynamic compromise.
Dosing
- High-risk PE: systemic thrombolysis - e.g. alteplase 10 mg IV bolus over 1–2 minutes, then 90 mg over 2 hours (maximum 1.5 mg/kg if under 65 kg). In cardiac arrest, alteplase 50 mg bolus and continue CPR for 60–90 minutes.
Cardiology: Cardiology Emergencies - Alteplase High-risk PE | 10 mg IV bolus, then 90 mg over 2 hours. In arrest: 50 mg bolus, continue CPR 60–90 minutes.
Cardiology: Cardiology Emergencies - Alteplase (accelerated 90-minute regimen): 15 mg IV bolus, then 0.75 mg/kg over 30 minutes (max 50 mg), then 0.5 mg/kg over 60 minutes (max 35 mg); total max 100 mg.
Cardiology: Ischaemic Heart Disease (ACS) › 1.21 STEMI: Fibrinolysis - Alteplase 0.9 mg/kg (maximum 90 mg): 10% as a bolus, the rest over 60 minutes. Or
Neurology: Stroke Emergencies
1 more dose entries from the chapters
- Alteplase Ischaemic stroke | 0.9 mg/kg (maximum 90 mg): 10% bolus, rest over 60 minutes; within 4.5 hours.
Neurology: Stroke Emergencies
Side effects
Bleeding (including intracranial), hypotension, angioedema, reperfusion arrhythmias.
Interactions
Anticoagulants and antiplatelets increase bleeding risk.
Special advice
Strict eligibility and contraindication checks; time window matters; neurological and BP monitoring afterwards.
More from the textbook: uses, cautions and other points
- Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
Cardiology: Anatomy Physiology and Pharmacology - Mechanism - recombinant tissue plasminogen activators ( alteplase , tenecteplase ) convert plasminogen to plasmin , which dissolves fibrin clot.
Cardiology: Anatomy Physiology and Pharmacology - High-risk PE | Systemic thrombolysis (alteplase); heparin; consider embolectomy
Cardiology: Cardiology Emergencies - Systemic thrombolysis (alteplase) — unless contraindicated.
Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease - Other drugs - gliptins, sacubitril/valsartan, tPA (alteplase).
Respiratory: Emergencies - Alteplase / tenecteplase | Thrombolysis within 4.5 hours; haemorrhage; BP under 185/110; no antithrombotics for 24 hours.
Neurology: Anatomy, Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Cardiology Emergencies (3 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease (1 mention)
- Respiratory: Emergencies (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Stroke Emergencies (5 mentions)
- Haematology: Anatomy Physiology and Pharmacology (3 mentions)
- Haematology: Emergencies (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- ENT: Emergencies (1 mention)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (2 mentions)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Acute Medicine: Acute chest pain, breathlessness, collapse and blood gases (1 mention)
- Acute Medicine: The acute medical take (1 mention)
- Clinical imaging: Neuroimaging — head, brain and spine (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (1 mention)
- Integrated cardiology chapter (1 mention)
- Integrated respiratory chapter (1 mention)
- Pathology: Haemodynamic disorders, thrombosis, embolism and atherosclerosis (1 mention)
Amikacin
BNF entry for Amikacin · Stand-alone drug page
Mechanism
Aminoglycoside binding the 30S ribosome to inhibit bacterial protein synthesis.
Uses
Serious Gram-negative infections resistant to gentamicin; some mycobacterial infections.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nephrotoxicity, ototoxicity (vestibular and cochlear), neuromuscular blockade.
Interactions
Loop diuretics, ciclosporin and other nephrotoxic agents increase toxicity; neuromuscular blockers potentiated.
Special advice
Monitor levels and renal function; adjust dose for renal impairment; avoid in myasthenia gravis.
More from the textbook: uses, cautions and other points
- MAC: Rifampicin, ethambutol and azithromycin , continued for at least 12 months after cultures become negative. Amikacin (IV or nebulised) for severe or refractory disease.
Respiratory: Infections - Aminoglycosides (gentamicin, amikacin, tobramycin) | Permanent cochlear (high-frequency hearing loss) and vestibular toxicity (gentamicin — oscillopsia, imbalance); risk with high or prolonged levels, renal impairment, loop diuretics; MT-RNR1 m.1555A>G carriers can go deaf after a single dose — monitor levels, shortest course, …
ENT Anatomy Physiology - Aminoglycosides (gentamicin, amikacin, tobramycin) | Permanent hearing loss and balance loss (vestibular toxicity -"oscillopsia" and unsteadiness). Monitor levels; higher risk with the m.1555A>G mitochondrial variant (rapid genetic testing in neonatal units).
ENT: Common Ear disorders - Protein synthesis -30S ribosome | Aminoglycosides (gentamicin, amikacin), tetracyclines (doxycycline)
ID: How Infection Happens - Amikacin | As for gentamicin (different targets) | Ototoxicity, nephrotoxicity
ID: How Infection Happens - Protein synthesis 30S | Aminoglycosides | Gentamicin, amikacin, tobramycin | Gram-negative, synergy in endocarditis; nephro- and ototoxic; concentration-dependent
Microbiology: Diagnostic microbiology, antimicrobials and resistance
Where it is discussed
- Respiratory: Infections (1 mention)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Ear disorders (1 mention)
- ID: How Infection Happens (2 mentions)
- Integrated respiratory chapter (1 mention)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (1 mention)
Amiloride
BNF entry for Amiloride · Stand-alone drug page
Mechanism
Epithelial sodium channel blocker in the distal tubule; potassium-sparing diuretic.
Uses
Adjunct to loop or thiazide diuretics to prevent hypokalaemia; heart failure; lithium-induced diabetes insipidus.
Dosing
- Spironolactone first-line (100 mg rising to 400 mg) - blocks the raised aldosterone; side effects - hyperkalaemia , hyponatraemia , painful gynaecomastia (amiloride is an alternative), AKI.
Gastroenterology: Anatomy Physiology Pharmacology - Spironolactone 100 mg daily, up to 400 mg | First-line diuretic for ascites; high potassium, gynaecomastia (amiloride alternative).
Gastroenterology: Cirrhosis and Transplantation - Loop diuretic - often high doses (e.g. furosemide 80–250 mg), sometimes IV because gut oedema reduces absorption. Add a thiazide or amiloride if needed.
Renal: Glomerular Disease
Side effects
Hyperkalaemia, hyponatraemia, GI upset, rash.
Interactions
ACE inhibitors, ARBs, spironolactone and potassium supplements increase hyperkalaemia risk; lithium levels rise.
Special advice
Monitor potassium and renal function; avoid in hyperkalaemia and severe renal impairment.
More from the textbook: uses, cautions and other points
- Other potassium-sparing diuretics - amiloride (blocks the epithelial sodium channel).
Cardiology: Anatomy Physiology and Pharmacology - Amiloride for lithium-induced AVP resistance.
Endocrinology: Sodium and Water disorders - Amiloride for lithium-induced nephrogenic DI.
Endocrinology: Pituitary Disease - A man on lithium has polyuria. Glucose and calcium are normal; water deprivation leaves the urine dilute, with no response to desmopressin. Answer: Lithium-induced nephrogenic DI. Review lithium with psychiatry; free access to water; consider amiloride or a thiazide.
Endocrinology: Pituitary Disease - Stop for 4–6 weeks: Spironolactone, eplerenone, amiloride and high-dose loop diuretics.
Endocrinology: Adrenal Disease - Amiloride is an alternative.
Endocrinology: Adrenal Disease
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: Sodium and Water disorders (1 mention)
- Endocrinology: Pituitary Disease (2 mentions)
- Endocrinology: Adrenal Disease (5 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Cirrhosis and Transplantation (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (7 mentions)
- Renal: Emergencies (1 mention)
- Renal: Tubular Inherited Stones (4 mentions)
- Renal: Glomerular Disease (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Acute Medicine: Electrolytes, acid–base, AKI and metabolic emergencies (1 mention)
- Physiology: Cells, tissues, homeostasis, fluids and acid–base balance (1 mention)
- Renal physiology, electrolytes, water balance and acid–base control (1 mention)
Amiodarone
BNF entry for Amiodarone · Stand-alone drug page
Mechanism
Class III antiarrhythmic prolonging repolarisation; also blocks sodium and calcium channels and beta receptors.
Uses
VT/VF, AF and flutter rhythm control, supraventricular tachycardias.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| VT / VF | 300 mg IV in arrest; 150 mg over 10 min for stable VT | Monitor QT, BP, bradycardia. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
- Shockable rhythms — VF and pulseless VT — defibrillate, CPR for 2 minutes; adrenaline 1 mg and amiodarone 300 mg after the 3rd shock.
Cardiology: Presentations - Cardiac arrest - VF/pulseless VT | CPR; shock; 2 minutes CPR between shocks; adrenaline 1 mg and amiodarone 300 mg after the 3rd shock
Cardiology: Cardiology Emergencies - Unstable tachycardia | Synchronised DC cardioversion (up to 3 attempts, under sedation); then amiodarone 300 mg IV
Cardiology: Cardiology Emergencies - Immediate defibrillation and ALS: adrenaline 1 mg and amiodarone 300 mg after the third shock.
Cardiology: Ischaemic Heart Disease (ACS) › 1.26 Arrhythmias After MI
4 more dose entries from the chapters
- Pulse but adverse features (shock, syncope, ischaemia, heart failure): synchronised DC cardioversion (up to 3 attempts), then amiodarone 300 mg IV over 10–20 minutes.
Cardiology: Ischaemic Heart Disease (ACS) › 1.26 Arrhythmias After MI - Stable monomorphic VT: RCUK March 2026 favours synchronised cardioversion for most; if sedation risks are high, expert-guided procainamide 10–15 mg/kg IV over 20 min (maximum 1 g), or amiodarone 300 mg IV over 10–60 min followed by 900 mg over 24 h when procainamide unsuitable.
Cardiology: Cardiac Arrhythmias › 5.21 Monomorphic Ventricular Tachycardia - Amiodarone: 300 mg IV/IO after three shocks; 150 mg after five shocks for recurrent/persistent VF/pVT. Lidocaine is an alternative where specified.
Cardiology: Cardiac Arrhythmias › 5.23 Ventricular Fibrillation and Pulseless VT - Amiodarone | Arrhythmia: 200 mg three times daily for 1 week, twice daily for 1 week, then 200 mg daily; monitor TFT, LFT, lungs, eyes and skin.
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses
Side effects
Thyroid dysfunction, pulmonary fibrosis, hepatitis, photosensitivity, corneal deposits, bradycardia, QT prolongation, neuropathy.
Interactions
Raises levels of digoxin, warfarin and simvastatin; avoid other QT-prolonging drugs; additive bradycardia with beta-blockers and verapamil.
Special advice
Baseline then regular TFT, LFT, chest X-ray, ECG; sun protection; central IV line for infusions; very long half-life.
More from the textbook: uses, cautions and other points
- Phase 3 - repolarisation: potassium channels (e.g. hERG) let potassium out - blocked by class III drugs (amiodarone, sotalol) and many QT-prolonging drugs.
Cardiology: Anatomy Physiology and Pharmacology - Conduction block - fibrosis or ischaemia of the conduction system (heart block), drugs (beta-blockers, calcium channel blockers, digoxin, amiodarone), hyperkalaemia.
Cardiology: Anatomy Physiology and Pharmacology - Unstable tachyarrhythmia (shock, syncope, myocardial ischaemia, heart failure) — synchronised DC cardioversion (up to 3 attempts), then amiodarone.
Cardiology: Presentations - Stable tachyarrhythmia — narrow regular (vagal manoeuvres, adenosine), narrow irregular (AF — rate control), broad regular (VT — amiodarone).
Cardiology: Presentations - Drugs: Beta-blockers, rate-limiting calcium channel blockers (verapamil, diltiazem), digoxin, amiodarone, ivabradine.
Cardiology: Cardiology Emergencies - Amiodarone in critically ill patients or acute heart failure where other drugs are unsuitable.
Cardiology: Cardiology Emergencies
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (15 mentions)
- Cardiology: Presentations (5 mentions)
- Cardiology: Cardiology Emergencies (17 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (4 mentions)
- Cardiology: Cardiac Arrhythmias (14 mentions)
- Cardiology: Cardiomyopathies (9 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (2 mentions)
- Respiratory: Interstitial Lung Disease (4 mentions)
- Respiratory: Lung Cancer (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (3 mentions)
- Endocrinology: Thyroid disease (18 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (4 mentions)
- Gastroenterology: Liver disease (3 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Movement Disorders (1 mention)
- Neurology: Neuromuscular disease (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (3 mentions)
- Haematology: Haemostasis and Thrombosis (1 mention)
- Obstetrics (1 mention)
- Obstetrics: Medical Problems (1 mention)
- Gynaecology: Sexual health (1 mention)
- Dermatology: Skin lesions and skin cancer (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (3 mentions)
- Ophthalmology: Anatomy Physiology and Pharmacology (2 mentions)
Amitriptyline
BNF entry for Amitriptyline · Stand-alone drug page
Mechanism
Tricyclic antidepressant inhibiting serotonin and noradrenaline reuptake; strong antimuscarinic and antihistamine effects.
Uses
Neuropathic pain, migraine prophylaxis, depression, nocturnal enuresis.
Dosing
- Amitriptyline / duloxetine / pregabalin / gabapentin Painful neuropathy | E.g. amitriptyline 10 mg at night, titrated; duloxetine 60 mg daily; pregabalin 75 mg twice daily, titrated. Adjust for renal function and frailty.
Endocrinology: Diabetes - Low-dose tricyclic antidepressants (amitriptyline 5–10 mg at night, increased slowly) as second-line for pain - act as gut "neuromodulators"; SSRIs if TCAs don't help.
Gastroenterology: Anatomy Physiology Pharmacology - Low-dose tricyclic antidepressant (e.g. amitriptyline 10 mg at night).
Gastroenterology: Oesophagus and Stomach - Amitriptyline 10 mg at night | Functional dyspepsia, cyclical vomiting; increase slowly.
Gastroenterology: Oesophagus and Stomach
4 more dose entries from the chapters
- Second line: Low-dose amitriptyline (10 mg at night, increasing to 30–50 mg; the ATLANTIS trial showed benefit in primary care); an SSRI if a tricyclic doesn't help.
Gastroenterology: Bowel Disorders - Amitriptyline 10 mg at night, up to 30–50 mg | IBS second line; drowsiness, dry mouth.
Gastroenterology: Bowel Disorders - Amitriptyline (and nortriptyline) - TCA; start low at night (10 mg); side effects - drowsiness, dry mouth, constipation, urinary retention, weight gain, postural hypotension, QT prolongation ; dangerous in overdose (arrhythmias, seizures); caution in older people and heart disease.
Neurology: Anatomy, Physiology and Pharmacology - Amitriptyline 10 mg at night, increasing to 25–75 mg (off-label) - also helps sleep and tension-type headache.
Neurology: Headache and Facial Pain
Side effects
Dry mouth, constipation, urinary retention, sedation, postural hypotension, weight gain, arrhythmias; dangerous in overdose.
Interactions
Serotonergic drugs and MAOIs risk serotonin syndrome; CYP2D6 inhibitors raise levels; additive sedation and antimuscarinic effects.
Special advice
Start low and increase gradually; caution in older people, cardiac disease and epilepsy; limit supply in suicide risk; avoid abrupt withdrawal.
More from the textbook: uses, cautions and other points
- Offer amitriptyline, duloxetine, gabapentin or pregabalin ; switch to another if one is ineffective or not tolerated.
Endocrinology: Diabetes - Cyclical vomiting syndrome: Stereotyped episodes of vomiting with normal health in between. Linked to migraine. Prevention with amitriptyline; acute treatment with antiemetics and sedation.
Gastroenterology: Oesophagus and Stomach - If negative and still symptomatic: functional dyspepsia - consider low-dose amitriptyline.
Gastroenterology: Oesophagus and Stomach - Low-dose amitriptyline if no improvement; CBT or hypnotherapy.
Gastroenterology: Bowel Disorders - Neuropathic - nerve damage: burning, shooting, electric shock-like , pins and needles, allodynia (pain from light touch) - responds poorly to standard painkillers; use amitriptyline, duloxetine, gabapentin or pregabalin.
Neurology: Anatomy, Physiology and Pharmacology - Propranolol (avoid in asthma), amitriptyline (drowsiness, weight gain, anticholinergic), topiramate (teratogenic - Pregnancy Prevention Programme; reduces the combined pill's effect), candesartan (off-label).
Neurology: Anatomy, Physiology and Pharmacology
Where it is discussed
- Endocrinology: Diabetes (2 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Oesophagus and Stomach (4 mentions)
- Gastroenterology: Bowel Disorders (3 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (5 mentions)
- Neurology: Headache and Facial Pain (8 mentions)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Neurology: Neuromuscular disease (6 mentions)
- Neurology: Dementia and Cognition Disorders (Complete) (1 mention)
- Palliative: Symptoms Management (3 mentions)
- Paediatrics: Neurology, bones and joints in children (1 mention)
- Gynaecology: Pelvic floor ovary and vulva (3 mentions)
- Dermatology: Skin infections and infestations (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (2 mentions)
- ENT: Common Ear disorders (1 mention)
- ID: Viral, fungal and parasitic infections (1 mention)
- Psychiatric emergencies (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (2 mentions)
- Psychiatry: Mood disorders (2 mentions)
- Surgery: Vascular surgery (1 mention)
- Surgey: Urology (1 mention)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (2 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (8 mentions)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (1 mention)
Amlodipine
BNF entry for Amlodipine · Stand-alone drug page
Mechanism
Dihydropyridine calcium channel blocker causing arterial vasodilation.
Uses
Hypertension, stable angina.
Dosing
- Amlodipine (dihydropyridine): 5 mg once daily, increased to 10 mg if needed. Safe to combine with a beta blocker.
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina - Amlodipine | 5 mg daily, increase to 10 mg if needed.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - Amlodipine, diltiazem, verapamil - maximum simvastatin dose 20 mg.
Endocrinology: Lipids and obesity - 1. A 62-year-old with type 2 diabetes has eGFR 41 and ACR 58 mg/mmol (confirmed). She takes metformin 1 g twice daily and amlodipine. BP 148/88. Answer: Diabetic kidney disease, CKD G3b A3.
Renal: Chronic Kidney Disease
1 more dose entries from the chapters
- 1. An 86-year-old woman (CFS 6) is admitted after a fall. She takes: amlodipine 10 mg, ramipril 10 mg, indapamide, doxazosin, atorvastatin, aspirin 75 mg (no history of vascular disease), omeprazole 40 mg (started 6 years ago for dyspepsia), amitriptyline 25 mg (sleep), zopiclone, oxybutynin and gliclazide (HbA1c 49). Standing …
Medicine of the older adult: .Prescribing and deprescribing in older people
Side effects
Ankle oedema, flushing, headache, palpitations, gum hyperplasia.
Interactions
Simvastatin dose cap; strong CYP3A4 inhibitors raise levels; additive hypotension.
Special advice
Oedema is dose-related and not responsive to diuretics; avoid in severe aortic stenosis and acute unstable angina.
More from the textbook: uses, cautions and other points
- Amlodipine | Dihydropyridine CCB; hypertension, angina; ankle oedema.
Cardiology: Anatomy Physiology and Pharmacology - Swollen ankles on amlodipine, normal JVP | Dihydropyridine vasodilator oedema (diuretics don't help)
Cardiology: Anatomy Physiology and Pharmacology - Ankle swelling - both legs (heart failure, nephrotic syndrome, liver disease, drugs - amlodipine and other calcium channel blockers, NSAIDs, steroids, pregabalin) versus one leg (DVT, cellulitis, Baker's cyst, venous obstruction). Ask about weight gain (fluid), abdominal swelling (ascites), and swelling of the sacrum in …
Cardiology: History and Examination - Ankle swelling after starting amlodipine | Calcium channel blocker oedema
Cardiology: History and Examination - Drugs — calcium channel blockers (amlodipine), NSAIDs, steroids, pioglitazone.
Cardiology: Presentations - Ankle swelling after starting amlodipine; normal JVP | Drug-induced oedema
Cardiology: Presentations
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: History and Examination (2 mentions)
- Cardiology: Presentations (2 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (5 mentions)
- Cardiology: Hypertension, Blood Pressure and Prevention (1 mention)
- Endocrinology: Lipids and obesity (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Obstetrics: Medical Problems (1 mention)
- Rheumatology: Connective tissue diseases (1 mention)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (2 mentions)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (5 mentions)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Integrated cardiology chapter (6 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (2 mentions)
- Physiology: Cells, tissues, homeostasis, fluids and acid–base balance (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)
Amoxicillin
BNF entry for Amoxicillin · Stand-alone drug page
Mechanism
Aminopenicillin binding penicillin-binding proteins to inhibit bacterial cell-wall synthesis.
Uses
Respiratory, ENT, urinary and dental infections, H. pylori regimens, listeria.
Dosing
- Low | Amoxicillin 500 mg three times daily (doxycycline or clarithromycin)
Respiratory: Emergencies - Moderate | Amoxicillin, plus clarithromycin 500 mg twice daily if atypical infection suspected (doxycycline or clarithromycin)
Respiratory: Emergencies - First line: PPI + amoxicillin 1 g + clarithromycin 500 mg or metronidazole 400 mg .
Gastroenterology: Oesophagus and Stomach - Second line: PPI + amoxicillin 1 g + whichever of clarithromycin or metronidazole was not used first. If both have been used - PPI + amoxicillin + tetracycline (or levofloxacin).
Gastroenterology: Oesophagus and Stomach
4 more dose entries from the chapters
- Bacterial meningitis | Blood cultures; ceftriaxone 2 g IV (plus amoxicillin if Listeria risk) within 1 hour; dexamethasone
Neurology: Emergencies - Add amoxicillin 2 g IV every 4 hours for Listeria risk: aged 60 or over, immunocompromised, pregnancy, diabetes or alcohol dependence.
Neurology: Emergencies - IV antibiotics - e.g. ceftriaxone 80 mg/kg (cefotaxime plus amoxicillin under 3 months), per local policy.
Paediatrics: Infections in children - Pregnancy, breastfeeding or doxycycline unsuitable - azithromycin 1 g then 500 mg daily for 2 days (or erythromycin, amoxicillin).
Gynaecology: Sexual health
Side effects
Rash, diarrhoea, nausea; rarely severe hypersensitivity, C. difficile infection.
Interactions
Methotrexate toxicity risk; rash common in infectious mononucleosis; may increase warfarin effect.
Special advice
Check penicillin allergy history; adjust in renal impairment; broad-spectrum so consider C. difficile risk.
More from the textbook: uses, cautions and other points
- Amoxicillin | Not routine endocarditis prophylaxis. Any prophylaxis in high-risk patients follows individual assessment and UK implementation advice.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table - Amoxicillin Endocarditis prophylaxis | Not routine (NICE CG64). Individual decisions for high-risk patients only.
Cardiology: Congenital heart disease › 6.36 Drug Reference Table - Low severity - amoxicillin for 5 days (doxycycline or clarithromycin if penicillin-allergic).
Respiratory: Anatomy, Physiology and Pharmacology - Moderate - amoxicillin plus clarithromycin (atypical cover).
Respiratory: Anatomy, Physiology and Pharmacology - Antibiotics if sputum is purulent or there are signs of pneumonia (NICE NG114): e.g. amoxicillin, doxycycline or clarithromycin orally for 5 days; IV options if severe.
Respiratory: Emergencies - Low severity: Amoxicillin.
Respiratory: Infections
Where it is discussed
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Congenital heart disease (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (4 mentions)
- Respiratory: Emergencies (4 mentions)
- Respiratory: Infections (3 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Oesophagus and Stomach (5 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Emergencies (5 mentions)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Tubular Inherited Stones (3 mentions)
- Renal: Dialysis and Transplant (1 mention)
- Haematology: Anaemia (1 mention)
- Paediatrics: Respiratory and heart problems in children (3 mentions)
- Paediatrics: Neonatology (3 mentions)
- Paediatrics: Kidneys, urinary tract and hormones in children (1 mention)
- Paediatrics: Infections in children (8 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Medical Problems (1 mention)
- Gynaecology: Sexual health (1 mention)
- Dermatology: Skin infections and infestations (3 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (3 mentions)
- Rheumatology: Vasculitis, GCA and PMR (1 mention)
- ENT Anatomy Physiology (5 mentions)
- ENT: Common Ear disorders (4 mentions)
Anastrozole
BNF entry for Anastrozole · Stand-alone drug page
Mechanism
Non-steroidal aromatase inhibitor lowering oestrogen synthesis.
Uses
Hormone receptor-positive breast cancer in postmenopausal women.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hot flushes, arthralgia, bone loss, vaginal dryness, fatigue.
Interactions
Do not combine with tamoxifen or oestrogens.
Special advice
Baseline bone density and vitamin D/calcium advice; not for premenopausal women unless ovarian suppression.
More from the textbook: uses, cautions and other points
- Chemoprevention (tamoxifen or anastrozole for women at moderate or high breast cancer risk; aspirin in Lynch syndrome).
Oncology: Principles - Anastrozole / letrozole | Joint pain, osteoporosis (DEXA, bisphosphonate).
Oncology: Principles - Anastrozole / letrozole | Postmenopausal ER-positive breast cancer; joint pain, bone loss; also prevention in high-risk women.
Oncology: Breast and Gynae Cancers - Options for high-risk women - earlier and more frequent screening (annual MRI from 30 for BRCA carriers, with mammography from 40), chemoprevention (tamoxifen or raloxifene before menopause/after; anastrozole after menopause), risk-reducing mastectomy (reduces risk by about 90% or more) and risk-reducing salpingo-oophorectomy.
Surgey: Breast and endocrine surgery - Risk management for moderate or high risk without a known variant - enhanced mammographic surveillance from 40 (annual), MRI in selected high-risk women, chemoprevention - tamoxifen (premenopausal) or anastrozole (postmenopausal) for 5 years.
Clinical Genetics: Cancer genetics and inherited cardiovascular conditions
Where it is discussed
- Oncology: Principles (2 mentions)
- Oncology: Breast and Gynae Cancers (1 mention)
- Surgey: Breast and endocrine surgery (1 mention)
- Clinical Genetics: Cancer genetics and inherited cardiovascular conditions (1 mention)
Apixaban
BNF entry for Apixaban · Stand-alone drug page
Mechanism
Direct factor Xa inhibitor.
Uses
Stroke prevention in non-valvular AF, treatment and prevention of VTE.
Dosing
- Apixaban | AF with non-mechanical valve disease: 5 mg twice daily; 2.5 mg twice daily only if two of: age ≥80, weight ≤60 kg, creatinine ≥133 µmol/L. Never for mechanical valves.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table - Apixaban AF stroke prevention | Usually 5 mg orally twice daily; 2.5 mg twice daily if at least two of age ≥80 years, weight ≤60 kg, creatinine ≥133 micromol/L, or for NVAF with CrCl 15–29 mL/min. Check product information.
Cardiology: Cardiac Arrhythmias › 5.42 Two-Column Drug and Dose Table - Apixaban | AF: 5 mg twice daily; 2.5 mg twice daily if two of: age ≥80, weight ≤60 kg, creatinine ≥133 µmol/L.
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses - Apixaban 10 mg twice daily for 7 days, then 5 mg twice daily.
Respiratory: Emergencies
4 more dose entries from the chapters
- Apixaban PE | 10 mg twice daily for 7 days, then 5 mg twice daily.
Respiratory: Emergencies - Apixaban VTE treatment | 10 mg twice daily for 7 days, then 5 mg twice daily; after 6 months, 2.5 mg twice daily can be used for extended prevention.
Respiratory: Pulmonary Vascular Disease - Discuss long-term anticoagulation (e.g. continuing apixaban, possibly at the reduced 2.5 mg dose after 6 months).
Respiratory: Pulmonary Vascular Disease - 1. A 72-year-old on apixaban for AF needs a colonoscopy with removal of a 25 mm polyp. Creatinine clearance is 60 mL/min. Answer: High-risk procedure.
Gastroenterology: Investigations
Side effects
Bleeding, anaemia, nausea; rarely hepatic injury.
Interactions
Strong CYP3A4 and P-gp inhibitors or inducers alter levels; avoid with other anticoagulants and caution with antiplatelets.
Special advice
Dose reduce by age, weight and renal function criteria; andexanet alfa is the reversal agent; avoid in mechanical valves and antiphospholipid syndrome.
More from the textbook: uses, cautions and other points
- Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
Cardiology: Anatomy Physiology and Pharmacology - Factor Xa inhibitors - apixaban (twice daily), rivaroxaban (once daily with food in AF), edoxaban (once daily).
Cardiology: Anatomy Physiology and Pharmacology - Lifelong warfarin (VKA) . DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) must never be used - they caused excess valve thrombosis and stroke in trials.
Cardiology: Valvular heart disease › 4.34 Anticoagulation and Valves - A patient with a mechanical mitral valve and AF asks to switch from warfarin to apixaban. Answer: No. DOACs are contraindicated with mechanical valves; continue warfarin to the target INR (typically about 3.0 for mitral).
Cardiology: Valvular heart disease › 4.43 Exam-style Scenarios - First line (NICE NG158) for confirmed proximal DVT or PE — apixaban or rivaroxaban (no LMWH lead-in needed).
Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease - First-line treatment | Apixaban or rivaroxaban
Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Valvular heart disease (3 mentions)
- Cardiology: Cardiac Arrhythmias (1 mention)
- Cardiology: Cardiomyopathies (1 mention)
- Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease (4 mentions)
- Respiratory: Emergencies (3 mentions)
- Respiratory: Pulmonary Vascular Disease (4 mentions)
- Respiratory: Sleep and Breathing (Complete) (1 mention)
- Endocrinology: Pituitary Disease (1 mention)
- Gastroenterology: Gastroenterology Emergencies (Complete) (4 mentions)
- Gastroenterology: Investigations (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Stroke Emergencies (2 mentions)
- Renal: Chronic Kidney Disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (5 mentions)
- Haematology: Emergencies (1 mention)
- Haematology: Haemostasis and Thrombosis (13 mentions)
- Oncology: Emergencies (2 mentions)
- ENT: Emergencies (2 mentions)
- Ophthalmology: Red emergencies (1 mention)
- Surgery: Surgical principles and perioperative care (5 mentions)
- Surgery: Major trauma and burns (1 mention)
- Surgery: Acute abdomen and emergency general surgery (1 mention)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (4 mentions)
Aripiprazole
BNF entry for Aripiprazole · Stand-alone drug page
Mechanism
Partial agonist at dopamine D2 and serotonin 5-HT1A, antagonist at 5-HT2A.
Uses
Schizophrenia, mania in bipolar disorder, adjunct in depression.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Akathisia, insomnia, nausea, restlessness; low prolactin and metabolic effect compared with others; impulse-control problems.
Interactions
CYP2D6 and CYP3A4 inhibitors increase levels; inducers lower levels.
Special advice
Monitor weight, glucose and lipids; ask about impulsive behaviours such as gambling.
More from the textbook: uses, cautions and other points
- Stop the drug if possible - recovery can take months. If an antipsychotic is essential, switch to one with lower risk (quetiapine, clozapine, aripiprazole).
Neurology: Movement Disorders - Drugs for disabling tics: aripiprazole , clonidine or guanfacine (also helps ADHD), risperidone.
Neurology: Movement Disorders - Tourette syndrome - multiple motor tics and at least one vocal tic for over a year, starting before 18; associated with ADHD, OCD and anxiety. Education, behavioural therapy (habit reversal, CBIT); medication (aripiprazole, clonidine) if severe.
Paediatrics: Neurology, bones and joints in children - Severe or refractory - specialist services; antipsychotic augmentation (e.g. aripiprazole, risperidone); deep brain stimulation (research).
Psychiatry: Anxiety, stress and somatic disorders - Behaviour that challenges - look for pain, illness, sensory overload or anxiety first; positive behaviour support; antipsychotics (risperidone or aripiprazole) only short term for severe aggression, with specialist monitoring.
Psychiatry: Safeguarding - Risperidone / aripiprazole | Short-term for severe aggression in autism or learning disability (specialist); weight gain, metabolic monitoring, prolactin (risperidone); tics (aripiprazole).
Psychiatry: Safeguarding
Where it is discussed
- Neurology: Movement Disorders (3 mentions)
- Paediatrics: Neurology, bones and joints in children (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (1 mention)
- Psychiatry: Safeguarding (2 mentions)
- Psychiatry: Mood disorders (3 mentions)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Psychiatry: Psychosis and schizophrenia (10 mentions)
- Integrated paediatrics chapter (1 mention)
Aspirin
BNF entry for Aspirin · Stand-alone drug page
Mechanism
Irreversibly inhibits cyclooxygenase-1, reducing thromboxane A2 and platelet aggregation.
Uses
Secondary prevention in ischaemic heart disease and stroke, ACS, TIA, analgesia and antipyresis at higher doses.
Dosing
- Aspirin | Irreversible COX-1 inhibitor; ACS 300 mg then 75 mg; GI bleeding - PPI if at risk.
Cardiology: Anatomy Physiology and Pharmacology - STEMI | Aspirin 300 mg; call the PPCI centre; primary PCI within 120 minutes, or fibrinolysis
Cardiology: Cardiology Emergencies - Aspirin 300 mg chewed or dispersed - as soon as possible.
Cardiology: Cardiology Emergencies - Aspirin: 75 mg daily (consider, balancing bleeding risk).
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina
4 more dose entries from the chapters
- Aspirin 300 mg orally (chewed or dispersed) as soon as ACS is suspected, unless there is true allergy or suspected dissection.
Cardiology: Ischaemic Heart Disease (ACS) › 1.19 Immediate Management - No other indication for anticoagulation: Single antiplatelet therapy (usually aspirin 75 mg daily). Routine dual antiplatelet therapy is not needed.
Cardiology: Valvular heart disease › 4.34 Anticoagulation and Valves - Aspirin | 75 mg daily as single antiplatelet therapy after TAVI if no anticoagulation is needed.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table - Aspirin Fontan / after device closure (adult) | 75 mg daily, per specialist plan.
Cardiology: Congenital heart disease › 6.36 Drug Reference Table
Side effects
Dyspepsia, GI bleeding, bronchospasm in sensitive asthmatics, tinnitus in overdose; Reye syndrome in children.
Interactions
Anticoagulants, SSRIs and NSAIDs increase bleeding; interacts with ibuprofen antiplatelet effect.
Special advice
Avoid under 16 years; PPI cover for those at GI risk; do not start routine primary prevention in most older adults.
More from the textbook: uses, cautions and other points
- Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
Cardiology: Anatomy Physiology and Pharmacology - Side effects - GI bleeding and ulcers (add a PPI if at risk), aspirin-sensitive asthma, Reye's syndrome in under 16s.
Cardiology: Anatomy Physiology and Pharmacology - Allergies - including contrast and aspirin.
Cardiology: History and Examination - Aspirin if ACS likely and no contraindication; analgesia; consider dissection and PE.
Cardiology: Presentations - Benzodiazepines first; GTN; aspirin if ACS; cooling. Avoid beta-blockers in the acute phase; sodium bicarbonate for broad QRS.
Cardiology: Cardiology Emergencies - STEMI: aspirin and primary PCI within 120 minutes. Always consider dissection before thrombolysis.
Cardiology: Cardiology Emergencies
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (4 mentions)
- Cardiology: History and Examination (1 mention)
- Cardiology: Presentations (1 mention)
- Cardiology: Cardiology Emergencies (7 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (20 mentions)
- Cardiology: Valvular heart disease (2 mentions)
- Cardiology: Cardiac Arrhythmias (2 mentions)
- Cardiology: Pericardial Disease (3 mentions)
- Cardiology: Congenital heart disease (2 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (2 mentions)
- Respiratory: Airways Disease (3 mentions)
- Endocrinology: Diabetes (4 mentions)
- Endocrinology: Emergencies (2 mentions)
- Endocrinology: Thyroid disease (3 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (4 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (3 mentions)
- Gastroenterology: Investigations (5 mentions)
- Gastroenterology: Oesophagus and Stomach (5 mentions)
- Gastroenterology: Bowel Disorders (3 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (8 mentions)
- Neurology: Stroke Emergencies (11 mentions)
- Neurology: Headache and Facial Pain (3 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Chronic Kidney Disease (2 mentions)
- Renal: Tubular Inherited Stones (3 mentions)
Atenolol
BNF entry for Atenolol · Stand-alone drug page
Mechanism
Cardioselective (beta-1) adrenoceptor antagonist, water soluble.
Uses
Hypertension, angina, arrhythmia rate control, post-MI.
Dosing
- Atenolol: 100 mg daily (once daily or 50 mg twice daily).
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina
Side effects
Bradycardia, fatigue, cold extremities, bronchospasm, masking of hypoglycaemia, sleep disturbance.
Interactions
Verapamil and diltiazem risk bradycardia or heart block; clonidine rebound hypertension if stopped first.
Special advice
Renally cleared so reduce dose in renal impairment; avoid abrupt withdrawal; caution in asthma and peripheral vascular disease.
More from the textbook: uses, cautions and other points
- Beta-1 | Heart - faster rate (chronotropy), stronger contraction (inotropy), faster AV conduction; kidney - renin release | Agonist: dobutamine. Blockers: bisoprolol, metoprolol, atenolol
Cardiology: Anatomy Physiology and Pharmacology - Cardioselective (beta-1) - bisoprolol, metoprolol, atenolol, nebivolol.
Cardiology: Anatomy Physiology and Pharmacology - HCM in pregnancy: Usually well tolerated if asymptomatic; continue beta blockers (avoid atenolol); avoid dehydration and haemorrhage-related hypovolaemia at delivery.
Cardiology: Cardiomyopathies › 3.56 Pregnancy, Exercise, Driving and Family - Beta blockade only after adequate alpha blockade , to control tachycardia (e.g. propranolol or atenolol).
Endocrinology: Adrenal Disease - Propranolol / atenolol Phaeochromocytoma tachycardia | Only after adequate alpha blockade.
Endocrinology: Adrenal Disease - Removed - gentamicin, many penicillins and cephalosporins, vancomycin (partly, with high-flux), lithium , metformin , salicylates , toxic alcohols (methanol, ethylene glycol), atenolol, gabapentin.
Renal: Anatomy, Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Cardiology: Cardiomyopathies (1 mention)
- Endocrinology: Adrenal Disease (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Integrated cardiology chapter (2 mentions)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)
Atorvastatin
BNF entry for Atorvastatin · Stand-alone drug page
Mechanism
HMG-CoA reductase inhibitor lowering hepatic cholesterol synthesis and increasing LDL receptors.
Uses
Primary and secondary cardiovascular prevention, hypercholesterolaemia.
Dosing
- Primary prevention (QRISK3 10% or more) - atorvastatin 20 mg ; secondary prevention - atorvastatin 80 mg (NICE NG238).
Cardiology: Anatomy Physiology and Pharmacology - Atorvastatin | HMG-CoA reductase inhibitor; 20 mg primary, 80 mg secondary prevention; LFTs at 0, 3, 12 months; clarithromycin interaction.
Cardiology: Anatomy Physiology and Pharmacology - High-intensity statin (atorvastatin 80 mg).
Cardiology: Cardiology Emergencies - Primary prevention: If QRISK3 is 10% or more, offer atorvastatin 20 mg daily after a shared discussion.
Cardiology: Ischaemic Heart Disease (ACS) › 1.05 Risk Factors and Risk Assessment
4 more dose entries from the chapters
- High-intensity statin: Atorvastatin 80 mg daily.
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina - Type 2: Atorvastatin 20 mg if QRISK3 is 10% or more.
Endocrinology: Diabetes - Type 1: Offer atorvastatin 20 mg if aged over 40, diabetes for more than 10 years, nephropathy, or other cardiovascular risk factors.
Endocrinology: Diabetes - QRISK3 of 10% or more: Offer atorvastatin 20 mg after discussing lifestyle.
Endocrinology: Lipids and obesity
Side effects
Myalgia, raised ALT, GI upset; rarely myopathy, rhabdomyolysis, new-onset diabetes.
Interactions
Clarithromycin, azole antifungals and ciclosporin raise levels; grapefruit juice in large amounts; fibrates increase myopathy risk.
Special advice
Baseline lipids and LFT; report unexplained muscle pain; check CK if symptomatic; avoid in pregnancy.
More from the textbook: uses, cautions and other points
- Clarithromycin and erythromycin - pause simvastatin and atorvastatin during the course.
Endocrinology: Lipids and obesity - Grapefruit juice - simvastatin and atorvastatin.
Endocrinology: Lipids and obesity - CK 12,000 and progressive weakness after stopping atorvastatin | Anti-HMGCR necrotising myopathy
Neurology: Neuromuscular disease - 2. A 28-year-old woman with hypertension on ramipril and atorvastatin wants to become pregnant. Answer: Pre-conception medication review.
Obstetrics - CK 8,000 persisting months after stopping atorvastatin | Anti-HMGCR necrotising myopathy
Rheumatology: Connective tissue diseases - Interactions - clarithromycin and erythromycin are strong CYP3A4 inhibitors : simvastatin and atorvastatin (myopathy - pause the statin), warfarin , DOACs, colchicine (dangerous), theophylline, carbamazepine, ciclosporin and tacrolimus , some calcium channel blockers; azithromycin has fewer interactions.
ID: How Infection Happens
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Cardiology Emergencies (1 mention)
- Cardiology: Ischaemic Heart Disease (ACS) (6 mentions)
- Endocrinology: Diabetes (4 mentions)
- Endocrinology: Lipids and obesity (8 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Stroke Emergencies (3 mentions)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Chronic Kidney Disease (4 mentions)
- Obstetrics (1 mention)
- Rheumatology: Connective tissue diseases (1 mention)
- ID: How Infection Happens (2 mentions)
- ID: HIV, viral hepatitis and blood-borne viruses (2 mentions)
- Surgery: Vascular surgery (2 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (4 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (2 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical Immunology: Autoimmunity, autoantibodies and complement (1 mention)
- Clinical Genetics: Cancer genetics and inherited cardiovascular conditions (1 mention)
- Integrated cardiology chapter (6 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (5 mentions)
Atropine
BNF entry for Atropine · Stand-alone drug page
Mechanism
Competitive muscarinic antagonist.
Uses
Symptomatic bradycardia, organophosphate and cholinergic poisoning, antimuscarinic premedication.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Symptomatic bradycardia | 500 microg IV every 3–5 min (max 3 mg) | May not work in high-grade block; prepare pacing. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
This drug is not covered by a dedicated section of the textbook chapters.
Side effects
Dry mouth, blurred vision, tachycardia, urinary retention, confusion, hot dry skin.
Interactions
Additive antimuscarinic effects with tricyclics and antihistamines.
Special advice
May not work in high-grade or infranodal block (prepare pacing); caution in glaucoma and prostatic hypertrophy; in organophosphate poisoning large doses may be needed.
Azathioprine
BNF entry for Azathioprine · Stand-alone drug page
Mechanism
Prodrug of mercaptopurine; purine analogue inhibiting lymphocyte DNA synthesis.
Uses
Immunosuppression in transplantation, autoimmune disease, inflammatory bowel disease, vasculitis.
Dosing
- Thiopurines - azathioprine (2–2.5 mg/kg/day) and mercaptopurine (1–1.5 mg/kg/day):
Gastroenterology: Inflammatory Bowel Disease - Azathioprine 2–2.5 mg/kg/day | Maintenance; check TPMT first; FBC and LFT monitoring; pancreatitis, marrow suppression, skin cancer; avoid allopurinol.
Gastroenterology: Inflammatory Bowel Disease - Prednisolone (e.g. 30–40 mg daily, then reducing), with azathioprine (1–2 mg/kg) added after about 2 weeks once bilirubin falls (check TPMT first).
Gastroenterology: Liver disease - Immunosuppressants compatible with pregnancy — prednisolone (mostly inactivated by the placenta), hydroxychloroquine , azathioprine , sulfasalazine (with folic acid 5 mg), ciclosporin, tacrolimus, most anti-TNF drugs (certolizumab minimal transfer).
Obstetrics
3 more dose entries from the chapters
- … µmol/L (under 300 if tophi or frequent flares); risks — rash, severe cutaneous reactions (SJS/TEN, DRESS — HLA-B*58:01 in Han Chinese, Thai and Korean ancestry); azathioprine and mercaptopurine interaction (xanthine oxidase metabolises them — toxicity).
Rheumatology Anatomy Physiology Pharmacology - 5. A 48-year-old man with chronic tophaceous gout has had flares despite allopurinol 300 mg for a year. His urate is 450 µmol/L. He has a kidney transplant and takes azathioprine. Answer: Uncontrolled gout with a dangerous drug interaction.
Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain - Idiopathic, trauma, steroids, mumps and other viruses, autoimmune, scorpion venom, hypercalcaemia , hypertriglyceridaemia (often over 10 mmol/L), hypothermia, ERCP , drugs (azathioprine, valproate, thiazides, mesalazine, GLP-1 agonists and others), pancreatic cancer.
Surgery: Acute abdomen and emergency general surgery
Side effects
Bone marrow suppression, nausea, hepatotoxicity, infection, skin cancer, pancreatitis.
Interactions
Allopurinol markedly raises toxicity (reduce dose to a quarter); warfarin effect reduced; live vaccines contraindicated.
Special advice
Check TPMT or NUDT15 before starting; regular FBC and LFT; sun protection; avoid in pregnancy unless benefit outweighs risk.
More from the textbook: uses, cautions and other points
- Avoid immunosuppression with steroids and azathioprine in IPF (harmful); steroids and immunosuppressants are used in inflammatory ILDs (e.g. CTD-ILD, hypersensitivity pneumonitis, NSIP).
Respiratory: Anatomy, Physiology and Pharmacology - Prednisolone for significant disease; mycophenolate or azathioprine to spare steroids.
Respiratory: Interstitial Lung Disease - Steroid-sparing: Methotrexate (most used), azathioprine, mycophenolate, leflunomide.
Respiratory: Interstitial Lung Disease - Autoimmune hepatitis - prednisolone (or budesonide) plus azathioprine.
Gastroenterology: Anatomy Physiology Pharmacology - Vascular (sinusoidal obstruction) | Chemotherapy (oxaliplatin), azathioprine, herbal pyrrolizidine alkaloids
Gastroenterology: Anatomy Physiology Pharmacology - Drugs - azathioprine, valproate, thiazides, GLP-1 receptor agonists, steroids, oestrogens.
Gastroenterology: Gastroenterology Emergencies (Complete)
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Respiratory: Interstitial Lung Disease (2 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (7 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Inflammatory Bowel Disease (7 mentions)
- Gastroenterology: Pancreas and Biliary (1 mention)
- Gastroenterology: Liver disease (5 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Multiple Sclerosis and inflammatory disease (2 mentions)
- Neurology: Neuromuscular disease (6 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Dialysis and Transplant (7 mentions)
- Renal: Glomerular Disease (4 mentions)
- Haematology: Anatomy Physiology and Pharmacology (4 mentions)
- Haematology: History and Examination (1 mention)
- Haematology: Anaemia (2 mentions)
- Paediatrics: Gastroenterology and surgery in children (4 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Medical Problems (1 mention)
- Dermatology: Skin basics, eczema and psoriasis (1 mention)
- Dermatology: Skin lesions and skin cancer (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (5 mentions)
- Rheumatology: assessment, investigations and drugs (4 mentions)
Azithromycin
BNF entry for Azithromycin · Stand-alone drug page
Mechanism
Macrolide binding the 50S ribosome to inhibit protein synthesis.
Uses
Atypical pneumonia, chlamydia, some enteric and sexually transmitted infections, COPD exacerbation prophylaxis.
Dosing
- Azithromycin Prophylaxis | e.g. 250 mg three times a week; check ECG (QT), LFTs, hearing; exclude NTM first.
Respiratory: Airways Disease - Pregnancy, breastfeeding or doxycycline unsuitable - azithromycin 1 g then 500 mg daily for 2 days (or erythromycin, amoxicillin).
Gynaecology: Sexual health - Azithromycin 1 g then 500 mg for 2 days | Chlamydia in pregnancy or if doxycycline unsuitable.
Gynaecology: Sexual health - Chlamydia: doxycycline 100 mg twice daily for 7 days (azithromycin if pregnant); partner notification; test of cure if pregnant.
General Practice: Child health, women's health and men's health in primary care
Side effects
Nausea, diarrhoea, abdominal pain; QT prolongation, hearing loss, hepatotoxicity.
Interactions
Other QT-prolonging drugs; may raise levels of digoxin and ciclosporin.
Special advice
ECG caution in QT risk; long tissue half-life allows short courses; check for alternatives in pregnancy.
More from the textbook: uses, cautions and other points
- Long-term macrolides (azithromycin) - anti-inflammatory and fewer exacerbations in bronchiectasis, CF and COPD (selected patients); check ECG (QT), hearing, LFTs, and exclude non-tuberculous mycobacteria first.
Respiratory: Anatomy, Physiology and Pharmacology - Azithromycin (long-term) | Fewer exacerbations in bronchiectasis and COPD; ECG (QT), hearing, LFTs; exclude NTM.
Respiratory: Anatomy, Physiology and Pharmacology - Three or more exacerbations a year: Consider long-term macrolide (azithromycin, after excluding NTM and checking QT) or nebulised antibiotics (colistin, gentamicin) if Pseudomonas is present.
Respiratory: Airways Disease - Treatment: A macrolide (clarithromycin or azithromycin) if started within 3 weeks of cough onset - mainly to reduce spread rather than symptoms.
Respiratory: Infections - MAC: Rifampicin, ethambutol and azithromycin , continued for at least 12 months after cultures become negative. Amikacin (IV or nebulised) for severe or refractory disease.
Respiratory: Infections - Macrolide if within 21 days of cough onset (reduces spread, not symptoms) - azithromycin (under 1 month and others) or clarithromycin; co-trimoxazole if macrolides unsuitable.
Paediatrics: Respiratory and heart problems in children
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (2 mentions)
- Respiratory: Airways Disease (2 mentions)
- Respiratory: Infections (4 mentions)
- Paediatrics: Respiratory and heart problems in children (2 mentions)
- Gynaecology: Sexual health (6 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Nose and Throat disorders (1 mention)
- Ophthalmology: Red emergencies (2 mentions)
- ID: How Infection Happens (5 mentions)
- ID: Sepsis, fever and serious bacterial infections (1 mention)
- ID: Tropical and travel medicine (4 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical Immunology: Primary immunodeficiency (1 mention)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (2 mentions)
- Integrated respiratory chapter (6 mentions)
- Integrated paediatrics chapter (2 mentions)
- General Practice: Child health, women's health and men's health in primary care (1 mention)
- Microbiology: Bacteriology - structure, classification and important pathogens (1 mention)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (2 mentions)
B
Baclofen
BNF entry for Baclofen · Stand-alone drug page
Mechanism
GABA-B agonist reducing spinal reflex activity.
Uses
Spasticity in multiple sclerosis and spinal cord disease.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Drowsiness, weakness, dizziness, confusion, hypotonia; abrupt withdrawal can cause seizures and hallucinations.
Interactions
Additive sedation with alcohol and CNS depressants; antihypertensives increase hypotension.
Special advice
Taper slowly; renally cleared so reduce dose in renal impairment; caution in epilepsy and in older people.
More from the textbook: uses, cautions and other points
- Baclofen is sometimes used by specialists in liver disease (off-label).
Gastroenterology: Anatomy Physiology Pharmacology - Baclofen is used off-label in liver disease.
Gastroenterology: Liver disease - Muscle cramps : Check electrolytes; reduce diuretics; consider baclofen.
Gastroenterology: Cirrhosis and Transplantation - GABA | Main inhibitory transmitter in the brain | Benzodiazepines , barbiturates, Z-drugs, propofol, alcohol enhance GABA-A; baclofen acts on GABA-B; valproate and vigabatrin raise GABA; withdrawal of these → seizures
Neurology: Anatomy, Physiology and Pharmacology - Symptom treatments - spasticity (baclofen, gabapentin, tizanidine, botulinum toxin, physiotherapy); bladder (antimuscarinics or mirabegron, intermittent self-catheterisation if residual volume is high); fatigue (exercise, amantadine - NICE recommends against modafinil and others routinely); neuropathic pain ; fampridine …
Neurology: Anatomy, Physiology and Pharmacology - Oxcarbazepine as an alternative. Lamotrigine, baclofen, gabapentin, pregabalin as add-ons (specialist).
Neurology: Headache and Facial Pain
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Liver disease (1 mention)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (6 mentions)
- Neurology: Headache and Facial Pain (1 mention)
- Neurology: Movement Disorders (1 mention)
- Neurology: Multiple Sclerosis and inflammatory disease (3 mentions)
- Neurology: Neuromuscular disease (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Palliative: Symptoms Management (1 mention)
- Paediatrics: Neurology, bones and joints in children (3 mentions)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (2 mentions)
- Integrated paediatrics chapter (3 mentions)
Beclometasone
BNF entry for Beclometasone · Stand-alone drug page
Mechanism
Inhaled corticosteroid reducing airway inflammation by gene regulation.
Uses
Asthma maintenance and COPD (combination inhalers), allergic rhinitis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Oral candidiasis, hoarseness; at high doses systemic steroid effects.
Interactions
CYP3A4 inhibitors may raise systemic exposure; additive with oral steroids.
Special advice
Rinse mouth and use spacer; check inhaler technique; step down to lowest effective dose; carry steroid card at high doses.
More from the textbook: uses, cautions and other points
- Examples - beclometasone, budesonide, fluticasone (propionate and furoate), mometasone, ciclesonide. Doses are graded as low, moderate or high (devices aren't interchangeable dose-for-dose - prescribe by brand).
Respiratory: Anatomy, Physiology and Pharmacology - ICS + LABA - budesonide–formoterol, beclometasone–formoterol, fluticasone–salmeterol, fluticasone furoate–vilanterol.
Respiratory: Anatomy, Physiology and Pharmacology - Inhaled corticosteroid (beclometasone, budesonide, fluticasone) | Asthma preventer; spacer; monitor growth at higher doses.
Paediatrics: Respiratory and heart problems in children - Intranasal corticosteroids (mometasone, fluticasone, beclometasone) — allergic rhinitis, nasal polyps , chronic rhinosinusitis — regular use, take days to work; technique — head forward, aim away from the septum (reduces nosebleeds and septal irritation); minimal systemic absorption with modern agents.
ENT Anatomy Physiology - Intranasal corticosteroid - mometasone, fluticasone, beclometasone - the most effective treatment , especially for blockage. Takes days to work fully; use regularly through the season; teach technique (aim away from the septum).
ENT: Common Nose and Throat disorders - Treatment - chlorhexidine mouthwash, benzydamine spray, topical steroids (e.g. hydrocortisone mucoadhesive buccal tablets, beclometasone inhaler sprayed onto ulcers).
ENT: Common Nose and Throat disorders
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (4 mentions)
- Paediatrics: Respiratory and heart problems in children (1 mention)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Nose and Throat disorders (2 mentions)
- ID: HIV, viral hepatitis and blood-borne viruses (2 mentions)
- Integrated paediatrics chapter (1 mention)
Bendroflumethiazide
BNF entry for Bendroflumethiazide · Stand-alone drug page
Mechanism
Thiazide diuretic inhibiting sodium-chloride cotransport in the distal tubule.
Uses
Hypertension, mild oedema.
Dosing
- 5. An 80-year-old woman started on carbamazepine for trigeminal neuralgia is brought in confused. Sodium 119 mmol/L. She also takes bendroflumethiazide and warfarin; her INR has fallen to 1.4. Answer: Carbamazepine-induced hyponatraemia (worsened by the thiazide) and enzyme induction lowering warfarin effect.
Neurology: Anatomy, Physiology and Pharmacology - 5. A 70-year-old man on lithium was started on bendroflumethiazide for hypertension 2 weeks ago. He is confused and unsteady with a coarse tremor. Lithium level 2.1 mmol/L. Answer: Chronic lithium toxicity (thiazide interaction).
Psychiatric emergencies - 4. A 75-year-old woman on lithium for 20 years is admitted with diarrhoea and vomiting for 3 days. She is confused with a coarse tremor and ataxia. Creatinine 210 (baseline 110). Lithium level 2.4 mmol/L. She takes ramipril and bendroflumethiazide. Answer: Lithium toxicity precipitated by dehydration, AKI and interacting drugs.
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing - Scenario. An 80-year-old on bendroflumethiazide is confused with Na⁺ 118 mmol/L that developed over 2 weeks. How fast can it be corrected? Answer: Chronic hyponatraemia - aim for no more than 10 mmol/L in 24 hours (8 if high risk) to avoid osmotic demyelination; give hypertonic saline only if severe symptoms (seizures, reduced …
Physiology: Cells, tissues, homeostasis, fluids and acid–base balance
Side effects
Hyponatraemia, hypokalaemia, hyperuricaemia and gout, hyperglycaemia, postural hypotension, erectile dysfunction.
Interactions
NSAIDs reduce effect; lithium levels rise; digoxin toxicity with hypokalaemia.
Special advice
Monitor sodium, potassium and renal function; avoid in gout and severe renal impairment.
More from the textbook: uses, cautions and other points
- Indapamide / bendroflumethiazide | Thiazide-like; hyponatraemia, hypercalcaemia, gout; raise lithium.
Cardiology: Anatomy Physiology and Pharmacology - Thiazide (e.g. bendroflumethiazide) Nephrogenic DI | Reduces urine volume paradoxically; monitor electrolytes.
Endocrinology: Pituitary Disease - Thiazide and thiazide-like - bendroflumethiazide, indapamide , chlortalidone, metolazone | Distal tubule - NCC | Hypertension (indapamide preferred - NICE NG136); calcium stones; nephrogenic DI; added to loops for diuretic resistance (metolazone) | Low Na (older women), low K , high Ca , high urate (gout) , hyperglycaemia, …
Renal: Anatomy, Physiology and Pharmacology - Indapamide / bendroflumethiazide | Thiazide (NCC); hypertension; low Na (older women), low K, high Ca and urate; weak if eGFR under 30.
Renal: Anatomy, Physiology and Pharmacology - Bendroflumethiazide / indapamide | Recurrent calcium stones with high urine calcium.
Renal: Tubular Inherited Stones - First gout attack 2 weeks after starting bendroflumethiazide | Diuretic-induced hyperuricaemia
Rheumatology Anatomy Physiology Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: Pituitary Disease (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Tubular Inherited Stones (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (2 mentions)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (2 mentions)
- Psychiatric emergencies (1 mention)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (2 mentions)
- Physiology: Cells, tissues, homeostasis, fluids and acid–base balance (1 mention)
Benzylpenicillin
BNF entry for Benzylpenicillin · Stand-alone drug page
Mechanism
Penicillin disrupting bacterial cell-wall synthesis.
Uses
Meningococcal disease, streptococcal and syphilis infections, serious sensitive infections.
Dosing
- Community - if meningococcal disease is suspected, give IM or IV benzylpenicillin (adults 1.2 g) without delaying transfer.
ID: Sepsis, fever and serious bacterial infections
Side effects
Allergy and anaphylaxis, diarrhoea; high doses cause neurotoxicity and seizures in renal failure.
Interactions
Methotrexate toxicity; probenecid raises levels.
Special advice
Give urgently in suspected meningococcal disease if no allergy history of anaphylaxis; adjust in renal impairment.
More from the textbook: uses, cautions and other points
- Bacterial meningitis - ceftriaxone (or cefotaxime) urgently, plus amoxicillin if Listeria is possible (over 60, immunocompromised, pregnant); dexamethasone with or just before the first antibiotic dose in adults with suspected bacterial meningitis; benzylpenicillin IM in the community for suspected meningococcal disease.
Neurology: Anatomy, Physiology and Pharmacology - Before hospital: If meningococcal disease is suspected (non-blanching rash), give benzylpenicillin IM or IV - but do not delay transfer.
Neurology: Emergencies - Benzylpenicillin Pre-hospital meningococcal disease | IM or IV if non-blanching rash, without delaying transfer.
Neurology: Emergencies - Treatment: IV benzylpenicillin for 14 days (or procaine penicillin with probenecid); test for HIV.
Neurology: Spine and Sleep Disorders - Benzylpenicillin IV 14 days | Neurosyphilis.
Neurology: Spine and Sleep Disorders - Early-onset - IV benzylpenicillin with gentamicin , within 1 hour of the decision.
Paediatrics: Neonatology
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Emergencies (2 mentions)
- Neurology: Spine and Sleep Disorders (2 mentions)
- Paediatrics: Neonatology (4 mentions)
- Paediatrics: Infections in children (4 mentions)
- Obstetrics: Complications (1 mention)
- Obstetrics: Medical Problems (2 mentions)
- Gynaecology: Sexual health (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Nose and Throat disorders (2 mentions)
- ENT: Emergencies (3 mentions)
- ID: How Infection Happens (2 mentions)
- ID: Sepsis, fever and serious bacterial infections (3 mentions)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
- Emergency Medicine: Paediatric emergency medicine (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Integrated paediatrics chapter (8 mentions)
- General Practice: Undifferentiated presentations, red flags and suspected cancer (1 mention)
- General Practice: Child health, women's health and men's health in primary care (1 mention)
- Microbiology: Bacteriology - structure, classification and important pathogens (6 mentions)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (1 mention)
Betahistine
BNF entry for Betahistine · Stand-alone drug page
Mechanism
Histamine H3 antagonist and weak H1 agonist improving inner-ear microcirculation.
Uses
Meniere disease symptoms.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, headache, dyspepsia; rarely rash.
Interactions
Antihistamines may oppose effect.
Special advice
Caution in asthma, peptic ulcer and phaeochromocytoma; evidence of benefit is limited.
More from the textbook: uses, cautions and other points
- Ménière's disease - betahistine (prevention - evidence is weak), salt restriction; specialist referral.
Neurology: Anatomy, Physiology and Pharmacology - Prevention: betahistine (limited evidence).
Neurology: Spine and Sleep Disorders - Betahistine | Ménière's disease (limited evidence).
Neurology: Spine and Sleep Disorders - Ménière's disease — betahistine (evidence is weak — caution in asthma, peptic ulcer, phaeochromocytoma), salt restriction, intratympanic steroids or gentamicin (specialist — ablates vestibular function).
ENT Anatomy Physiology - Don't use vestibular suppressants (prochlorperazine, betahistine) - they don't help and slow compensation.
ENT: Common Ear disorders - Betahistine is widely used, but a large trial (BEMED) showed no benefit over placebo.
ENT: Common Ear disorders
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Spine and Sleep Disorders (2 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Ear disorders (4 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
Betamethasone
BNF entry for Betamethasone · Stand-alone drug page
Mechanism
Potent glucocorticoid with minimal mineralocorticoid activity.
Uses
Antenatal fetal lung maturation, inflammatory skin disease (topical), systemic inflammation.
Dosing
- Antenatal corticosteroids - 24+0 to 33+6 weeks (consider from 22–23 weeks after discussion, and to 35+6 weeks): betamethasone 12 mg IM, two doses 24 hours apart (or dexamethasone). Reduce breathing problems, brain bleeds, NEC and death. Best effect 24 hours to 7 days after the first dose.
Obstetrics: Complications - Betamethasone 12 mg IM, two doses 24 hours apart | Antenatal steroids 24+0–33+6 weeks (consider to 35+6); can raise maternal glucose (diabetes - adjust insulin).
Obstetrics: Complications
Side effects
Systemic: hyperglycaemia, immunosuppression, mood effects, adrenal suppression, osteoporosis; topical: skin atrophy.
Interactions
CYP3A4 inducers lower effect; NSAIDs raise GI risk.
Special advice
Single antenatal courses are used for threatened preterm birth; long-term systemic use needs bone protection and steroid card.
More from the textbook: uses, cautions and other points
- Antenatal corticosteroids (dexamethasone or betamethasone) speed lung maturation - offered for threatened preterm birth (from 24 weeks to 33+6 weeks, and considered up to 35+6 weeks).
Respiratory: Anatomy, Physiology and Pharmacology - Topical steroid (e.g. betamethasone) | Pathological phimosis (BXO).
Paediatrics: Gastroenterology and surgery in children - Antenatal corticosteroids (betamethasone or dexamethasone — IM, 2 doses) | Fetal lung maturation (also reduce IVH and NEC) — preterm birth expected between 24+0 and 33+6 weeks (consider from 22 weeks and to 35+6 — NICE NG25) | Transient maternal hyperglycaemia (adjust insulin in diabetes); best effect if birth within 7 days
Obstetrics - Antenatal corticosteroids (betamethasone or dexamethasone — 2 IM doses).
Obstetrics - Potent | Betamethasone valerate 0.1% (Betnovate), mometasone furoate 0.1% (Elocon) | Severe eczema, psoriasis on body, scalp
Dermatology: Skin basics, eczema and psoriasis - Severe eczema - potent topical steroid (betamethasone valerate) for the body (not the face or neck; specialist advice under 12 months); short courses (up to 7–14 days for flares).
Dermatology: Skin basics, eczema and psoriasis
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Paediatrics: Gastroenterology and surgery in children (1 mention)
- Obstetrics (2 mentions)
- Obstetrics: Complications (3 mentions)
- Dermatology: Skin basics, eczema and psoriasis (7 mentions)
- Integrated paediatrics chapter (1 mention)
Bisoprolol
BNF entry for Bisoprolol · Stand-alone drug page
Mechanism
Highly cardioselective beta-1 blocker.
Uses
Heart failure with reduced EF, hypertension, angina, AF rate control.
Dosing
- 5. A 70-year-old woman with HFrEF on ramipril, bisoprolol and spironolactone has potassium 6.2 mmol/L and creatinine up 40% from baseline after a diarrhoeal illness. Answer: Hyperkalaemia and AKI from RAAS blockade during dehydrating illness.
Cardiology: Presentations - Bisoprolol: 2.5–5 mg once daily initially, usually 5–10 mg once daily (max 20 mg).
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina - Bisoprolol | Angina: 2.5–5 mg daily, usually 5–10 mg (max 20 mg). Target heart rate 55–60 bpm.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - Bisoprolol | Rate control or HFrEF: 1.25 mg daily initially in HFrEF, titrated to 10 mg daily if tolerated.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table
3 more dose entries from the chapters
- Bisoprolol | 1.25 mg daily initially; increase gradually to 10 mg daily if tolerated.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Bisoprolol AF rate control | Often 1.25–2.5 mg orally daily initially, titrated to response; commonly up to 10 mg daily. Assess BP, HR and LV function.
Cardiology: Cardiac Arrhythmias › 5.42 Two-Column Drug and Dose Table - Bisoprolol | HFrEF: 1.25 mg once daily, titrated every 2–4 weeks to 10 mg daily if tolerated. HCM: titrated to symptoms and heart rate.
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses
Side effects
Bradycardia, fatigue, cold extremities, bronchospasm, vivid dreams, impotence.
Interactions
Rate-limiting calcium channel blockers (verapamil, diltiazem) risk heart block; clonidine withdrawal rebound.
Special advice
Start low and titrate in heart failure when euvolaemic; avoid abrupt withdrawal; caution in asthma.
More from the textbook: uses, cautions and other points
- Beta-1 | Heart - faster rate (chronotropy), stronger contraction (inotropy), faster AV conduction; kidney - renin release | Agonist: dobutamine. Blockers: bisoprolol, metoprolol, atenolol
Cardiology: Anatomy Physiology and Pharmacology - Cardioselective (beta-1) - bisoprolol, metoprolol, atenolol, nebivolol.
Cardiology: Anatomy Physiology and Pharmacology - Beta-blocker (e.g. bisoprolol orally, or IV metoprolol in increments) or rate-limiting calcium channel blocker (diltiazem, verapamil) - avoid calcium channel blockers in heart failure with reduced EF.
Cardiology: Cardiology Emergencies - A patient with stable angina on bisoprolol still has symptoms. Which drug should be added? Answer: A dihydropyridine CCB such as amlodipine - not verapamil, because of the risk of heart block.
Cardiology: Ischaemic Heart Disease (ACS) › 1.35 Exam-style Scenarios - Evidence-based agents : Bisoprolol. Carvedilol. Metoprolol succinate modified-release. Nebivolol in selected patients.
Cardiology: Heart Failure › 2.19 💊 Beta Blockers - First-line in suitable patients: Oral beta blocker (for example bisoprolol) or rate-limiting calcium blocker (diltiazem/verapamil) when LV systolic function permits.
Cardiology: Cardiac Arrhythmias › 5.16 AF: Rate Control
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (6 mentions)
- Cardiology: Presentations (1 mention)
- Cardiology: Cardiology Emergencies (1 mention)
- Cardiology: Ischaemic Heart Disease (ACS) (3 mentions)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Heart Failure (2 mentions)
- Cardiology: Cardiac Arrhythmias (2 mentions)
- Cardiology: Cardiomyopathies (2 mentions)
- Acute Medicine: The deteriorating patient (1 mention)
- Acute Medicine: Cardiac arrest, advanced life support and peri-arrest arrhythmias (2 mentions)
- Acute Medicine: The acute medical take (1 mention)
- Integrated cardiology chapter (10 mentions)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)
Budesonide
BNF entry for Budesonide · Stand-alone drug page
Mechanism
Glucocorticoid with high first-pass hepatic metabolism, giving topical action.
Uses
Asthma (inhaled), Crohn disease and microscopic colitis (oral), nasal polyps.
Dosing
- Prednisolone / IV hydrocortisone / budesonide | IBD flares only; 100 mg hydrocortisone QDS for acute severe UC; budesonide - high first-pass.
Gastroenterology: Anatomy Physiology Pharmacology - Orodispersible budesonide (Jorveza 1 mg twice daily, NICE TA708) - a topical steroid that dissolves on the tongue. Avoid eating or drinking for 30 minutes afterwards. Oral thrush is a side effect.
Gastroenterology: Oesophagus and Stomach - Orodispersible budesonide 1 mg twice daily | Eosinophilic oesophagitis; nothing to eat or drink for 30 min; oral thrush.
Gastroenterology: Oesophagus and Stomach - Or budesonide MMX (9 mg daily) for mild to moderate disease (fewer side effects).
Gastroenterology: Inflammatory Bowel Disease
3 more dose entries from the chapters
- Budesonide 9 mg daily - for mild to moderate ileocaecal disease (fewer side effects, less effective).
Gastroenterology: Inflammatory Bowel Disease - Oral dexamethasone 0.15 mg/kg single dose for all severities (oral prednisolone 1–2 mg/kg, or nebulised budesonide if vomiting).
Paediatrics: Respiratory and heart problems in children - Oral dexamethasone 0.15 mg/kg (some use 0.6 mg/kg for severe) for all severities — prednisolone 1–2 mg/kg or nebulised budesonide alternatives.
Emergency Medicine: Paediatric emergency medicine
Side effects
Inhaled: candidiasis, dysphonia; oral: lower systemic steroid effects than prednisolone but still possible.
Interactions
CYP3A4 inhibitors (ketoconazole, ritonavir) increase systemic exposure.
Special advice
Rinse mouth after inhalation; check technique; steroid-sparing but long courses still need monitoring.
More from the textbook: uses, cautions and other points
- Examples - beclometasone, budesonide, fluticasone (propionate and furoate), mometasone, ciclesonide. Doses are graded as low, moderate or high (devices aren't interchangeable dose-for-dose - prescribe by brand).
Respiratory: Anatomy, Physiology and Pharmacology - ICS + LABA - budesonide–formoterol, beclometasone–formoterol, fluticasone–salmeterol, fluticasone furoate–vilanterol.
Respiratory: Anatomy, Physiology and Pharmacology - … SABA without inhaled steroid is linked to severe attacks and asthma deaths. Treatment is now built around a combined inhaled steroid plus formoterol inhaler (e.g. budesonide/formoterol). Formoterol works within minutes, so the same inhaler can be both the reliever and the preventer.
Respiratory: Airways Disease - ICS/formoterol (e.g. budesonide/formoterol) Asthma AIR and MART | AIR: 1 inhalation as needed. Low-dose MART: 1 inhalation twice daily plus as needed; moderate-dose MART: 2 inhalations twice daily plus as needed. Check the licensed maximum daily inhalations.
Respiratory: Airways Disease - Interactions - CYP3A4 inhibitors (ritonavir and cobicistat, itraconazole, clarithromycin) block breakdown of inhaled or nasal fluticasone and budesonide → Cushing's syndrome and adrenal suppression; enzyme inducers (rifampicin, carbamazepine, phenytoin) reduce steroid effect - double replacement doses may be needed.
Endocrine: Anatomy Physiology and Pharmacology - Budesonide - high first-pass metabolism (fewer systemic effects) - mild ileocaecal Crohn's, microscopic colitis , mild UC (MMX formulation).
Gastroenterology: Anatomy Physiology Pharmacology
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (6 mentions)
- Respiratory: Airways Disease (3 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Oesophagus and Stomach (4 mentions)
- Gastroenterology: Inflammatory Bowel Disease (7 mentions)
- Gastroenterology: Liver disease (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Glomerular Disease (5 mentions)
- Paediatrics: Respiratory and heart problems in children (2 mentions)
- ID: HIV, viral hepatitis and blood-borne viruses (1 mention)
- Emergency Medicine: Paediatric emergency medicine (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (2 mentions)
- Integrated respiratory chapter (3 mentions)
- Integrated paediatrics chapter (2 mentions)
Bumetanide
BNF entry for Bumetanide · Stand-alone drug page
Mechanism
Loop diuretic inhibiting the Na-K-2Cl cotransporter in the thick ascending limb.
Uses
Oedema from heart failure, cirrhosis and renal disease.
Dosing
- Bumetanide | 0.5–1 mg orally daily initially; titrate to congestion.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table - Bumetanide | Usually 0.5–1 mg daily initially; titrate to response.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Dose equivalence - oral bumetanide 1 mg ≈ furosemide 40 mg; oral furosemide is about half as available as IV (variable - less absorbed with gut oedema in heart failure, so IV works better when very overloaded).
Renal: Anatomy, Physiology and Pharmacology - Furosemide / bumetanide | Loop (NKCC2); fluid overload; low K, Mg and Na, AKI, gout, ototoxicity; bumetanide 1 mg ≈ furosemide 40 mg.
Renal: Anatomy, Physiology and Pharmacology
3 more dose entries from the chapters
- Loop diuretics (furosemide, bumetanide) | Usually reversible hearing loss and tinnitus with rapid high-dose IV infusion — give IV furosemide no faster than 4 mg/minute; potentiate aminoglycosides
ENT Anatomy Physiology - Potency - the dose needed to produce a given effect (EC50) - a more potent drug works at a lower dose (e.g. fentanyl is more potent than morphine, bumetanide more potent than furosemide -1 mg bumetanide ≈ 40 mg furosemide).
Clinical pharmacology and prescribing: Principles of clinical pharmacology - "Bumetanide 1.0 mg" | Trailing zero - risk of 10 mg
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law
Side effects
Hypokalaemia, hyponatraemia, hypomagnesaemia, hypotension, ototoxicity, gout.
Interactions
Aminoglycosides increase ototoxicity; NSAIDs blunt effect; lithium levels rise; digoxin toxicity with low potassium.
Special advice
Monitor weight, electrolytes and renal function; potency about 40 times furosemide by weight.
More from the textbook: uses, cautions and other points
- Furosemide / bumetanide | Loop diuretics; low K, Na, Mg; gout; ototoxicity.
Cardiology: Anatomy Physiology and Pharmacology - Loop diuretics : Furosemide. Bumetanide. Act on the Na-K-2Cl cotransporter in the thick ascending limb of Henle. Effective for pulmonary and peripheral congestion. Can cause hypokalaemia, hyponatraemia, dehydration and renal dysfunction.
Cardiology: Heart Failure › 2.16 💉 Diuretics in Heart Failure - Loop of Henle - thick ascending limb | Reabsorbs about 25% of sodium via NKCC2 ; impermeable to water (dilutes urine and builds the concentration gradient in the medulla); reabsorbs calcium and magnesium between cells | Loop diuretics (furosemide, bumetanide) | Bartter syndrome (like taking a loop diuretic)
Renal: Anatomy, Physiology and Pharmacology - Loop - furosemide, bumetanide | Thick ascending limb - NKCC2 | Fluid overload - heart failure, pulmonary oedema, nephrotic syndrome, CKD; hypercalcaemia (after fluids) | Low K , low Na, low Mg , low Ca, alkalosis, dehydration and AKI , gout, hyperglycaemia; ototoxicity with fast high-dose IV
Renal: Anatomy, Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Heart Failure (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (4 mentions)
- ENT Anatomy Physiology (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Integrated cardiology chapter (3 mentions)
Buprenorphine
BNF entry for Buprenorphine · Stand-alone drug page
Mechanism
Partial mu-opioid agonist with high receptor affinity and long duration.
Uses
Opioid dependence maintenance and chronic pain (transdermal).
Dosing
- Buprenorphine patch | 5 micrograms/hour (7-day patch) ≈ about 12 mg oral morphine a day
Palliative: Symptoms Management
Side effects
Nausea, constipation, sedation, respiratory depression (ceiling effect), hepatitis with misuse.
Interactions
Other CNS depressants and benzodiazepines increase respiratory depression; precipitates withdrawal if started too early in full agonist users.
Special advice
Start only when in mild withdrawal; slow-release patches change dose only after several days; naloxone supply for community settings.
More from the textbook: uses, cautions and other points
- Opioids - avoid morphine and codeine in advanced CKD (metabolites accumulate); oxycodone with caution; fentanyl, alfentanil and buprenorphine are safer.
Renal: Chronic Kidney Disease - Pain - renally safe opioids (fentanyl, alfentanil, buprenorphine).
Renal: Chronic Kidney Disease - eGFR under 30: Use oxycodone at reduced doses with longer intervals, or fentanyl or alfentanil (and buprenorphine). Seek specialist advice.
Palliative: Symptoms Management - Fentanyl / buprenorphine patches | Stable pain; kidney failure; slow onset; heat increases absorption.
Palliative: Symptoms Management - What it is: Withdrawal in a baby exposed in the womb to opioids (heroin, methadone, buprenorphine), benzodiazepines, or other drugs.
Paediatrics: Neonatology - Substance misuse - opioid substitution (methadone, buprenorphine) safer than withdrawal; neonatal abstinence syndrome; safeguarding.
Obstetrics: Medical Problems
Where it is discussed
- Renal: Chronic Kidney Disease (2 mentions)
- Palliative: Symptoms Management (3 mentions)
- Paediatrics: Neonatology (1 mention)
- Obstetrics: Medical Problems (1 mention)
- Psychiatry: Alcohol, drugs and addiction (7 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (7 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (3 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (2 mentions)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (2 mentions)
- Integrated paediatrics chapter (1 mention)
- General Practice: Mental health, safeguarding, certification and the law (1 mention)
- Public Health: Prevention, health promotion and behaviour change (1 mention)
- Physiology: Cells, tissues, homeostasis, fluids and acid–base balance (1 mention)
- Cell Biology: Cell cycle, signalling, cell death and stem cells (1 mention)
Bupropion
BNF entry for Bupropion · Stand-alone drug page
Mechanism
Noradrenaline and dopamine reuptake inhibitor.
Uses
Smoking cessation (as aid) and depression in some regions.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Insomnia, dry mouth, headache, anxiety; seizure risk dose-related; hypertension.
Interactions
CYP2D6 inhibition raises levels of antidepressants, beta-blockers and antipsychotics; avoid with MAOIs.
Special advice
Contraindicated in epilepsy, eating disorders and abrupt alcohol or benzodiazepine withdrawal.
More from the textbook: uses, cautions and other points
- Stop smoking - the only measure (with oxygen in selected people) proven to slow decline and improve survival. Offer behavioural support plus drugs (NRT, varenicline where available, bupropion). E-cigarettes are a less harmful alternative to smoking.
Respiratory: Airways Disease - Smoking cessation | NRT (combination patch plus short-acting form), varenicline where available, bupropion; with behavioural support.
Respiratory: Airways Disease - Seizures (lower threshold) | Tramadol , bupropion, theophylline , ciprofloxacin and other quinolones, high-dose penicillins and carbapenems, clozapine and other antipsychotics, TCAs, lithium toxicity, isoniazid (pyridoxine), local anaesthetic toxicity, withdrawal of alcohol, benzodiazepines, baclofen or antiseizure drugs; drugs …
Neurology: Anatomy, Physiology and Pharmacology - Look for provoking causes: Hypoglycaemia, hyponatraemia, hypocalcaemia, alcohol or benzodiazepine withdrawal, drugs (tramadol, bupropion, recreational drugs), head injury, infection.
Neurology: Emergencies - Drugs (tramadol, bupropion, ciprofloxacin, cocaine).
Neurology: Epilepsy - Others - vortioxetine, agomelatine, trazodone, bupropion (smoking) | Vortioxetine - fewer sexual side effects; agomelatine - LFT monitoring; trazodone - sedating.
Psychiatry: Mood disorders
Where it is discussed
- Respiratory: Airways Disease (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Emergencies (1 mention)
- Neurology: Epilepsy (1 mention)
- Psychiatry: Mood disorders (1 mention)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (1 mention)
- Integrated respiratory chapter (2 mentions)
- Public Health: Prevention, health promotion and behaviour change (1 mention)
C
Cabergoline
BNF entry for Cabergoline · Stand-alone drug page
Mechanism
Long-acting dopamine D2 agonist reducing prolactin secretion.
Uses
Hyperprolactinaemia and prolactinoma, acromegaly adjunct, suppression of lactation.
Dosing
- Cabergoline (preferred): Usually 250–500 micrograms once or twice weekly, titrated to normalise prolactin. In most patients it normalises prolactin, shrinks the tumour (often within weeks) and restores vision and fertility.
Endocrinology: Pituitary Disease - Cabergoline Prolactinoma | Typically 250–500 micrograms once or twice weekly, titrated monthly to normalise prolactin. Warn about impulse control disorders; echo surveillance at higher cumulative doses.
Endocrinology: Pituitary Disease
Side effects
Nausea, dizziness, headache, postural hypotension; psychiatric effects including impulse-control disorders; valvular fibrosis at high doses.
Interactions
Dopamine antagonists (antipsychotics, metoclopramide) oppose effect.
Special advice
Echocardiography for long-term or high-dose use; monitor prolactin and tumour size.
More from the textbook: uses, cautions and other points
- Serotonergic drugs: Historically pergolide, cabergoline and fenfluramine.
Cardiology: Valvular heart disease › 4.29 Carcinoid Heart Disease - Ergot derivatives (cabergoline, bromocriptine) | Pleural and pulmonary fibrosis
Respiratory: Anatomy, Physiology and Pharmacology - Cabergoline | Prolactinoma first-line; impulse control disorders; valve fibrosis at high doses.
Endocrine: Anatomy Physiology and Pharmacology - Compulsive gambling after starting a prolactinoma drug | Cabergoline impulse control disorder
Endocrine: Anatomy Physiology and Pharmacology - 💡 Clinical Pearl: Unlike other pituitary tumours, a macroprolactinoma compressing the chiasm is treated first with medicine (cabergoline), not surgery. Vision often improves within days.
Endocrinology: Pituitary Disease - Cabergoline - for mild disease.
Endocrinology: Pituitary Disease
Where it is discussed
- Cardiology: Valvular heart disease (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Pituitary Disease (7 mentions)
- Endocrinology: Adrenal Disease (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Movement Disorders (1 mention)
- Obstetrics (3 mentions)
- Obstetrics: Complications (3 mentions)
- Gynaecology: Fertility Contraception Menopause (2 mentions)
- Integrated cardiology chapter (1 mention)
Calcitriol
BNF entry for Calcitriol · Stand-alone drug page
Mechanism
Active vitamin D (1,25-dihydroxycholecalciferol) increasing gut calcium and phosphate absorption.
Uses
Hypocalcaemia in CKD and hypoparathyroidism, renal osteodystrophy.
Dosing
- Glucocorticoids (e.g. prednisolone 20–40 mg daily): For calcitriol-driven hypercalcaemia - sarcoidosis, lymphoma, vitamin D toxicity.
Endocrinology: Bone Medicine - Normal physiology: The fetus takes about 30 g of calcium, mostly in the third trimester. The mother adapts by doubling gut absorption (calcitriol rises). During breastfeeding, calcium is drawn from the skeleton, but bone density usually recovers after weaning.
Endocrinology: Bone Medicine - Calcium — gut absorption doubles (more calcitriol) to supply the fetal skeleton; vitamin D supplements recommended (10 micrograms daily).
Obstetrics
Side effects
Hypercalcaemia, hypercalciuria, nausea, polyuria.
Interactions
Thiazides and calcium supplements increase hypercalcaemia risk.
Special advice
Monitor calcium, phosphate and PTH regularly; avoid in hypercalcaemia.
More from the textbook: uses, cautions and other points
- Calcium: Granulomas make active vitamin D (calcitriol), causing hypercalcaemia and hypercalciuria (kidney stones, nephrocalcinosis).
Respiratory: Interstitial Lung Disease - Made in the skin with UVB (or eaten) → liver makes 25-hydroxyvitamin D (the measured storage form) → kidney makes 1,25-dihydroxyvitamin D (calcitriol - active).
Endocrine: Anatomy Physiology and Pharmacology - CKD - the kidney can't activate vitamin D → low calcium, high phosphate → secondary hyperparathyroidism (use alfacalcidol or calcitriol, which don't need kidney activation).
Endocrine: Anatomy Physiology and Pharmacology - Then hydroxylated in the kidney to 1,25-dihydroxyvitamin D (calcitriol) - the active hormone. It increases gut absorption of calcium and phosphate.
Endocrinology: Bone Medicine - FGF23: Made by osteocytes when phosphate is high. It makes the kidney excrete phosphate and suppresses calcitriol. Excess FGF23 causes phosphate-wasting rickets and osteomalacia.
Endocrinology: Bone Medicine - Vitamin D activation - the kidney makes active 1,25-dihydroxyvitamin D (calcitriol) using 1-alpha-hydroxylase (stimulated by PTH and low phosphate).
Renal: Anatomy, Physiology and Pharmacology
Where it is discussed
- Respiratory: Interstitial Lung Disease (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (3 mentions)
- Endocrinology: Bone Medicine (12 mentions)
- Renal: Anatomy, Physiology and Pharmacology (3 mentions)
- Renal: Chronic Kidney Disease (2 mentions)
- Oncology: Emergencies (1 mention)
- Obstetrics (1 mention)
- Dermatology: Skin basics, eczema and psoriasis (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (2 mentions)
- Acute Medicine: Electrolytes, acid–base, AKI and metabolic emergencies (1 mention)
- Integrated respiratory chapter (1 mention)
- Physiology: Cells, tissues, homeostasis, fluids and acid–base balance (3 mentions)
- Pathology: Neoplasia - tumour biology, spread, staging and markers (1 mention)
- Neurophysiology, neuromuscular transmission and endocrine feedback (1 mention)
- Biochemistry III: enzymes, vitamins, genetics and molecular mechanisms (1 mention)
- Clinical biochemistry: interpretation, test limitations and case mechanisms (1 mention)
Calcium carbonate
BNF entry for Calcium carbonate · Stand-alone drug page
Mechanism
Calcium salt used as a supplement, antacid and phosphate binder.
Uses
Calcium deficiency, osteoporosis adjunct, heartburn, hyperphosphataemia in CKD.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Constipation, bloating, hypercalcaemia, milk-alkali syndrome.
Interactions
Reduces absorption of levothyroxine, quinolones and tetracyclines; thiazides raise calcium.
Special advice
Take with food as a binder; space from interacting drugs; avoid in hypercalcaemia.
More from the textbook: uses, cautions and other points
- Milk-alkali syndrome (excess calcium carbonate).
Endocrinology: Bone Medicine - Calcium-based (calcium acetate, calcium carbonate) - cheap; risk of high calcium and vascular calcification.
Renal: Anatomy, Physiology and Pharmacology - Lanthanum; sucroferric oxyhydroxide; calcium carbonate.
Renal: Chronic Kidney Disease - Utricle and saccule (otolith organs) — detect linear acceleration and gravity using calcium carbonate crystals ( otoconia ).
ENT Anatomy Physiology
Where it is discussed
- Endocrinology: Bone Medicine (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- ENT Anatomy Physiology (1 mention)
Calcium gluconate 10%
BNF entry for Calcium gluconate 10% · Stand-alone drug page
Mechanism
Calcium salt that stabilises cardiac myocyte membranes against hyperkalaemic depolarisation.
Uses
Hyperkalaemia with ECG changes, hypocalcaemia, calcium channel blocker or magnesium toxicity.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Hyperkalaemia with ECG changes | 30 mL IV over 2–5 min | Protects the myocardium only; does not lower potassium. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
Check: the MHRA national patient safety alert on calcium gluconate in severe hyperkalaemia advises 30 mL of 10% (6.8 mmol) given over 10 minutes, repeated if ECG changes persist at 5–10 minutes. The 2–5 minute rate above is as written on the topics site and may need updating.
This drug is not covered by a dedicated section of the textbook chapters.
Side effects
Hypotension, bradycardia, arrhythmias, tissue necrosis if extravasated, peripheral vein irritation.
Interactions
Digoxin toxicity risk with IV calcium.
Special advice
Give with ECG monitoring; does not lower potassium, so also give insulin-dextrose; use the protocol-stated volume and rate (MHRA alert).
Candesartan
BNF entry for Candesartan · Stand-alone drug page
Mechanism
Angiotensin II type 1 receptor blocker.
Uses
Hypertension, heart failure with reduced EF.
Dosing
- Candesartan | 4 mg daily initially; target 32 mg daily.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Candesartan 16 mg daily (off-label) - useful if BP is high.
Neurology: Headache and Facial Pain - Candesartan 16 mg daily | Migraine prevention (off-label); avoid in pregnancy.
Neurology: Headache and Facial Pain
Side effects
Dizziness, hyperkalaemia, renal impairment, hypotension; angioedema rare.
Interactions
NSAIDs, potassium-sparing diuretics and ACE inhibitors increase renal and potassium risk; lithium levels rise.
Special advice
Check U&E 1 to 2 weeks after starting or increasing; avoid in pregnancy and bilateral renal artery stenosis.
More from the textbook: uses, cautions and other points
- Angiotensin receptor blockers (ARBs) (losartan, candesartan, valsartan) - block the AT1 receptor; same uses; no cough (used when ACE inhibitors cause it); angioedema much less common.
Cardiology: Anatomy Physiology and Pharmacology - Candesartan / losartan | ARB; no cough; don't combine with ACE inhibitor.
Cardiology: Anatomy Physiology and Pharmacology - Common drugs : Ramipril. Enalapril. Lisinopril. Candesartan, an ARB alternative.
Cardiology: Heart Failure › 2.18 💊 ACE Inhibitors and ARBs - Propranolol (avoid in asthma), amitriptyline (drowsiness, weight gain, anticholinergic), topiramate (teratogenic - Pregnancy Prevention Programme; reduces the combined pill's effect), candesartan (off-label).
Neurology: Anatomy, Physiology and Pharmacology - Prevention: Propranolol or amitriptyline. Avoid topiramate, valproate and candesartan .
Neurology: Headache and Facial Pain - Prevention for 4 or more migraine days a month: propranolol, amitriptyline, topiramate (pregnancy prevention programme) or candesartan.
Neurology: Headache and Facial Pain
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Heart Failure (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Headache and Facial Pain (4 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- ENT: Common Ear disorders (1 mention)
- Integrated cardiology chapter (2 mentions)
- General Practice: Undifferentiated presentations, red flags and suspected cancer (1 mention)
Capecitabine
BNF entry for Capecitabine · Stand-alone drug page
Mechanism
Oral prodrug of fluorouracil activated preferentially in tumour tissue.
Uses
Colorectal, breast and gastric cancer.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hand-foot syndrome, diarrhoea, mucositis, nausea, myelosuppression, cardiotoxicity.
Interactions
Warfarin interaction with major INR rise; phenytoin levels rise; folinic acid increases toxicity.
Special advice
Check DPD deficiency risk; monitor INR with warfarin; stop for severe diarrhoea or hand-foot reactions.
More from the textbook: uses, cautions and other points
- Chemotherapy: Capecitabine and temozolomide for pancreatic NETs. Platinum and etoposide for neuroendocrine carcinomas.
Endocrinology: NETS and Hypoglycaemia - Surgery is the only cure, but fewer than 1 in 4 tumours are resectable. Adjuvant capecitabine afterwards.
Gastroenterology: Pancreas and Biliary - Then adjuvant chemotherapy - modified FOLFIRINOX if fit, or gemcitabine with capecitabine.
Gastroenterology: Pancreas and Biliary - Antimetabolites | 5-fluorouracil and capecitabine - diarrhoea, mucositis, hand–foot syndrome , coronary vasospasm; test for DPD deficiency first (risk of fatal toxicity). Methotrexate - mucositis, kidney and liver toxicity (folinic acid rescue). Gemcitabine - flu-like symptoms, rarely HUS
Oncology: Principles - ⚠️ Safety Pearl: Chemotherapy prescribing is a specialist task, with checked protocols. Never prescribe or continue oral anti-cancer drugs (e.g. capecitabine) without clear specialist guidance - dosing errors cause serious harm.
Oncology: Principles - Hold oral chemotherapy (capecitabine).
Oncology: Emergencies
Where it is discussed
- Endocrinology: NETS and Hypoglycaemia (1 mention)
- Gastroenterology: Pancreas and Biliary (3 mentions)
- Oncology: Principles (4 mentions)
- Oncology: Emergencies (1 mention)
- Oncology: Breast and Gynae Cancers (1 mention)
- Surgery: Colorectal and anal surgery (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics (6 mentions)
- Biochemistry: Enzymes, vitamins and trace elements (1 mention)
Captopril
BNF entry for Captopril · Stand-alone drug page
Mechanism
Short-acting ACE inhibitor containing a thiol group.
Uses
Hypertension, heart failure, post-MI, diabetic nephropathy.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Dry cough, hypotension, hyperkalaemia, renal impairment, angioedema, taste disturbance, neutropenia.
Interactions
NSAIDs, potassium-sparing diuretics and lithium; first-dose hypotension with diuretics.
Special advice
Check renal function and potassium; avoid in pregnancy and bilateral renal artery stenosis; stop if angioedema.
More from the textbook: uses, cautions and other points
- After delivery: Full HFrEF therapy (enalapril or captopril are compatible with breastfeeding); bromocriptine with prophylactic anticoagulation considered in specialist care.
Cardiology: Cardiomyopathies › 3.42 Peripartum Cardiomyopathy (PPCM) - Afterload reduction: Sometimes an ACE inhibitor (captopril), under specialist supervision.
Cardiology: Congenital heart disease › 6.13 Heart Failure in Infants - Alternatives: oral salt loading, the fludrocortisone suppression test, the captopril challenge test.
Endocrinology: Adrenal Disease - Management - diuretics (furosemide, spironolactone); ACE inhibitors (captopril) in some; high-calorie feeds, NG feeding; treat anaemia; surgery or catheter intervention for the underlying defect.
Paediatrics: Respiratory and heart problems in children - Treatment - ACE inhibitor (e.g. captopril, rapidly increased) even if creatinine rises; dialysis if needed (kidneys may recover over months).
Rheumatology: Connective tissue diseases - Admit; start an ACE inhibitor (e.g. captopril, increasing rapidly) to control BP - continue even if creatinine rises; add other agents (calcium channel blocker) if needed.
Rheumatology: Connective tissue diseases
Where it is discussed
- Cardiology: Cardiomyopathies (1 mention)
- Cardiology: Congenital heart disease (1 mention)
- Endocrinology: Adrenal Disease (1 mention)
- Paediatrics: Respiratory and heart problems in children (1 mention)
- Rheumatology: Connective tissue diseases (2 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (1 mention)
- ENT Anatomy Physiology (1 mention)
- Integrated cardiology chapter (2 mentions)
- Integrated paediatrics chapter (1 mention)
Carbamazepine
BNF entry for Carbamazepine · Stand-alone drug page
Mechanism
Blocks voltage-gated sodium channels; stabilises neuronal membranes.
Uses
Focal and generalised tonic-clonic epilepsy, trigeminal neuralgia, bipolar disorder.
Dosing
- … is euvolaemic - after excluding hypothyroidism, adrenal insufficiency and diuretics. Causes include lung disease, CNS disease, cancers (small cell), drugs (SSRIs, carbamazepine, PPIs, opioids), pain, nausea and surgery.
Endocrine: Anatomy Physiology and Pharmacology - Increased dose needs - pregnancy (increase as soon as pregnancy is confirmed - often by 25–50 micrograms - and check TFTs each trimester), oral oestrogen, enzyme inducers (rifampicin, carbamazepine, phenytoin), weight gain.
Endocrine: Anatomy Physiology and Pharmacology - Carbamazepine level | About 4–12 mg/L
Neurology: Anatomy, Physiology and Pharmacology - 5. An 80-year-old woman started on carbamazepine for trigeminal neuralgia is brought in confused. Sodium 119 mmol/L. She also takes bendroflumethiazide and warfarin; her INR has fallen to 1.4. Answer: Carbamazepine-induced hyponatraemia (worsened by the thiazide) and enzyme induction lowering warfarin effect.
Neurology: Anatomy, Physiology and Pharmacology
3 more dose entries from the chapters
- Carbamazepine Start 100 mg once or twice daily | Trigeminal neuralgia; low sodium, rash, enzyme induction.
Neurology: Headache and Facial Pain - Carbamazepine 100 mg once or twice daily, increasing slowly.
Neurology: Headache and Facial Pain - Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
Obstetrics
Side effects
Dizziness, diplopia, ataxia, hyponatraemia, rash, leucopenia; serious skin reactions (HLA-B*15:02), hepatotoxicity.
Interactions
Potent enzyme inducer lowering warfarin, DOACs, COC pill and many drugs; levels raised by macrolides and some azoles.
Special advice
Check sodium, LFT and FBC; contraception advice; avoid in pregnancy where possible (neural tube defects); do not stop abruptly.
More from the textbook: uses, cautions and other points
- Many interactions - enzyme inhibitors raise INR (amiodarone, clarithromycin, erythromycin, fluconazole, metronidazole, ciprofloxacin, alcohol binges); inducers lower it (rifampicin, carbamazepine, phenytoin, St John's wort); diet (vitamin K-rich foods).
Cardiology: Anatomy Physiology and Pharmacology - Metabolised by CYP1A2 - levels raised by ciprofloxacin , clarithromycin , erythromycin, fluvoxamine, cimetidine, heart failure, liver disease, viral infection, stopping smoking; lowered by smoking , rifampicin, carbamazepine, phenytoin, alcohol.
Respiratory: Anatomy, Physiology and Pharmacology - Interactions - CYP3A4 inhibitors (ritonavir and cobicistat, itraconazole, clarithromycin) block breakdown of inhaled or nasal fluticasone and budesonide → Cushing's syndrome and adrenal suppression; enzyme inducers (rifampicin, carbamazepine, phenytoin) reduce steroid effect - double replacement doses may be needed.
Endocrine: Anatomy Physiology and Pharmacology - Combined pill (oestrogen raises binding proteins) - falsely raises total T4 and cortisol; interacts with enzyme inducers (rifampicin, carbamazepine, St John's wort) and lamotrigine.
Endocrine: Anatomy Physiology and Pharmacology - SSRIs , SNRIs, tricyclics. Carbamazepine , oxcarbazepine, sodium valproate.
Endocrinology: Sodium and Water disorders - Drugs (thiazides, SSRIs, carbamazepine, PPIs) are the commonest reversible causes.
Endocrinology: Sodium and Water disorders
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (5 mentions)
- Endocrinology: Sodium and Water disorders (2 mentions)
- Endocrinology: Pituitary Disease (1 mention)
- Endocrinology: Adrenal Disease (2 mentions)
- Endocrinology: Thyroid disease (1 mention)
- Gastroenterology: Liver disease (2 mentions)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (18 mentions)
- Neurology: Localisation and Investigation (1 mention)
- Neurology: Epilepsy (13 mentions)
- Neurology: Headache and Facial Pain (3 mentions)
- Neurology: Movement Disorders (1 mention)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Dialysis and Transplant (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (6 mentions)
- Haematology: Anaemia (1 mention)
- Haematology: Haemostasis and Thrombosis (1 mention)
- Oncology: Emergencies (1 mention)
- Paediatrics: Neurology, bones and joints in children (5 mentions)
- Obstetrics (1 mention)
- Obstetrics: Medical Problems (1 mention)
Carbimazole
BNF entry for Carbimazole · Stand-alone drug page
Mechanism
Prodrug of methimazole; inhibits thyroid peroxidase and hormone synthesis.
Uses
Graves disease and hyperthyroidism.
Dosing
- Titration regimen: Carbimazole 20–40 mg daily initially, reduced gradually to a maintenance dose (typically 5–15 mg) as FT4 normalises. Check TFTs every 4–6 weeks.
Endocrinology: Thyroid disease - Block-and-replace: Carbimazole 40 mg daily plus levothyroxine, usually for about 6 months. It gives more stable levels but higher drug exposure. Not used in pregnancy.
Endocrinology: Thyroid disease
Side effects
Rash, itch, nausea; agranulocytosis, cholestatic jaundice, acute pancreatitis rare.
Interactions
Warfarin effect may reduce as thyroid state normalises.
Special advice
Counsel to report sore throat, fever or mouth ulcers immediately and check FBC; pregnancy teratogenicity risk.
More from the textbook: uses, cautions and other points
- Thyroid peroxidase (TPO) attaches iodine to tyrosines on thyroglobulin and couples them into T4 and T3 (the step blocked by carbimazole and propylthiouracil ; TPO antibodies mark autoimmune thyroid disease).
Endocrine: Anatomy Physiology and Pharmacology - Rash and itch (common), joint pains, liver problems (cholestatic with carbimazole; severe hepatitis with PTU ), vasculitis (PTU - ANCA).
Endocrine: Anatomy Physiology and Pharmacology - Thionamide: Propylthiouracil preferred, or high-dose carbimazole, to block new hormone synthesis.
Endocrinology: Emergencies - 4. A woman with Graves' disease who stopped carbimazole is febrile, in fast AF and agitated. Answer: Thyroid storm.
Endocrinology: Emergencies - Drugs: Amiodarone, lithium, immune checkpoint inhibitors, tyrosine kinase inhibitors, interferon, over-treatment with carbimazole.
Endocrinology: Thyroid disease - 💡 Clinical Pearl: Before starting carbimazole, make sure the gland is actually overproducing. Antithyroid drugs are useless in thyroiditis - the problem is leakage of stored hormone, not overproduction.
Endocrinology: Thyroid disease
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (9 mentions)
- Endocrinology: Emergencies (2 mentions)
- Endocrinology: Thyroid disease (24 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Haematology: History and Examination (1 mention)
- Haematology: Emergencies (3 mentions)
- Haematology: Anaemia (2 mentions)
- Paediatrics: Kidneys, urinary tract and hormones in children (2 mentions)
- Obstetrics (4 mentions)
- Obstetrics: Medical Problems (3 mentions)
- ENT: Common Nose and Throat disorders (3 mentions)
- Surgey: Breast and endocrine surgery (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (3 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (4 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Acute Medicine: Electrolytes, acid–base, AKI and metabolic emergencies (1 mention)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (3 mentions)
- Integrated paediatrics chapter (2 mentions)
- Physiology: Endocrine control, metabolism and thermoregulation (1 mention)
Carvedilol
BNF entry for Carvedilol · Stand-alone drug page
Mechanism
Non-selective beta blocker with alpha-1 blocking activity.
Uses
Heart failure with reduced EF, hypertension, post-MI.
Dosing
- Carvedilol | 3.125 mg twice daily initially; target commonly 25 mg twice daily.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Carvedilol | HFrEF: 3.125 mg twice daily, titrated to 25 mg twice daily (50 mg twice daily if >85 kg).
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses - Carvedilol (a non-selective beta-blocker) - 6.25 mg once daily, increasing to 12.5 mg daily if tolerated (keep systolic BP over 90 mmHg).
Gastroenterology: Cirrhosis and Transplantation - Carvedilol 6.25 mg daily, up to 12.5 mg daily | Primary and secondary variceal prophylaxis; prevents decompensation in CSPH; reduce or stop if systolic BP under 90, AKI or refractory ascites.
Gastroenterology: Cirrhosis and Transplantation
Side effects
Dizziness, postural hypotension, fatigue, bradycardia, fluid retention initially.
Interactions
Amiodarone and rate-limiting calcium channel blockers risk bradycardia and block; insulin hypoglycaemia masking.
Special advice
Introduce when euvolaemic and titrate slowly; avoid in asthma and decompensated heart failure.
More from the textbook: uses, cautions and other points
- Non-selective - propranolol (also used for thyrotoxicosis, migraine, varices, anxiety), sotalol (also class III), carvedilol (also alpha-blocking), labetalol (pregnancy hypertension).
Cardiology: Anatomy Physiology and Pharmacology - Uses - angina, after MI, HFrEF (bisoprolol, carvedilol, nebivolol, metoprolol succinate -"start low, go slow"), AF rate control, SVT, hypertension (not first-line alone), thyrotoxicosis.
Cardiology: Anatomy Physiology and Pharmacology - Evidence-based agents : Bisoprolol. Carvedilol. Metoprolol succinate modified-release. Nebivolol in selected patients.
Cardiology: Heart Failure › 2.19 💊 Beta Blockers - Non-selective beta-blockers - carvedilol (preferred in BSG guidance) or propranolol - lower portal pressure; for primary prevention of variceal bleeding (medium or large varices) and, with banding, secondary prevention. Hold or reduce if systolic BP is under 90 , AKI, sepsis or SBP, and use with care in refractory ascites.
Gastroenterology: Anatomy Physiology Pharmacology - Carvedilol / propranolol | Lower portal pressure; prevent variceal bleeding; hold if hypotensive or AKI.
Gastroenterology: Anatomy Physiology Pharmacology - Afterwards: Non-selective beta-blocker (carvedilol or propranolol) plus a band ligation programme to prevent rebleeding.
Gastroenterology: Gastroenterology Emergencies (Complete)
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Heart Failure (2 mentions)
- Cardiology: Cardiomyopathies (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Cirrhosis and Transplantation (5 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Integrated cardiology chapter (3 mentions)
Cefalexin
BNF entry for Cefalexin · Stand-alone drug page
Mechanism
First-generation cephalosporin inhibiting cell-wall synthesis.
Uses
Skin and soft tissue, urinary and respiratory tract infections, surgical prophylaxis.
Dosing
- Systemically unwell, immunosuppressed or significant comorbidity: Co-amoxiclav (500/125 mg three times daily for 5 days) - or cefalexin plus metronidazole, or trimethoprim plus metronidazole, if allergic to penicillin.
Gastroenterology: Bowel Disorders - Cefalexin 500 mg twice or three times daily for 7–10 days.
Renal: Tubular Inherited Stones - Cefalexin 500 mg two to three times daily | Pyelonephritis 7–10 days, including pregnancy.
Renal: Tubular Inherited Stones
Side effects
Diarrhoea, nausea, rash; C. difficile infection; rarely hypersensitivity.
Interactions
Probenecid raises levels; may increase warfarin effect.
Special advice
Cross-reactivity with penicillin allergy is low but avoid after anaphylaxis; adjust in renal impairment.
More from the textbook: uses, cautions and other points
- Pregnancy - always send a urine culture and treat (including asymptomatic bacteriuria): nitrofurantoin (avoid near term - neonatal haemolysis), amoxicillin (only if sensitive) or cefalexin; avoid trimethoprim in the first trimester (folate antagonist - neural tube defects).
Renal: Anatomy, Physiology and Pharmacology - Pyelonephritis (NICE NG111) - cefalexin, co-amoxiclav (if sensitive), trimethoprim (if sensitive), or ciprofloxacin ; IV options (e.g. gentamicin, cefuroxime, ceftriaxone) if severe.
Renal: Anatomy, Physiology and Pharmacology - Nitrofurantoin (avoid at term - risk of neonatal haemolysis); amoxicillin or cefalexin depending on sensitivity.
Renal: Tubular Inherited Stones - Pregnancy - cefalexin orally, or IV cefuroxime.
Renal: Tubular Inherited Stones - Upper UTI - oral cefalexin or co-amoxiclav for 7–10 days ; IV (e.g. co-amoxiclav, cefuroxime, ceftriaxone or gentamicin) if severe, under 3 months, or unable to take oral.
Paediatrics: Kidneys, urinary tract and hormones in children - Cefalexin / co-amoxiclav | Upper UTI -7–10 days oral; IV options if severe.
Paediatrics: Kidneys, urinary tract and hormones in children
Where it is discussed
- Gastroenterology: Bowel Disorders (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Tubular Inherited Stones (5 mentions)
- Paediatrics: Kidneys, urinary tract and hormones in children (3 mentions)
- Obstetrics (2 mentions)
- ID: How Infection Happens (4 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Acute Medicine: The acute medical take (2 mentions)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (1 mention)
- Integrated paediatrics chapter (3 mentions)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (2 mentions)
Cefotaxime
BNF entry for Cefotaxime · Stand-alone drug page
Mechanism
Third-generation cephalosporin with good CSF penetration.
Uses
Meningitis, sepsis, serious Gram-negative and streptococcal infections.
Dosing
- IV antibiotics - e.g. ceftriaxone 80 mg/kg (cefotaxime plus amoxicillin under 3 months), per local policy.
Paediatrics: Infections in children - Ceftriaxone (once daily - useful for OPAT) and cefotaxime - bacterial meningitis , severe pneumonia, pyelonephritis, gonorrhoea (1 g IM), Lyme neuroborreliosis, typhoid; ceftriaxone can cause biliary sludge and must not be mixed with calcium in neonates.
ID: How Infection Happens - IV antibiotics — e.g. ceftriaxone 80 mg/kg (cefotaxime plus amoxicillin under 3 months), per local policy.
Integrated paediatrics chapter › Sepsis in Children
Side effects
Diarrhoea, rash, C. difficile; rarely haemolytic anaemia, neutropenia.
Interactions
Aminoglycosides increase nephrotoxicity; may enhance warfarin effect.
Special advice
Check allergy history; adjust in renal impairment; neonatal calcium precipitation warning applies to ceftriaxone, not cefotaxime.
More from the textbook: uses, cautions and other points
- SBP - treat with IV antibiotics (e.g. cefotaxime or per local policy); prophylaxis after an episode (ciprofloxacin or co-trimoxazole) and in some high-risk patients.
Gastroenterology: Anatomy Physiology Pharmacology - Bacterial meningitis - ceftriaxone (or cefotaxime) urgently, plus amoxicillin if Listeria is possible (over 60, immunocompromised, pregnant); dexamethasone with or just before the first antibiotic dose in adults with suspected bacterial meningitis; benzylpenicillin IM in the community for suspected meningococcal disease.
Neurology: Anatomy, Physiology and Pharmacology - Meningitis - cefotaxime (or ceftriaxone after the first days) plus amoxicillin (Listeria).
Paediatrics: Neonatology - Late-onset (in the community) - e.g. cefotaxime plus amoxicillin; on neonatal units per local policy.
Paediatrics: Neonatology - IV cefotaxime (or ceftriaxone if over 28 days old) plus amoxicillin (for Listeria).
Paediatrics: Infections in children - Under 3 months - IV cefotaxime plus amoxicillin (Listeria).
Paediatrics: Infections in children
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Paediatrics: Neonatology (3 mentions)
- Paediatrics: Infections in children (6 mentions)
- ID: How Infection Happens (1 mention)
- Emergency Medicine: Paediatric emergency medicine (3 mentions)
- Integrated paediatrics chapter (9 mentions)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (1 mention)
Ceftazidime
BNF entry for Ceftazidime · Stand-alone drug page
Mechanism
Third-generation cephalosporin with antipseudomonal activity.
Uses
Pseudomonas infections, hospital-acquired pneumonia, neutropenic sepsis, melioidosis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Diarrhoea, rash, C. difficile; neurotoxicity in renal failure.
Interactions
Aminoglycosides increase nephrotoxicity.
Special advice
Adjust in renal impairment to avoid encephalopathy; weaker against Gram-positives.
More from the textbook: uses, cautions and other points
- Cover both Gram-positives ( vancomycin or a cephalosporin) and Gram-negatives ( ceftazidime or an aminoglycoside), as per local policy.
Renal: Dialysis and Transplant - Ceftazidime / gentamicin | Gram-negative cover in PD peritonitis (intraperitoneal) or line sepsis.
Renal: Dialysis and Transplant - Necrotising (malignant) otitis externa — older people with diabetes or immunosuppression; severe pain, granulation tissue at the bony–cartilaginous junction, cranial nerve palsies — Pseudomonas skull base osteomyelitis — urgent ENT, CT or MRI, prolonged IV anti-pseudomonal antibiotics (e.g. ceftazidime, ciprofloxacin).
ENT Anatomy Physiology - Prolonged antipseudomonal antibiotics - IV (e.g. ceftazidime, piperacillin–tazobactam) then oral ciprofloxacin , often for 6 weeks or more .
ENT: Emergencies - Ciprofloxacin / ceftazidime / piperacillin–tazobactam | Necrotising otitis externa (Pseudomonas) for 6 weeks or more.
ENT: Emergencies - Endophthalmitis (after surgery or injection) — intravitreal antibiotics (vancomycin and ceftazidime) — emergency.
Ophthalmology: Anatomy Physiology and Pharmacology
Where it is discussed
- Renal: Dialysis and Transplant (2 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Emergencies (2 mentions)
- Ophthalmology: Anatomy Physiology and Pharmacology (1 mention)
- Ophthalmology: Red emergencies (1 mention)
- ID: How Infection Happens (6 mentions)
- ID: Tropical and travel medicine (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (1 mention)
- Microbiology: Bacteriology - structure, classification and important pathogens (1 mention)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (1 mention)
Ceftriaxone
BNF entry for Ceftriaxone · Stand-alone drug page
Mechanism
Third-generation cephalosporin with long half-life and biliary excretion.
Uses
Meningitis, pneumonia, gonorrhoea, sepsis, biliary sepsis, Lyme disease.
Dosing
- IV antibiotics - infection is common and increases rebleeding and death. For example, co-amoxiclav 1.2 g IV three times daily, or ciprofloxacin or ceftriaxone, per local policy.
Gastroenterology: Gastroenterology Emergencies (Complete) - Antibiotics Variceal bleed | e.g. co-amoxiclav 1.2 g IV three times daily, or ciprofloxacin or ceftriaxone, per local policy.
Gastroenterology: Gastroenterology Emergencies (Complete) - Bacterial meningitis | Blood cultures; ceftriaxone 2 g IV (plus amoxicillin if Listeria risk) within 1 hour; dexamethasone
Neurology: Emergencies - Ceftriaxone 2 g IV every 12 hours (high dose).
Neurology: Emergencies
4 more dose entries from the chapters
- IV antibiotics - e.g. ceftriaxone 80 mg/kg (cefotaxime plus amoxicillin under 3 months), per local policy.
Paediatrics: Infections in children - Over 3 months - IV ceftriaxone (80 mg/kg once daily, or as per local policy).
Paediatrics: Infections in children - Ceftriaxone 1 g IM single dose .
Gynaecology: Sexual health - Ceftriaxone 1 g IM single dose , plus
Gynaecology: Sexual health
Side effects
Diarrhoea, rash, biliary sludging, C. difficile; rarely haemolysis.
Interactions
Calcium-containing infusions in neonates (fatal precipitates); may increase warfarin effect.
Special advice
Avoid with IV calcium in neonates; useful once-daily dosing; no renal adjustment unless combined renal and hepatic impairment.
More from the textbook: uses, cautions and other points
- IV antibiotics (e.g. ceftriaxone) for supraglottitis.
Respiratory: Emergencies - Treatment: IV ceftriaxone for 2 weeks, then oral co-trimoxazole for 12 months . Fatal if untreated.
Gastroenterology: Bowel Disorders - Drugs - octreotide, fibrates, ceftriaxone.
Gastroenterology: Pancreas and Biliary - Bacterial meningitis - ceftriaxone (or cefotaxime) urgently, plus amoxicillin if Listeria is possible (over 60, immunocompromised, pregnant); dexamethasone with or just before the first antibiotic dose in adults with suspected bacterial meningitis; benzylpenicillin IM in the community for suspected meningococcal disease.
Neurology: Anatomy, Physiology and Pharmacology - Aciclovir / ceftriaxone / dexamethasone | Encephalitis / meningitis (add amoxicillin for Listeria risk) / adjunct in bacterial meningitis.
Neurology: Anatomy, Physiology and Pharmacology - ⚠️ Safety Pearl: Never delay antibiotics for a CT scan or LP in suspected bacterial meningitis. Take blood cultures, give ceftriaxone (and dexamethasone), then investigate.
Neurology: Emergencies
Where it is discussed
- Respiratory: Emergencies (1 mention)
- Gastroenterology: Gastroenterology Emergencies (Complete) (2 mentions)
- Gastroenterology: Bowel Disorders (1 mention)
- Gastroenterology: Pancreas and Biliary (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Emergencies (6 mentions)
- Neurology: Spine and Sleep Disorders (3 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Tubular Inherited Stones (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Emergencies (2 mentions)
- Paediatrics: Neonatology (1 mention)
- Paediatrics: Kidneys, urinary tract and hormones in children (1 mention)
- Paediatrics: Infections in children (7 mentions)
- Paediatrics: Neurology, bones and joints in children (2 mentions)
- Gynaecology: Sexual health (10 mentions)
- Dermatology: Skin infections and infestations (2 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Rheumatology: assessment, investigations and drugs (1 mention)
- ENT: Emergencies (6 mentions)
- Ophthalmology: Red emergencies (3 mentions)
- ID: How Infection Happens (7 mentions)
- ID: Sepsis, fever and serious bacterial infections (10 mentions)
- ID: Tropical and travel medicine (2 mentions)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
Celecoxib
BNF entry for Celecoxib · Stand-alone drug page
Mechanism
Selective cyclooxygenase-2 inhibitor.
Uses
Osteoarthritis, rheumatoid arthritis, ankylosing spondylitis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Dyspepsia, hypertension, fluid retention, renal impairment; increased cardiovascular risk.
Interactions
Warfarin effect rises; ACE inhibitors and diuretics raise renal risk; fluconazole increases levels.
Special advice
Avoid in ischaemic heart disease, stroke and heart failure; lowest dose for shortest time; sulfonamide allergy caution.
More from the textbook: uses, cautions and other points
- COX-2 selective (celecoxib, etoricoxib) — fewer GI effects but similar renal and CV risks.
Rheumatology Anatomy Physiology Pharmacology - NSAIDs (naproxen, ibuprofen, diclofenac, etoricoxib, celecoxib) - reduce pain and stiffness in inflammatory arthritis; don't alter disease progression in RA (but are first-line in axial spondyloarthritis).
Rheumatology: assessment, investigations and drugs
Where it is discussed
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (1 mention)
Cetirizine
BNF entry for Cetirizine · Stand-alone drug page
Mechanism
Second-generation H1 antihistamine with little CNS penetration.
Uses
Allergic rhinitis, urticaria.
Dosing
- 5. A 35-year-old has had daily itchy wheals for 4 months. Each wheal fades within a day. Cetirizine 10 mg helps a little. Answer: Chronic spontaneous urticaria.
Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema
Side effects
Mild drowsiness, dry mouth, headache.
Interactions
Additive sedation with alcohol and other sedatives.
Special advice
Reduce dose in renal impairment; avoid with prolonged driving effect risk if drowsy.
More from the textbook: uses, cautions and other points
- Antihistamines — chlorphenamine, loratadine, cetirizine.
Obstetrics - Non-sedating antihistamine (cetirizine, loratadine, fexofenadine) daily; if not controlled, increase up to four times the standard dose (off-label, specialist advice).
Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies - Cetirizine / loratadine / fexofenadine | Urticaria - daily; up to four times standard dose for chronic urticaria (specialist advice).
Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies - Antihistamines — oral non-sedating (cetirizine, loratadine, fexofenadine) or intranasal (azelastine) — sneezing, itch, rhinorrhoea; less effect on blockage.
ENT Anatomy Physiology - Oral non-sedating antihistamines - cetirizine, loratadine, fexofenadine - for mild or intermittent symptoms.
ENT: Common Nose and Throat disorders - Cetirizine / loratadine / fexofenadine | Non-sedating oral antihistamines for allergic rhinitis.
ENT: Common Nose and Throat disorders
Where it is discussed
- Obstetrics (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Nose and Throat disorders (2 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (4 mentions)
Chloramphenicol
BNF entry for Chloramphenicol · Stand-alone drug page
Mechanism
Binds the 50S ribosome, inhibiting bacterial protein synthesis.
Uses
Bacterial conjunctivitis (topical); systemic use for severe infections in rare circumstances.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Topical: local irritation; systemic: bone marrow suppression, aplastic anaemia, grey baby syndrome.
Interactions
Warfarin, phenytoin and sulfonylurea levels rise with systemic use.
Special advice
Systemic use needs blood monitoring and is avoided in neonates and pregnancy.
More from the textbook: uses, cautions and other points
- Agranulocytosis / aplastic anaemia | Carbimazole , propylthiouracil, clozapine (mandatory FBC monitoring), sulfasalazine, carbamazepine , co-trimoxazole, chloramphenicol, deferiprone , methotrexate, azathioprine (TPMT), mirtazapine (rare), NSAIDs (rare) - warn about sore throat and fever
Haematology: Anatomy Physiology and Pharmacology - Sideroblastic anaemia | Isoniazid (pyridoxine), linezolid, chloramphenicol, alcohol, lead
Haematology: Anatomy Physiology and Pharmacology - Drugs - chloramphenicol, carbamazepine, sulfonamides, gold, NSAIDs, antithyroid drugs.
Haematology: Anaemia - Chloramphenicol (systemic) in neonates - grey baby syndrome.
Paediatrics: Infections in children - Bacterial conjunctivitis — usually self-limiting within 1–2 weeks — lid hygiene and delayed treatment; chloramphenicol drops (or ointment) if severe or persisting; fusidic acid (twice daily — easier for children, pregnancy); no need to exclude children from school (UKHSA).
Ophthalmology: Anatomy Physiology and Pharmacology - Antibiotic drops - chloramphenicol (drops or ointment), fusidic acid, ofloxacin (for contact lens wearers), levofloxacin.
Ophthalmology Basics Cataract Glaucoma
Where it is discussed
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Haematology: Anaemia (1 mention)
- Paediatrics: Infections in children (1 mention)
- Ophthalmology: Anatomy Physiology and Pharmacology (1 mention)
- Ophthalmology Basics Cataract Glaucoma (2 mentions)
- Ophthalmology: Red emergencies (4 mentions)
- Ophthalmology: Neuro-ophthalmology (1 mention)
- ID: How Infection Happens (4 mentions)
- Emergency Medicine: Minor injuries wounds, bites, minor burns, hands and foreign bodies (2 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Integrated paediatrics chapter (1 mention)
- Cell Biology: Cell structure, organelles and membrane transport (1 mention)
- Cell Biology: Molecular biology, gene expression and laboratory techniques (1 mention)
Chlorphenamine
BNF entry for Chlorphenamine · Stand-alone drug page
Mechanism
Sedating first-generation H1 antihistamine.
Uses
Urticaria, allergic reactions, pruritus.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Drowsiness, dry mouth, urinary retention, confusion in older adults.
Interactions
Additive sedation with alcohol, opioids and sedatives.
Special advice
Not part of first-line anaphylaxis treatment; avoid driving and in older people if possible.
More from the textbook: uses, cautions and other points
- ⚠️ Safety Pearl: IM adrenaline is the treatment for anaphylaxis - give it early and repeat it. Delaying adrenaline to give chlorphenamine and hydrocortisone is a common and dangerous mistake.
Respiratory: Emergencies - Anticholinergic burden - drugs with antimuscarinic effects (oxybutynin, TCAs, chlorphenamine, some antipsychotics) worsen confusion and are linked to dementia risk - review and deprescribe.
Neurology: Anatomy, Physiology and Pharmacology - Anticholinergics - oxybutynin, tolterodine, amitriptyline, chlorphenamine, promethazine, hyoscine, procyclidine, many others. Use an anticholinergic burden score (e.g. ACB).
Neurology: Dementia and Cognition Disorders (Complete) - Chlorphenamine | Mild allergic transfusion reaction.
Haematology: Haemoglobinopathies and Transfusion - Supportive - paracetamol, fluids, calamine or emollients, chlorphenamine (over 1 year) for itch; cut nails.
Paediatrics: Infections in children - Antihistamines — chlorphenamine, loratadine, cetirizine.
Obstetrics
Where it is discussed
- Respiratory: Emergencies (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Dementia and Cognition Disorders (Complete) (1 mention)
- Haematology: Haemoglobinopathies and Transfusion (1 mention)
- Paediatrics: Infections in children (1 mention)
- Obstetrics (1 mention)
- Obstetrics: Antenatal Care (1 mention)
- Obstetrics: Medical Problems (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (5 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Integrated respiratory chapter (1 mention)
- Integrated paediatrics chapter (1 mention)
Chlorpromazine
BNF entry for Chlorpromazine · Stand-alone drug page
Mechanism
Typical phenothiazine antipsychotic blocking dopamine D2 and several other receptors.
Uses
Schizophrenia, severe agitation, intractable hiccups, nausea.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Sedation, postural hypotension, extrapyramidal effects, anticholinergic effects, hyperprolactinaemia, QT prolongation, photosensitivity.
Interactions
Other QT-prolonging drugs and CNS depressants; anticholinergics additive; lowers seizure threshold.
Special advice
Monitor ECG, weight and glucose; neuroleptic malignant syndrome risk; caution in dementia (stroke and mortality risk).
More from the textbook: uses, cautions and other points
- Cholestatic (ALP up) | Co-amoxiclav (may start up to 6 weeks after the course), flucloxacillin (older people; may be delayed), chlorpromazine, combined pill , anabolic steroids , carbimazole, sulfonylureas, erythromycin, terbinafine
Gastroenterology: Anatomy Physiology Pharmacology - Cholestatic | Co-amoxiclav (often weeks after the course ends; older men), flucloxacillin , chlorpromazine, anabolic steroids , the combined pill, erythromycin, terbinafine
Gastroenterology: Liver disease - Chlorpromazine or haloperidol.
Palliative: Symptoms Management - Phenothiazines (thioridazine, chlorpromazine) | Pigmentary retinopathy (thioridazine), lens and corneal deposits
Ophthalmology: Anatomy Physiology and Pharmacology - Causes - TCAs, antihistamines (diphenhydramine, promethazine), antipsychotics (chlorpromazine, clozapine, olanzapine), procyclidine, hyoscine, oxybutynin, some plants (deadly nightshade, Jimson weed); older people on multiple anticholinergic drugs (anticholinergic burden).
Psychiatric emergencies - Chlorpromazine (first-generation) | Sedation, hypotension, anticholinergic effects, photosensitivity, jaundice.
Psychiatry: Psychosis and schizophrenia
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Liver disease (1 mention)
- Palliative: Symptoms Management (1 mention)
- Ophthalmology: Anatomy Physiology and Pharmacology (1 mention)
- Psychiatric emergencies (1 mention)
- Psychiatry: Psychosis and schizophrenia (2 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Biochemistry: Clinical biochemistry - interpreting laboratory tests (1 mention)
Ciclosporin
BNF entry for Ciclosporin · Stand-alone drug page
Mechanism
Calcineurin inhibitor blocking IL-2 transcription and T-cell activation.
Uses
Transplant immunosuppression, severe psoriasis, atopic dermatitis, nephrotic syndrome, rheumatoid arthritis.
Dosing
- IV hydrocortisone 100 mg four times daily (or IV methylprednisolone) in acute severe ulcerative colitis (Truelove and Witts criteria) - with VTE prophylaxis, stool cultures and C. difficile test; review on day 3 for rescue therapy (ciclosporin or infliximab) or surgery.
Gastroenterology: Anatomy Physiology Pharmacology - Rescue therapy: Infliximab (e.g. 5 mg/kg; some centres use higher or accelerated dosing) or ciclosporin .
Gastroenterology: Gastroenterology Emergencies (Complete) - Infliximab / ciclosporin Steroid-refractory UC | Rescue therapy (specialist); infliximab 5 mg/kg (higher or accelerated in some protocols).
Gastroenterology: Gastroenterology Emergencies (Complete) - Severe: Admit - IV hydrocortisone 100 mg four times daily or methylprednisolone 60 mg daily; rescue with infliximab or ciclosporin; colectomy if no response.
Gastroenterology: Inflammatory Bowel Disease
3 more dose entries from the chapters
- Immunosuppressants compatible with pregnancy — prednisolone (mostly inactivated by the placenta), hydroxychloroquine , azathioprine , sulfasalazine (with folic acid 5 mg), ciclosporin, tacrolimus, most anti-TNF drugs (certolizumab minimal transfer).
Obstetrics - … (e.g. 500 micrograms 2–4 times daily); diarrhoea is the dose-limiting effect; toxic in overdose; reduce dose in renal impairment; interactions — clarithromycin , ciclosporin, verapamil, diltiazem (CYP3A4 and P-glycoprotein) — myopathy and toxicity.
Rheumatology Anatomy Physiology Pharmacology - … course dose) is as effective as high dose with fewer side effects; diarrhoea is common; reduce or avoid in CKD; interactions - clarithromycin, erythromycin, ciclosporin, verapamil, diltiazem, some statins (toxicity, myopathy).
Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain
Side effects
Nephrotoxicity, hypertension, tremor, hirsutism, gum hyperplasia, hyperkalaemia, hypomagnesaemia.
Interactions
Many CYP3A4 interactions (macrolides, azoles, diltiazem raise levels; rifampicin, phenytoin lower); nephrotoxic drugs; statins myopathy.
Special advice
Monitor trough levels, creatinine, BP, potassium; avoid grapefruit; live vaccines contraindicated.
More from the textbook: uses, cautions and other points
- Inhibit CYP3A4 - raise levels of simvastatin, ciclosporin and others; raise digoxin levels.
Cardiology: Anatomy Physiology and Pharmacology - Treatment: Combined immunosuppression (high-dose corticosteroid plus ciclosporin or tacrolimus, ± anti-thymocyte globulin) improves survival.
Cardiology: Cardiomyopathies › 3.36 Giant-cell Myocarditis - Tacrolimus and ciclosporin - post-transplant diabetes.
Endocrinology: Diabetes - Drugs: ACE inhibitors, ARBs, spironolactone and eplerenone, heparin (which inhibits aldosterone production), NSAIDs, ciclosporin and tacrolimus. Trimethoprim and amiloride cause a similar picture by blocking the sodium channel.
Endocrinology: Adrenal Disease - Drugs - thiazides, beta-blockers, glucocorticoids, ciclosporin, retinoids, atypical antipsychotics, antiretrovirals.
Endocrinology: Lipids and obesity - Ciclosporin and tacrolimus, cisplatin.
Endocrinology: Bone Medicine
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: Cardiomyopathies (1 mention)
- Endocrinology: Diabetes (1 mention)
- Endocrinology: Adrenal Disease (1 mention)
- Endocrinology: Lipids and obesity (1 mention)
- Endocrinology: Bone Medicine (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (3 mentions)
- Gastroenterology: Inflammatory Bowel Disease (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Movement Disorders (1 mention)
- Neurology: Spine and Sleep Disorders (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (5 mentions)
- Renal: Emergencies (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Dialysis and Transplant (5 mentions)
- Renal: Glomerular Disease (3 mentions)
- Haematology: History and Examination (2 mentions)
- Haematology: Anaemia (2 mentions)
- Obstetrics (1 mention)
- Dermatology: Skin basics, eczema and psoriasis (3 mentions)
- Dermatology: Skin lesions and skin cancer (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (7 mentions)
- Rheumatology Anatomy Physiology Pharmacology (3 mentions)
Ciprofloxacin
BNF entry for Ciprofloxacin · Stand-alone drug page
Mechanism
Fluoroquinolone inhibiting bacterial DNA gyrase and topoisomerase IV.
Uses
Complicated urinary tract infection, pseudomonal infection, anthrax, travellers diarrhoea.
Dosing
- Theophylline / aminophylline | Level 10–20 mg/L; ciprofloxacin and clarithromycin raise levels; smoking lowers; toxicity - vomiting, arrhythmias, seizures.
Respiratory: Anatomy, Physiology and Pharmacology - IV antibiotics - infection is common and increases rebleeding and death. For example, co-amoxiclav 1.2 g IV three times daily, or ciprofloxacin or ceftriaxone, per local policy.
Gastroenterology: Gastroenterology Emergencies (Complete) - Antibiotics Variceal bleed | e.g. co-amoxiclav 1.2 g IV three times daily, or ciprofloxacin or ceftriaxone, per local policy.
Gastroenterology: Gastroenterology Emergencies (Complete) - Ciprofloxacin 500 mg orally only if the strain is known to be sensitive.
Gynaecology: Sexual health
Side effects
Nausea, diarrhoea, tendon rupture, QT prolongation, seizures, aortic aneurysm risk, dysglycaemia.
Interactions
Antacids, calcium and iron chelate it; theophylline levels rise; corticosteroids increase tendon risk; warfarin effect rises.
Special advice
MHRA restrictions: use only when other agents are unsuitable; stop at first tendon pain; avoid in epilepsy and myasthenia gravis.
More from the textbook: uses, cautions and other points
- Many interactions - enzyme inhibitors raise INR (amiodarone, clarithromycin, erythromycin, fluconazole, metronidazole, ciprofloxacin, alcohol binges); inducers lower it (rifampicin, carbamazepine, phenytoin, St John's wort); diet (vitamin K-rich foods).
Cardiology: Anatomy Physiology and Pharmacology - Metabolised by CYP1A2 - levels raised by ciprofloxacin , clarithromycin , erythromycin, fluvoxamine, cimetidine, heart failure, liver disease, viral infection, stopping smoking; lowered by smoking , rifampicin, carbamazepine, phenytoin, alcohol.
Respiratory: Anatomy, Physiology and Pharmacology - Vomiting and seizure in a theophylline user given ciprofloxacin | Theophylline toxicity (CYP1A2 inhibition)
Respiratory: Anatomy, Physiology and Pharmacology - New Pseudomonas aeruginosa : Eradication treatment (e.g. oral ciprofloxacin, sometimes with nebulised colistin).
Respiratory: Airways Disease - Eradication treatment (e.g. ciprofloxacin ± nebulised colistin).
Respiratory: Airways Disease - SBP - treat with IV antibiotics (e.g. cefotaxime or per local policy); prophylaxis after an episode (ciprofloxacin or co-trimoxazole) and in some high-risk patients.
Gastroenterology: Anatomy Physiology Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (4 mentions)
- Respiratory: Airways Disease (2 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Gastroenterology Emergencies (Complete) (3 mentions)
- Gastroenterology: Inflammatory Bowel Disease (3 mentions)
- Gastroenterology: Cirrhosis and Transplantation (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (4 mentions)
- Neurology: Emergencies (1 mention)
- Neurology: Epilepsy (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Tubular Inherited Stones (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Oncology: Emergencies (1 mention)
- Paediatrics: Infections in children (2 mentions)
- Gynaecology: Sexual health (1 mention)
- ENT Anatomy Physiology (5 mentions)
- ENT: Common Ear disorders (3 mentions)
- ENT: Emergencies (3 mentions)
- ID: How Infection Happens (6 mentions)
- ID: Sepsis, fever and serious bacterial infections (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (4 mentions)
- Psychiatry: Psychosis and schizophrenia (1 mention)
- Surgery: Colorectal and anal surgery (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
Citalopram
BNF entry for Citalopram · Stand-alone drug page
Mechanism
SSRI blocking serotonin reuptake.
Uses
Depression, panic disorder.
Dosing
- SSRIs - sertraline, citalopram, escitalopram, fluoxetine, paroxetine | Usual first choice - safer in overdose. Sertraline - preferred after MI or with heart disease. Citalopram/escitalopram - QT prolongation (citalopram max 20 mg over 65). Fluoxetine - long half-life (fewer withdrawal effects), many interactions; first-line in …
Psychiatry: Mood disorders - Citalopram / escitalopram | QT prolongation - citalopram max 20 mg over 65.
Psychiatry: Mood disorders - SSRIs - sertraline is often first choice in older people (fewer interactions); citalopram (max 20 mg over 65 - QT); watch for hyponatraemia (check sodium at baseline and 2–4 weeks), GI bleeding (add PPI with NSAIDs or anticoagulants), falls.
Medicine of the older adult: Delirium, dementia and mood in older people - Antidepressants - SSRIs (sertraline) - hyponatraemia (check sodium), bleeding (with NSAIDs, anticoagulants), falls; citalopram max 20 mg over 65 (QT); avoid tricyclics ; mirtazapine (sedation, weight gain).
Medicine of the older adult: .Prescribing and deprescribing in older people
Side effects
Nausea, insomnia, sexual dysfunction, hyponatraemia, QT prolongation (dose-related), bleeding risk.
Interactions
Other QT-prolonging drugs; MAOIs and triptans (serotonin syndrome); NSAIDs and anticoagulants increase bleeding.
Special advice
Maximum dose is lower in older people and hepatic impairment; monitor sodium in older adults; taper on stopping.
More from the textbook: uses, cautions and other points
- Antipsychotics (haloperidol), citalopram, escitalopram, methadone, ondansetron, domperidone.
Cardiology: Cardiology Emergencies - Depression - psychological approaches; antidepressants have little evidence in moderate to severe dementia (sertraline, mirtazapine are used; citalopram - QT limit). Avoid tricyclics (anticholinergic).
Neurology: Dementia and Cognition Disorders (Complete) - CYP2D6 inhibitors (fluoxetine, paroxetine) may reduce its effect - use other antidepressants (venlafaxine, citalopram).
Oncology: Principles - Use a different antidepressant (e.g. sertraline, citalopram or venlafaxine).
Oncology: Principles - SSRIs or SNRIs (venlafaxine, citalopram - avoid fluoxetine and paroxetine with tamoxifen ).
Oncology: Breast and Gynae Cancers - SSRIs or SNRIs (e.g. venlafaxine, citalopram) - avoid fluoxetine and paroxetine with tamoxifen (they reduce its effect).
Gynaecology: Fertility Contraception Menopause
Where it is discussed
- Cardiology: Cardiology Emergencies (1 mention)
- Neurology: Dementia and Cognition Disorders (Complete) (1 mention)
- Oncology: Principles (2 mentions)
- Oncology: Breast and Gynae Cancers (1 mention)
- Gynaecology: Fertility Contraception Menopause (2 mentions)
- Psychiatric emergencies (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (1 mention)
- Psychiatry: Safeguarding (2 mentions)
- Psychiatry: Mood disorders (6 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (3 mentions)
- Medicine of the older adult: Delirium, dementia and mood in older people (2 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (3 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (3 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (2 mentions)
Clarithromycin
BNF entry for Clarithromycin · Stand-alone drug page
Mechanism
Macrolide binding 50S ribosome.
Uses
Community-acquired pneumonia (atypical cover), H. pylori eradication, Penicillin-allergic respiratory infections.
Dosing
- Atorvastatin | HMG-CoA reductase inhibitor; 20 mg primary, 80 mg secondary prevention; LFTs at 0, 3, 12 months; clarithromycin interaction.
Cardiology: Anatomy Physiology and Pharmacology - Theophylline / aminophylline | Level 10–20 mg/L; ciprofloxacin and clarithromycin raise levels; smoking lowers; toxicity - vomiting, arrhythmias, seizures.
Respiratory: Anatomy, Physiology and Pharmacology - Low | Amoxicillin 500 mg three times daily (doxycycline or clarithromycin)
Respiratory: Emergencies - Moderate | Amoxicillin, plus clarithromycin 500 mg twice daily if atypical infection suspected (doxycycline or clarithromycin)
Respiratory: Emergencies
4 more dose entries from the chapters
- First line: PPI + amoxicillin 1 g + clarithromycin 500 mg or metronidazole 400 mg .
Gastroenterology: Oesophagus and Stomach - Penicillin allergy: PPI + clarithromycin 250 mg + metronidazole 400 mg.
Gastroenterology: Oesophagus and Stomach - Antibiotics - flucloxacillin 500 mg four times daily for 10–14 days (erythromycin or clarithromycin if allergic) if symptoms don't improve within 12–24 hours, if there is a cracked nipple that looks infected, or if culture is positive.
Obstetrics: Post Natal Care - … — low dose (e.g. 500 micrograms 2–4 times daily); diarrhoea is the dose-limiting effect; toxic in overdose; reduce dose in renal impairment; interactions — clarithromycin , ciclosporin, verapamil, diltiazem (CYP3A4 and P-glycoprotein) — myopathy and toxicity.
Rheumatology Anatomy Physiology Pharmacology
Side effects
Nausea, diarrhoea, taste disturbance, QT prolongation, hepatotoxicity.
Interactions
Strong CYP3A4 inhibitor: raises statins, colchicine, ciclosporin, DOACs, carbamazepine and warfarin effect.
Special advice
Check interactions before prescribing; stop simvastatin and atorvastatin cautiously; ECG risk with QT-prolonging drugs.
More from the textbook: uses, cautions and other points
- Many interactions - enzyme inhibitors raise INR (amiodarone, clarithromycin, erythromycin, fluconazole, metronidazole, ciprofloxacin, alcohol binges); inducers lower it (rifampicin, carbamazepine, phenytoin, St John's wort); diet (vitamin K-rich foods).
Cardiology: Anatomy Physiology and Pharmacology - Interactions - CYP3A4 inhibitors ( clarithromycin , erythromycin, itraconazole, grapefruit juice with simvastatin), amiodarone and diltiazem (simvastatin dose limits), fibrates (gemfibrozil - avoid).
Cardiology: Anatomy Physiology and Pharmacology - Macrolides (clarithromycin, erythromycin), quinolones.
Cardiology: Cardiology Emergencies - Twisting polymorphic VT on clarithromycin and haloperidol | Torsades de pointes
Cardiology: Cardiology Emergencies - Metabolised by CYP1A2 - levels raised by ciprofloxacin , clarithromycin , erythromycin, fluvoxamine, cimetidine, heart failure, liver disease, viral infection, stopping smoking; lowered by smoking , rifampicin, carbamazepine, phenytoin, alcohol.
Respiratory: Anatomy, Physiology and Pharmacology - Monitoring - LFTs (raised transaminases), eye checks in children (cataracts), mood; many CYP3A4 interactions (e.g. rifampicin, clarithromycin, azole antifungals).
Respiratory: Anatomy, Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (6 mentions)
- Cardiology: Cardiology Emergencies (2 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (10 mentions)
- Respiratory: Emergencies (8 mentions)
- Respiratory: Infections (5 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Adrenal Disease (2 mentions)
- Endocrinology: Lipids and obesity (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (6 mentions)
- Gastroenterology: Oesophagus and Stomach (9 mentions)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Epilepsy (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (6 mentions)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Dialysis and Transplant (6 mentions)
- Haematology: Anatomy Physiology and Pharmacology (3 mentions)
- Haematology: Haemostasis and Thrombosis (1 mention)
- Oncology: Principles (1 mention)
- Paediatrics: Respiratory and heart problems in children (3 mentions)
- Paediatrics: Infections in children (1 mention)
- Obstetrics: Post Natal Care (1 mention)
- Dermatology: Skin basics, eczema and psoriasis (2 mentions)
- Dermatology: Skin infections and infestations (5 mentions)
Clindamycin
BNF entry for Clindamycin · Stand-alone drug page
Mechanism
Lincosamide binding 50S ribosome.
Uses
Bone and joint infection, skin and soft tissue, toxin suppression in necrotising infection, dental infection.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Diarrhoea, C. difficile colitis, rash, nausea.
Interactions
Neuromuscular blockers potentiated; erythromycin antagonism.
Special advice
Highest risk of C. difficile among common antibiotics; stop for significant diarrhoea.
More from the textbook: uses, cautions and other points
- Alternatives for co-trimoxazole allergy: clindamycin with primaquine (check G6PD), atovaquone, IV pentamidine.
Respiratory: Infections - Antibiotics (especially clindamycin, cephalosporins, co-amoxiclav and quinolones) and PPIs → C. difficile infection .
Gastroenterology: Anatomy Physiology Pharmacology - C. difficile risk | Clindamycin, cephalosporins, co-amoxiclav, quinolones; PPIs
Gastroenterology: Anatomy Physiology Pharmacology - Mechanism: Antibiotics (especially broad-spectrum - cephalosporins, co-amoxiclav, clindamycin, quinolones) disrupt the normal gut flora, letting toxin-producing C. difficile overgrow and cause colitis. PPIs, older age and hospital stay add to the risk.
Gastroenterology: Gastroenterology Emergencies (Complete) - Antibiotics - especially clindamycin, cephalosporins, co-amoxiclav and quinolones ("the 4 Cs").
Gastroenterology: Bowel Disorders - Toxic shock syndrome (staphylococcal or streptococcal) - add clindamycin ; consider IVIG.
Paediatrics: Infections in children
Where it is discussed
- Respiratory: Infections (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Bowel Disorders (1 mention)
- Paediatrics: Infections in children (4 mentions)
- Obstetrics (1 mention)
- Obstetrics: Obstetrics: Emergencies (4 mentions)
- Obstetrics: Post Natal Care (1 mention)
- Gynaecology: Sexual health (1 mention)
- Dermatology: Skin infections and infestations (8 mentions)
- ENT: Common Nose and Throat disorders (3 mentions)
- ID: How Infection Happens (8 mentions)
- ID: Sepsis, fever and serious bacterial infections (11 mentions)
- ID: Tropical and travel medicine (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (2 mentions)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (4 mentions)
- Surgey: Urology (2 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Emergency Medicine: Paediatric emergency medicine (1 mention)
- Emergency Medicine: ED procedures (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (2 mentions)
- Acute Medicine: The acute medical take (2 mentions)
- Integrated respiratory chapter (1 mention)
Clobazam
BNF entry for Clobazam · Stand-alone drug page
Mechanism
Benzodiazepine enhancing GABA-A receptor activity (1,5-benzodiazepine).
Uses
Adjunct in epilepsy, Lennox-Gastaut, intermittent seizure prophylaxis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Drowsiness, dizziness, tolerance, withdrawal seizures, behavioural change.
Interactions
Additive sedation with alcohol and opioids; enzyme inducers lower levels; stiripentol and cannabidiol raise active metabolite.
Special advice
Avoid abrupt withdrawal; tolerance may develop; avoid driving until effects known.
More from the textbook: uses, cautions and other points
- Brand consistency (MHRA categories) - keep patients on the same manufacturer for category 1 drugs ( phenytoin, carbamazepine, phenobarbital, primidone ); use clinical judgement for category 2 (valproate, lamotrigine, topiramate, oxcarbazepine, clobazam, others).
Neurology: Anatomy, Physiology and Pharmacology - Clobazam and clonazepam (benzodiazepines) - add-on and short-term "cover" (e.g. around periods - catamenial epilepsy); tolerance, sedation, dependence.
Neurology: Anatomy, Physiology and Pharmacology - Catamenial epilepsy (around periods) - specialist options include intermittent clobazam.
Neurology: Epilepsy - Clobazam | Short-term add-on (e.g. catamenial, clusters); tolerance.
Neurology: Epilepsy - Dravet syndrome | SCN1A mutation; prolonged febrile and afebrile seizures from the first year, then developmental slowing. Avoid sodium channel blockers (carbamazepine, lamotrigine, phenytoin). Valproate, clobazam, stiripentol, fenfluramine, cannabidiol.
Paediatrics: Neurology, bones and joints in children
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Epilepsy (2 mentions)
- Paediatrics: Neurology, bones and joints in children (1 mention)
- Integrated paediatrics chapter (1 mention)
Clopidogrel
BNF entry for Clopidogrel · Stand-alone drug page
Mechanism
Irreversible P2Y12 platelet receptor antagonist (prodrug activated by CYP2C19).
Uses
ACS, after stent, secondary prevention after stroke, peripheral arterial disease.
Dosing
- Clopidogrel (75 mg) - prodrug activated by CYP2C19 (poor metabolisers respond less; omeprazole may reduce effect - use lansoprazole or pantoprazole); irreversible.
Cardiology: Anatomy Physiology and Pharmacology - Second antiplatelet (per local PPCI protocol): prasugrel (60 mg loading, then 10 mg daily; 5 mg if aged 75 or over or under 60 kg) if not on an oral anticoagulant, or ticagrelor (180 mg loading, then 90 mg twice daily). Clopidogrel if high bleeding risk or on an anticoagulant.
Cardiology: Cardiology Emergencies - Clopidogrel: 300 mg loading if aged 75 or under; 75 mg (no loading) if over 75; then 75 mg daily. Ticagrelor and prasugrel are not used with fibrinolysis.
Cardiology: Ischaemic Heart Disease (ACS) › 1.21 STEMI: Fibrinolysis - Clopidogrel | 300–600 mg loading (600 mg before PCI), then 75 mg daily. With fibrinolysis: 300 mg if ≤75 years, 75 mg if >75.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table
4 more dose entries from the chapters
- Omeprazole 20 mg once daily (full dose) | GORD, dyspepsia, ulcer healing. 40 mg for severe disease. Before breakfast. Interacts with clopidogrel.
Gastroenterology: Oesophagus and Stomach - Lansoprazole 30 mg once daily | Alternative full-dose PPI; preferred with clopidogrel (with pantoprazole). Linked to microscopic colitis.
Gastroenterology: Oesophagus and Stomach - Acute ischaemic stroke - aspirin 300 mg daily for 2 weeks (once haemorrhage is excluded), then clopidogrel 75 mg daily long term.
Neurology: Anatomy, Physiology and Pharmacology - Aspirin 300 mg then clopidogrel | Ischaemic stroke -2 weeks aspirin, then clopidogrel long term; DAPT 21 days for high-risk TIA or minor stroke.
Neurology: Anatomy, Physiology and Pharmacology
Side effects
Bleeding, dyspepsia, rash; rarely TTP.
Interactions
Omeprazole and esomeprazole reduce activation (use pantoprazole instead); anticoagulants and NSAIDs increase bleeding.
Special advice
Stop 5 to 7 days before elective surgery where possible; poor CYP2C19 metabolisers have less benefit.
More from the textbook: uses, cautions and other points
- Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
Cardiology: Anatomy Physiology and Pharmacology - Before surgery - clopidogrel and ticagrelor usually stopped 5 days, prasugrel 7 days before (balance against stent thrombosis - discuss with cardiology).
Cardiology: Anatomy Physiology and Pharmacology - Conservative management: Ticagrelor (or clopidogrel if high bleeding risk).
Cardiology: Cardiology Emergencies - After the procedure: In stable disease, patients need aspirin plus clopidogrel (dual antiplatelet therapy) for about 6 months, to prevent clot forming on the stent.
Cardiology: Ischaemic Heart Disease (ACS) › 1.09 Revascularisation: PCI and CABG - STEMI with primary PCI: Prasugrel with aspirin if not on an oral anticoagulant; ticagrelor or clopidogrel as alternatives depending on bleeding risk.
Cardiology: Ischaemic Heart Disease (ACS) › 1.23 Antiplatelet Therapy - Bronchoscopy and EBUS - sedation (midazolam, opioids - respiratory depression in type 2 respiratory failure); risks of bleeding (stop anticoagulants and clopidogrel per protocol before biopsy), pneumothorax after transbronchial biopsy, hypoxia, infection; fast beforehand; check platelets and clotting.
Respiratory: Investigations
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (4 mentions)
- Cardiology: Cardiology Emergencies (2 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (6 mentions)
- Respiratory: Investigations (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (6 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Investigations (2 mentions)
- Gastroenterology: Oesophagus and Stomach (4 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (4 mentions)
- Neurology: Stroke Emergencies (7 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (7 mentions)
- Haematology: History and Examination (1 mention)
- Haematology: Emergencies (1 mention)
- Haematology: Haemostasis and Thrombosis (4 mentions)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
- Surgey: Trauma and orthopaedics (1 mention)
- Surgery: Vascular surgery (5 mentions)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (9 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (5 mentions)
Clozapine
BNF entry for Clozapine · Stand-alone drug page
Mechanism
Atypical antipsychotic with weak D2 and strong 5-HT2A and other receptor blockade.
Uses
Treatment-resistant schizophrenia.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Sedation, hypersalivation, constipation (can cause ileus), tachycardia, weight gain, seizures, myocarditis, agranulocytosis.
Interactions
Smoking cessation raises levels; ciprofloxacin and fluvoxamine raise levels; avoid with marrow-suppressant drugs and carbamazepine.
Special advice
Mandatory blood monitoring programme (neutrophils); treat constipation actively; re-titrate after missed doses; fever may signal neutropenia or myocarditis.
More from the textbook: uses, cautions and other points
- Causes: Viruses (parvovirus B19, HHV-6, enteroviruses such as Coxsackie B, SARS-CoV-2, influenza); mRNA vaccines (young males, within days of the second dose, usually mild); drugs (clozapine); autoimmune disease (SLE, sarcoid); bacterial (diphtheria, Lyme).
Cardiology: Cardiomyopathies › 3.35 Acute Myocarditis - 💡 Clinical / MRCP Pearl: Clozapine myocarditis usually occurs within the first 2 months; fever, tachycardia and a rising troponin or CRP during titration should prompt urgent review and stopping the drug.
Cardiology: Cardiomyopathies › 3.35 Acute Myocarditis - Antipsychotics , metoclopramide, domperidone | Hyperprolactinaemia ; olanzapine and clozapine - weight gain and diabetes
Endocrine: Anatomy Physiology and Pharmacology - Antipsychotics (olanzapine, clozapine).
Endocrinology: Diabetes - Constipation | Opioids , anticholinergics (oxybutynin, TCAs), iron, calcium, aluminium antacids, verapamil, ondansetron, clozapine (can cause fatal bowel obstruction - MHRA)
Gastroenterology: Anatomy Physiology Pharmacology - MHRA Drug Safety Updates: PPIs, metoclopramide, domperidone, ondansetron, loperamide, hyoscine butylbromide injection, JAK inhibitors, terlipressin, clozapine
Gastroenterology: Anatomy Physiology Pharmacology
Where it is discussed
- Cardiology: Cardiomyopathies (3 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: Diabetes (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Movement Disorders (5 mentions)
- Neurology: Dementia and Cognition Disorders (Complete) (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (4 mentions)
- Haematology: History and Examination (1 mention)
- Haematology: Emergencies (3 mentions)
- Haematology: Anaemia (2 mentions)
- ENT: Common Nose and Throat disorders (3 mentions)
- Psychiatry: assessment, treatment and the law (2 mentions)
- Psychiatric emergencies (2 mentions)
- Psychiatry: Alcohol, drugs and addiction (2 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (3 mentions)
- Psychiatry: Psychosis and schizophrenia (31 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (2 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (7 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (2 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Clinical Immunology: Primary immunodeficiency (1 mention)
Codeine
BNF entry for Codeine · Stand-alone drug page
Mechanism
Weak opioid agonist, prodrug converted to morphine by CYP2D6.
Uses
Mild to moderate pain, cough suppression, diarrhoea.
Dosing
- Oral codeine → oral morphine | Divide by 10 (240 mg codeine a day ≈ 24 mg morphine)
Palliative: Symptoms Management - 240 mg codeine a day ≈ 24 mg oral morphine a day: start MR morphine 10–15 mg twice daily (keep paracetamol).
Palliative: Symptoms Management - Restrict hypotonic oral fluids (about 500–1,000 mL a day) and give an oral rehydration solution (St Mark's); loperamide 30–60 minutes before meals (high doses may be needed), ± codeine and a PPI.
Surgery: Colorectal and anal surgery - Step-wise approach (by pain severity — RCEM): Pain Options Mild (1–3) Oral paracetamol and/or ibuprofen Moderate (4–6) Paracetamol plus ibuprofen; oral codeine or oral morphine; Entonox for short periods Severe (7–10) IV morphine (titrated — e.g. 0.1 mg/kg in 1–2 mg increments in adults); IV paracetamol; intranasal fentanyl or …
Emergency Medicine: ED procedures
3 more dose entries from the chapters
- 5 | Low-strength opioid preparations - co-codamol , low-strength codeine and dihydrocodeine, oral morphine solution 10 mg in 5 mL (Oramorph) | Minimal controls; ordinary prescription rules
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law - … (approximate) Oral morphine 10 mg SC morphine 5 mg Oral morphine 10 mg Oral oxycodone 5–7.5 mg (ratio 1.5–2:1) Oral morphine 10 mg SC diamorphine about 3.3 mg Oral codeine 60 mg Oral morphine about 6 mg (codeine is about one-tenth as potent) Oral morphine about 60 mg/24 hours Fentanyl 12 micrograms/hour patch (roughly - check …
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing - Oral codeine 60 mg | Oral morphine about 6 mg (codeine is about one-tenth as potent)
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing
Side effects
Constipation, nausea, drowsiness, dependence, respiratory depression in ultra-rapid metabolisers.
Interactions
CNS depressants additive; CYP2D6 inhibitors reduce effect; MAOIs contraindicated.
Special advice
Avoid in children under 12 and breastfeeding; give laxatives; avoid in ultra-rapid metabolisers.
More from the textbook: uses, cautions and other points
- Causes: Overdose, accumulation in renal impairment (morphine, codeine), transdermal patches, combinations with gabapentinoids or benzodiazepines.
Respiratory: Emergencies - Cough: Treat the cause; simple linctus, opioids (codeine or morphine).
Respiratory: Lung Cancer - Codeine phosphate - also slows the gut (high-output stomas); dependence and sedation.
Gastroenterology: Anatomy Physiology Pharmacology - Sedatives, opioids and constipating drugs - precipitate hepatic encephalopathy (if needed, use small doses, avoid codeine and long-acting drugs, give laxatives).
Gastroenterology: Anatomy Physiology Pharmacology - Loperamide in high doses (taken 30–60 minutes before meals; can be opened from capsules), with codeine if needed.
Gastroenterology: Investigations - Opioids: Use cautiously at low doses; they can trigger encephalopathy (through constipation and sedation). Give laxatives. Avoid codeine, and avoid morphine in severe disease (oxycodone in low doses, or fentanyl, is used with specialist advice).
Gastroenterology: Cirrhosis and Transplantation
Where it is discussed
- Respiratory: Emergencies (1 mention)
- Respiratory: Lung Cancer (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (5 mentions)
- Gastroenterology: Investigations (1 mention)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Headache and Facial Pain (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Dialysis and Transplant (1 mention)
- Palliative: Symptoms Management (7 mentions)
- Paediatrics: Infections in children (2 mentions)
- Obstetrics (5 mentions)
- Obstetrics: Medical Problems (1 mention)
- Obstetrics: Post Natal Care (1 mention)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (2 mentions)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Surgery: Colorectal and anal surgery (2 mentions)
- Medicine of the older adult. Ageing, frailty and comprehensive geriatric assessment (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (6 mentions)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (4 mentions)
- Emergency Medicine: ED procedures (4 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (12 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (2 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (10 mentions)
Colchicine
BNF entry for Colchicine · Stand-alone drug page
Mechanism
Binds tubulin, inhibiting microtubule assembly and neutrophil chemotaxis.
Uses
Acute gout, gout prophylaxis during urate-lowering therapy, pericarditis, familial Mediterranean fever.
Dosing
- High-dose aspirin plus colchicine 500 micrograms twice daily (once daily if under 70 kg) for about 3 months.
Cardiology: Ischaemic Heart Disease (ACS) › 1.30 Pericarditis and Late Complications - Colchicine — inhibits microtubule polymerisation → blocks neutrophil migration and NLRP3 inflammasome activation — low dose (e.g. 500 micrograms 2–4 times daily); diarrhoea is the dose-limiting effect; toxic in overdose; reduce dose in renal impairment; interactions — clarithromycin , ciclosporin, verapamil, diltiazem (CYP3A4 …
Rheumatology Anatomy Physiology Pharmacology - Colchicine - best started within 24 hours; low dose (500 micrograms 2–4 times a day - see BNF for maximum course dose) is as effective as high dose with fewer side effects; diarrhoea is common; reduce or avoid in CKD; interactions - clarithromycin, erythromycin, ciclosporin, verapamil, diltiazem, some statins (toxicity, …
Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain - Short course of oral steroid (e.g. prednisolone 30–35 mg daily for 3–5 days) - useful when NSAIDs and colchicine are unsuitable (CKD, heart failure).
Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain
Side effects
Diarrhoea, nausea, vomiting; toxicity causes marrow suppression, multi-organ failure, neuromyopathy.
Interactions
Clarithromycin, ciclosporin and strong CYP3A4/P-gp inhibitors raise levels; statins increase myopathy.
Special advice
Narrow therapeutic index; reduce in renal impairment and avoid with strong inhibitors; stop if severe diarrhoea.
More from the textbook: uses, cautions and other points
- Dressler's syndrome (weeks later) - autoimmune pericarditis, fever, effusion. NSAIDs or colchicine.
Cardiology: Cardiology Emergencies - Treat with high-dose aspirin; colchicine may be added.
Cardiology: Ischaemic Heart Disease (ACS) › 1.30 Pericarditis and Late Complications - First-line: Full anti-inflammatory-dose ibuprofen or aspirin plus colchicine (usually for at least three months after a first episode); give gastroprotection with anti-inflammatory therapy and check contraindications and interactions.
Cardiology: Pericardial Disease › 8.04 Treatment of Acute and Recurrent Pericarditis - Review before prescribing: Renal function, peptic ulcer or bleeding risk, anticoagulant use, pregnancy and colchicine interactions or hepatic impairment; dose and duration are individualised.
Cardiology: Pericardial Disease › 8.04 Treatment of Acute and Recurrent Pericarditis - Side effects to warn about - diarrhoea and C. difficile, taste disturbance; metronidazole with alcohol (disulfiram-like reaction - flushing, vomiting); clarithromycin - QT prolongation and CYP3A4 interactions (statins - pause simvastatin; warfarin; colchicine).
Gastroenterology: Anatomy Physiology Pharmacology - Diarrhoea | Antibiotics (and C. difficile ), metformin, magnesium, colchicine (also an early sign of toxicity), mycophenolate, PPIs, SSRIs, laxative misuse, checkpoint inhibitors (colitis)
Gastroenterology: Anatomy Physiology Pharmacology
Where it is discussed
- Cardiology: Cardiology Emergencies (1 mention)
- Cardiology: Ischaemic Heart Disease (ACS) (2 mentions)
- Cardiology: Pericardial Disease (5 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Neuromuscular disease (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Glomerular Disease (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (8 mentions)
- Rheumatology: assessment, investigations and drugs (1 mention)
- Rheumatology: Connective tissue diseases (1 mention)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (18 mentions)
- Rheumatology: Vasculitis, GCA and PMR (4 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (6 mentions)
- ID: How Infection Happens (3 mentions)
- ID: HIV, viral hepatitis and blood-borne viruses (1 mention)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (3 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Clinical Immunology: Immune system basics and immunological investigations (1 mention)
- Clinical Immunology: Primary immunodeficiency (2 mentions)
- Integrated cardiology chapter (6 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)
- Physiology: Cells, tissues, homeostasis, fluids and acid–base balance (2 mentions)
Colecalciferol
BNF entry for Colecalciferol · Stand-alone drug page
Mechanism
Vitamin D3, hydroxylated in liver and kidney to active calcitriol.
Uses
Vitamin D deficiency, osteoporosis treatment, rickets and osteomalacia prevention.
Dosing
- Colecalciferol (deficiency) | Loading of about 300,000 units over 6–10 weeks (e.g. 50,000 units weekly for 6 weeks). Then 800–2,000 units daily. Check calcium at 1 month.
Endocrinology: Bone Medicine - Colecalciferol | Prevention (400 units) and treatment of vitamin D deficiency and rickets.
Paediatrics: Growth, development and nutrition - Vitamin D status - measure 25-hydroxyvitamin D: <25 nmol/L deficient, 25–50 insufficient (UK). Treatment: loading (e.g. colecalciferol 300,000 IU over 6–10 weeks), then maintenance 800–2,000 IU daily; check calcium after loading.
Biochemistry: Enzymes, vitamins and trace elements
Side effects
Hypercalcaemia and hypercalciuria with excess dosing; nausea.
Interactions
Thiazides raise calcium risk; orlistat and anticonvulsants lower levels.
Special advice
Check calcium in high dose, sarcoidosis and renal disease; usual maintenance is daily or weekly.
More from the textbook: uses, cautions and other points
- Colecalciferol / alfacalcidol | Check calcium 1 month after loading; active forms risk hypercalcaemia.
Endocrine: Anatomy Physiology and Pharmacology - Plus vitamin D - colecalciferol for deficiency; alfacalcidol or calcitriol for hypoparathyroidism or CKD.
Endocrinology: Bone Medicine - Treatment (colecalciferol):
Endocrinology: Bone Medicine - Native vitamin D (colecalciferol) - replace deficiency in CKD too.
Renal: Anatomy, Physiology and Pharmacology - Colecalciferol or ergocalciferol - for vitamin D deficiency.
Renal: Chronic Kidney Disease - Colecalciferol for deficiency; alfacalcidol if PTH stays high.
Renal: Chronic Kidney Disease
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: Bone Medicine (3 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Chronic Kidney Disease (2 mentions)
- Paediatrics: Growth, development and nutrition (3 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Acute Medicine: Electrolytes, acid–base, AKI and metabolic emergencies (1 mention)
- Integrated paediatrics chapter (3 mentions)
- Biochemistry: Enzymes, vitamins and trace elements (1 mention)
D
Dabigatran
BNF entry for Dabigatran · Stand-alone drug page
Mechanism
Direct thrombin inhibitor (prodrug dabigatran etexilate).
Uses
Stroke prevention in non-valvular AF, treatment and prevention of VTE.
Dosing
- Dabigatran: Idarucizumab 5 g IV. Dabigatran can also be removed by dialysis.
Gastroenterology: Gastroenterology Emergencies (Complete) - Idarucizumab | 5 g IV for dabigatran reversal.
Gastroenterology: Gastroenterology Emergencies (Complete) - Dabigatran with creatinine clearance 30–50 mL/min: 72 hours .
Gastroenterology: Investigations - Dabigatran: Idarucizumab 5 g IV. Haemodialysis is an option.
Haematology: Emergencies
2 more dose entries from the chapters
- Idarucizumab 5 g IV | Dabigatran reversal.
Haematology: Emergencies - Avoid most DOACs under 15 mL/min (dabigatran under 30).
Haematology: Haemostasis and Thrombosis
Side effects
Dyspepsia, bleeding, GI bleeding; rarely hepatic injury.
Interactions
P-gp inhibitors (dronedarone, ketoconazole) and inducers (rifampicin) alter levels; avoid other anticoagulants.
Special advice
Idarucizumab reverses; avoid in severe renal impairment; capsules must be swallowed whole in original packaging.
More from the textbook: uses, cautions and other points
- Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
Cardiology: Anatomy Physiology and Pharmacology - Direct thrombin inhibitor - dabigatran (twice daily; mostly renally excreted; dyspepsia).
Cardiology: Anatomy Physiology and Pharmacology - Lifelong warfarin (VKA) . DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) must never be used - they caused excess valve thrombosis and stroke in trials.
Cardiology: Valvular heart disease › 4.34 Anticoagulation and Valves - Alternatives — LMWH for at least 5 days then dabigatran or edoxaban; or LMWH with warfarin (INR 2–3) until the INR is 2 or more for 2 days.
Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease - Most patients: A DOAC - apixaban or rivaroxaban (no heparin lead-in needed), or LMWH then dabigatran or edoxaban.
Respiratory: Pulmonary Vascular Disease - Reverse anticoagulants: vitamin K with PCC for warfarin; andexanet for apixaban or rivaroxaban GI bleeds; idarucizumab for dabigatran.
Gastroenterology: Gastroenterology Emergencies (Complete)
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (4 mentions)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease (1 mention)
- Respiratory: Pulmonary Vascular Disease (1 mention)
- Gastroenterology: Gastroenterology Emergencies (Complete) (3 mentions)
- Gastroenterology: Investigations (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Stroke Emergencies (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (8 mentions)
- Haematology: Emergencies (3 mentions)
- Haematology: Haemostasis and Thrombosis (7 mentions)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Surgery: Major trauma and burns (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (3 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (5 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Acute Medicine: The acute medical take (2 mentions)
- Clinical imaging: Neuroimaging — head, brain and spine (1 mention)
- Clinical imaging: Imaging pathways and interventional radiology (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (2 mentions)
- Integrated cardiology chapter (1 mention)
- Integrated respiratory chapter (1 mention)
Dalteparin
BNF entry for Dalteparin · Stand-alone drug page
Mechanism
Low molecular weight heparin enhancing antithrombin inhibition of factor Xa.
Uses
VTE prophylaxis and treatment, ACS, cancer-associated VTE, dialysis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Bleeding, injection-site haematoma, thrombocytopenia (HIT), hyperkalaemia, osteoporosis in long-term use.
Interactions
Anticoagulants, antiplatelets and NSAIDs increase bleeding risk.
Special advice
Dose by weight; reduce or monitor anti-Xa in renal impairment; check platelet count on prolonged treatment.
More from the textbook: uses, cautions and other points
- Low molecular weight heparin (enoxaparin, dalteparin, tinzaparin) - subcutaneous, weight-based dosing; mainly anti-Xa ; renally excreted (reduce dose with low creatinine clearance); monitor anti-Xa levels in pregnancy, extremes of weight or CKD; only partly reversed by protamine.
Cardiology: Anatomy Physiology and Pharmacology - Enoxaparin / dalteparin | SC by weight; reduce if CrCl under 30; anti-Xa monitoring in pregnancy, CKD, extreme weight; HIT, hyperkalaemia.
Haematology: Anatomy Physiology and Pharmacology - LMWH (enoxaparin, dalteparin, tinzaparin) | Weight-based; reduce in severe kidney impairment; monitor platelets if exposed to unfractionated heparin recently (HIT); anti-Xa levels in pregnancy, kidney failure or extremes of weight
Haematology: Haemostasis and Thrombosis
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Haemostasis and Thrombosis (1 mention)
Dantrolene
BNF entry for Dantrolene · Stand-alone drug page
Mechanism
Inhibits ryanodine receptor calcium release from sarcoplasmic reticulum.
Uses
Malignant hyperthermia, neuroleptic malignant syndrome (selected), spasticity.
Dosing
- Treatment (AAGBI MH guideline) — stop volatile agents (switch to TIVA), high-flow 100% oxygen, hyperventilate, call for help, IV dantrolene 2.5 mg/kg (repeat 1 mg/kg boluses up to 10 mg/kg), active cooling, treat hyperkalaemia and arrhythmias, ICU.
Anaesthesia: Airway management and anaesthetic drugs - Malignant hyperthermia | RYR1; rising ETCO 2 ; dantrolene 2.5 mg/kg
Anaesthesia: Airway management and anaesthetic drugs
Side effects
Muscle weakness, drowsiness, hepatotoxicity, phlebitis.
Interactions
Calcium channel blockers (IV) risk hyperkalaemia and cardiovascular collapse.
Special advice
Early IV use in malignant hyperthermia with supportive cooling; monitor LFT with prolonged use.
More from the textbook: uses, cautions and other points
- Neuroleptic malignant syndrome - dopamine blockade (antipsychotics) or sudden withdrawal of Parkinson's drugs : fever, rigidity ("lead pipe"), confusion, autonomic instability, very high CK; slower onset (days); stop the drug, cooling, fluids, ITU; dantrolene or bromocriptine in severe cases.
Neurology: Anatomy, Physiology and Pharmacology - Suxamethonium (depolarising) - fast and short; causes hyperkalaemia (avoid in burns, crush injury, neuromuscular disease), malignant hyperthermia (with volatile anaesthetics - treat with dantrolene ), and prolonged paralysis with plasma cholinesterase deficiency.
Neurology: Anatomy, Physiology and Pharmacology - Treatment | NMS: Stop the drug; cooling; fluids; benzodiazepines; dantrolene or bromocriptine in severe cases. Serotonin syndrome: Stop the drugs; benzodiazepines; cooling; cyproheptadine in moderate or severe cases
Neurology: Emergencies - Malignant hyperthermia - volatile anaesthetics or suxamethonium; treat with dantrolene.
Neurology: Emergencies - Dantrolene (muscle relaxant) and/or bromocriptine (dopamine agonist) in severe cases; ECT for refractory cases.
Psychiatric emergencies - Specific treatment | Dantrolene, bromocriptine | Cyproheptadine
Psychiatric emergencies
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (4 mentions)
- Neurology: Emergencies (2 mentions)
- Psychiatric emergencies (5 mentions)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Surgery: Surgical principles and perioperative care (3 mentions)
- Emergency Medicine: Environmental emergencies (3 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics (4 mentions)
- Anaesthesia: Airway management and anaesthetic drugs (6 mentions)
- Physiology: Endocrine control, metabolism and thermoregulation (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (2 mentions)
Dapagliflozin
BNF entry for Dapagliflozin · Stand-alone drug page
Mechanism
SGLT2 inhibitor increasing urinary glucose excretion; also natriuretic with cardiorenal benefits.
Uses
Type 2 diabetes, heart failure, chronic kidney disease.
Dosing
- Dapagliflozin / empagliflozin | 10 mg once daily for eligible heart failure, with or without diabetes; sick-day rules.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table - Drugs Dapagliflozin 10 mg daily. Empagliflozin 10 mg daily.
Cardiology: Heart Failure › 2.21 💊 SGLT2 Inhibitors - Dapagliflozin | 10 mg once daily.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Dapagliflozin / empagliflozin | Heart failure: 10 mg once daily; sick-day rules; check eGFR thresholds.
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses
4 more dose entries from the chapters
- Examples: Dapagliflozin 10 mg, empagliflozin 10 mg (25 mg for extra glucose lowering), canagliflozin 100–300 mg, ertugliflozin - once daily.
Endocrinology: Diabetes - Dapagliflozin / empagliflozin Type 2 first-line with metformin; HF; CKD | 10 mg once daily (empagliflozin 25 mg for extra glucose lowering). Genital infection, volume depletion, euglycaemic DKA. Sick day rules; omit around surgery.
Endocrinology: Diabetes - Dapagliflozin 10 mg daily (TA775) - eGFR 25–75 , plus either type 2 diabetes or ACR 22.6 mg/mmol or more .
Renal: Chronic Kidney Disease - Dapagliflozin 10 mg daily | CKD (TA775): eGFR 25–75 with type 2 diabetes or ACR 22.6 or more. Thrush, euglycaemic DKA, early eGFR dip.
Renal: Chronic Kidney Disease
Side effects
Genital candidiasis, urinary infection, volume depletion, euglycaemic ketoacidosis, Fournier gangrene (rare).
Interactions
Loop diuretics and insulin or sulfonylureas increase volume depletion or hypoglycaemia.
Special advice
Sick-day rules: stop during acute illness, fasting or before surgery; ketone check if unwell even with normal glucose.
More from the textbook: uses, cautions and other points
- Drugs - dapagliflozin , empagliflozin .
Cardiology: Anatomy Physiology and Pharmacology - Dapagliflozin / empagliflozin | SGLT2 inhibitors; heart failure, CKD; genital infections, euglycaemic DKA; sick day rules.
Cardiology: Anatomy Physiology and Pharmacology - Recommended treatment approach : SGLT2 inhibitor: Consider dapagliflozin or empagliflozin, including in suitable patients without diabetes; MRA: NICE 2025 recommends considering an MRA, with careful monitoring of renal function and potassium; Loop diuretics: Use when fluid retention or congestion is present; Hypertension: Treat …
Cardiology: Heart Failure › 2.24 💊 Management of HFpEF - NICE TA388: Sacubitril/Valsartan - ARNI treatment in HFrEF; NICE TA902: Dapagliflozin - heart failure with mildly reduced or preserved ejection fraction; NICE TA929: Empagliflozin - chronic heart failure with preserved or mildly reduced ejection fraction.
Cardiology: Heart Failure › 2.42 📌 NICE and European Guidelines - Examples - dapagliflozin, empagliflozin, canagliflozin, ertugliflozin.
Endocrine: Anatomy Physiology and Pharmacology - Dapagliflozin / empagliflozin | SGLT2; heart and kidney benefit; thrush, euglycaemic DKA, Fournier's; stop on sick days and before surgery.
Endocrine: Anatomy Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (4 mentions)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Heart Failure (4 mentions)
- Cardiology: Cardiomyopathies (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (3 mentions)
- Endocrinology: Diabetes (4 mentions)
- Endocrinology: Emergencies (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Chronic Kidney Disease (3 mentions)
- Surgery: Surgical principles and perioperative care (3 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Acute Medicine: Electrolytes, acid–base, AKI and metabolic emergencies (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Integrated cardiology chapter (6 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)
Desmopressin
BNF entry for Desmopressin · Stand-alone drug page
Mechanism
Synthetic vasopressin analogue acting at V2 receptors; increases water reabsorption and factor VIII/vWF release.
Uses
Cranial diabetes insipidus, nocturnal enuresis, mild haemophilia A and von Willebrand disease.
Dosing
- Consider IV desmopressin (e.g. 1–2 micrograms), with specialist advice, to bring sodium back down.
Endocrinology: Sodium and Water disorders - Desmopressin AVP deficiency | Oral 100–200 micrograms two to three times daily (range varies), or 1–2 micrograms SC/IV. Never omit. Risk of hyponatraemia.
Endocrinology: Sodium and Water disorders - Desmopressin AVP deficiency (DI) | Oral 100 micrograms two to three times daily (maintenance often 100–200 micrograms three times daily); sublingual 60–120 micrograms; intranasal 10–40 micrograms daily; injection 1–4 micrograms daily. Risk of hyponatraemia. Never omit in hospital.
Endocrinology: Pituitary Disease - … (overactive bladder) if persisting Antimuscarinics - dry mouth, constipation, confusion in older people (anticholinergic burden), retention; mirabegron - raises BP Desmopressin or late-afternoon loop diuretic Nocturnal polyuria Desmopressin - hyponatraemia (check sodium; caution in older people)
Surgey: Urology
2 more dose entries from the chapters
- … - risk of osmotic demyelination syndrome (dysarthria, dysphagia, quadriparesis, locked-in - days later). If over-correction occurs - relower with 5% glucose and/or desmopressin (specialist).
Acute Medicine: Electrolytes, acid–base, AKI and metabolic emergencies - … slowly - no more than about 10 mmol/L in 24 hours in chronic hypernatraemia (risk of cerebral oedema); monitor sodium every 4–6 hours initially; treat the cause (desmopressin for cranial DI).
Acute Medicine: Electrolytes, acid–base, AKI and metabolic emergencies
Side effects
Hyponatraemia, headache, nausea; fluid retention.
Interactions
NSAIDs, SSRIs, carbamazepine and tricyclics increase hyponatraemia risk.
Special advice
Fluid restriction around dosing; monitor sodium; avoid in heart failure and hyponatraemia.
More from the textbook: uses, cautions and other points
- Cranial - pituitary surgery, trauma, tumours, infiltration (sarcoid, histiocytosis) - responds to desmopressin.
Endocrine: Anatomy Physiology and Pharmacology - Nephrogenic - lithium , hypercalcaemia , hypokalaemia , genetic - doesn't respond to desmopressin.
Endocrine: Anatomy Physiology and Pharmacology - If overcorrecting: 5% glucose, and consider desmopressin with specialist advice.
Endocrinology: Emergencies - Think of missed desmopressin in AVP deficiency.
Endocrinology: Emergencies - Urine stays dilute, then concentrates after desmopressin : AVP deficiency.
Endocrinology: Sodium and Water disorders - Urine stays dilute even after desmopressin : AVP resistance.
Endocrinology: Sodium and Water disorders
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (5 mentions)
- Endocrinology: Emergencies (2 mentions)
- Endocrinology: Sodium and Water disorders (13 mentions)
- Endocrinology: Pituitary Disease (18 mentions)
- Endocrinology: Adrenal Disease (1 mention)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Tubular Inherited Stones (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (4 mentions)
- Haematology: Haemostasis and Thrombosis (4 mentions)
- Paediatrics: Kidneys, urinary tract and hormones in children (3 mentions)
- Gynaecology: Pelvic floor ovary and vulva (1 mention)
- Surgey: Urology (2 mentions)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (2 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Acute Medicine: Electrolytes, acid–base, AKI and metabolic emergencies (2 mentions)
- Critical care: common problems, ethics and recovery (3 mentions)
- Integrated paediatrics chapter (3 mentions)
- Physiology: Cells, tissues, homeostasis, fluids and acid–base balance (1 mention)
- Physiology: Endocrine control, metabolism and thermoregulation (1 mention)
Dexamethasone
BNF entry for Dexamethasone · Stand-alone drug page
Mechanism
Potent long-acting glucocorticoid with negligible mineralocorticoid effect.
Uses
Cerebral oedema, croup, COVID-19 hypoxia, antiemetic, myeloma, adrenal testing.
Dosing
- Dexamethasone IV (e.g. 6.6–8 mg) for inflammatory swelling.
Respiratory: Emergencies - Dexamethasone Upper airway oedema | e.g. 6.6–8 mg IV.
Respiratory: Emergencies - Hospital patients needing oxygen: Dexamethasone (6 mg daily for up to 10 days) and, in selected patients, an IL-6 inhibitor (tocilizumab). VTE prophylaxis.
Respiratory: Infections - Dexamethasone COVID-19 needing oxygen | 6 mg daily for up to 10 days.
Respiratory: Infections
4 more dose entries from the chapters
- Overnight dexamethasone suppression -1 mg at 11 pm–midnight, cortisol at 9 am; failure to suppress (cortisol over 50 nmol/L) suggests Cushing's syndrome. Also late-night salivary cortisol and 24-hour urinary free cortisol .
Endocrine: Anatomy Physiology and Pharmacology - Dexamethasone | 750 micrograms | Almost none
Endocrine: Anatomy Physiology and Pharmacology - Overnight dexamethasone suppression test: Dexamethasone 1 mg at 11 pm; serum cortisol at 9 am. A normal person suppresses cortisol to below 50 nmol/L ; failure to suppress suggests Cushing's.
Endocrinology: Adrenal Disease - Low-dose 48-hour dexamethasone suppression test: 0.5 mg every 6 hours for 48 hours. Used in specialist centres.
Endocrinology: Adrenal Disease
Side effects
Hyperglycaemia, insomnia, psychiatric effects, infection, adrenal suppression, osteoporosis, myopathy.
Interactions
CYP3A4 inducers reduce levels; NSAIDs raise GI bleed risk; antidiabetic drugs need adjustment.
Special advice
Give PPI cover in higher-risk patients; taper after prolonged courses; monitor glucose.
More from the textbook: uses, cautions and other points
- Treatment: Urgent plasma-cell-directed therapy - daratumumab with cyclophosphamide, bortezomib and dexamethasone (Dara-CyBorD) is standard first-line; autologous stem cell transplant in selected patients.
Cardiology: Cardiomyopathies › 3.29 AL Cardiac Amyloidosis - Treatment (by cause) — endovascular stenting (rapid relief), chemotherapy or radiotherapy (sensitive tumours), dexamethasone (selected cases), anticoagulation for thrombotic obstruction (remove or treat the line); acute oncology, respiratory or vascular advice.
Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease - Antenatal corticosteroids (dexamethasone or betamethasone) speed lung maturation - offered for threatened preterm birth (from 24 weeks to 33+6 weeks, and considered up to 35+6 weeks).
Respiratory: Anatomy, Physiology and Pharmacology - Stridor | Sit up; high-flow oxygen; nebulised adrenaline; dexamethasone; anaesthetics and ENT immediately
Respiratory: Emergencies - Steroids: Dexamethasone for COVID-19 requiring oxygen. Use in other ARDS remains debated - follow ICU guidance.
Respiratory: Emergencies - CNS TB (meningitis): 12 months of treatment, plus dexamethasone (or prednisolone) at the start.
Respiratory: Infections
Where it is discussed
- Cardiology: Cardiomyopathies (1 mention)
- Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Respiratory: Emergencies (5 mentions)
- Respiratory: Infections (4 mentions)
- Respiratory: Lung Cancer (3 mentions)
- Respiratory: Sleep and Breathing (Complete) (3 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (3 mentions)
- Endocrinology: Pituitary Disease (1 mention)
- Endocrinology: Adrenal Disease (17 mentions)
- Endocrinology: Bone Medicine (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (5 mentions)
- Neurology: Emergencies (12 mentions)
- Neurology: Localisation and Investigation (1 mention)
- Neurology: Spine and Sleep Disorders (2 mentions)
- Neurology: Oncology and Hydrocephalus (4 mentions)
- Renal: Glomerular Disease (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (3 mentions)
- Haematology: History and Examination (1 mention)
- Haematology: Emergencies (2 mentions)
- Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia (2 mentions)
- Haematology: Haemostasis and Thrombosis (3 mentions)
- Haematology: Myeloma and Lymphoma (11 mentions)
- Oncology: Principles (1 mention)
Diazepam
BNF entry for Diazepam · Stand-alone drug page
Mechanism
Benzodiazepine increasing GABA-A receptor chloride channel opening.
Uses
Status epilepticus and seizures, alcohol withdrawal, anxiety, muscle spasm, sedation.
Dosing
- No IV access (or in the community) - buccal midazolam 10 mg (or rectal diazepam 10–20 mg).
Neurology: Anatomy, Physiology and Pharmacology - Buccal midazolam 10 mg (or rectal diazepam 10–20 mg) in the community or without IV access.
Neurology: Emergencies - Or rectal diazepam 10–20 mg.
Neurology: Epilepsy - First benzodiazepine (5 minutes) - IV lorazepam 0.1 mg/kg (max 4 mg), or if no IV access buccal midazolam (about 0.3 mg/kg, max 10 mg) or rectal diazepam.
Paediatrics: Neurology, bones and joints in children
4 more dose entries from the chapters
- … levels, toxicology) 5 minutes - first-line benzodiazepine IV lorazepam (0.1 mg/kg, usually 4 mg) - or if no IV access, buccal midazolam 10 mg (or rectal diazepam 10–20 mg); repeat once after 5–10 minutes if still seizing Thiamine and glucose IV Pabrinex if alcohol excess or malnutrition; glucose if hypoglycaemic …
Acute Medicine: Reduced consciousness, seizures, headache and acute confusion - 5 minutes - first-line benzodiazepine | IV lorazepam (0.1 mg/kg, usually 4 mg) - or if no IV access, buccal midazolam 10 mg (or rectal diazepam 10–20 mg); repeat once after 5–10 minutes if still seizing
Acute Medicine: Reduced consciousness, seizures, headache and acute confusion - First benzodiazepine (5 minutes) — IV lorazepam 0.1 mg/kg (max 4 mg), or if no IV access buccal midazolam (about 0.3 mg/kg, max 10 mg) or rectal diazepam.
Integrated paediatrics chapter › Status Epilepticus - Status epilepticus | ABCDE, glucose, benzodiazepine at 5 minutes (IV lorazepam 4 mg, or buccal midazolam 10 mg / rectal diazepam 10 mg if no access), repeat once after 5–10 minutes, then levetiracetam 60 mg/kg (max 4.5 g), phenytoin or valproate ; anaesthetics/ICU if continuing at 45 minutes
OSCEs II: Practical procedures, prescribing and acute care stations
Side effects
Drowsiness, ataxia, respiratory depression, dependence, paradoxical agitation; accumulates in older people.
Interactions
Opioids, alcohol and other CNS depressants increase respiratory depression; cimetidine and omeprazole raise levels.
Special advice
Long active metabolites in older adults and liver disease; slow IV injection; flumazenil is a poor routine antidote in mixed overdose.
More from the textbook: uses, cautions and other points
- Slower drug metabolism (fewer working cells) → longer half-lives (benzodiazepines like diazepam - prefer lorazepam or oxazepam).
Gastroenterology: Anatomy Physiology Pharmacology - Follow an individualised rescue plan if available. NICE NG217 recommends an initial benzodiazepine: community buccal midazolam or rectal diazepam, or intravenous lorazepam when IV access and resuscitation facilities are immediately available. If convulsions continue, a second benzodiazepine dose may be given after 5–10 minutes; …
Neurology: Epilepsy - Muscle spasm - baclofen, diazepam.
Palliative: Symptoms Management - Spasticity - oral baclofen , diazepam (short term), botulinum toxin injections, intrathecal baclofen, selective dorsal rhizotomy, orthopaedic surgery.
Paediatrics: Neurology, bones and joints in children - Often switch to an equivalent dose of diazepam (long half-life), then reduce gradually - e.g. by about 1/8 to 1/10 of the dose every 2–4 weeks; slower near the end; may take months.
Psychiatry: Anxiety, stress and somatic disorders - Diazepam | Long half-life - used for tapering benzodiazepine dependence and in alcohol withdrawal (with chlordiazepoxide as an alternative).
Psychiatry: Anxiety, stress and somatic disorders
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Emergencies (1 mention)
- Neurology: Epilepsy (2 mentions)
- Palliative: Symptoms Management (1 mention)
- Paediatrics: Neurology, bones and joints in children (2 mentions)
- Psychiatry: Anxiety, stress and somatic disorders (4 mentions)
- Psychiatry: Alcohol, drugs and addiction (2 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (2 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (2 mentions)
- Integrated paediatrics chapter (2 mentions)
- OSCEs II: Practical procedures, prescribing and acute care stations (1 mention)
Diclofenac
BNF entry for Diclofenac · Stand-alone drug page
Mechanism
Non-selective NSAID inhibiting cyclo-oxygenase.
Uses
Pain and inflammation in arthritis, musculoskeletal and postoperative pain, renal colic.
Dosing
- Post-ERCP pancreatitis (about 3–5%) - reduced by giving rectal diclofenac or indometacin 100 mg , IV fluids, and pancreatic stents in high-risk cases.
Gastroenterology: Pancreas and Biliary - Rectal diclofenac or indometacin 100 mg | Given around ERCP to prevent post-ERCP pancreatitis.
Gastroenterology: Pancreas and Biliary
Side effects
Dyspepsia, GI bleeding, hypertension, renal impairment, fluid retention; higher cardiovascular thrombotic risk.
Interactions
Anticoagulants, SSRIs, ACE inhibitors, diuretics and lithium.
Special advice
Contraindicated in heart failure, ischaemic heart disease, stroke and peripheral arterial disease; lowest dose for shortest time with PPI.
More from the textbook: uses, cautions and other points
- Hepatocellular (ALT up) | Paracetamol (overdose), isoniazid , rifampicin, pyrazinamide, valproate , methotrexate, statins (usually mild), amiodarone, nitrofurantoin , ketoconazole, NSAIDs (diclofenac), herbal supplements (green tea extract, kava, turmeric), checkpoint inhibitors
Gastroenterology: Anatomy Physiology Pharmacology - Hepatocellular | Paracetamol (dose-related), isoniazid, rifampicin, pyrazinamide , NSAIDs (diclofenac), statins (rarely serious), valproate, ketoconazole, nitrofurantoin, herbal products (green tea extract, ashwagandha, turmeric)
Gastroenterology: Liver disease - NSAIDs first-line (e.g. diclofenac IM, oral or PR) if not contraindicated; IV paracetamol if NSAIDs can't be used; opioids only if both are unsuitable.
Renal: Anatomy, Physiology and Pharmacology - NSAID first line by any route (e.g. diclofenac) - if not contraindicated (kidney impairment, bleeding, heart failure).
Renal: Tubular Inherited Stones - Diclofenac (NSAID) | First-line renal colic pain relief if no contraindication.
Renal: Tubular Inherited Stones - Actinic (solar) keratoses - rough, scaly, sun-damaged patches; a small risk of SCC. Sun protection, 5-fluorouracil cream, imiquimod, diclofenac gel, cryotherapy, photodynamic therapy.
Oncology: Skin Cancer
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Pancreas and Biliary (2 mentions)
- Gastroenterology: Liver disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Tubular Inherited Stones (2 mentions)
- Oncology: Skin Cancer (1 mention)
- Dermatology: Skin lesions and skin cancer (3 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (2 mentions)
- Surgey: Urology (1 mention)
- Emergency Medicine: ED procedures (1 mention)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (1 mention)
Digoxin
BNF entry for Digoxin · Stand-alone drug page
Mechanism
Inhibits Na-K ATPase, increasing intracellular calcium and vagal tone.
Uses
AF rate control, heart failure with AF symptoms.
Dosing
- 2. A 70-year-old woman on furosemide and digoxin for AF and heart failure has nausea, blurred yellow vision and a heart rate of 42. Potassium is 2.9 mmol/L. Answer: Digoxin toxicity precipitated by hypokalaemia.
Cardiology: Anatomy Physiology and Pharmacology - Digoxin | 62.5–125 micrograms daily (older or renally impaired patients) for AF rate control; monitor level and renal function.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table - Digoxin | Often 62.5–125 micrograms daily in older or renally impaired patients; individualise dosing.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Digoxin AF rate control | Maintenance often 62.5–250 micrograms orally daily; loading, if needed, is individualised. Check renal function, K and toxicity.
Cardiology: Cardiac Arrhythmias › 5.42 Two-Column Drug and Dose Table
4 more dose entries from the chapters
- Protect the heart - IV calcium if there are ECG changes: calcium gluconate 10%, 30 mL IV over 5–10 minutes (or calcium chloride 10%, 10 mL via a large or central vein). Works in minutes, lasts 30–60 minutes, doesn't lower potassium ; repeat if ECG changes persist. Caution with digoxin (give slowly).
Renal: Anatomy, Physiology and Pharmacology - Loading dose - a larger first dose to reach the target level quickly, when waiting 4–5 half-lives would be too slow: digoxin , amiodarone , phenytoin (and levetiracetam in status), vancomycin , teicoplanin, aminophylline , warfarin (in some regimens), clopidogrel (300–600 mg in ACS), ticagrelor.
Clinical pharmacology and prescribing: Principles of clinical pharmacology - 1. A 72-year-old man with new fast AF and heart failure is started on oral digoxin 125 micrograms daily. Three days later his heart rate is still 130. Answer: Digoxin without a loading dose - not yet at steady state.
Clinical pharmacology and prescribing: Principles of clinical pharmacology - "Digoxin 125 µg daily" | Write "micrograms" in full
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law
Side effects
Nausea, visual disturbance (yellow-green), confusion, arrhythmias, gynaecomastia; hypokalaemia increases toxicity.
Interactions
Amiodarone, verapamil, clarithromycin raise levels; diuretics cause hypokalaemia; calcium IV caution.
Special advice
Narrow therapeutic index; check level 6 hours post-dose if toxicity suspected; reduce dose in renal impairment and older people; antibody fragments for severe toxicity.
More from the textbook: uses, cautions and other points
- Contractility (inotropy) - the strength of contraction at a given preload; increased by sympathetic stimulation and inotropes (dobutamine, adrenaline, milrinone, digoxin); reduced by beta-blockers, rate-limiting calcium channel blockers, ischaemia, acidosis and hypoxia.
Cardiology: Anatomy Physiology and Pharmacology - Digoxin inhibits the Na+/K+ ATPase → more sodium inside → less calcium removed by the exchanger → more calcium → stronger contraction.
Cardiology: Anatomy Physiology and Pharmacology - Digoxin — renal function, potassium, levels if toxicity suspected.
Cardiology: Presentations - Look for causes — inferior MI, drugs (beta-blockers, digoxin), hyperkalaemia; permanent pacemaker.
Cardiology: Presentations - ST depression and T wave inversion - ischaemia (NSTEMI, unstable angina), strain, digoxin, or reciprocal change.
Cardiology Investigations - Digoxin effect: " Reverse tick " (sloping) ST depression - not by itself toxicity. Toxicity causes almost any arrhythmia.
Cardiology Investigations
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (19 mentions)
- Cardiology: Presentations (2 mentions)
- Cardiology Investigations (6 mentions)
- Cardiology: Cardiology Emergencies (7 mentions)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Heart Failure (4 mentions)
- Cardiology: Cardiac Arrhythmias (13 mentions)
- Cardiology: Cardiomyopathies (6 mentions)
- Endocrinology: Reproductive (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Investigations (1 mention)
- Gastroenterology: Oesophagus and Stomach (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Dementia and Cognition Disorders (Complete) (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (7 mentions)
- Renal: Emergencies (1 mention)
- Renal: Chronic Kidney Disease (2 mentions)
- Renal: Tubular Inherited Stones (1 mention)
- Haematology: Myeloma and Lymphoma (2 mentions)
- Ophthalmology: Anatomy Physiology and Pharmacology (3 mentions)
- Ophthalmology: Neuro-ophthalmology (2 mentions)
- Ophthalmology: Paediatrics (1 mention)
- Surgey: Breast and endocrine surgery (1 mention)
- Medicine of the older adult: Delirium, dementia and mood in older people (2 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (7 mentions)
Diltiazem
BNF entry for Diltiazem · Stand-alone drug page
Mechanism
Non-dihydropyridine calcium channel blocker with negative chronotropic and inotropic effects.
Uses
Angina, hypertension, AF and SVT rate control.
Dosing
- Diltiazem (rate-limiting): standard-release 60 mg three times daily (60 mg twice daily in older people), max 360 mg/day. Modified-release preparations differ, so prescribe by brand.
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina - Diltiazem | 60 mg three times daily (twice daily in older people), max 360 mg/day. Prescribe MR by brand.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - Diltiazem AF rate control | Example: standard-release 60 mg orally three times daily, titrate by response/formulation. Avoid in HFrEF.
Cardiology: Cardiac Arrhythmias › 5.42 Two-Column Drug and Dose Table - Diltiazem | Selected HCM: immediate-release 60 mg three times daily initially; modified-release preparations are not interchangeable.
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses
4 more dose entries from the chapters
- Propranolol Thyrotoxic symptoms | 10–40 mg three to four times daily. Storm: e.g. 60–80 mg orally 4-hourly. Avoid in asthma (use a cardioselective beta blocker or diltiazem).
Endocrinology: Thyroid disease - Amlodipine, diltiazem, verapamil - maximum simvastatin dose 20 mg.
Endocrinology: Lipids and obesity - … times daily); diarrhoea is the dose-limiting effect; toxic in overdose; reduce dose in renal impairment; interactions — clarithromycin , ciclosporin, verapamil, diltiazem (CYP3A4 and P-glycoprotein) — myopathy and toxicity.
Rheumatology Anatomy Physiology Pharmacology - … effective as high dose with fewer side effects; diarrhoea is common; reduce or avoid in CKD; interactions - clarithromycin, erythromycin, ciclosporin, verapamil, diltiazem, some statins (toxicity, myopathy).
Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain
Side effects
Bradycardia, ankle oedema, headache, constipation, heart block.
Interactions
Beta-blockers risk bradycardia and block; raises levels of statins, ciclosporin, carbamazepine; avoid with ivabradine.
Special advice
Avoid in reduced EF heart failure and with beta-blockers if conduction disease.
More from the textbook: uses, cautions and other points
- Phase 0 - slower upstroke via L-type calcium channels (blocked by verapamil and diltiazem - slowing AV conduction).
Cardiology: Anatomy Physiology and Pharmacology - Interactions - CYP3A4 inhibitors ( clarithromycin , erythromycin, itraconazole, grapefruit juice with simvastatin), amiodarone and diltiazem (simvastatin dose limits), fibrates (gemfibrozil - avoid).
Cardiology: Anatomy Physiology and Pharmacology - Avoid — verapamil and diltiazem in HFrEF (negatively inotropic) unless a specialist advises; NSAIDs in heart failure; QT-prolonging combinations.
Cardiology: Presentations - Prescribing | Check renal function and K + ; no verapamil or diltiazem in HFrEF
Cardiology: Presentations - Drugs: Beta-blockers, rate-limiting calcium channel blockers (verapamil, diltiazem), digoxin, amiodarone, ivabradine.
Cardiology: Cardiology Emergencies - Beta-blocker (e.g. bisoprolol orally, or IV metoprolol in increments) or rate-limiting calcium channel blocker (diltiazem, verapamil) - avoid calcium channel blockers in heart failure with reduced EF.
Cardiology: Cardiology Emergencies
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (7 mentions)
- Cardiology: Presentations (2 mentions)
- Cardiology: Cardiology Emergencies (3 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (6 mentions)
- Cardiology: Heart Failure (2 mentions)
- Cardiology: Cardiac Arrhythmias (6 mentions)
- Cardiology: Cardiomyopathies (4 mentions)
- Endocrinology: Thyroid disease (1 mention)
- Endocrinology: Lipids and obesity (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Bowel Disorders (3 mentions)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Dialysis and Transplant (2 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: Connective tissue diseases (1 mention)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (1 mention)
- Surgery: Colorectal and anal surgery (3 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (3 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (3 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
Dipyridamole
BNF entry for Dipyridamole · Stand-alone drug page
Mechanism
Inhibits platelet phosphodiesterase and adenosine reuptake.
Uses
Secondary stroke prevention (modified release); diagnostic stress agent.
Dosing
- Use a lower dose (e.g. 3 mg) via a central line, after heart transplant, or with dipyridamole. Effect reduced by theophylline and caffeine.
Cardiology: Cardiology Emergencies
Side effects
Headache, dizziness, GI upset, flushing; worsens angina.
Interactions
Potentiates adenosine; antacids reduce absorption of tablets.
Special advice
Headache usually settles; avoid in unstable angina and aortic stenosis; stop before adenosine testing as directed.
More from the textbook: uses, cautions and other points
- Dipyridamole - phosphodiesterase inhibitor; stroke prevention (now less used); potentiates adenosine.
Cardiology: Anatomy Physiology and Pharmacology - Contraindications and cautions - asthma (bronchospasm), second- or third-degree heart block or sick sinus without a pacemaker, pre-excited AF (can cause VF); reduce the dose with dipyridamole or after heart transplant (more sensitive); theophylline and caffeine reduce its effect.
Cardiology: Anatomy Physiology and Pharmacology - If clopidogrel is unsuitable: aspirin plus modified-release dipyridamole.
Neurology: Stroke Emergencies - Dipyridamole - phosphodiesterase inhibitor; with aspirin after stroke if clopidogrel isn't tolerated; headache .
Haematology: Anatomy Physiology and Pharmacology - Adenosine - very short half-life; warn the patient (transient chest discomfort, flushing, feeling of impending doom); avoid in asthma ; reduce dose with dipyridamole, after heart transplant, or via central line; dipyridamole and carbamazepine enhance; theophylline blocks.
Acute Medicine: Cardiac arrest, advanced life support and peri-arrest arrhythmias
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Cardiology Emergencies (1 mention)
- Neurology: Stroke Emergencies (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Acute Medicine: Cardiac arrest, advanced life support and peri-arrest arrhythmias (1 mention)
Dobutamine
BNF entry for Dobutamine · Stand-alone drug page
Mechanism
Beta-1 agonist increasing inotropy with mild vasodilation.
Uses
Cardiogenic shock and low-output states; stress echocardiography.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Tachycardia, arrhythmias, hypotension, hypokalaemia.
Interactions
Beta-blockers antagonise effect; MAOIs potentiate.
Special advice
Central or large peripheral vein; titrate to response; monitor continuously.
More from the textbook: uses, cautions and other points
- Contractility (inotropy) - the strength of contraction at a given preload; increased by sympathetic stimulation and inotropes (dobutamine, adrenaline, milrinone, digoxin); reduced by beta-blockers, rate-limiting calcium channel blockers, ischaemia, acidosis and hypoxia.
Cardiology: Anatomy Physiology and Pharmacology - Beta-agonists (dobutamine) → cAMP → more calcium entry and faster uptake (stronger contraction and faster relaxation).
Cardiology: Anatomy Physiology and Pharmacology - Stress echocardiography - exercise or dobutamine. Wall motion abnormalities under stress. No radiation.
Cardiology Investigations - Dobutamine stress: Avoid with severe hypertension or significant arrhythmias.
Cardiology Investigations - Cardiogenic shock | ICU; echo; revascularise culprit artery; noradrenaline ± dobutamine
Cardiology: Cardiology Emergencies - Mean arterial pressure above 65 mmHg , with fluids, noradrenaline and dobutamine as needed.
Cardiology: Cardiology Emergencies
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (5 mentions)
- Cardiology Investigations (4 mentions)
- Cardiology: Cardiology Emergencies (4 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Cardiology: Valvular heart disease (3 mentions)
- Cardiology: Cardiomyopathies (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (4 mentions)
- Critical care: Admission and organ support (4 mentions)
- Integrated cardiology chapter (5 mentions)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)
Domperidone
BNF entry for Domperidone · Stand-alone drug page
Mechanism
Peripheral dopamine D2 antagonist enhancing gastric motility.
Uses
Nausea and vomiting, gastroparesis.
Dosing
- Domperidone - 10 mg up to three times daily, for the shortest time (QT prolongation; avoid in cardiac disease).
Gastroenterology: Oesophagus and Stomach - Domperidone 10 mg up to three times daily | Shortest duration; QT prolongation; avoid in heart disease.
Gastroenterology: Oesophagus and Stomach - Domperidone 10 mg up to three times daily | Antiemetic of choice in PD; QT prolongation.
Neurology: Movement Disorders - Gastric stasis - "squashed stomach" (liver enlargement, ascites), autonomic failure, opioids | Early fullness, large-volume vomits soon after eating, relief after vomiting. Metoclopramide 10 mg three times daily (or domperidone). Avoid in complete bowel obstruction
Palliative: Symptoms Management
Side effects
Dry mouth, headache, QT prolongation and arrhythmias, hyperprolactinaemia.
Interactions
QT-prolonging drugs and strong CYP3A4 inhibitors contraindicated.
Special advice
Short course at lowest dose; avoid in cardiac disease and electrolyte disturbance.
More from the textbook: uses, cautions and other points
- Antipsychotics (haloperidol), citalopram, escitalopram, methadone, ondansetron, domperidone.
Cardiology: Cardiology Emergencies - Causes of high prolactin - pregnancy and breastfeeding, drugs (antipsychotics, metoclopramide, domperidone, some antidepressants), prolactinoma, stalk compression, primary hypothyroidism (high TRH stimulates prolactin), kidney failure, stress (including a difficult blood test), seizures, chest wall injury, macroprolactin …
Endocrine: Anatomy Physiology and Pharmacology - Antipsychotics , metoclopramide, domperidone | Hyperprolactinaemia ; olanzapine and clozapine - weight gain and diabetes
Endocrine: Anatomy Physiology and Pharmacology - Gastroparesis - early fullness, vomiting, bloating and erratic glucose (food absorbed unpredictably, causing post-meal hypoglycaemia). Manage with small, low-fat, low-fibre meals; prokinetics (metoclopramide or domperidone short-term, erythromycin); adjust insulin timing; gastric electrical stimulation in severe cases.
Endocrinology: Diabetes - Metoclopramide and domperidone .
Endocrinology: Pituitary Disease - Domperidone | Peripheral D2 antagonist (doesn't cross the blood–brain barrier) | Nausea in Parkinson's (e.g. with dopaminergic drugs), gastroparesis | QT prolongation and sudden cardiac death - lowest dose, shortest time (usually up to 7 days), avoid with QT-prolonging drugs and CYP3A4 inhibitors and in cardiac disease (MHRA)
Gastroenterology: Anatomy Physiology Pharmacology
Where it is discussed
- Cardiology: Cardiology Emergencies (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Diabetes (1 mention)
- Endocrinology: Pituitary Disease (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (6 mentions)
- Gastroenterology: Oesophagus and Stomach (4 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Movement Disorders (7 mentions)
- Palliative: Symptoms Management (2 mentions)
- Obstetrics (1 mention)
- Gynaecology: Menstrual Disorders (1 mention)
- Rheumatology: Connective tissue diseases (1 mention)
- Surgey: Breast and endocrine surgery (1 mention)
- Medicine of the older adult: Delirium, dementia and mood in older people (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Acute Medicine: The acute medical take (2 mentions)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (1 mention)
- Physiology: Endocrine control, metabolism and thermoregulation (1 mention)
- OSCEs II: Practical procedures, prescribing and acute care stations (1 mention)
Donepezil
BNF entry for Donepezil · Stand-alone drug page
Mechanism
Reversible acetylcholinesterase inhibitor.
Uses
Mild to moderate Alzheimer disease.
Dosing
- Donepezil 5 mg at night, increased to 10 mg after a month.
Neurology: Dementia and Cognition Disorders (Complete) - Donepezil 5 mg at night, up to 10 mg | Mild to moderate AD; DLB; PDD. Bradycardia, heart block, syncope, GI upset, vivid dreams; not for MCI, pure vascular dementia or FTD.
Neurology: Dementia and Cognition Disorders (Complete)
Side effects
Nausea, diarrhoea, insomnia, vivid dreams, bradycardia, syncope, weight loss, urinary incontinence.
Interactions
Anticholinergics oppose effect; beta-blockers risk bradycardia; neuromuscular blockers affected.
Special advice
Check pulse and ECG in cardiac disease; caution in asthma and peptic ulcer; review benefit.
More from the textbook: uses, cautions and other points
- Acetylcholine | Neuromuscular junction (nicotinic), autonomic nerves, memory and attention (brain) | Loss in Alzheimer's (donepezil); myasthenia gravis; anticholinergic drugs cause confusion
Neurology: Anatomy, Physiology and Pharmacology - Side effects - nausea, vomiting, diarrhoea, loss of appetite and weight; bradycardia , heart block and syncope (check pulse; ECG if slow or cardiac disease); vivid dreams and insomnia (donepezil - move to the morning); urinary incontinence; muscle cramps.
Neurology: Anatomy, Physiology and Pharmacology - Nausea, diarrhoea, weight loss, vivid dreams and insomnia (give donepezil in the morning if so).
Neurology: Dementia and Cognition Disorders (Complete) - AChEIs - donepezil or rivastigmine (NICE) - often help cognition, fluctuations and hallucinations. Galantamine if these aren't tolerated; memantine if AChEIs are unsuitable.
Neurology: Dementia and Cognition Disorders (Complete) - Mild to moderate Alzheimer's disease ; also dementia with Lewy bodies (donepezil or rivastigmine) and Parkinson's disease dementia.
Medicine of the older adult: Delirium, dementia and mood in older people - Lewy body dementia | Fluctuations, visual hallucinations, parkinsonism | Rivastigmine or donepezil; avoid antipsychotics
Medicine of the older adult: Delirium, dementia and mood in older people
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (4 mentions)
- Neurology: Dementia and Cognition Disorders (Complete) (8 mentions)
- Medicine of the older adult: Delirium, dementia and mood in older people (3 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (6 mentions)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (2 mentions)
Dopamine
BNF entry for Dopamine · Stand-alone drug page
Mechanism
Endogenous catecholamine; dose-dependent dopaminergic, beta-1 and alpha-1 agonist.
Uses
Cardiogenic and vasodilatory shock where noradrenaline unavailable or bradycardia with hypotension (specialist).
Dosing
- Restless legs syndrome - check ferritin and give iron if low (ferritin under about 75 micrograms/L); gabapentinoids or dopamine agonists (low dose - augmentation : symptoms get worse and earlier over time); avoid antihistamines, antidepressants and dopamine blockers that worsen it.
Neurology: Anatomy, Physiology and Pharmacology - If still not responding - isoprenaline or adrenaline infusion (2–10 micrograms/minute), or other drugs (dopamine; glucagon for beta-blocker or CCB overdose; DigiFab for digoxin toxicity), and/or transcutaneous pacing (with analgesia and sedation).
Acute Medicine: Cardiac arrest, advanced life support and peri-arrest arrhythmias
Side effects
Tachycardia, arrhythmias, hypertension, peripheral ischaemia, extravasation necrosis, nausea.
Interactions
MAOIs and tricyclics potentiate; beta-blockers antagonise; phenytoin IV hypotension.
Special advice
Central line preferred; titrate to response with continuous monitoring; low-dose "renal" use is not supported by evidence.
More from the textbook: uses, cautions and other points
- Other: Carcinoid syndrome, chest radiotherapy, drugs (historically ergot-derived dopamine agonists and fenfluramine), connective tissue disease and pacemaker leads crossing the tricuspid valve.
Cardiology: Valvular heart disease › 4.04 Causes - Dopamine agonists can cause "augmentation" (symptoms getting worse with treatment) - gabapentinoids are increasingly used.
Respiratory: Sleep and Breathing (Complete) - Dopamine (inhibits) | Prolactin | Breast → milk | Prolactin increases dopamine
Endocrine: Anatomy Physiology and Pharmacology - Prolactin is the exception - it is held down by dopamine, so pituitary stalk compression (any large tumour) raises prolactin modestly ("stalk effect"), as do dopamine-blocking drugs .
Endocrine: Anatomy Physiology and Pharmacology - Prolactin | Dopamine inhibits it (tonic suppression). Excess: galactorrhoea, hypogonadism. Deficiency: failure to lactate
Endocrinology: Pituitary Disease - 💡 Key concept: Prolactin is the only anterior hormone mainly under inhibitory control (dopamine). Anything that compresses the stalk and blocks dopamine - even a non-secreting tumour - raises prolactin (the "stalk effect"), while the other hormones fall.
Endocrinology: Pituitary Disease
Where it is discussed
- Cardiology: Valvular heart disease (1 mention)
- Respiratory: Sleep and Breathing (Complete) (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (5 mentions)
- Endocrinology: Pituitary Disease (10 mentions)
- Endocrinology: Thyroid disease (3 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (16 mentions)
- Neurology: Emergencies (2 mentions)
- Neurology: Localisation and Investigation (1 mention)
- Neurology: Movement Disorders (11 mentions)
- Neurology: Spine and Sleep Disorders (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Obstetrics (2 mentions)
- Gynaecology: Fertility Contraception Menopause (1 mention)
- Psychiatric emergencies (3 mentions)
- Psychiatry: Anxiety, stress and somatic disorders (1 mention)
- Psychiatry: Alcohol, drugs and addiction (2 mentions)
- Psychiatry: Psychosis and schizophrenia (2 mentions)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
- Medicine of the older adult: Delirium, dementia and mood in older people (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (3 mentions)
- Acute Medicine: Cardiac arrest, advanced life support and peri-arrest arrhythmias (1 mention)
- Acute Medicine: The acute medical take (1 mention)
- Critical care: Admission and organ support (2 mentions)
Doxycycline
BNF entry for Doxycycline · Stand-alone drug page
Mechanism
Tetracycline binding the 30S ribosome.
Uses
Chlamydia, Lyme disease, rickettsiae, COPD exacerbation, acne, malaria prophylaxis.
Dosing
- Low | Amoxicillin 500 mg three times daily (doxycycline or clarithromycin)
Respiratory: Emergencies - Moderate | Amoxicillin, plus clarithromycin 500 mg twice daily if atypical infection suspected (doxycycline or clarithromycin)
Respiratory: Emergencies - Doxycycline 100 mg twice daily for 7 days (first line).
Gynaecology: Sexual health - Pregnancy, breastfeeding or doxycycline unsuitable - azithromycin 1 g then 500 mg daily for 2 days (or erythromycin, amoxicillin).
Gynaecology: Sexual health
4 more dose entries from the chapters
- Antibiotic choice: Phenoxymethylpenicillin 500 mg four times daily for 5 days first line; doxycycline or clarithromycin if allergic; co-amoxiclav if very unwell or high risk.
ENT: Common Nose and Throat disorders - Probable STI - ceftriaxone 1 g IM (gonorrhoea) plus doxycycline 100 mg twice daily for 10–14 days; contact tracing and partner notification; refer to sexual health.
Surgey: Urology - Treatment (NICE NG141) - flucloxacillin 500 mg–1 g four times daily (oral for mild; IV for severe); clarithromycin , doxycycline or erythromycin in penicillin allergy; co-amoxiclav for facial cellulitis (near the eyes or nose); 5–7 days; mark the edge; elevate the leg; treat the entry point (tinea pedis, ulcers).
Acute Medicine: The acute medical take - Chlamydia: doxycycline 100 mg twice daily for 7 days (azithromycin if pregnant); partner notification; test of cure if pregnant.
General Practice: Child health, women's health and men's health in primary care
Side effects
Nausea, oesophagitis, photosensitivity, thrush; avoid in pregnancy and children for dental staining.
Interactions
Antacids, iron and calcium reduce absorption; warfarin effect rises; carbamazepine reduces levels.
Special advice
Take upright with a full glass of water; sun protection.
More from the textbook: uses, cautions and other points
- Low severity - amoxicillin for 5 days (doxycycline or clarithromycin if penicillin-allergic).
Respiratory: Anatomy, Physiology and Pharmacology - Clarithromycin - QT prolongation; CYP3A4 inhibitor (raises statin, warfarin and theophylline effects). Doxycycline - avoid in pregnancy and under 12; photosensitivity; take upright with water.
Respiratory: Anatomy, Physiology and Pharmacology - Antibiotics if sputum is purulent or there are signs of pneumonia (NICE NG114): e.g. amoxicillin, doxycycline or clarithromycin orally for 5 days; IV options if severe.
Respiratory: Emergencies - Non-severe, low resistance risk: e.g. co-amoxiclav orally (NICE NG250); alternatives include doxycycline or co-trimoxazole.
Respiratory: Emergencies - Tablets and swallowing - some drugs cause pill oesophagitis if they stick (doxycycline, bisphosphonates, potassium, iron, NSAIDs) - take with plenty of water while upright.
Gastroenterology: Anatomy Physiology Pharmacology - Pill oesophagitis | Doxycycline, bisphosphonates, potassium chloride, iron, NSAIDs
Gastroenterology: Anatomy Physiology Pharmacology
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (3 mentions)
- Respiratory: Emergencies (4 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Oesophagus and Stomach (2 mentions)
- Gastroenterology: Bowel Disorders (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Headache and Facial Pain (2 mentions)
- Neurology: Spine and Sleep Disorders (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Dialysis and Transplant (1 mention)
- Obstetrics (2 mentions)
- Gynaecology: Sexual health (17 mentions)
- Dermatology: Skin infections and infestations (6 mentions)
- Dermatology: Skin lesions and skin cancer (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (6 mentions)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (1 mention)
- Rheumatology: Inflammatory arthritis (2 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Nose and Throat disorders (2 mentions)
- Ophthalmology Basics Cataract Glaucoma (2 mentions)
- Ophthalmology: Red emergencies (2 mentions)
- ID: How Infection Happens (8 mentions)
- ID: Sepsis, fever and serious bacterial infections (11 mentions)
- ID: Tropical and travel medicine (9 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (2 mentions)
Duloxetine
BNF entry for Duloxetine · Stand-alone drug page
Mechanism
Serotonin and noradrenaline reuptake inhibitor.
Uses
Depression, generalised anxiety, diabetic neuropathic pain, stress urinary incontinence.
Dosing
- Amitriptyline / duloxetine / pregabalin / gabapentin Painful neuropathy | E.g. amitriptyline 10 mg at night, titrated; duloxetine 60 mg daily; pregabalin 75 mg twice daily, titrated. Adjust for renal function and frailty.
Endocrinology: Diabetes
Side effects
Nausea, dry mouth, insomnia, hypertension, hyponatraemia, sexual dysfunction.
Interactions
MAOIs and other serotonergic drugs; fluvoxamine and ciprofloxacin raise levels.
Special advice
Monitor BP; taper on stopping; avoid in uncontrolled hypertension and liver disease.
More from the textbook: uses, cautions and other points
- Offer amitriptyline, duloxetine, gabapentin or pregabalin ; switch to another if one is ineffective or not tolerated.
Endocrinology: Diabetes - Noradrenaline | Arousal, attention, mood, pain modulation | SNRIs (duloxetine) and TCAs for neuropathic pain and depression
Neurology: Anatomy, Physiology and Pharmacology - Neuropathic - nerve damage: burning, shooting, electric shock-like , pins and needles, allodynia (pain from light touch) - responds poorly to standard painkillers; use amitriptyline, duloxetine, gabapentin or pregabalin.
Neurology: Anatomy, Physiology and Pharmacology - Neuropathic pain - amitriptyline, duloxetine, gabapentin, pregabalin.
Neurology: Multiple Sclerosis and inflammatory disease - First line: Amitriptyline, duloxetine, gabapentin or pregabalin . If one fails, switch to another.
Neurology: Neuromuscular disease - Amitriptyline / duloxetine / gabapentin / pregabalin | Neuropathic pain first line (NICE CG173); gabapentinoids are controlled drugs.
Neurology: Neuromuscular disease
Where it is discussed
- Endocrinology: Diabetes (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (5 mentions)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Neurology: Neuromuscular disease (4 mentions)
- Palliative: Symptoms Management (2 mentions)
- Gynaecology: Pelvic floor ovary and vulva (3 mentions)
- Dermatology: Skin infections and infestations (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (2 mentions)
- ID: Viral, fungal and parasitic infections (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (4 mentions)
- Psychiatry: Mood disorders (2 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Surgey: Urology (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Acute Medicine: The acute medical take (1 mention)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (2 mentions)
E
Edoxaban
BNF entry for Edoxaban · Stand-alone drug page
Mechanism
Direct factor Xa inhibitor.
Uses
Stroke prevention in non-valvular AF, treatment and prevention of VTE.
Dosing
- Factor Xa inhibitors - apixaban (twice daily), rivaroxaban (once daily for AF - with food at 15 mg and 20 mg doses), edoxaban (once daily).
Haematology: Anatomy Physiology and Pharmacology - Edoxaban (Xa inhibitor) | 60 mg daily (30 mg if CrCl 15–50, weight 60 kg or less, or certain interacting drugs). After 5 days of LMWH for VTE
Haematology: Haemostasis and Thrombosis - Low body weight (under 50 kg) - reduce paracetamol (e.g. 15 mg/kg per dose; maximum per local guidance), DOAC dose criteria (apixaban - weight 60 kg or less is one criterion; edoxaban 60 kg or less), care with nephrotoxic and sedating drugs.
Clinical pharmacology and prescribing: Prescribing in special groups
Side effects
Bleeding, anaemia, rash, abnormal LFT.
Interactions
P-gp inhibitors raise levels; avoid with other anticoagulants.
Special advice
Dose reduce by weight, renal function and interacting drugs; reduced efficacy with CrCl above 95 in AF.
More from the textbook: uses, cautions and other points
- Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
Cardiology: Anatomy Physiology and Pharmacology - Factor Xa inhibitors - apixaban (twice daily), rivaroxaban (once daily with food in AF), edoxaban (once daily).
Cardiology: Anatomy Physiology and Pharmacology - Lifelong warfarin (VKA) . DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) must never be used - they caused excess valve thrombosis and stroke in trials.
Cardiology: Valvular heart disease › 4.34 Anticoagulation and Valves - Alternatives — LMWH for at least 5 days then dabigatran or edoxaban; or LMWH with warfarin (INR 2–3) until the INR is 2 or more for 2 days.
Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease - Most patients: A DOAC - apixaban or rivaroxaban (no heparin lead-in needed), or LMWH then dabigatran or edoxaban.
Respiratory: Pulmonary Vascular Disease - Anticoagulation for AF-related stroke - a DOAC (apixaban, edoxaban, rivaroxaban, dabigatran) rather than aspirin; timing depends on stroke size (earlier start is increasingly used; follow current guidance). Never anticoagulate until haemorrhage has been excluded.
Neurology: Anatomy, Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease (1 mention)
- Respiratory: Pulmonary Vascular Disease (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Stroke Emergencies (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Haematology: Haemostasis and Thrombosis (3 mentions)
- Oncology: Emergencies (1 mention)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Acute Medicine: The acute medical take (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Integrated cardiology chapter (1 mention)
- Integrated respiratory chapter (1 mention)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)
- Pathology: Haemodynamic disorders, thrombosis, embolism and atherosclerosis (1 mention)
Empagliflozin
BNF entry for Empagliflozin · Stand-alone drug page
Mechanism
SGLT2 inhibitor increasing urinary glucose and sodium excretion.
Uses
Type 2 diabetes, heart failure, chronic kidney disease.
Dosing
- Dapagliflozin / empagliflozin | 10 mg once daily for eligible heart failure, with or without diabetes; sick-day rules.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table - Drugs Dapagliflozin 10 mg daily. Empagliflozin 10 mg daily.
Cardiology: Heart Failure › 2.21 💊 SGLT2 Inhibitors - Empagliflozin | 10 mg once daily.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Dapagliflozin / empagliflozin | Heart failure: 10 mg once daily; sick-day rules; check eGFR thresholds.
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses
4 more dose entries from the chapters
- Examples: Dapagliflozin 10 mg, empagliflozin 10 mg (25 mg for extra glucose lowering), canagliflozin 100–300 mg, ertugliflozin - once daily.
Endocrinology: Diabetes - Dapagliflozin / empagliflozin Type 2 first-line with metformin; HF; CKD | 10 mg once daily (empagliflozin 25 mg for extra glucose lowering). Genital infection, volume depletion, euglycaemic DKA. Sick day rules; omit around surgery.
Endocrinology: Diabetes - Empagliflozin 10 mg daily (TA942) - eGFR 20–45 , or eGFR 45–90 with ACR 22.6 or more or type 2 diabetes.
Renal: Chronic Kidney Disease - Empagliflozin 10 mg daily | CKD (TA942): eGFR 20–45, or 45–90 with ACR 22.6 or more or type 2 diabetes.
Renal: Chronic Kidney Disease
Side effects
Genital infections, urinary infection, volume depletion, euglycaemic ketoacidosis, Fournier gangrene.
Interactions
Diuretics increase volume depletion; insulin and sulfonylureas increase hypoglycaemia risk.
Special advice
Sick-day rules and pre-operative stopping; ketone check if unwell.
More from the textbook: uses, cautions and other points
- Drugs - dapagliflozin , empagliflozin .
Cardiology: Anatomy Physiology and Pharmacology - Dapagliflozin / empagliflozin | SGLT2 inhibitors; heart failure, CKD; genital infections, euglycaemic DKA; sick day rules.
Cardiology: Anatomy Physiology and Pharmacology - Recommended treatment approach : SGLT2 inhibitor: Consider dapagliflozin or empagliflozin, including in suitable patients without diabetes; MRA: NICE 2025 recommends considering an MRA, with careful monitoring of renal function and potassium; Loop diuretics: Use when fluid retention or congestion is present; Hypertension: Treat …
Cardiology: Heart Failure › 2.24 💊 Management of HFpEF - NICE TA388: Sacubitril/Valsartan - ARNI treatment in HFrEF; NICE TA902: Dapagliflozin - heart failure with mildly reduced or preserved ejection fraction; NICE TA929: Empagliflozin - chronic heart failure with preserved or mildly reduced ejection fraction.
Cardiology: Heart Failure › 2.42 📌 NICE and European Guidelines - Examples - dapagliflozin, empagliflozin, canagliflozin, ertugliflozin.
Endocrine: Anatomy Physiology and Pharmacology - Dapagliflozin / empagliflozin | SGLT2; heart and kidney benefit; thrush, euglycaemic DKA, Fournier's; stop on sick days and before surgery.
Endocrine: Anatomy Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Heart Failure (4 mentions)
- Cardiology: Cardiomyopathies (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (4 mentions)
- Endocrinology: Diabetes (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Chronic Kidney Disease (3 mentions)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (2 mentions)
- Integrated cardiology chapter (6 mentions)
Enalapril
BNF entry for Enalapril · Stand-alone drug page
Mechanism
ACE inhibitor prodrug (active enalaprilat).
Uses
Hypertension, heart failure, post-MI left ventricular dysfunction.
Dosing
- Enalapril | 2.5 mg twice daily initially; target 10–20 mg twice daily.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses
Side effects
Dry cough, hypotension, hyperkalaemia, renal impairment, angioedema, taste change.
Interactions
NSAIDs, potassium-sparing diuretics, lithium, ARBs.
Special advice
Check U&E before and after starting; avoid in pregnancy; stop if angioedema.
More from the textbook: uses, cautions and other points
- Common drugs : Ramipril. Enalapril. Lisinopril. Candesartan, an ARB alternative.
Cardiology: Heart Failure › 2.18 💊 ACE Inhibitors and ARBs - After delivery: Full HFrEF therapy (enalapril or captopril are compatible with breastfeeding); bromocriptine with prophylactic anticoagulation considered in specialist care.
Cardiology: Cardiomyopathies › 3.42 Peripartum Cardiomyopathy (PPCM) - … 3 weeks postpartum and breastfeeding, is breathless with an LVEF of 28%. Answer: Peripartum cardiomyopathy - HFrEF therapy compatible with breastfeeding (e.g. enalapril, metoprolol), diuretics, consider bromocriptine with anticoagulation (stops lactation), wearable defibrillator, and counselling against further pregnancy …
Cardiology: Cardiomyopathies › 3.59 Exam-style Scenarios - ACE inhibitors (ramipril, lisinopril, perindopril, enalapril) block angiotensin II production; ARBs (losartan, candesartan, irbesartan, valsartan) block its receptor.
Renal: Anatomy, Physiology and Pharmacology - Generally compatible — paracetamol, ibuprofen, penicillins, cephalosporins, macrolides, LMWH and warfarin, labetalol, nifedipine, enalapril, insulin, metformin, levothyroxine, most inhalers, prednisolone, sertraline, lamotrigine (monitor baby), levetiracetam, hydroxychloroquine, sulfasalazine (caution in preterm or jaundiced …
Obstetrics - Methyldopa — avoid postpartum (depression) — switch to enalapril, nifedipine or labetalol (NICE NG133).
Obstetrics
Where it is discussed
- Cardiology: Heart Failure (2 mentions)
- Cardiology: Cardiomyopathies (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Obstetrics (2 mentions)
- Obstetrics: Medical Problems (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Integrated cardiology chapter (4 mentions)
Enoxaparin
BNF entry for Enoxaparin · Stand-alone drug page
Mechanism
Low molecular weight heparin enhancing antithrombin activity against factor Xa.
Uses
VTE prophylaxis and treatment, ACS, bridging anticoagulation.
Dosing
- Enoxaparin | NSTEMI: 1 mg/kg SC twice daily. STEMI: see Anticoagulation for age- and renal-adjusted regimens.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - VTE prophylaxis in hospital (NICE NG89) - assess every adult on admission for VTE and bleeding risk; LMWH (e.g. enoxaparin 40 mg daily, adjusted for weight and kidney function) or fondaparinux; mechanical options (intermittent pneumatic compression - not anti-embolism stockings in acute stroke ); reassess regularly.
Haematology: Anatomy Physiology and Pharmacology - LMWH (e.g. enoxaparin 40 mg once daily ; 20 mg if creatinine clearance is under 30), or fondaparinux, for at least 7 days if risk outweighs bleeding risk.
Haematology: Haemostasis and Thrombosis - Enoxaparin Prophylaxis 40 mg daily; treatment 1.5 mg/kg daily | Reduce if CrCl under 30; anti-Xa monitoring in pregnancy and extremes of weight.
Haematology: Haemostasis and Thrombosis
3 more dose entries from the chapters
- Pharmacological prophylaxis - usually LMWH (e.g. enoxaparin 40 mg daily, adjusted for weight and kidney function), starting 6–12 hours after surgery (timing around neuraxial anaesthesia matters), continued until mobility returns (often at least 7 days for major surgery).
Surgery: Surgical principles and perioperative care - Pharmacological prophylaxis - LMWH (e.g. enoxaparin 40 mg daily - adjust for weight and kidney function) or fondaparinux, for at least 7 days if VTE risk outweighs bleeding risk; unfractionated heparin in severe kidney impairment (eGFR under 15–30).
Acute Medicine: The acute medical take - VTE prophylaxis (NICE NG89) - assess risk on admission; LMWH (e.g. enoxaparin 40 mg SC once daily, adjusted for weight and renal function) unless contraindicated (active bleeding, low platelets, recent stroke with haemorrhage); mechanical prophylaxis (anti-embolism stockings) for some surgical patients - not after stroke.
OSCEs II: Practical procedures, prescribing and acute care stations
Side effects
Bleeding, injection-site bruising, thrombocytopenia (HIT), hyperkalaemia, elevated transaminases.
Interactions
Anticoagulants, antiplatelets, NSAIDs and SSRIs increase bleeding.
Special advice
Dose by weight; reduce in severe renal impairment; platelet counts during prolonged use; neuraxial anaesthesia timing.
More from the textbook: uses, cautions and other points
- Low molecular weight heparin (enoxaparin, dalteparin, tinzaparin) - subcutaneous, weight-based dosing; mainly anti-Xa ; renally excreted (reduce dose with low creatinine clearance); monitor anti-Xa levels in pregnancy, extremes of weight or CKD; only partly reversed by protamine.
Cardiology: Anatomy Physiology and Pharmacology - 5. A 72-year-old woman develops a DVT on day 8 of enoxaparin after hip surgery. Platelets have fallen from 310 to 110. Answer: Heparin-induced thrombocytopenia.
Cardiology: Anatomy Physiology and Pharmacology - Enoxaparin / dalteparin | SC by weight; reduce if CrCl under 30; anti-Xa monitoring in pregnancy, CKD, extreme weight; HIT, hyperkalaemia.
Haematology: Anatomy Physiology and Pharmacology - Platelets fall from 280 to 95 on day 7 of enoxaparin, new DVT | HIT - stop all heparin, non-heparin anticoagulant
Haematology: Anatomy Physiology and Pharmacology - LMWH (enoxaparin, dalteparin, tinzaparin) | Weight-based; reduce in severe kidney impairment; monitor platelets if exposed to unfractionated heparin recently (HIT); anti-Xa levels in pregnancy, kidney failure or extremes of weight
Haematology: Haemostasis and Thrombosis - Enoxaparin / tinzaparin (LMWH) | VTE prophylaxis and treatment; dose by booking weight.
Obstetrics: Medical Problems
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (4 mentions)
- Haematology: Haemostasis and Thrombosis (3 mentions)
- Obstetrics: Medical Problems (1 mention)
- Surgery: Surgical principles and perioperative care (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Acute Medicine: The acute medical take (2 mentions)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Integrated cardiology chapter (1 mention)
- OSCEs II: Practical procedures, prescribing and acute care stations (1 mention)
Eplerenone
BNF entry for Eplerenone · Stand-alone drug page
Mechanism
Selective mineralocorticoid receptor antagonist.
Uses
Heart failure after MI, heart failure with reduced EF.
Dosing
- Eplerenone | Post-MI LV dysfunction: 25 mg daily, increasing to 50 mg daily.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - Eplerenone | 25 mg daily initially; increase to 50 mg daily if tolerated.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Eplerenone , e.g. 25–50 mg twice daily. Fewer sex-hormone side effects, but less potent.
Endocrinology: Adrenal Disease - Eplerenone Primary aldosteronism | 25–50 mg twice daily (off-label for this use). Fewer sex-hormone side effects.
Endocrinology: Adrenal Disease
Side effects
Hyperkalaemia, renal impairment, dizziness; fewer endocrine effects than spironolactone.
Interactions
CYP3A4 inhibitors (clarithromycin, ketoconazole) contraindicated; ACE inhibitors, ARBs, potassium raise potassium.
Special advice
Monitor potassium and creatinine early and regularly.
More from the textbook: uses, cautions and other points
- Side effects - hyperkalaemia (check U&E regularly; caution with ACE inhibitors, ARBs, potassium supplements, CKD), gynaecomastia and breast pain with spironolactone (less with eplerenone).
Cardiology: Anatomy Physiology and Pharmacology - Spironolactone / eplerenone | MRAs; HFrEF survival; hyperkalaemia; gynaecomastia (spironolactone).
Cardiology: Anatomy Physiology and Pharmacology - ⚠️ Prescribing Pearls: Aspirin plus one P2Y12 inhibitor after ACS. Prasugrel is contraindicated after stroke or TIA. Never give nitrates with PDE-5 inhibitors or in RV infarction. Monitor potassium and creatinine with ACE inhibitors and eplerenone. Do not start beta blockers in shock or heart block.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - Drugs : Spironolactone. Eplerenone.
Cardiology: Heart Failure › 2.20 💊 Mineralocorticoid Receptor Antagonists - Adverse effects : Hyperkalaemia. Renal dysfunction. Gynaecomastia with spironolactone. Menstrual or sexual adverse effects with spironolactone. Eplerenone is more selective for the mineralocorticoid receptor and causes fewer endocrine adverse effects.
Cardiology: Heart Failure › 2.20 💊 Mineralocorticoid Receptor Antagonists - Drugs acting on the system - ACE inhibitors, ARBs, spironolactone, eplerenone (all can raise potassium); heparin suppresses aldosterone (hyperkalaemia); NSAIDs reduce renin.
Endocrine: Anatomy Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (4 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (2 mentions)
- Cardiology: Heart Failure (3 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Adrenal Disease (5 mentions)
- Renal: Anatomy, Physiology and Pharmacology (4 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Integrated cardiology chapter (5 mentions)
Ergocalciferol
BNF entry for Ergocalciferol · Stand-alone drug page
Mechanism
Vitamin D2 converted to active vitamin D metabolites.
Uses
Vitamin D deficiency, hypoparathyroidism, rickets and osteomalacia.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hypercalcaemia, hypercalciuria, nausea with excess.
Interactions
Thiazides, anticonvulsants.
Special advice
Monitor calcium on high doses.
More from the textbook: uses, cautions and other points
- Colecalciferol or ergocalciferol - for vitamin D deficiency.
Renal: Chronic Kidney Disease
Where it is discussed
- Renal: Chronic Kidney Disease (1 mention)
Ertapenem
BNF entry for Ertapenem · Stand-alone drug page
Mechanism
Carbapenem inhibiting cell-wall synthesis; once-daily dosing.
Uses
Intra-abdominal and pelvic infection, ESBL infections, diabetic foot and complicated urinary infection.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Diarrhoea, nausea, headache, injection-site reactions, seizures (rare).
Interactions
Valproate levels fall markedly (avoid); probenecid raises levels.
Special advice
No activity against Pseudomonas or Acinetobacter; adjust in renal impairment; seizure caution.
More from the textbook: uses, cautions and other points
- Meropenem / ertapenem | ESBL and severe sepsis; reserve; seizures; lowers valproate.
ID: How Infection Happens - Treatment - serious infections usually need a carbapenem (meropenem or ertapenem); alternatives by sensitivity (piperacillin–tazobactam sometimes, temocillin, aminoglycosides); oral options for UTI - nitrofurantoin, fosfomycin, pivmecillinam.
ID: Hospital infection, the immunocompromised host, vaccination and public health - Cell wall | Carbapenems | Meropenem, ertapenem (no Pseudomonas cover) | Very broad - reserve for ESBL and severe infection
Microbiology: Diagnostic microbiology, antimicrobials and resistance
Where it is discussed
Escitalopram
BNF entry for Escitalopram · Stand-alone drug page
Mechanism
SSRI, the S-enantiomer of citalopram.
Uses
Depression, generalised anxiety, panic and social anxiety disorders.
Dosing
- SSRIs - sertraline, citalopram, escitalopram, fluoxetine, paroxetine | Usual first choice - safer in overdose. Sertraline - preferred after MI or with heart disease. Citalopram/escitalopram - QT prolongation (citalopram max 20 mg over 65). Fluoxetine - long half-life (fewer withdrawal effects), many interactions; first-line in …
Psychiatry: Mood disorders - Citalopram / escitalopram | QT prolongation - citalopram max 20 mg over 65.
Psychiatry: Mood disorders
Side effects
Nausea, insomnia, sexual dysfunction, hyponatraemia, QT prolongation (dose-related), bleeding risk.
Interactions
MAOIs, serotonergic drugs and QT-prolonging drugs; NSAIDs increase bleeding.
Special advice
Taper on stopping; lower maximum in older adults; monitor sodium.
More from the textbook: uses, cautions and other points
- Antipsychotics (haloperidol), citalopram, escitalopram, methadone, ondansetron, domperidone.
Cardiology: Cardiology Emergencies - SSRIs | Usually mild - nausea, drowsiness, tremor; citalopram and escitalopram - QT prolongation and seizures; serotonin syndrome.
Psychiatric emergencies - Then another SSRI or an SNRI (escitalopram, paroxetine, venlafaxine, duloxetine).
Psychiatry: Anxiety, stress and somatic disorders - SSRI (licensed for panic - e.g. sertraline, citalopram, escitalopram, paroxetine); start low (initial worsening).
Psychiatry: Anxiety, stress and somatic disorders - QT prolongation - citalopram, escitalopram, TCAs (ECG if cardiac risk).
Psychiatry: Mood disorders - Heart disease | Sertraline - antidepressant of choice after MI. Avoid TCAs (arrhythmias). QT - citalopram, escitalopram, haloperidol, amisulpride, methadone; check ECG and electrolytes. Clozapine - myocarditis, cardiomyopathy. Venlafaxine - raises BP.
Psychiatry: Personality, eating and neurodevelopmental disorders
Where it is discussed
- Cardiology: Cardiology Emergencies (1 mention)
- Psychiatric emergencies (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (5 mentions)
- Psychiatry: Mood disorders (3 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
Esomeprazole
BNF entry for Esomeprazole · Stand-alone drug page
Mechanism
Proton pump inhibitor irreversibly inhibiting H+/K+ ATPase.
Uses
GORD, peptic ulcer and prevention with NSAIDs, H. pylori regimens, Zollinger-Ellison.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Headache, diarrhoea; hypomagnesaemia, B12 deficiency, fracture risk, C. difficile, microscopic colitis with long-term use.
Interactions
Clopidogrel activation reduced; levothyroxine and iron absorption reduced; methotrexate levels rise.
Special advice
Review long-term need; use lowest effective dose.
More from the textbook: uses, cautions and other points
- Omeprazole and esomeprazole inhibit CYP2C19 → less activation of clopidogrel (avoid the combination - use lansoprazole or pantoprazole).
Gastroenterology: Anatomy Physiology Pharmacology - Clopidogrel: Omeprazole and esomeprazole reduce its activation - use lansoprazole or pantoprazole instead.
Gastroenterology: Oesophagus and Stomach - Clopidogrel - a prodrug activated by CYP2C19 (poor metabolisers and omeprazole or esomeprazole reduce its effect - use lansoprazole or pantoprazole); used after stroke, in peripheral arterial disease and with aspirin after ACS or stents.
Haematology: Anatomy Physiology and Pharmacology
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Oesophagus and Stomach (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
Estradiol
BNF entry for Estradiol · Stand-alone drug page
Mechanism
Natural oestrogen acting at oestrogen receptors.
Uses
Menopausal vasomotor symptoms, atrophic vaginitis, hypoestrogenism, gender-affirming care.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Breast tenderness, nausea, headache, VTE, endometrial hyperplasia (without progestogen), breast cancer risk.
Interactions
Enzyme inducers lower effect; warfarin and thyroid hormone needs may change.
Special advice
Add progestogen if uterus intact; transdermal route carries lower VTE risk; review annually.
More from the textbook: uses, cautions and other points
- Gonadal axis: LH, FSH and oestradiol (women) or 9 am testosterone (men). Low sex hormones with low or normal gonadotrophins means pituitary failure. In post-menopausal women, "normal" gonadotrophins are abnormally low.
Endocrinology: Pituitary Disease - In women: FSH grows follicles, which make oestradiol; a mid-cycle LH surge triggers ovulation; the corpus luteum then makes progesterone.
Endocrinology: Reproductive - Low testosterone (or oestradiol) with low LH and FSH .
Endocrinology: Reproductive - Tests: LFTs, U&E, TFTs, testosterone, LH, FSH, oestradiol, prolactin, hCG , AFP; examine the testes.
Oncology: Breast and Gynae Cancers - Tests - growth chart, bone age, LH and FSH (GnRH stimulation test), oestradiol or testosterone, 17-hydroxyprogesterone, pelvic ultrasound (girls), MRI brain (central).
Paediatrics: Growth, development and nutrition - Tests - growth chart, bone age, LH, FSH, oestradiol or testosterone, TFTs, prolactin, coeliac serology, FBC, ESR; karyotype if FSH and LH high; MRI pituitary if indicated.
Paediatrics: Growth, development and nutrition
Where it is discussed
- Endocrinology: Pituitary Disease (1 mention)
- Endocrinology: Reproductive (3 mentions)
- Oncology: Breast and Gynae Cancers (1 mention)
- Paediatrics: Growth, development and nutrition (3 mentions)
- Gynaecology: Menstrual Disorders (8 mentions)
- Gynaecology: Fertility Contraception Menopause (3 mentions)
- Surgey: Breast and endocrine surgery (1 mention)
- Integrated paediatrics chapter (3 mentions)
- General Practice: Child health, women's health and men's health in primary care (1 mention)
- Physiology: Endocrine control, metabolism and thermoregulation (3 mentions)
Etanercept
BNF entry for Etanercept · Stand-alone drug page
Mechanism
TNF-alpha receptor fusion protein.
Uses
Rheumatoid, psoriatic and juvenile arthritis, ankylosing spondylitis, plaque psoriasis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Injection-site reactions, infections, headache; reactivated TB, demyelination, cytopenias.
Interactions
Avoid with other biologics; live vaccines contraindicated.
Special advice
Screen for TB and hepatitis B; avoid in active infection.
More from the textbook: uses, cautions and other points
- Biologics - etanercept, adalimumab (also for uveitis), tocilizumab and anakinra (systemic JIA).
Paediatrics: Neurology, bones and joints in children - Etanercept / adalimumab / tocilizumab | Biologics for JIA (adalimumab also for uveitis; tocilizumab for systemic JIA).
Paediatrics: Neurology, bones and joints in children - TNF inhibitors - adalimumab, etanercept, infliximab, certolizumab.
Dermatology: Skin basics, eczema and psoriasis - TNF | Adalimumab, etanercept, infliximab, certolizumab, golimumab | RA, psoriatic arthritis, axial SpA, uveitis
Rheumatology Anatomy Physiology Pharmacology - TNF-alpha | Adalimumab, etanercept, infliximab, certolizumab, golimumab | RA, axial SpA, PsA, IBD, uveitis | TB reactivation , serious infections, avoid in moderate–severe heart failure and demyelinating disease , drug-induced lupus, skin cancers
Rheumatology: assessment, investigations and drugs - 1. A 74-year-old man with rheumatoid arthritis on etanercept has a 1-day hot, swollen right knee. He feels slightly unwell; temperature 37.4°C. CRP 95. Joint fluid is turbid with gram-positive cocci; calcium pyrophosphate crystals are also seen. Answer: Septic arthritis (with coexisting CPPD).
Rheumatology: assessment, investigations and drugs
Where it is discussed
- Paediatrics: Neurology, bones and joints in children (2 mentions)
- Dermatology: Skin basics, eczema and psoriasis (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (3 mentions)
- Rheumatology: Inflammatory arthritis (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Clinical Immunology: Immune system basics and immunological investigations (2 mentions)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (1 mention)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (2 mentions)
- Integrated paediatrics chapter (2 mentions)
- Cell Biology: Cell cycle, signalling, cell death and stem cells (1 mention)
Ezetimibe
BNF entry for Ezetimibe · Stand-alone drug page
Mechanism
Inhibits intestinal cholesterol absorption (NPC1L1).
Uses
Primary hypercholesterolaemia (add-on to statin or statin-intolerant).
Dosing
- If the target is not met: Add ezetimibe 10 mg daily, then consider other NICE-approved options (e.g. inclisiran, PCSK9 inhibitors).
Cardiology: Ischaemic Heart Disease (ACS) › 1.31 Secondary Prevention - Ezetimibe | 10 mg daily when further LDL lowering is needed.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - Ezetimibe 10 mg daily: Blocks gut cholesterol absorption and lowers LDL by about 20% more. The first add-on (NICE TA385).
Endocrinology: Lipids and obesity - Ezetimibe | 10 mg daily. First add-on when targets are not met.
Endocrinology: Lipids and obesity
2 more dose entries from the chapters
- High-intensity statin (e.g. atorvastatin 20–80 mg) aiming for at least a 50% LDL reduction; add ezetimibe .
Clinical Genetics: Cancer genetics and inherited cardiovascular conditions - Secondary prevention: atorvastatin 80 mg (lower dose if interactions or CKD); lipid-lowering targets LDL ≤2.0 mmol/L or non-HDL ≤2.6 mmol/L; add ezetimibe, then inclisiran or a PCSK9 inhibitor if criteria are met.
General Practice: Long-term conditions, multimorbidity and polypharmacy
Side effects
Diarrhoea, abdominal pain, myalgia, raised liver enzymes.
Interactions
Ciclosporin raises levels; fibrates and cholestyramine alter absorption.
Special advice
Check LFT with a statin; modest LDL lowering.
More from the textbook: uses, cautions and other points
- Ezetimibe - blocks intestinal cholesterol absorption (NPC1L1); added to statins or used if statins aren't tolerated.
Cardiology: Anatomy Physiology and Pharmacology - Ezetimibe / inclisiran / PCSK9 inhibitors | Additional LDL lowering.
Cardiology: Anatomy Physiology and Pharmacology - Bempedoic acid with ezetimibe (NICE TA694): When statins are contraindicated or not tolerated, and ezetimibe alone is not enough.
Endocrinology: Lipids and obesity - True intolerance of all statins is uncommon. If it occurs, use ezetimibe, bempedoic acid or inclisiran.
Endocrinology: Lipids and obesity - Normal or mildly raised CK - consider a break and re-challenge, a lower dose, or a different statin. Don't abandon lipid lowering - consider ezetimibe, bempedoic acid or inclisiran.
Neurology: Neuromuscular disease - FH | LDLR, APOB, PCSK9 | High-intensity statin + ezetimibe; cascade testing
Clinical Genetics: Cancer genetics and inherited cardiovascular conditions
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (2 mentions)
- Endocrinology: Lipids and obesity (8 mentions)
- Neurology: Neuromuscular disease (1 mention)
- Clinical Genetics: Cancer genetics and inherited cardiovascular conditions (4 mentions)
- Integrated cardiology chapter (2 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)
- Biochemistry: Metabolism of carbohydrates, lipids and proteins (1 mention)
F
Famotidine
BNF entry for Famotidine · Stand-alone drug page
Mechanism
Histamine H2 receptor antagonist reducing acid secretion.
Uses
Dyspepsia, GORD, peptic ulcer.
Dosing
- Famotidine 20–40 mg at night | H2 blocker; add-on for night-time symptoms.
Gastroenterology: Oesophagus and Stomach
Side effects
Headache, dizziness, constipation or diarrhoea; confusion in older adults with renal impairment.
Interactions
Reduces absorption of drugs needing acid (itraconazole, ketoconazole).
Special advice
Adjust in renal impairment; tolerance can develop.
More from the textbook: uses, cautions and other points
- H2 receptor antagonists - famotidine , nizatidine (ranitidine was withdrawn in 2020 because of an impurity, NDMA); weaker than PPIs; useful for night-time symptoms; cimetidine inhibits many CYP enzymes (interactions).
Gastroenterology: Anatomy Physiology Pharmacology - Famotidine (H2 blocker) | Weaker than PPIs; ranitidine withdrawn.
Gastroenterology: Anatomy Physiology Pharmacology - If PPIs fail: Check that they are being taken properly; double the dose or switch PPI; add an H2 blocker at night (famotidine); arrange endoscopy and 24-hour pH-impedance monitoring to confirm reflux before surgery.
Gastroenterology: Oesophagus and Stomach - Omeprazole (or an H2 blocker such as famotidine) | 4-week trial for suspected oesophagitis with distress or faltering growth.
Paediatrics: Gastroenterology and surgery in children - Reflux — antacids and alginates, then ranitidine alternatives (famotidine) or omeprazole .
Obstetrics - Reflux and constipation | Antacids, alginates; ranitidine alternatives (famotidine) or omeprazole; lactulose, ispaghula
Clinical pharmacology and prescribing: Prescribing in special groups
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Oesophagus and Stomach (2 mentions)
- Paediatrics: Gastroenterology and surgery in children (1 mention)
- Obstetrics (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Integrated paediatrics chapter (1 mention)
Fentanyl
BNF entry for Fentanyl · Stand-alone drug page
Mechanism
Potent synthetic mu-opioid agonist.
Uses
Severe pain, anaesthesia, breakthrough pain, palliative care.
Dosing
- Fentanyl patch | 12 micrograms/hour ≈ about 30 mg oral morphine a day. Takes 12–24 hours to start working; lasts 72 hours. Not for unstable pain or opioid-naive patients
Palliative: Symptoms Management - … 5 mg; 5–9 years 7.5 mg; 10 years and over 10 mg) Lorazepam IV 0.1 mg/kg (max 4 mg) Ceftriaxone (sepsis or meningitis) 80 mg/kg (max 4 g) once daily Intranasal fentanyl 1.5 micrograms/kg Paracetamol oral 15 mg/kg (max 4 doses a day; age-banded doses on packets) Ibuprofen oral 5–10 mg/kg (up to 3 times a day)
Emergency Medicine: Paediatric emergency medicine - Intranasal fentanyl | 1.5 micrograms/kg
Emergency Medicine: Paediatric emergency medicine - … or oral morphine; Entonox for short periods Severe (7–10) IV morphine (titrated — e.g. 0.1 mg/kg in 1–2 mg increments in adults); IV paracetamol; intranasal fentanyl or diamorphine (children); nerve blocks; methoxyflurane (Penthrox) inhaler
Emergency Medicine: ED procedures
4 more dose entries from the chapters
- Severe (7–10) | IV morphine (titrated — e.g. 0.1 mg/kg in 1–2 mg increments in adults); IV paracetamol; intranasal fentanyl or diamorphine (children); nerve blocks; methoxyflurane (Penthrox) inhaler
Emergency Medicine: ED procedures - Potency - the dose needed to produce a given effect (EC50) - a more potent drug works at a lower dose (e.g. fentanyl is more potent than morphine, bumetanide more potent than furosemide -1 mg bumetanide ≈ 40 mg furosemide).
Clinical pharmacology and prescribing: Principles of clinical pharmacology - Safety - opioid conversions , high-strength preparations (e.g. confusing morphine 10 mg/5 mL with 20 mg/mL concentrate), fentanyl patches in opioid-naïve patients, and combining opioids with gabapentinoids or benzodiazepines (respiratory depression).
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law - Fentanyl 25 microgram/hour patch for acute post-operative pain in an opioid-naïve patient | Inappropriate - slow onset, respiratory depression risk
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law
Side effects
Respiratory depression, nausea, constipation, bradycardia, muscle rigidity, dependence.
Interactions
CYP3A4 inhibitors (clarithromycin, ritonavir) markedly raise levels; additive sedation with benzodiazepines.
Special advice
Patches only for opioid-tolerant patients and change every 72 hours; heat increases absorption; avoid in acute pain.
More from the textbook: uses, cautions and other points
- Opioids: Use cautiously at low doses; they can trigger encephalopathy (through constipation and sedation). Give laxatives. Avoid codeine, and avoid morphine in severe disease (oxycodone in low doses, or fentanyl, is used with specialist advice).
Gastroenterology: Cirrhosis and Transplantation - Serotonin syndrome | SSRIs and SNRIs with tramadol , MAOIs, linezolid , triptans (rare), St John's wort, fentanyl, MDMA
Neurology: Anatomy, Physiology and Pharmacology - Morphine and codeine (active metabolites - drowsiness, myoclonus, respiratory depression) - prefer low-dose oxycodone, or fentanyl or alfentanil in advanced CKD and palliative care; tramadol with caution.
Renal: Anatomy, Physiology and Pharmacology - Switch to a safer opioid at a low dose (e.g. oxycodone with caution, or fentanyl or alfentanil with specialist advice); regular paracetamol; consider a nerve block for the hip.
Renal: Anatomy, Physiology and Pharmacology - Opioids - avoid morphine and codeine in advanced CKD (metabolites accumulate); oxycodone with caution; fentanyl, alfentanil and buprenorphine are safer.
Renal: Chronic Kidney Disease - Pain - renally safe opioids (fentanyl, alfentanil, buprenorphine).
Renal: Chronic Kidney Disease
Where it is discussed
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (3 mentions)
- Renal: Chronic Kidney Disease (4 mentions)
- Palliative: Symptoms Management (6 mentions)
- Palliative: End of Life Care (4 mentions)
- Obstetrics: Post Natal Care (1 mention)
- Psychiatric emergencies (1 mention)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Surgery: Surgical principles and perioperative care (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Emergency Medicine: Paediatric emergency medicine (2 mentions)
- Emergency Medicine: ED procedures (5 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (7 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (3 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (3 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (2 mentions)
- Acute Medicine: The deteriorating patient (1 mention)
- Critical care: Admission and organ support (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Anaesthesia: Airway management and anaesthetic drugs (2 mentions)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (4 mentions)
Ferrous fumarate
BNF entry for Ferrous fumarate · Stand-alone drug page
Mechanism
Oral iron salt replacing body iron stores.
Uses
Iron deficiency anaemia.
Dosing
- Management - limit cow's milk to about 500 mL a day ; iron-rich foods; oral iron (e.g. sodium feredetate or ferrous fumarate) for about 3 months after Hb normalises.
Paediatrics: Growth, development and nutrition - Management — limit cow's milk to about 500 mL a day ; iron-rich foods; oral iron (e.g. sodium feredetate or ferrous fumarate) for about 3 months after Hb normalises.
Integrated paediatrics chapter › Iron Deficiency and Other Deficiencies
Side effects
Constipation, dark stools, nausea, abdominal pain.
Interactions
Absorption reduced by antacids, calcium, PPIs and tetracyclines; levothyroxine absorption reduced.
Special advice
Take on an empty stomach or with vitamin C if tolerated; alternate-day dosing may improve tolerance; check Hb after a few weeks; keep away from children.
More from the textbook: uses, cautions and other points
- Sodium feredetate / ferrous fumarate | Iron deficiency anaemia; dark stools, constipation.
Paediatrics: Growth, development and nutrition
Where it is discussed
- Paediatrics: Growth, development and nutrition (2 mentions)
- Integrated paediatrics chapter (2 mentions)
Ferrous sulfate
BNF entry for Ferrous sulfate · Stand-alone drug page
Mechanism
Oral iron salt replacing body iron stores.
Uses
Iron deficiency anaemia and prevention.
Dosing
- Ferrous sulfate Iron deficiency in cyanotic CHD | 200 mg once daily (adult), monitoring the haemoglobin response carefully.
Cardiology: Congenital heart disease › 6.36 Drug Reference Table - Oral iron - e.g. ferrous sulfate 200 mg once daily (or on alternate days, which is better absorbed and tolerated).
Gastroenterology: Investigations - Ferrous sulfate 200 mg once daily or alternate days | IDA; expect Hb rise of about 20 g/L in 3–4 weeks; continue 3 months after normal.
Gastroenterology: Investigations - Oral iron - e.g. ferrous sulfate 200 mg once daily or on alternate days . Alternate-day dosing is better absorbed and tolerated.
Haematology: Anaemia
2 more dose entries from the chapters
- Ferrous sulfate 200 mg once daily or alternate days | Iron deficiency; Hb rise about 20 g/L in 3–4 weeks; continue 3 months after normal.
Haematology: Anaemia - Oral iron (e.g. ferrous sulfate 200 mg once daily, or on alternate days to improve absorption); recheck Hb in 2–4 weeks (should rise).
Obstetrics: Medical Problems
Side effects
Constipation, dark stools, nausea, epigastric pain.
Interactions
Absorption reduced by antacids, calcium, PPIs and tetracyclines.
Special advice
Alternate-day dosing; continue for several months after Hb corrects; investigate the cause of deficiency; accidental overdose in children is dangerous.
More from the textbook: uses, cautions and other points
- TSH still high despite rising levothyroxine doses; takes it with ferrous sulfate | Absorption interaction - separate by 4 hours
Endocrine: Anatomy Physiology and Pharmacology - Ferrous sulfate | Once daily or alternate days; constipation, black stools; separate from levothyroxine and quinolones; continue 3 months after Hb normal.
Haematology: Anatomy Physiology and Pharmacology - Ferrous sulfate / IV iron | Iron deficiency anaemia.
Obstetrics: Medical Problems
Where it is discussed
- Cardiology: Congenital heart disease (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Gastroenterology: Investigations (3 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Anaemia (3 mentions)
- Obstetrics: Medical Problems (2 mentions)
- Integrated cardiology chapter (1 mention)
Fidaxomicin
BNF entry for Fidaxomicin · Stand-alone drug page
Mechanism
Narrow-spectrum macrolide inhibiting RNA polymerase in C. difficile.
Uses
Clostridioides difficile infection.
Dosing
- First episode: Oral vancomycin 125 mg four times daily for 10 days . Fidaxomicin 200 mg twice daily for 10 days is second-line.
Gastroenterology: Gastroenterology Emergencies (Complete) - Fidaxomicin | 200 mg twice daily for 10 days - second-line, or for recurrence.
Gastroenterology: Gastroenterology Emergencies (Complete) - Second line: Fidaxomicin 200 mg twice daily for 10 days .
Gastroenterology: Bowel Disorders - Fidaxomicin 200 mg twice daily for 10 days | C. difficile second line and early recurrence.
Gastroenterology: Bowel Disorders
1 more dose entries from the chapters
- First episode - oral vancomycin 125 mg four times daily for 10 days ; fidaxomicin 200 mg twice daily for 10 days if vancomycin fails.
ID: Hospital infection, the immunocompromised host, vaccination and public health
Side effects
Nausea, vomiting, abdominal pain; rarely hypersensitivity.
Interactions
P-gp inhibitors (ciclosporin) may raise levels.
Special advice
Preferred first-line; lower recurrence than vancomycin; stop the offending antibiotic where possible.
More from the textbook: uses, cautions and other points
- C. difficile treatment - stop the causing antibiotic and PPIs if possible; oral vancomycin first-line (fidaxomicin for recurrence or high risk of recurrence - NICE NG199); avoid antidiarrhoeals.
Gastroenterology: Anatomy Physiology Pharmacology - Oral vancomycin / fidaxomicin | C. difficile infection.
Gastroenterology: Anatomy Physiology Pharmacology - Within 12 weeks: fidaxomicin.
Gastroenterology: Gastroenterology Emergencies (Complete) - After 12 weeks: vancomycin or fidaxomicin.
Gastroenterology: Gastroenterology Emergencies (Complete) - Recurrence within 12 weeks: Fidaxomicin. After 12 weeks: vancomycin or fidaxomicin.
Gastroenterology: Bowel Disorders - C. difficile: isolate, soap and water, oral vancomycin first line, fidaxomicin second line or for recurrence.
Gastroenterology: Bowel Disorders
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (4 mentions)
- Gastroenterology: Bowel Disorders (4 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (3 mentions)
- Microbiology: Bacteriology - structure, classification and important pathogens (1 mention)
Finasteride
BNF entry for Finasteride · Stand-alone drug page
Mechanism
5-alpha reductase type 2 inhibitor reducing dihydrotestosterone.
Uses
Benign prostatic hyperplasia, male-pattern hair loss.
Dosing
- … in days Postural hypotension , dizziness, retrograde ejaculation, floppy iris syndrome (tell the eye surgeon before cataract surgery) 5-alpha reductase inhibitor (finasteride, dutasteride) Enlarged prostate (over about 30 g, or PSA over 1.4) at high risk of progression; takes 6 months ; reduces retention and surgery Reduced …
Surgey: Urology - 5-alpha reductase inhibitor (finasteride, dutasteride) | Enlarged prostate (over about 30 g, or PSA over 1.4) at high risk of progression; takes 6 months ; reduces retention and surgery | Reduced libido, erectile dysfunction, gynaecomastia; halves PSA (double the value when interpreting)
Surgey: Urology - … PSA after counselling; frequency–volume chart. Treatment: lifestyle, alpha-blocker (tamsulosin) for moderate–severe voiding symptoms, 5-alpha reductase inhibitor (finasteride) if prostate is estimated >30 g or PSA >1.4; antimuscarinic or mirabegron for storage symptoms.
General Practice: Child health, women's health and men's health in primary care
Side effects
Reduced libido, erectile dysfunction, ejaculatory problems, gynaecomastia; mood changes.
Interactions
Few clinically important interactions.
Special advice
PSA falls by about half after 6 months; do not handle crushed tablets in pregnancy; breast changes need review.
More from the textbook: uses, cautions and other points
- Testosterone is converted to DHT (5-alpha-reductase - blocked by finasteride) and to oestrogen (aromatase - gynaecomastia).
Endocrine: Anatomy Physiology and Pharmacology - Anti-androgens - cyproterone acetate (liver toxicity, meningioma risk with high doses - MHRA), spironolactone (hirsutism), finasteride (5-alpha-reductase inhibitor - BPH; MHRA warning on depression and suicidal thoughts and sexual side effects).
Endocrine: Anatomy Physiology and Pharmacology - Anti-androgens (bicalutamide), finasteride, GnRH analogues.
Endocrinology: Reproductive - Growth depends on DHT (testosterone converted by 5-alpha-reductase - blocked by finasteride).
Renal: Anatomy, Physiology and Pharmacology - 5-alpha-reductase inhibitors ( finasteride , dutasteride) - shrink the prostate over 6 months or more ; for large prostates; halve the PSA (double it when interpreting); reduced libido, erectile dysfunction; finasteride - depression and suicidal thoughts (MHRA); women who could be pregnant shouldn't handle crushed or broken …
Renal: Anatomy, Physiology and Pharmacology - Lowered by: 5-alpha reductase inhibitors (finasteride, dutasteride - halve it).
Oncology: Urology and Genital cancers
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Reproductive (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (3 mentions)
- Oncology: Urology and Genital cancers (2 mentions)
- Oncology: Breast and Gynae Cancers (1 mention)
- Oncology: Skin Cancer (1 mention)
- Psychiatry: Mood disorders (1 mention)
- Surgey: Urology (3 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- General Practice: Child health, women's health and men's health in primary care (1 mention)
Flucloxacillin
BNF entry for Flucloxacillin · Stand-alone drug page
Mechanism
Penicillinase-resistant penicillin.
Uses
Skin and soft-tissue infection, staphylococcal sepsis, osteomyelitis, endocarditis (selected).
Dosing
- Antibiotics - flucloxacillin 500 mg four times daily for 10–14 days (erythromycin or clarithromycin if allergic) if symptoms don't improve within 12–24 hours, if there is a cracked nipple that looks infected, or if culture is positive.
Obstetrics: Post Natal Care - Flucloxacillin 500 mg four times daily | Mastitis not settling in 12–24 hours; 10–14 days.
Obstetrics: Post Natal Care - Oral flucloxacillin (500 mg to 1 g four times a day) for 5–7 days .
Dermatology: Skin infections and infestations - Treatment (NICE NG141) - flucloxacillin 500 mg–1 g four times daily (oral for mild; IV for severe); clarithromycin , doxycycline or erythromycin in penicillin allergy; co-amoxiclav for facial cellulitis (near the eyes or nose); 5–7 days; mark the edge; elevate the leg; treat the entry point (tinea pedis, ulcers).
Acute Medicine: The acute medical take
Side effects
Diarrhoea, rash, cholestatic jaundice (can occur weeks after stopping), C. difficile.
Interactions
Warfarin effect may reduce; paracetamol with flucloxacillin can cause metabolic acidosis (pyroglutamic acidosis) in at-risk patients.
Special advice
Avoid in penicillin allergy and previous flucloxacillin liver injury; take on an empty stomach.
More from the textbook: uses, cautions and other points
- Cholestatic pattern (ALP and GGT up more than ALT) - bile duct obstruction, PBC, PSC, drugs (co-amoxiclav, flucloxacillin), infiltration (cancer, sarcoid).
Gastroenterology: Anatomy Physiology Pharmacology - Cholestatic (ALP up) | Co-amoxiclav (may start up to 6 weeks after the course), flucloxacillin (older people; may be delayed), chlorpromazine, combined pill , anabolic steroids , carbimazole, sulfonylureas, erythromycin, terbinafine
Gastroenterology: Anatomy Physiology Pharmacology - Cholestatic (ALP and GGT mainly raised) | Bile duct stones, tumours (pancreas, cholangiocarcinoma), PBC, PSC, drugs (co-amoxiclav, flucloxacillin), liver metastases, infiltration (sarcoid, lymphoma)
Gastroenterology: Liver disease - Cholestatic | Co-amoxiclav (often weeks after the course ends; older men), flucloxacillin , chlorpromazine, anabolic steroids , the combined pill, erythromycin, terbinafine
Gastroenterology: Liver disease - Flucloxacillin ; continue feeding or expressing.
Oncology: Breast and Gynae Cancers - Flucloxacillin | Lactational mastitis (continue breastfeeding).
Oncology: Breast and Gynae Cancers
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Liver disease (2 mentions)
- Oncology: Breast and Gynae Cancers (2 mentions)
- Paediatrics: Respiratory and heart problems in children (1 mention)
- Paediatrics: Infections in children (6 mentions)
- Paediatrics: Neurology, bones and joints in children (2 mentions)
- Obstetrics (1 mention)
- Obstetrics: Post Natal Care (4 mentions)
- Dermatology: Skin basics, eczema and psoriasis (2 mentions)
- Dermatology: Skin infections and infestations (10 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Rheumatology: assessment, investigations and drugs (2 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Ear disorders (2 mentions)
- ENT: Neck lumps and cancer (3 mentions)
- ID: How Infection Happens (5 mentions)
- ID: Sepsis, fever and serious bacterial infections (9 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Surgery: Surgical principles and perioperative care (1 mention)
- Surgey: Trauma and orthopaedics (1 mention)
- Surgey: Breast and endocrine surgery (4 mentions)
- Emergency Medicine: ED procedures (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (3 mentions)
Fluconazole
BNF entry for Fluconazole · Stand-alone drug page
Mechanism
Triazole inhibiting fungal ergosterol synthesis (CYP51).
Uses
Candidiasis, cryptococcal meningitis, fungal prophylaxis.
Dosing
- Oral candida - white plaques, sore red mouth. Nystatin suspension or fluconazole 50 mg daily for 7 days (watch interactions). Clean dentures.
Palliative: Symptoms Management - Fluconazole 50 mg daily for 7 days | Oral candida; check interactions.
Palliative: Symptoms Management - Fluconazole 150 mg orally (single dose) - avoid in pregnancy (use topical clotrimazole for 7 nights).
Gynaecology: Sexual health - Induction (e.g. fluconazole 150 mg every 72 hours for 3 doses) then maintenance (fluconazole 150 mg weekly for 6 months).
Gynaecology: Sexual health
2 more dose entries from the chapters
- Vulvovaginal candidiasis - itch, thick white discharge - clotrimazole pessary or single-dose oral fluconazole 150 mg (not in pregnancy - topical only); recurrent - check for diabetes, longer suppressive courses.
ID: Viral, fungal and parasitic infections - Fluconazole | Oesophageal and vaginal candida (150 mg single dose; not in pregnancy); CYP inhibitor.
ID: Viral, fungal and parasitic infections
Side effects
Nausea, headache, raised LFT, QT prolongation; teratogenic at high doses in pregnancy.
Interactions
CYP2C9 and 3A4 inhibitor: raises warfarin, phenytoin, sulfonylureas, statins; QT-prolonging drugs.
Special advice
Reduce dose in renal impairment; avoid in pregnancy for high doses.
More from the textbook: uses, cautions and other points
- Many interactions - enzyme inhibitors raise INR (amiodarone, clarithromycin, erythromycin, fluconazole, metronidazole, ciprofloxacin, alcohol binges); inducers lower it (rifampicin, carbamazepine, phenytoin, St John's wort); diet (vitamin K-rich foods).
Cardiology: Anatomy Physiology and Pharmacology - Warfarin: factors II, VII, IX, X; many interactions (amiodarone, clarithromycin, fluconazole).
Cardiology: Anatomy Physiology and Pharmacology - Interactions - hypoglycaemia increased by other glucose-lowering drugs, alcohol, some antibiotics (clarithromycin, co-trimoxazole, fluconazole).
Endocrine: Anatomy Physiology and Pharmacology - Candida (inhaled steroids, diabetes, HIV, chemotherapy) - fluconazole.
Gastroenterology: Oesophagus and Stomach - Strong enzyme inducer - including its own metabolism (autoinduction - levels fall over the first few weeks); many interactions (contraception, warfarin, DOACs, steroids); levels raised by clarithromycin, erythromycin, fluconazole, diltiazem, verapamil.
Neurology: Anatomy, Physiology and Pharmacology - Enzyme inducer; teratogenic (fetal hydantoin syndrome); many interactions (warfarin, valproate, fluconazole, amiodarone raise levels).
Neurology: Anatomy, Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Gastroenterology: Oesophagus and Stomach (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Dialysis and Transplant (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (3 mentions)
- Palliative: Symptoms Management (2 mentions)
- Gynaecology: Sexual health (5 mentions)
- Dermatology: Skin infections and infestations (3 mentions)
- ENT: Common Nose and Throat disorders (2 mentions)
- ID: How Infection Happens (6 mentions)
- ID: HIV, viral hepatitis and blood-borne viruses (3 mentions)
- ID: Viral, fungal and parasitic infections (4 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (1 mention)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (1 mention)
- Microbiology: Fungi, parasites and travel-related infection (5 mentions)
Flumazenil
BNF entry for Flumazenil · Stand-alone drug page
Mechanism
Competitive benzodiazepine receptor antagonist.
Uses
Reversal of benzodiazepine sedation after procedures.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Iatrogenic benzodiazepine oversedation | 0.2 mg IV increments up to 1 mg | Avoid in mixed overdose, seizure risk or chronic benzodiazepine use. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
Side effects
Seizures, agitation, nausea, withdrawal in dependent patients.
Interactions
Reverses benzodiazepines only; seizure risk with tricyclic co-ingestion.
Special advice
Avoid in mixed overdose, epilepsy and chronic benzodiazepine use; short half-life so resedation can occur.
More from the textbook: uses, cautions and other points
- Reversal - naloxone for opioids (titrated in small IV doses in palliative or chronic opioid users to avoid severe pain and withdrawal; short half-life - infusion may be needed); flumazenil for benzodiazepines (rarely used - seizure risk).
Respiratory: Anatomy, Physiology and Pharmacology - Benzodiazepines: Supportive care. Flumazenil is not routinely used - it can cause seizures, especially in mixed overdoses or long-term users.
Respiratory: Emergencies - Reversal agents: flumazenil (benzodiazepines) and naloxone (opioids).
Gastroenterology: Investigations - Midazolam | Conscious sedation; lower doses in older people; reverse with flumazenil.
Gastroenterology: Investigations - Have available - flumazenil (benzodiazepine reversal), procyclidine (dystonia), oxygen, suction, bag-valve-mask, defibrillator.
Psychiatric emergencies - Respiratory depression (benzodiazepines) - oxygen, airway support; flumazenil if respiratory rate under 10.
Psychiatric emergencies
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Respiratory: Emergencies (1 mention)
- Gastroenterology: Investigations (2 mentions)
- Psychiatric emergencies (6 mentions)
- Psychiatry: Anxiety, stress and somatic disorders (2 mentions)
- Surgery: Surgical principles and perioperative care (1 mention)
- Emergency Medicine: ED procedures (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (6 mentions)
- Integrated respiratory chapter (1 mention)
Fluoxetine
BNF entry for Fluoxetine · Stand-alone drug page
Mechanism
SSRI with a long half-life active metabolite.
Uses
Depression, bulimia nervosa, OCD, in young people (first-line antidepressant).
Dosing
- SSRIs - sertraline, citalopram, escitalopram, fluoxetine, paroxetine | Usual first choice - safer in overdose. Sertraline - preferred after MI or with heart disease. Citalopram/escitalopram - QT prolongation (citalopram max 20 mg over 65). Fluoxetine - long half-life (fewer withdrawal effects), many interactions; first-line in …
Psychiatry: Mood disorders
Side effects
Nausea, insomnia, anxiety, sexual dysfunction, hyponatraemia, bleeding risk; activation.
Interactions
CYP2D6 inhibitor: raises tricyclics, beta-blockers and antipsychotics; MAOIs; warfarin effect rises.
Special advice
Long half-life means slow washout; fewer discontinuation symptoms; review young patients for suicidal thoughts early.
More from the textbook: uses, cautions and other points
- SSRIs or SNRIs - avoid paroxetine and fluoxetine with tamoxifen.
Endocrinology: Reproductive - Enzyme inhibitors - amiodarone , fluconazole and miconazole (including oral gel ), metronidazole , clarithromycin and erythromycin, ciprofloxacin , co-trimoxazole , allopurinol, cimetidine, SSRIs (fluoxetine, fluvoxamine).
Haematology: Anatomy Physiology and Pharmacology - CYP2D6 inhibitors (fluoxetine, paroxetine) may reduce its effect - use other antidepressants (venlafaxine, citalopram).
Oncology: Principles - Tamoxifen | VTE, endometrial cancer, hot flushes; avoid fluoxetine and paroxetine.
Oncology: Principles - SSRIs or SNRIs (venlafaxine, citalopram - avoid fluoxetine and paroxetine with tamoxifen ).
Oncology: Breast and Gynae Cancers - Tamoxifen | ER-positive breast cancer and prevention; VTE, endometrial cancer, hot flushes; avoid fluoxetine and paroxetine.
Oncology: Breast and Gynae Cancers
Where it is discussed
- Endocrinology: Reproductive (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Oncology: Principles (4 mentions)
- Oncology: Breast and Gynae Cancers (3 mentions)
- Gynaecology: Menstrual Disorders (2 mentions)
- Gynaecology: Fertility Contraception Menopause (2 mentions)
- Rheumatology: Connective tissue diseases (1 mention)
- Psychiatric emergencies (3 mentions)
- Psychiatry: Anxiety, stress and somatic disorders (2 mentions)
- Psychiatry: Safeguarding (3 mentions)
- Psychiatry: Mood disorders (6 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (3 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics (2 mentions)
- Biochemistry: Enzymes, vitamins and trace elements (1 mention)
Fluticasone
BNF entry for Fluticasone · Stand-alone drug page
Mechanism
Potent inhaled or nasal corticosteroid.
Uses
Asthma, COPD (combination), allergic rhinitis.
Dosing
- Mometasone / fluticasone nasal spray | Most effective treatment for allergic rhinitis and chronic rhinosinusitis; high dose (mometasone 200 micrograms twice daily for 14 days) for sinusitis over 10 days.
ENT: Common Nose and Throat disorders - 4. A 52-year-old man with HIV, well controlled on darunavir with cobicistat plus two NRTIs, is started on simvastatin 40 mg by his GP and uses a fluticasone nasal spray for rhinitis. Two months later he has muscle pain, weight gain and a round face. Answer: CYP3A4 interactions - statin myopathy and iatrogenic Cushing's syndrome …
ID: HIV, viral hepatitis and blood-borne viruses
Side effects
Oral candidiasis, dysphonia, nasal irritation; systemic effects at high doses.
Interactions
Ritonavir and ketoconazole markedly increase systemic exposure.
Special advice
Spacer and mouth rinse; check technique; carry steroid card at high doses.
More from the textbook: uses, cautions and other points
- Examples - beclometasone, budesonide, fluticasone (propionate and furoate), mometasone, ciclesonide. Doses are graded as low, moderate or high (devices aren't interchangeable dose-for-dose - prescribe by brand).
Respiratory: Anatomy, Physiology and Pharmacology - Pneumonia - increased risk with ICS in COPD (especially fluticasone).
Respiratory: Anatomy, Physiology and Pharmacology - Interactions - CYP3A4 inhibitors (ritonavir and cobicistat, itraconazole, clarithromycin) block breakdown of inhaled or nasal fluticasone and budesonide → Cushing's syndrome and adrenal suppression; enzyme inducers (rifampicin, carbamazepine, phenytoin) reduce steroid effect - double replacement doses may be needed.
Endocrine: Anatomy Physiology and Pharmacology - Cushingoid features in a patient on ritonavir and inhaled fluticasone | CYP3A4 inhibition - iatrogenic Cushing's and adrenal suppression
Endocrine: Anatomy Physiology and Pharmacology - Any steroid combined with a CYP3A4 inhibitor (e.g. ritonavir, cobicistat, itraconazole, clarithromycin). These block steroid breakdown - even inhaled fluticasone or injected triamcinolone can then cause Cushing's syndrome and adrenal suppression.
Endocrinology: Adrenal Disease - Inhaled corticosteroid (beclometasone, budesonide, fluticasone) | Asthma preventer; spacer; monitor growth at higher doses.
Paediatrics: Respiratory and heart problems in children
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (5 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Adrenal Disease (1 mention)
- Paediatrics: Respiratory and heart problems in children (1 mention)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Nose and Throat disorders (2 mentions)
- ID: HIV, viral hepatitis and blood-borne viruses (6 mentions)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (2 mentions)
- Integrated paediatrics chapter (1 mention)
- Microbiology: Virology - structure, replication and important viral infections (1 mention)
Folic acid
BNF entry for Folic acid · Stand-alone drug page
Mechanism
Vitamin B9 required for DNA synthesis.
Uses
Megaloblastic anaemia from folate deficiency, neural tube defect prevention, methotrexate toxicity mitigation.
Dosing
- Contraception and pregnancy planning: Every woman of child-bearing age should be advised to plan pregnancy, aiming for an HbA1c below 48 mmol/mol, and to take folic acid 5 mg beforehand.
Endocrinology: Diabetes - Folic acid 5 mg daily from before conception until 12 weeks.
Endocrinology: Diabetes - Folic acid 5 mg weekly , on a different day.
Gastroenterology: Inflammatory Bowel Disease - Sulfasalazine (with folic acid 5 mg ).
Gastroenterology: Inflammatory Bowel Disease
4 more dose entries from the chapters
- Folic acid 5 mg daily before conception and in the first trimester (all women on antiseizure medicines who could become pregnant).
Neurology: Anatomy, Physiology and Pharmacology - Folic acid 5 mg if she might become pregnant; discuss contraception (lamotrigine levels fall with the combined pill); DVLA advice.
Neurology: Anatomy, Physiology and Pharmacology - Folic acid 5 mg daily from before conception (for those on antiseizure medicines).
Neurology: Epilepsy - Folic acid 5 mg daily | Before conception and in early pregnancy in women on antiseizure medicines.
Neurology: Epilepsy
Side effects
Rarely GI upset; may mask B12 deficiency.
Interactions
Phenytoin levels fall; methotrexate rescue regimens.
Special advice
Check B12 first or together; higher dose in pregnancy with risk factors.
More from the textbook: uses, cautions and other points
- Methotrexate | Steroid-sparing in sarcoidosis; can itself cause pneumonitis; folic acid; FBC and LFT monitoring.
Respiratory: Interstitial Lung Disease - Iron , and folic acid as needed.
Endocrinology: Lipids and obesity - Methotrexate (weekly, oral or subcutaneous) - mainly Crohn's; folic acid on another day; FBC, LFTs and U&E monitoring; teratogenic (effective contraception, for men and women); pneumonitis; avoid trimethoprim and co-trimoxazole (marrow suppression); "once weekly" prescribing errors are a known cause of death.
Gastroenterology: Anatomy Physiology Pharmacology - Methotrexate | Weekly; folic acid; teratogenic; avoid trimethoprim.
Gastroenterology: Anatomy Physiology Pharmacology - Tropical sprue: Malabsorption after long stays in the tropics. Folate deficiency. Treated with tetracycline and folic acid.
Gastroenterology: Bowel Disorders - Vitamin D and folic acid supplementation.
Neurology: Multiple Sclerosis and inflammatory disease
Where it is discussed
- Respiratory: Interstitial Lung Disease (1 mention)
- Endocrinology: Diabetes (5 mentions)
- Endocrinology: Lipids and obesity (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Bowel Disorders (1 mention)
- Gastroenterology: Inflammatory Bowel Disease (4 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Epilepsy (5 mentions)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Renal: Tubular Inherited Stones (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (4 mentions)
- Haematology: Emergencies (1 mention)
- Haematology: Anaemia (4 mentions)
- Haematology: Haemoglobinopathies and Transfusion (1 mention)
- Paediatrics: Neurology, bones and joints in children (4 mentions)
- Obstetrics (8 mentions)
- Obstetrics: Antenatal Care (6 mentions)
- Obstetrics: Complications (1 mention)
- Obstetrics: Medical Problems (2 mentions)
- Gynaecology: Fertility Contraception Menopause (2 mentions)
- Dermatology: Skin basics, eczema and psoriasis (3 mentions)
- Rheumatology Anatomy Physiology Pharmacology (4 mentions)
- Rheumatology: assessment, investigations and drugs (5 mentions)
- Rheumatology: Inflammatory arthritis (1 mention)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (2 mentions)
Furosemide
BNF entry for Furosemide · Stand-alone drug page
Mechanism
Loop diuretic inhibiting Na-K-2Cl cotransporter.
Uses
Pulmonary oedema, heart failure and renal oedema, ascites.
Dosing
- 2. A 70-year-old woman on furosemide and digoxin for AF and heart failure has nausea, blurred yellow vision and a heart rate of 42. Potassium is 2.9 mmol/L. Answer: Digoxin toxicity precipitated by hypokalaemia.
Cardiology: Anatomy Physiology and Pharmacology - IV loop diuretic: e.g. furosemide 40–80 mg IV - or at least the usual oral dose given IV if already on a loop diuretic. Monitor urine output, weight and U&E.
Cardiology: Cardiology Emergencies - Furosemide Acute heart failure | 40–80 mg IV, or at least the usual oral dose given IV.
Cardiology: Cardiology Emergencies - IV furosemide 40–80 mg (higher if already on a loop diuretic).
Cardiology: Ischaemic Heart Disease (ACS) › 1.27 Heart Failure and Cardiogenic Shock
4 more dose entries from the chapters
- Furosemide (oral) | 20–40 mg once daily initially for congestion; titrate to response, renal function and electrolytes.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table - Furosemide (IV) | 20–40 mg IV if diuretic-naive in acute congestion; higher if already on a loop diuretic. Monitor BP, urine output and U&E.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table - IV loop diuretics : Give IV furosemide for congestive acute heart failure. A commonly used initial dose in a diuretic-naive adult is 20–40 mg IV, adjusted to the clinical situation. Patients already taking loop diuretics may require larger IV doses. Monitor urine output, blood pressure, renal function and electrolytes. Escalate …
Cardiology: Heart Failure › 2.15 🚑 Acute Pulmonary Oedema - Furosemide PO | 20–40 mg daily initially; titrate to congestion and response.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses
Side effects
Hypokalaemia, hyponatraemia, hypotension, hyperuricaemia, ototoxicity at high infusion rates.
Interactions
NSAIDs blunt effect; aminoglycosides ototoxicity; digoxin toxicity if potassium low; lithium levels rise.
Special advice
Daily weights, U&E monitoring; give IV slowly at high doses.
More from the textbook: uses, cautions and other points
- Furosemide / bumetanide | Loop diuretics; low K, Na, Mg; gout; ototoxicity.
Cardiology: Anatomy Physiology and Pharmacology - Yellow vision, nausea and bradycardia on furosemide and digoxin | Digoxin toxicity (from hypokalaemia)
Cardiology: Anatomy Physiology and Pharmacology - Priority — treat hypoxia and shock immediately (oxygen, sit up, IV furosemide for pulmonary oedema, CPAP) before specialist investigations.
Cardiology: Presentations - Acute pulmonary oedema | Sit up; oxygen to target; IV furosemide; CPAP or NIV if severe
Cardiology: Cardiology Emergencies - Sit up; oxygen; IV furosemide.
Cardiology: Cardiology Emergencies - Loop diuretics : Furosemide. Bumetanide. Act on the Na-K-2Cl cotransporter in the thick ascending limb of Henle. Effective for pulmonary and peripheral congestion. Can cause hypokalaemia, hyponatraemia, dehydration and renal dysfunction.
Cardiology: Heart Failure › 2.16 💉 Diuretics in Heart Failure
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Presentations (1 mention)
- Cardiology: Cardiology Emergencies (4 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Cardiology: Valvular heart disease (2 mentions)
- Cardiology: Heart Failure (5 mentions)
- Cardiology: Cardiomyopathies (1 mention)
- Cardiology: Congenital heart disease (3 mentions)
- Endocrinology: Emergencies (1 mention)
- Endocrinology: Bone Medicine (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Cirrhosis and Transplantation (4 mentions)
- Renal: Anatomy, Physiology and Pharmacology (9 mentions)
- Renal: Emergencies (5 mentions)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Tubular Inherited Stones (2 mentions)
- Renal: Glomerular Disease (2 mentions)
- Haematology: Emergencies (1 mention)
- Haematology: Haemoglobinopathies and Transfusion (3 mentions)
- Palliative: Symptoms Management (1 mention)
- Paediatrics: Respiratory and heart problems in children (3 mentions)
- Rheumatology Anatomy Physiology Pharmacology (2 mentions)
- ENT Anatomy Physiology (2 mentions)
- ENT: Common Ear disorders (1 mention)
- ID: How Infection Happens (1 mention)
G
Gabapentin
BNF entry for Gabapentin · Stand-alone drug page
Mechanism
Binds the alpha-2-delta subunit of voltage-gated calcium channels.
Uses
Neuropathic pain, focal seizures adjunct.
Dosing
- Amitriptyline / duloxetine / pregabalin / gabapentin Painful neuropathy | E.g. amitriptyline 10 mg at night, titrated; duloxetine 60 mg daily; pregabalin 75 mg twice daily, titrated. Adjust for renal function and frailty.
Endocrinology: Diabetes
Side effects
Drowsiness, dizziness, ataxia, weight gain, peripheral oedema; misuse potential; respiratory depression with opioids.
Interactions
Opioids and CNS depressants; antacids reduce absorption.
Special advice
Controlled drug in the UK; reduce in renal impairment; taper on stopping.
More from the textbook: uses, cautions and other points
- Respiratory depressants - opioids , benzodiazepines , Z-drugs, gabapentin and pregabalin , alcohol, barbiturates, anaesthetic agents. Combinations are especially dangerous (MHRA warnings on opioids with benzodiazepines or gabapentinoids). Highest risk - COPD, sleep apnoea, obesity hypoventilation, neuromuscular disease, older …
Respiratory: Anatomy, Physiology and Pharmacology - Offer amitriptyline, duloxetine, gabapentin or pregabalin ; switch to another if one is ineffective or not tolerated.
Endocrinology: Diabetes - The action potential reaches the nerve ending → voltage-gated calcium channels open (target of gabapentin and pregabalin , and of antibodies in Lambert–Eaton syndrome) → calcium enters.
Neurology: Anatomy, Physiology and Pharmacology - Neuropathic - nerve damage: burning, shooting, electric shock-like , pins and needles, allodynia (pain from light touch) - responds poorly to standard painkillers; use amitriptyline, duloxetine, gabapentin or pregabalin.
Neurology: Anatomy, Physiology and Pharmacology - Juvenile myoclonic epilepsy | Teenagers; morning myoclonic jerks , tonic-clonic seizures (often after sleep deprivation or alcohol), sometimes absences. Lifelong. Valproate (men), levetiracetam or lamotrigine. Carbamazepine, phenytoin and gabapentin worsen it
Neurology: Epilepsy - Myoclonic | Levetiracetam or valproate (males). Avoid carbamazepine, oxcarbazepine, phenytoin, gabapentin, pregabalin, vigabatrin (they can worsen it)
Neurology: Epilepsy
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Endocrinology: Diabetes (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (8 mentions)
- Neurology: Epilepsy (3 mentions)
- Neurology: Headache and Facial Pain (1 mention)
- Neurology: Movement Disorders (4 mentions)
- Neurology: Multiple Sclerosis and inflammatory disease (4 mentions)
- Neurology: Neuromuscular disease (4 mentions)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Emergencies (1 mention)
- Renal: Chronic Kidney Disease (4 mentions)
- Renal: Dialysis and Transplant (1 mention)
- Palliative: Symptoms Management (3 mentions)
- Gynaecology: Fertility Contraception Menopause (1 mention)
- Gynaecology: Pelvic floor ovary and vulva (2 mentions)
- Dermatology: Skin infections and infestations (2 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- ID: Viral, fungal and parasitic infections (1 mention)
- Psychiatric emergencies (1 mention)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Surgery: Vascular surgery (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (3 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
Gentamicin
BNF entry for Gentamicin · Stand-alone drug page
Mechanism
Aminoglycoside inhibiting 30S ribosome.
Uses
Sepsis, pyelonephritis, endocarditis (synergy), serious Gram-negative infection.
Dosing
- Weight-based doses - dose (mg/kg) × weight (kg) - e.g. gentamicin 5 mg/kg in a 70 kg patient = 350 mg; check maximum doses (children - don't exceed the adult dose).
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law - Gentamicin 7 mg/kg for a patient with eGFR 20 without level monitoring | Needs kidney dose adjustment and level-guided dosing
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law - Gentamicin | Pre-dose (trough) <1 mg/L for once-daily dosing; use local nomogram (e.g. Hartford) | Nephrotoxicity, ototoxicity (vestibular - irreversible)
Biochemistry: Clinical biochemistry - interpreting laboratory tests
Side effects
Nephrotoxicity, ototoxicity, neuromuscular blockade.
Interactions
Loop diuretics, vancomycin, ciclosporin increase toxicity; neuromuscular blockers potentiated.
Special advice
Weight-based dosing with level monitoring and local protocol; avoid in myasthenia gravis; check renal function.
More from the textbook: uses, cautions and other points
- Three or more exacerbations a year: Consider long-term macrolide (azithromycin, after excluding NTM and checking QT) or nebulised antibiotics (colistin, gentamicin) if Pseudomonas is present.
Respiratory: Airways Disease - Drugs that can worsen myasthenia - aminoglycosides (gentamicin), fluoroquinolones (ciprofloxacin), macrolides , magnesium , beta-blockers , quinine, chloroquine and hydroxychloroquine, penicillamine, lithium, phenytoin, statins (rarely), immune checkpoint inhibitors , botulinum toxin, neuromuscular blocking drugs. Check before …
Neurology: Anatomy, Physiology and Pharmacology - Weakness after gentamicin in a patient with ptosis | Aminoglycoside worsening myasthenia
Neurology: Anatomy, Physiology and Pharmacology - Myasthenia, given gentamicin, now choking and FVC falling | Myasthenic crisis
Neurology: Emergencies - Bilateral vestibular failure: Imbalance worse in the dark, and oscillopsia when walking. Often from gentamicin toxicity.
Neurology: Spine and Sleep Disorders - Pyelonephritis (NICE NG111) - cefalexin, co-amoxiclav (if sensitive), trimethoprim (if sensitive), or ciprofloxacin ; IV options (e.g. gentamicin, cefuroxime, ceftriaxone) if severe.
Renal: Anatomy, Physiology and Pharmacology
Where it is discussed
- Respiratory: Airways Disease (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (4 mentions)
- Neurology: Emergencies (1 mention)
- Neurology: Spine and Sleep Disorders (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (5 mentions)
- Renal: Emergencies (1 mention)
- Renal: Tubular Inherited Stones (1 mention)
- Renal: Dialysis and Transplant (3 mentions)
- Renal: Glomerular Disease (1 mention)
- Paediatrics: Neonatology (4 mentions)
- Paediatrics: Kidneys, urinary tract and hormones in children (1 mention)
- Paediatrics: Infections in children (1 mention)
- Obstetrics: Obstetrics: Emergencies (1 mention)
- Obstetrics: Post Natal Care (1 mention)
- ENT Anatomy Physiology (5 mentions)
- ENT: Common Ear disorders (6 mentions)
- ID: How Infection Happens (11 mentions)
- ID: Sepsis, fever and serious bacterial infections (3 mentions)
- Surgery: Surgical principles and perioperative care (1 mention)
- Surgey: Trauma and orthopaedics (1 mention)
- Surgey: Urology (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (6 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (2 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
Gliclazide
BNF entry for Gliclazide · Stand-alone drug page
Mechanism
Sulfonylurea increasing insulin secretion from pancreatic beta cells.
Uses
Type 2 diabetes.
Dosing
- 4. An 80-year-old woman on gliclazide 160 mg twice daily is found drowsy with glucose 1.9 mmol/L. eGFR has fallen from 55 to 24 with a UTI. Answer: Sulfonylurea-induced hypoglycaemia worsened by AKI.
Endocrine: Anatomy Physiology and Pharmacology - Example: Gliclazide - 40–80 mg daily initially, up to 160 mg twice daily (or a modified-release preparation).
Endocrinology: Diabetes - Morning gliclazide (e.g. 40 mg, titrated), or morning isophane (NPH) insulin (e.g. 10% dose increments), timed to match the steroid peak.
Endocrinology: Diabetes - 1. A 72-year-old man with AF on apixaban 5 mg twice daily (creatinine clearance 55 mL/min) is listed for an elective total hip replacement under spinal anaesthesia. He also takes ramipril and gliclazide. Answer: Peri-operative medicines plan.
Surgery: Surgical principles and perioperative care
4 more dose entries from the chapters
- 5. A 58-year-old man with type 2 diabetes is having a morning laparoscopic cholecystectomy as a day case. He takes metformin twice daily, gliclazide twice daily, dapagliflozin and insulin glargine at night. HbA1c is 62 mmol/mol. Answer: CPOC peri-operative diabetes plan.
Surgery: Surgical principles and perioperative care - … aspirin 75 mg (no history of vascular disease), omeprazole 40 mg (started 6 years ago for dyspepsia), amitriptyline 25 mg (sleep), zopiclone, oxybutynin and gliclazide (HbA1c 49). Standing BP 106/60. Answer: Problematic polypharmacy contributing to falls.
Medicine of the older adult: .Prescribing and deprescribing in older people - 1. A 76-year-old woman (55 kg) is admitted with AKI (creatinine 210, baseline 90) after diarrhoea. Her medicines are ramipril, furosemide, metformin, gliclazide, apixaban 5 mg twice daily and naproxen. Answer: Medicines review in AKI.
Clinical pharmacology and prescribing: Prescribing in special groups - 1. A 68-year-old man with type 2 diabetes on metformin, gliclazide and empagliflozin is listed for an elective right hemicolectomy. HbA1c is 62 mmol/mol. Answer: Perioperative diabetes management for major surgery with a long fast.
Anaesthesia: Preoperative assessment and principles of anaesthesia
Side effects
Hypoglycaemia, weight gain, GI upset, rash.
Interactions
Fluconazole, trimethoprim and beta-blockers increase hypoglycaemia or mask it; alcohol effects.
Special advice
Avoid or reduce in older and renal-impaired patients; take with meals.
More from the textbook: uses, cautions and other points
- Examples - gliclazide (the commonest in the UK), glimepiride, glipizide.
Endocrine: Anatomy Physiology and Pharmacology - Gliclazide | Closes KATP channels; prolonged hypoglycaemia in older people and CKD; weight gain.
Endocrine: Anatomy Physiology and Pharmacology - Diabetes at 22, parent and grandparent affected, antibody-negative | MODY (HNF1A - try gliclazide)
Endocrinology: Diabetes - Accidental: Dispensing errors - e.g. gliclazide supplied instead of another drug - and confusion in older people. Always check the actual tablets.
Endocrinology: NETS and Hypoglycaemia - Sulfonylureas (gliclazide preferred) and insulin - hypoglycaemia risk.
Renal: Chronic Kidney Disease - Steroids (dexamethasone) - monitor glucose; insulin or gliclazide if needed.
Oncology: Emergencies
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (5 mentions)
- Endocrinology: Diabetes (5 mentions)
- Endocrinology: NETS and Hypoglycaemia (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Oncology: Emergencies (1 mention)
- Surgery: Surgical principles and perioperative care (5 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (4 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (4 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (2 mentions)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (2 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)
Glimepiride
BNF entry for Glimepiride · Stand-alone drug page
Mechanism
Sulfonylurea increasing insulin secretion.
Uses
Type 2 diabetes.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hypoglycaemia, weight gain, GI upset.
Interactions
Fluconazole, warfarin interactions; alcohol.
Special advice
Long-acting so greater hypoglycaemia risk in older people.
More from the textbook: uses, cautions and other points
- Examples - gliclazide (the commonest in the UK), glimepiride, glipizide.
Endocrine: Anatomy Physiology and Pharmacology
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
Glucagon
BNF entry for Glucagon · Stand-alone drug page
Mechanism
Pancreatic hormone raising blood glucose by hepatic glycogenolysis.
Uses
Severe hypoglycaemia, beta-blocker overdose, bowel imaging.
Dosing
- If there is no IV access, glucagon 1 mg IM .
Endocrinology: Diabetes - Glucagon Severe hypoglycaemia | 1 mg IM or SC (once). Less effective in liver disease, alcohol excess and starvation.
Endocrinology: Diabetes - Hypoglycaemia | 15–20 g fast carbohydrate, or IV 10% glucose 150–200 mL, or glucagon 1 mg IM
Endocrinology: Emergencies - Or glucagon 1 mg IM if there is no IV access. Glucagon is less effective with sulfonylureas, alcohol, liver disease or starvation.
Endocrinology: Emergencies
4 more dose entries from the chapters
- Severe (can't swallow safely) - glucagon IM or SC (or nasal glucagon); in hospital - IV 10% glucose 2 mL/kg .
Paediatrics: Kidneys, urinary tract and hormones in children - Treatment - oral glucose if alert; IV 10% glucose 2 mL/kg then an infusion if not; glucagon IM (not in adrenal insufficiency or fatty acid oxidation disorders where it may not work); hydrocortisone if adrenal insufficiency suspected.
Paediatrics: Kidneys, urinary tract and hormones in children - Drowsy or unable to swallow safely - IV glucose (e.g. 150–160 mL of 10% glucose or 75–80 mL of 20% over about 15 minutes) or IM glucagon 1 mg (less effective in liver disease, alcohol, starvation or sulphonylurea overdose).
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing - Hypoglycaemia -15–20 g fast carbohydrate; IV glucose or IM glucagon if unable to swallow.
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing
Side effects
Nausea, vomiting, transient tachycardia; ineffective if glycogen depleted.
Interactions
Warfarin effect may increase.
Special advice
Needs hepatic glycogen stores; give carbohydrate once awake; less effective in starvation, alcohol and adrenal insufficiency.
More from the textbook: uses, cautions and other points
- Overdose - bradycardia and hypotension: atropine, glucagon, high-dose insulin with glucose, pacing (TOXBASE).
Cardiology: Anatomy Physiology and Pharmacology - Beta-blocker or calcium channel blocker toxicity: Consider glucagon and high-dose insulin (see Cardiotoxic Poisoning).
Cardiology: Cardiology Emergencies - Atropine; glucagon IV; high-dose insulin euglycaemia therapy ; vasopressors; pacing.
Cardiology: Cardiology Emergencies - Additional causes: If beta blocker or calcium blocker toxicity suspected, seek toxicology advice; glucagon and other specific treatment may be relevant.
Cardiology: Cardiac Arrhythmias › 5.26 RCUK 2025 Bradyarrhythmia Algorithm - Water-soluble (peptides and catecholamines - insulin, glucagon, PTH, ADH, ACTH, adrenaline) - act on cell-surface receptors and second messengers (cAMP, calcium); act in seconds to minutes; short half-lives.
Endocrine: Anatomy Physiology and Pharmacology - Delta cells - somatostatin (inhibits both insulin and glucagon).
Endocrine: Anatomy Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: Cardiology Emergencies (2 mentions)
- Cardiology: Cardiac Arrhythmias (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (8 mentions)
- Endocrinology: Diabetes (7 mentions)
- Endocrinology: Emergencies (4 mentions)
- Endocrinology: Pituitary Disease (1 mention)
- Endocrinology: NETS and Hypoglycaemia (3 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Investigations (1 mention)
- Gastroenterology: Pancreas and Biliary (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Paediatrics: Kidneys, urinary tract and hormones in children (3 mentions)
- ENT: Emergencies (1 mention)
- Emergency Medicine: Minor injuries wounds, bites, minor burns, hands and foreign bodies (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (4 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (5 mentions)
- Acute Medicine: Cardiac arrest, advanced life support and peri-arrest arrhythmias (2 mentions)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (2 mentions)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (1 mention)
- Integrated cardiology chapter (1 mention)
Glyceryl trinitrate (GTN)
BNF entry for Glyceryl trinitrate (GTN) · Stand-alone drug page
Mechanism
Nitric oxide donor causing venodilation and, at higher doses, arteriolar dilation.
Uses
Angina, acute coronary syndrome, acute heart failure, hypertensive emergency in specific settings.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| ACS / pulmonary oedema | 5–200 microg/min IV infusion | Avoid in RV infarct, hypotension, recent PDE5 inhibitor use. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
This drug is not covered by a dedicated section of the textbook chapters.
Side effects
Headache, flushing, hypotension, reflex tachycardia, tolerance.
Interactions
PDE5 inhibitors (sildenafil, tadalafil) cause profound hypotension; antihypertensives additive.
Special advice
Avoid in hypotension, RV infarction and severe aortic stenosis; sublingual use sitting down.
Glycopyrronium
BNF entry for Glycopyrronium · Stand-alone drug page
Mechanism
Quaternary antimuscarinic.
Uses
COPD (inhaled), excessive drooling and secretions, premedication.
Dosing
- Symptomatic: Pyridostigmine 30–60 mg 4–6 times daily. Side effects: diarrhoea, cramps, sweating, salivation (glycopyrronium or propantheline help). Too much causes a cholinergic crisis (weakness, secretions).
Neurology: Neuromuscular disease - Respiratory secretions | Glycopyrronium 200 micrograms SC 4-hourly, or hyoscine butylbromide 20 mg SC hourly to 4-hourly (maximum 120 mg in 24 hours)
Palliative: End of Life Care - Glycopyrronium SC 200 micrograms 4-hourly | Respiratory secretions; doesn't cross into the brain (no sedation).
Palliative: End of Life Care
Side effects
Dry mouth, urinary retention, tachycardia, constipation, blurred vision.
Interactions
Other antimuscarinics additive.
Special advice
Caution in glaucoma and urinary retention.
More from the textbook: uses, cautions and other points
- LAMA - tiotropium , umeclidinium, glycopyrronium, aclidinium - once or twice daily; mainly COPD; also add-on in severe asthma.
Respiratory: Anatomy, Physiology and Pharmacology - Triple therapy (LABA + LAMA + ICS in one inhaler - e.g. fluticasone furoate–umeclidinium–vilanterol, beclometasone–formoterol–glycopyrronium) - COPD with continued exacerbations (especially with raised eosinophils or asthmatic features); severe asthma.
Respiratory: Anatomy, Physiology and Pharmacology - Rocuronium , atracurium (non-depolarising) - reversed by neostigmine (with glycopyrronium) or sugammadex (rocuronium and vecuronium); people with myasthenia are very sensitive to them.
Neurology: Anatomy, Physiology and Pharmacology - Non-motor symptoms - Parkinson's psychosis (reduce drugs in reverse order of benefit; quetiapine or clozapine - clozapine needs blood monitoring); dementia ( rivastigmine ); depression; constipation; postural hypotension (fludrocortisone, midodrine); drooling (glycopyrronium).
Neurology: Anatomy, Physiology and Pharmacology - Drooling: Speech therapy; glycopyrronium ; botulinum toxin to the salivary glands.
Neurology: Movement Disorders - Drooling - glycopyrronium, amitriptyline, hyoscine patches, botulinum toxin.
Neurology: Neuromuscular disease
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Movement Disorders (1 mention)
- Neurology: Neuromuscular disease (3 mentions)
- Palliative: End of Life Care (8 mentions)
- Paediatrics: Neurology, bones and joints in children (2 mentions)
- ENT: Neck lumps and cancer (1 mention)
- Medicine of the older adult. Discharge, capacity, advance care planning and end of life (2 mentions)
- Critical care: common problems, ethics and recovery (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Anaesthesia: Airway management and anaesthetic drugs (4 mentions)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (1 mention)
- Integrated paediatrics chapter (2 mentions)
- General Practice: Mental health, safeguarding, certification and the law (1 mention)
H
Haloperidol
BNF entry for Haloperidol · Stand-alone drug page
Mechanism
Butyrophenone antipsychotic blocking dopamine D2 receptors.
Uses
Acute psychosis and agitation, delirium (short term), nausea in palliative care, tics.
Dosing
- Drugs only if the person is very distressed or a risk to themselves or others, and other measures have failed: e.g. haloperidol 0.5 mg , at the lowest dose for the shortest time.
Neurology: Emergencies - Haloperidol Delirium (distressed) | e.g. 0.5 mg, lowest dose for shortest time; avoid in Parkinson's and Lewy body dementia.
Neurology: Emergencies - Chemical or metabolic - opioids, other drugs, hypercalcaemia, uraemia, infection | Constant nausea, little relief from vomiting. Haloperidol 0.5–1.5 mg at night or twice daily (oral or SC). Correct the cause
Palliative: Symptoms Management - Cyclizine 150 mg over 24 hours and/or haloperidol 1.5–5 mg over 24 hours.
Palliative: Symptoms Management
4 more dose entries from the chapters
- Nausea and vomiting | Haloperidol 0.5–1 mg SC (maximum about 5 mg in 24 hours), or levomepromazine 2.5–5 mg SC, or cyclizine 50 mg SC 8-hourly
Palliative: End of Life Care - Delirium with distress | Haloperidol 0.5–1 mg SC, or levomepromazine
Palliative: End of Life Care - IM haloperidol with IM promethazine (e.g. haloperidol 5 mg plus promethazine 25–50 mg) - check an ECG first if possible (QT); promethazine reduces the risk of acute dystonia.
Psychiatric emergencies - Only if severely distressed or at risk - low-dose haloperidol (0.5 mg), short-term, after checking QT if possible; review daily; record delirium on the discharge summary.
Medicine of the older adult: Delirium, dementia and mood in older people
Side effects
Extrapyramidal effects, akathisia, QT prolongation, neuroleptic malignant syndrome, hyperprolactinaemia.
Interactions
QT-prolonging drugs, other dopamine antagonists, levodopa antagonism.
Special advice
ECG before use if cardiac risk; avoid in Parkinson disease and Lewy body dementia; lowest dose in older people.
More from the textbook: uses, cautions and other points
- Antipsychotics (haloperidol), citalopram, escitalopram, methadone, ondansetron, domperidone.
Cardiology: Cardiology Emergencies - Twisting polymorphic VT on clarithromycin and haloperidol | Torsades de pointes
Cardiology: Cardiology Emergencies - Antipsychotics - especially risperidone, amisulpride and haloperidol.
Endocrinology: Pituitary Disease - Haloperidol (low dose) | D2 antagonist | Chemical causes (drugs, renal failure, high calcium) - palliative care | Extrapyramidal effects, QT; avoid in Parkinson's and Lewy body dementia
Gastroenterology: Anatomy Physiology Pharmacology - Bowel obstruction - avoid prokinetics (metoclopramide, domperidone) in complete obstruction; use cyclizine, haloperidol or hyoscine butylbromide.
Gastroenterology: Anatomy Physiology Pharmacology - Delirium tremens: Oral lorazepam first-line. Parenteral lorazepam, haloperidol or olanzapine if symptoms persist. Treat in a safe environment, often HDU.
Gastroenterology: Gastroenterology Emergencies (Complete)
Where it is discussed
- Cardiology: Cardiology Emergencies (2 mentions)
- Endocrinology: Pituitary Disease (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Oesophagus and Stomach (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (5 mentions)
- Neurology: Emergencies (7 mentions)
- Neurology: Movement Disorders (5 mentions)
- Neurology: Dementia and Cognition Disorders (Complete) (4 mentions)
- Renal: Chronic Kidney Disease (1 mention)
- Palliative: Symptoms Management (11 mentions)
- Palliative: End of Life Care (9 mentions)
- Psychiatric emergencies (9 mentions)
- Psychiatry: Mood disorders (2 mentions)
- Psychiatry: Alcohol, drugs and addiction (3 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Psychiatry: Psychosis and schizophrenia (12 mentions)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (1 mention)
- Medicine of the older adult: Delirium, dementia and mood in older people (6 mentions)
- Medicine of the older adult. Discharge, capacity, advance care planning and end of life (1 mention)
- Emergency Medicine: Environmental emergencies (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (2 mentions)
Heparin
BNF entry for Heparin · Stand-alone drug page
Mechanism
Unfractionated heparin potentiating antithrombin inhibition of thrombin and factor Xa.
Uses
Acute VTE, ACS, dialysis circuits, bridging, patients with severe renal impairment.
Dosing
- Fondaparinux 2.5 mg SC daily unless high bleeding risk or angiography is planned within 24 hours. Avoid if eGFR is below 20 - use unfractionated heparin.
Cardiology: Cardiology Emergencies - Unfractionated heparin (alternative): 60 units/kg IV bolus (max 4,000 units), then 12 units/kg/hour (max 1,000 units/hour), adjusted to an aPTT ratio of 1.5–2.0, for 24–48 hours.
Cardiology: Ischaemic Heart Disease (ACS) › 1.21 STEMI: Fibrinolysis - Fondaparinux 2.5 mg SC daily for patients without high bleeding risk who are not having immediate angiography (NICE). Use unfractionated heparin instead if creatinine is above 265 µmol/L.
Cardiology: Ischaemic Heart Disease (ACS) › 1.22 NSTEMI and Unstable Angina - Unfractionated heparin: Protamine (1 mg per 100 units given in the last 2 hours; maximum 50 mg). Partial reversal of LMWH.
Haematology: Emergencies
3 more dose entries from the chapters
- Write "units" in full (insulin, heparin) | 10 units | 10 U, 10 IU ("U" read as 0 → 100)
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law - Pharmacological prophylaxis - LMWH (e.g. enoxaparin 40 mg daily - adjust for weight and kidney function) or fondaparinux, for at least 7 days if VTE risk outweighs bleeding risk; unfractionated heparin in severe kidney impairment (eGFR under 15–30).
Acute Medicine: The acute medical take - Practicalities — large-bore dual-lumen vascath (internal jugular or femoral), anticoagulation of the circuit ( citrate — regional; or heparin), dose about 20–25 mL/kg/hour effluent.
Critical care: Admission and organ support
Side effects
Bleeding, heparin-induced thrombocytopenia, osteoporosis, hyperkalaemia.
Interactions
Anticoagulants, antiplatelets, NSAIDs increase bleeding risk; GTN may reduce effect.
Special advice
Monitor APTT or anti-Xa as per local protocol; check platelet counts; protamine reverses.
More from the textbook: uses, cautions and other points
- Natural anticoagulants - antithrombin (enhanced by heparin), proteins C and S.
Cardiology: Anatomy Physiology and Pharmacology - Takes several days to work fully; early on it can be pro-thrombotic (protein C falls first) - overlap with heparin for VTE.
Cardiology: Anatomy Physiology and Pharmacology - Suddenly painful, pale, pulseless foot in AF | Acute limb ischaemia (embolus) — heparin, urgent vascular surgery
Cardiology: Presentations - High-risk PE | Systemic thrombolysis (alteplase); heparin; consider embolectomy
Cardiology: Cardiology Emergencies - Unstable (shock, syncope, ischaemia, heart failure, with AF as the cause): synchronised DC cardioversion at maximum output; heparin if possible without delay.
Cardiology: Cardiology Emergencies - Anticoagulation: Unfractionated heparin during the procedure.
Cardiology: Ischaemic Heart Disease (ACS) › 1.20 STEMI: Primary PCI
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (12 mentions)
- Cardiology: Presentations (1 mention)
- Cardiology: Cardiology Emergencies (6 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (5 mentions)
- Cardiology: Valvular heart disease (2 mentions)
- Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease (4 mentions)
- Respiratory: Emergencies (1 mention)
- Respiratory: Pulmonary Vascular Disease (2 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Adrenal Disease (2 mentions)
- Endocrinology: Thyroid disease (2 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (4 mentions)
- Neurology: Stroke Emergencies (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (5 mentions)
- Renal: Emergencies (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Tubular Inherited Stones (1 mention)
- Renal: Dialysis and Transplant (3 mentions)
- Haematology: Anatomy Physiology and Pharmacology (19 mentions)
- Haematology: History and Examination (3 mentions)
- Haematology: Emergencies (9 mentions)
- Haematology: Haemostasis and Thrombosis (21 mentions)
- Obstetrics (2 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (4 mentions)
- Surgery: Major trauma and burns (1 mention)
Hydralazine
BNF entry for Hydralazine · Stand-alone drug page
Mechanism
Direct arterial vasodilator.
Uses
Hypertensive emergencies in pregnancy, resistant hypertension, heart failure with nitrates.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Headache, tachycardia, fluid retention, lupus-like syndrome.
Interactions
Beta-blockers limit reflex tachycardia; additive hypotension.
Special advice
Slow acetylators have higher lupus risk; avoid in SLE.
More from the textbook: uses, cautions and other points
- Afterload - the resistance the ventricle pumps against (aortic pressure, systemic vascular resistance, aortic stenosis); reduced by vasodilators (ACE inhibitors, hydralazine, dihydropyridines).
Cardiology: Anatomy Physiology and Pharmacology - Severe pre-eclampsia / eclampsia | Below 160/105 (and 150/100 maintenance); labetalol, nifedipine or hydralazine; magnesium sulfate for seizures
Cardiology: Cardiology Emergencies - Hydralazine with nitrate: May be considered in selected patients who cannot tolerate RAAS-blocking therapies or in specific specialist populations.
Cardiology: Heart Failure › 2.27 🧬 Specialist and Advanced Heart Failure Treatment - Additional options: Ivabradine (sinus rhythm, heart rate ≥75/min, LVEF ≤35%), IV iron for iron deficiency, hydralazine/nitrate where ACE inhibitor/ARB/ARNI cannot be used.
Cardiology: Cardiomyopathies › 3.15 DCM: Management and Prognosis - Treatment before delivery: Beta blocker (e.g. metoprolol), loop diuretic for congestion, hydralazine and nitrates for afterload reduction; avoid ACE inhibitors, ARBs, ARNIs, MRAs and SGLT2 inhibitors. Urgent pregnancy heart team input for timing and mode of delivery.
Cardiology: Cardiomyopathies › 3.42 Peripartum Cardiomyopathy (PPCM) - Drugs causing lupus-like pleurisy (hydralazine, procainamide, isoniazid) | Pleuritis and effusions
Respiratory: Anatomy, Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: Cardiology Emergencies (1 mention)
- Cardiology: Heart Failure (1 mention)
- Cardiology: Cardiomyopathies (2 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Endocrinology: Adrenal Disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Glomerular Disease (1 mention)
- Obstetrics (1 mention)
- Obstetrics: Obstetrics: Emergencies (3 mentions)
- Obstetrics: Medical Problems (3 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Rheumatology: assessment, investigations and drugs (3 mentions)
- Rheumatology: Connective tissue diseases (3 mentions)
- Rheumatology: Vasculitis, GCA and PMR (3 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (2 mentions)
- Clinical Immunology: Autoimmunity, autoantibodies and complement (4 mentions)
- Integrated cardiology chapter (3 mentions)
- Pathology: Immunopathology, amyloidosis, genetic and environmental disease (1 mention)
Hydrocortisone
BNF entry for Hydrocortisone · Stand-alone drug page
Mechanism
Glucocorticoid and mineralocorticoid replacement.
Uses
Adrenal insufficiency, adrenal crisis, anaphylaxis adjunct, severe asthma, topical anti-inflammatory.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Adrenal crisis | 100 mg IV then 50 mg IV qds | Give fluids and treat the precipitant too. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
- Acute asthma - prednisolone 40–50 mg once daily for at least 5 days (IV hydrocortisone if unable to swallow); no need to taper short courses.
Respiratory: Anatomy, Physiology and Pharmacology - Steroids: Prednisolone 40–50 mg orally (or hydrocortisone 100 mg IV 6-hourly if unable to swallow). Continue for at least 5 days.
Respiratory: Emergencies - Hydrocortisone | 100 mg IV 6-hourly if unable to take oral steroid.
Respiratory: Emergencies - Hydrocortisone | 20 mg | High
Endocrine: Anatomy Physiology and Pharmacology
4 more dose entries from the chapters
- Replacement in adrenal insufficiency - hydrocortisone about 15–25 mg a day in 2–3 doses (largest on waking - e.g. 10 mg, 5 mg, 5 mg), plus fludrocortisone 50–100 micrograms daily in primary adrenal insufficiency.
Endocrine: Anatomy Physiology and Pharmacology - Adrenal crisis | Hydrocortisone 100 mg IV/IM now, then 200 mg over 24 hours; saline; glucose
Endocrinology: Emergencies - Pituitary apoplexy | Hydrocortisone 100 mg IV; urgent MRI; neurosurgical and ophthalmology review
Endocrinology: Emergencies - Hydrocortisone 15–25 mg daily in 2–3 divided doses, the largest on waking.
Endocrinology: Pituitary Disease
Side effects
Hyperglycaemia, fluid retention, mood changes, adrenal suppression, infection.
Interactions
CYP3A4 inducers lower effect; diuretics and hypokalaemia.
Special advice
Sick-day rules and emergency card in adrenal insufficiency; double or triple dose in illness; never stop abruptly.
More from the textbook: uses, cautions and other points
- ⚠️ Safety Pearl: IM adrenaline is the treatment for anaphylaxis - give it early and repeat it. Delaying adrenaline to give chlorphenamine and hydrocortisone is a common and dangerous mistake.
Respiratory: Emergencies - Severe pneumonia: NICE NG250 suggests considering corticosteroids (IV hydrocortisone first). Note the MHRA warning about combining fluoroquinolones with steroids (tendon rupture).
Respiratory: Emergencies - Pituitary apoplexy - bleeding into or infarction of a tumour: sudden headache, visual loss, eye movement problems and acute ACTH deficiency - give hydrocortisone.
Endocrine: Anatomy Physiology and Pharmacology - Too little (adrenal insufficiency) - tiredness, weight loss, nausea, abdominal pain, low blood pressure, hyponatraemia , hypoglycaemia; adrenal crisis if stressed - an emergency needing IV or IM hydrocortisone.
Endocrine: Anatomy Physiology and Pharmacology - … is in each system chapter. Your four questions for every patient: Is the patient shocked, hypoglycaemic or fitting? Could this be adrenal insufficiency (give hydrocortisone if in doubt)? What do glucose, ketones, sodium, potassium and calcium show? What triggered it?
Endocrinology: Emergencies - Thyroid storm | Propranolol; propylthiouracil; iodine 1 hour later; hydrocortisone; cooling; ICU
Endocrinology: Emergencies
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Respiratory: Emergencies (5 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (15 mentions)
- Endocrinology: Emergencies (21 mentions)
- Endocrinology: Sodium and Water disorders (2 mentions)
- Endocrinology: Pituitary Disease (19 mentions)
- Endocrinology: Adrenal Disease (48 mentions)
- Endocrinology: Thyroid disease (6 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (4 mentions)
- Gastroenterology: Inflammatory Bowel Disease (2 mentions)
- Oncology: Principles (4 mentions)
- Oncology: Emergencies (4 mentions)
- Paediatrics: Respiratory and heart problems in children (2 mentions)
- Paediatrics: Kidneys, urinary tract and hormones in children (11 mentions)
- Obstetrics: Antenatal Care (1 mention)
- Dermatology: Skin basics, eczema and psoriasis (5 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (8 mentions)
- ENT: Common Nose and Throat disorders (1 mention)
- ID: Sepsis, fever and serious bacterial infections (1 mention)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Surgery: Acute abdomen and emergency general surgery (1 mention)
- Emergency Medicine: Paediatric emergency medicine (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
Hydroxychloroquine
BNF entry for Hydroxychloroquine · Stand-alone drug page
Mechanism
Antimalarial that interferes with lysosomal activity and toll-like receptor signalling.
Uses
SLE, rheumatoid arthritis, Sjogren syndrome, malaria prophylaxis.
Dosing
- Immunosuppressants compatible with pregnancy — prednisolone (mostly inactivated by the placenta), hydroxychloroquine , azathioprine , sulfasalazine (with folic acid 5 mg), ciclosporin, tacrolimus, most anti-TNF drugs (certolizumab minimal transfer).
Obstetrics - Hydroxychloroquine | Raises lysosomal pH → impairs antigen presentation and Toll-like receptor signalling (reduces type I interferon) | Retinopathy (annual screening after 5 years; dose 5 mg/kg/day or less), QT prolongation, rare cardiomyopathy; safe in pregnancy — the backbone of SLE treatment
Rheumatology Anatomy Physiology Pharmacology - Stop methotrexate (1–3 months before conception per BSR); continue sulfasalazine (with folic acid 5 mg daily) and consider adding hydroxychloroquine to keep disease controlled.
Rheumatology: assessment, investigations and drugs - Hydroxychloroquine for all SLE patients unless contraindicated; aim for prednisolone 5 mg or less.
Rheumatology: Connective tissue diseases
4 more dose entries from the chapters
- 4. A 31-year-old woman with SLE (anti-Ro positive, antiphospholipid antibody negative) on hydroxychloroquine, mycophenolate and prednisolone 5 mg wants to become pregnant. Answer: Pre-pregnancy planning in SLE.
Rheumatology: Emergencies, pregnancy and other systemic diseases - Hydroxychloroquine (and chloroquine) | Retinal toxicity ("bull's-eye" maculopathy) — irreversible; risk with dose over 5 mg/kg/day (actual body weight), long duration, renal impairment, tamoxifen — annual screening (OCT and fields) after 5 years of use (after 1 year if additional risk factors — RCOphth 2020)
Ophthalmology: Anatomy Physiology and Pharmacology - 3. A 46-year-old woman with SLE has taken hydroxychloroquine 400 mg daily for 7 years. She weighs 58 kg and has eGFR 52. Answer: High risk of hydroxychloroquine retinopathy.
Ophthalmology: Anatomy Physiology and Pharmacology - Hydroxychloroquine | Retinal toxicity (bull's-eye maculopathy, permanent). Keep dose at 5 mg/kg/day or less (actual body weight). RCOphth : yearly screening (OCT and fields) after 5 years , or after 1 year if extra risk (eGFR under 60, tamoxifen, higher doses).
Ophthalmology: Neuro-ophthalmology
Side effects
Nausea, rash, headache; retinopathy with prolonged use; QT prolongation, cardiomyopathy rare.
Interactions
QT-prolonging drugs; antacids reduce absorption; digoxin levels may rise.
Special advice
Baseline and annual retinal screening after 5 years; weight-based daily dose limit.
More from the textbook: uses, cautions and other points
- Other drugs: Clozapine, high-dose 5-FU (vasospasm), some antiretrovirals, hydroxychloroquine (rare restrictive cardiomyopathy with conduction disease).
Cardiology: Cardiomyopathies › 3.43 Alcohol- and Drug-related Cardiomyopathy - Drugs that can worsen myasthenia - aminoglycosides (gentamicin), fluoroquinolones (ciprofloxacin), macrolides , magnesium , beta-blockers , quinine, chloroquine and hydroxychloroquine, penicillamine, lithium, phenytoin, statins (rarely), immune checkpoint inhibitors , botulinum toxin, neuromuscular blocking drugs. Check before …
Neurology: Anatomy, Physiology and Pharmacology - Chloroquine and hydroxychloroquine.
Neurology: Neuromuscular disease - Drugs and toxins - statins , steroids, alcohol , colchicine, hydroxychloroquine, zidovudine, checkpoint inhibitors.
Neurology: Neuromuscular disease - Hydroxychloroquine for all (reduces flares).
Renal: Glomerular Disease - Hydroxychloroquine | All lupus patients; yearly eye screening after 5 years.
Renal: Glomerular Disease
Where it is discussed
- Cardiology: Cardiomyopathies (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Neuromuscular disease (2 mentions)
- Renal: Glomerular Disease (4 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Medical Problems (2 mentions)
- Dermatology: Skin basics, eczema and psoriasis (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (6 mentions)
- Rheumatology: Connective tissue diseases (12 mentions)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (2 mentions)
- Rheumatology: Inflammatory arthritis (4 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (8 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Ear disorders (1 mention)
- Ophthalmology: Anatomy Physiology and Pharmacology (6 mentions)
- Ophthalmology Basics Cataract Glaucoma (1 mention)
- Ophthalmology: Retinal Visual Loss (2 mentions)
- Ophthalmology: Neuro-ophthalmology (6 mentions)
- Ophthalmology: Paediatrics (3 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Clinical Immunology: Autoimmunity, autoantibodies and complement (5 mentions)
- Integrated cardiology chapter (1 mention)
- Biochemistry: Inborn errors of metabolism and the molecular basis of disease (1 mention)
I
Ibuprofen
BNF entry for Ibuprofen · Stand-alone drug page
Mechanism
Non-selective NSAID inhibiting cyclo-oxygenase.
Uses
Pain, inflammation, fever, patent ductus arteriosus closure (neonates).
Dosing
- Ibuprofen PDA closure (preterm) | 10 mg/kg IV, then 5 mg/kg after 24 and 48 hours. Check renal function and platelets; avoid with bleeding or NEC.
Cardiology: Congenital heart disease › 6.36 Drug Reference Table - NSAIDs Subacute thyroiditis pain | E.g. ibuprofen 400 mg three times daily with food, if no contraindication.
Endocrinology: Thyroid disease - Simple painkillers - aspirin 900 mg , ibuprofen or paracetamol - taken early .
Neurology: Anatomy, Physiology and Pharmacology - Or for mild attacks: NSAID (e.g. ibuprofen 400–600 mg, aspirin 900 mg) or paracetamol 1 g.
Neurology: Headache and Facial Pain
4 more dose entries from the chapters
- Ibuprofen / aspirin 400–600 mg / 900 mg | Mild migraine and tension-type headache; under 15 days a month.
Neurology: Headache and Facial Pain - … or meningitis) 80 mg/kg (max 4 g) once daily Intranasal fentanyl 1.5 micrograms/kg Paracetamol oral 15 mg/kg (max 4 doses a day; age-banded doses on packets) Ibuprofen oral 5–10 mg/kg (up to 3 times a day)
Emergency Medicine: Paediatric emergency medicine - Ibuprofen oral | 5–10 mg/kg (up to 3 times a day)
Emergency Medicine: Paediatric emergency medicine - Step-wise approach (by pain severity — RCEM): Pain Options Mild (1–3) Oral paracetamol and/or ibuprofen Moderate (4–6) Paracetamol plus ibuprofen; oral codeine or oral morphine; Entonox for short periods Severe (7–10) IV morphine (titrated — e.g. 0.1 mg/kg in 1–2 mg increments in adults); IV paracetamol; intranasal fentanyl or …
Emergency Medicine: ED procedures
Side effects
Dyspepsia, GI bleeding, renal impairment, hypertension, fluid retention, bronchospasm.
Interactions
Aspirin, anticoagulants, ACE inhibitors, diuretics, methotrexate, lithium; blocks aspirin antiplatelet effect.
Special advice
Take with food; avoid in kidney disease, peptic ulcer, heart failure and late pregnancy; lowest dose shortest time.
More from the textbook: uses, cautions and other points
- Drugs and the duct - prostaglandin E1 (alprostadil) keeps the duct open in duct-dependent heart lesions; NSAIDs (ibuprofen, indomethacin) or paracetamol close a PDA in preterm babies; NSAIDs late in pregnancy can close the fetal duct early.
Cardiology: Anatomy Physiology and Pharmacology - First-line: Full anti-inflammatory-dose ibuprofen or aspirin plus colchicine (usually for at least three months after a first episode); give gastroprotection with anti-inflammatory therapy and check contraindications and interactions.
Cardiology: Pericardial Disease › 8.04 Treatment of Acute and Recurrent Pericarditis - Preterm babies: Drugs that inhibit prostaglandin can close the duct - ibuprofen, indometacin or paracetamol . Surgical ligation if this fails.
Cardiology: Congenital heart disease › 6.18 Patent Ductus Arteriosus (PDA) - 💡 Clinical Pearl: Prostaglandin opens the duct (for duct-dependent lesions); ibuprofen or indometacin closes it (for PDA in preterm babies).
Cardiology: Congenital heart disease › 6.18 Patent Ductus Arteriosus (PDA) - Asthma, nasal polyps, wheeze after ibuprofen | Aspirin-exacerbated respiratory disease
Respiratory: Airways Disease - 2. A 68-year-old woman with a recent coronary stent takes aspirin, clopidogrel, omeprazole and ibuprofen for knee pain. She is admitted with melaena. Answer: Upper GI bleed from NSAID-related ulceration, with a CYP2C19 interaction risk.
Gastroenterology: Anatomy Physiology Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: Pericardial Disease (1 mention)
- Cardiology: Congenital heart disease (4 mentions)
- Respiratory: Airways Disease (1 mention)
- Endocrinology: Thyroid disease (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Oesophagus and Stomach (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Headache and Facial Pain (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (3 mentions)
- Renal: Emergencies (1 mention)
- Paediatrics: Respiratory and heart problems in children (1 mention)
- Paediatrics: Neonatology (2 mentions)
- Paediatrics: Kidneys, urinary tract and hormones in children (1 mention)
- Paediatrics: Infections in children (2 mentions)
- Paediatrics: Neurology, bones and joints in children (6 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Post Natal Care (2 mentions)
- Gynaecology: Menstrual Disorders (2 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (4 mentions)
- Rheumatology: assessment, investigations and drugs (2 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (1 mention)
- ENT Anatomy Physiology (2 mentions)
- ENT: Common Ear disorders (2 mentions)
Imipramine
BNF entry for Imipramine · Stand-alone drug page
Mechanism
Tricyclic antidepressant blocking serotonin and noradrenaline reuptake.
Uses
Depression, nocturnal enuresis, panic disorder.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Dry mouth, constipation, urinary retention, sedation, arrhythmias, postural hypotension; dangerous in overdose.
Interactions
MAOIs, serotonergic drugs, QT-prolonging drugs; CYP2D6 inhibitors raise levels.
Special advice
Limit supplies in at-risk patients; avoid after recent MI.
More from the textbook: uses, cautions and other points
- If no improvement after 12 weeks - imipramine or clomipramine .
Psychiatry: Anxiety, stress and somatic disorders - Clomipramine / imipramine | Clomipramine for OCD after SSRIs; imipramine or clomipramine for panic after 12 weeks of no response. TCA toxicity in overdose.
Psychiatry: Anxiety, stress and somatic disorders - Tricyclics (TCAs) - amitriptyline, lofepramine, clomipramine, imipramine | Dangerous in overdose (arrhythmias, seizures); anticholinergic (dry mouth, constipation, urinary retention, confusion), sedation, postural hypotension; lofepramine is safer. Low dose amitriptyline is used for pain and migraine.
Psychiatry: Mood disorders - Antidepressants - amitriptyline , nortriptyline, imipramine, paroxetine.
Medicine of the older adult: .Prescribing and deprescribing in older people - Very dangerous in overdose (amitriptyline, dosulepin, nortriptyline, imipramine) - small amounts can kill; rapid deterioration is common in the first hours.
Clinical pharmacology and prescribing: Poisoning and overdose
Where it is discussed
Indapamide
BNF entry for Indapamide · Stand-alone drug page
Mechanism
Thiazide-like diuretic with vasodilator action.
Uses
Hypertension.
Dosing
- 1. An 80-year-old woman on indapamide is confused. Sodium is 114 mmol/L; she has vomited and had a seizure. Answer: Severe symptomatic hyponatraemia.
Endocrinology: Sodium and Water disorders - 1. An 86-year-old woman (CFS 6) is admitted after a fall. She takes: amlodipine 10 mg, ramipril 10 mg, indapamide, doxazosin, atorvastatin, aspirin 75 mg (no history of vascular disease), omeprazole 40 mg (started 6 years ago for dyspepsia), amitriptyline 25 mg (sleep), zopiclone, oxybutynin and gliclazide (HbA1c 49). Standing …
Medicine of the older adult: .Prescribing and deprescribing in older people
Side effects
Hyponatraemia, hypokalaemia, hyperuricaemia, hypercalcaemia, rash.
Interactions
Lithium, digoxin, NSAIDs, QT-prolonging drugs (low potassium).
Special advice
Monitor sodium and potassium; avoid in severe renal or hepatic impairment.
More from the textbook: uses, cautions and other points
- Uses - hypertension (indapamide or chlortalidone preferred); with loop diuretics for resistant oedema (metolazone - causes profound electrolyte loss).
Cardiology: Anatomy Physiology and Pharmacology - Indapamide / bendroflumethiazide | Thiazide-like; hyponatraemia, hypercalcaemia, gout; raise lithium.
Cardiology: Anatomy Physiology and Pharmacology - Step 3: A + C + D at optimal tolerated doses. Common options are ramipril, amlodipine and indapamide; monitor renal function, sodium and potassium.
Cardiology: Hypertension, Blood Pressure and Prevention › 7.06 Stepwise Drug Treatment for Hypertension - Thiazide and thiazide-like - bendroflumethiazide, indapamide , chlortalidone, metolazone | Distal tubule - NCC | Hypertension (indapamide preferred - NICE NG136); calcium stones; nephrogenic DI; added to loops for diuretic resistance (metolazone) | Low Na (older women), low K , high Ca , high urate (gout) , hyperglycaemia, …
Renal: Anatomy, Physiology and Pharmacology - Indapamide / bendroflumethiazide | Thiazide (NCC); hypertension; low Na (older women), low K, high Ca and urate; weak if eGFR under 30.
Renal: Anatomy, Physiology and Pharmacology - Bendroflumethiazide / indapamide | Recurrent calcium stones with high urine calcium.
Renal: Tubular Inherited Stones
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Hypertension, Blood Pressure and Prevention (1 mention)
- Endocrinology: Sodium and Water disorders (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Tubular Inherited Stones (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Integrated cardiology chapter (1 mention)
Infliximab
BNF entry for Infliximab · Stand-alone drug page
Mechanism
Chimeric monoclonal antibody neutralising TNF-alpha.
Uses
Crohn disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, sarcoidosis (selected).
Dosing
- IV hydrocortisone 100 mg four times daily (or IV methylprednisolone) in acute severe ulcerative colitis (Truelove and Witts criteria) - with VTE prophylaxis, stool cultures and C. difficile test; review on day 3 for rescue therapy (ciclosporin or infliximab) or surgery.
Gastroenterology: Anatomy Physiology Pharmacology - Rescue therapy: Infliximab (e.g. 5 mg/kg; some centres use higher or accelerated dosing) or ciclosporin .
Gastroenterology: Gastroenterology Emergencies (Complete) - Infliximab / ciclosporin Steroid-refractory UC | Rescue therapy (specialist); infliximab 5 mg/kg (higher or accelerated in some protocols).
Gastroenterology: Gastroenterology Emergencies (Complete) - Severe: Admit - IV hydrocortisone 100 mg four times daily or methylprednisolone 60 mg daily; rescue with infliximab or ciclosporin; colectomy if no response.
Gastroenterology: Inflammatory Bowel Disease
4 more dose entries from the chapters
- Infliximab (IV 5 mg/kg at weeks 0, 2 and 6, then every 8 weeks; subcutaneous versions are available) and adalimumab (subcutaneous).
Gastroenterology: Inflammatory Bowel Disease - Colitis | Diarrhoea, abdominal pain, blood. Exclude infection; steroids (prednisolone 1 mg/kg, or IV methylprednisolone if severe); infliximab or vedolizumab if no response in 48–72 hours
Oncology: Principles - Severe colitis - 7 or more stools a day above baseline, blood, pain, peritonism: admit, IV methylprednisolone 1–2 mg/kg, CT for perforation; infliximab if no response in 48–72 hours.
Oncology: Emergencies - Grade 2 - prednisolone 0.5–1 mg/kg; grade 3–4 - IV methylprednisolone; infliximab for refractory colitis, mycophenolate for hepatitis.
Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology
Side effects
Infusion reactions, infections, headache; reactivated TB, demyelination, hepatotoxicity, lupus-like syndrome.
Interactions
Methotrexate or azathioprine reduce antibody formation; live vaccines contraindicated.
Special advice
TB, hepatitis B and varicella screening; drug and antibody levels in loss of response.
More from the textbook: uses, cautions and other points
- Refractory disease: Anti-TNF (infliximab) - especially for cardiac, neuro and skin disease.
Respiratory: Interstitial Lung Disease - Infliximab | Refractory sarcoidosis (cardiac, neuro, skin); screen for TB first.
Respiratory: Interstitial Lung Disease - Steroids (oral prednisolone or IV methylprednisolone) for moderate or severe events; further immunosuppression (e.g. infliximab for colitis) if refractory.
Respiratory: Lung Cancer - IV methylprednisolone; infliximab if no response.
Respiratory: Lung Cancer - Infliximab (IV), adalimumab (SC), golimumab (UC) | TNF-alpha | Moderate to severe Crohn's and UC, perianal fistulas; TB reactivation , serious infections, worsens heart failure, demyelination, drug-induced lupus, paradoxical psoriasis, lymphoma (especially with thiopurines); infusion reactions; antibody formation - check drug …
Gastroenterology: Anatomy Physiology Pharmacology - Biosimilars - cheaper versions of infliximab and adalimumab; switching is usually safe.
Gastroenterology: Anatomy Physiology Pharmacology
Where it is discussed
- Respiratory: Interstitial Lung Disease (3 mentions)
- Respiratory: Lung Cancer (2 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (4 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (3 mentions)
- Gastroenterology: Inflammatory Bowel Disease (7 mentions)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Oncology: Principles (5 mentions)
- Oncology: Emergencies (2 mentions)
- Paediatrics: Infections in children (1 mention)
- Paediatrics: Gastroenterology and surgery in children (3 mentions)
- Dermatology: Skin basics, eczema and psoriasis (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (2 mentions)
- Rheumatology: Inflammatory arthritis (2 mentions)
- Rheumatology: Vasculitis, GCA and PMR (2 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (3 mentions)
- Surgery: Colorectal and anal surgery (2 mentions)
- Clinical Immunology: Immune system basics and immunological investigations (2 mentions)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (4 mentions)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (12 mentions)
- Integrated respiratory chapter (5 mentions)
- Integrated paediatrics chapter (4 mentions)
- Cell Biology: Cell cycle, signalling, cell death and stem cells (1 mention)
Insulin aspart
BNF entry for Insulin aspart · Stand-alone drug page
Mechanism
Rapid-acting insulin analogue activating insulin receptors.
Uses
Mealtime and correction insulin in type 1 and type 2 diabetes.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hypoglycaemia, weight gain, lipohypertrophy, injection-site reactions.
Interactions
Beta-blockers mask hypoglycaemia symptoms; corticosteroids and thiazides raise glucose; alcohol.
Special advice
Inject just before or after eating; rotate sites; sick-day rules; dose by carbohydrate counting.
More from the textbook: uses, cautions and other points
- Rapid-acting analogues | Insulin aspart (NovoRapid, Fiasp), lispro (Humalog), glulisine (Apidra). Onset 10–15 min, peak 1–2 h, lasts 3–5 h. Injected just before meals (bolus); used in pumps
Endocrinology: Diabetes - Types : Type Examples Use Rapid-acting analogue Insulin aspart (NovoRapid, Fiasp), lispro (Humalog) With meals (bolus); correction doses; insulin pumps Short-acting soluble Actrapid, Humulin S IV infusions (VRIII, DKA), meals Intermediate Isophane (Humulin I, Insulatard) Once or twice daily basal; type 2 diabetes; …
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing - Rapid-acting analogue | Insulin aspart (NovoRapid, Fiasp), lispro (Humalog) | With meals (bolus); correction doses; insulin pumps
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing
Where it is discussed
Insulin glargine
BNF entry for Insulin glargine · Stand-alone drug page
Mechanism
Long-acting basal insulin analogue forming microprecipitates at injection site.
Uses
Basal insulin in type 1 and type 2 diabetes.
Dosing
- 5. A 58-year-old man with type 2 diabetes is having a morning laparoscopic cholecystectomy as a day case. He takes metformin twice daily, gliclazide twice daily, dapagliflozin and insulin glargine at night. HbA1c is 62 mmol/mol. Answer: CPOC peri-operative diabetes plan.
Surgery: Surgical principles and perioperative care
Side effects
Hypoglycaemia, weight gain, injection-site reactions.
Interactions
Beta-blockers mask hypoglycaemia; corticosteroids raise glucose.
Special advice
Never stop basal insulin in type 1 diabetes during illness; different strengths exist; rotate injection sites.
Where it is discussed
Ipratropium
BNF entry for Ipratropium · Stand-alone drug page
Mechanism
Antimuscarinic bronchodilator.
Uses
COPD, acute asthma (add-on), rhinitis.
Dosing
- Acute severe asthma | Oxygen to 94–98%; salbutamol 5 mg and ipratropium 0.5 mg nebulised (oxygen-driven); prednisolone 40–50 mg
Respiratory: Emergencies - Ipratropium bromide 0.5 mg nebulised 4–6-hourly in acute severe or life-threatening asthma.
Respiratory: Emergencies - Ipratropium bromide nebulised (250 micrograms) - add if poor response to salbutamol (severe).
Paediatrics: Respiratory and heart problems in children - Oxygen; nebulised salbutamol 5 mg (back-to-back if needed) with ipratropium.
Paediatrics: Respiratory and heart problems in children
4 more dose entries from the chapters
- Ipratropium nebulised (250 micrograms) added if poor response — first hour.
Emergency Medicine: Paediatric emergency medicine - Nebulised ipratropium 500 micrograms (acute severe or life-threatening).
Acute Medicine: Acute chest pain, breathlessness, collapse and blood gases - Oxygen to 94–98%; back-to-back salbutamol 5 mg nebs (oxygen-driven) plus ipratropium 500 micrograms ; prednisolone 40–50 mg .
Acute Medicine: Acute chest pain, breathlessness, collapse and blood gases - Ipratropium nebulised (severe attack) | 500 micrograms with beta₂ agonist
Integrated respiratory chapter › 10.04 Selected Respiratory Drug and Dose Reference
Side effects
Dry mouth, cough, urinary retention, glaucoma risk with mask nebulisation.
Interactions
Additive antimuscarinic effects.
Special advice
Protect eyes from nebulised drug; use mouthpiece in glaucoma.
More from the textbook: uses, cautions and other points
- SAMA - ipratropium (in acute asthma and COPD exacerbations).
Respiratory: Anatomy, Physiology and Pharmacology - Don't use a LAMA and ipratropium together regularly.
Respiratory: Anatomy, Physiology and Pharmacology - … usually combines oxygen titrated to physiological need, repeated inhaled/nebulised short-acting bronchodilator treatment and prompt systemic corticosteroid; add ipratropium and consider intravenous magnesium in severe or poorly responsive attacks according to acute-care protocols. Ventilatory support decisions must …
Respiratory: Emergencies - Don't use - salbutamol, ipratropium, adrenaline, steroids, antibiotics, hypertonic saline, montelukast, chest physiotherapy.
Paediatrics: Respiratory and heart problems in children - Ipratropium nebulised | Add-on in severe acute asthma.
Paediatrics: Respiratory and heart problems in children - Treat as for non-pregnant asthma — oxygen (target 94–98%), nebulised salbutamol and ipratropium, steroids, IV magnesium; early critical care and anaesthetic review.
Obstetrics
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (4 mentions)
- Respiratory: Emergencies (6 mentions)
- Paediatrics: Respiratory and heart problems in children (5 mentions)
- Obstetrics (1 mention)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Nose and Throat disorders (2 mentions)
- Ophthalmology: Anatomy Physiology and Pharmacology (2 mentions)
- Ophthalmology Basics Cataract Glaucoma (1 mention)
- Ophthalmology: Neuro-ophthalmology (2 mentions)
- Ophthalmology: Paediatrics (1 mention)
- Emergency Medicine: Paediatric emergency medicine (4 mentions)
- Acute Medicine: The deteriorating patient (1 mention)
- Acute Medicine: Acute chest pain, breathlessness, collapse and blood gases (4 mentions)
- Integrated respiratory chapter (6 mentions)
- Integrated paediatrics chapter (5 mentions)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)
- OSCEs II: Practical procedures, prescribing and acute care stations (1 mention)
Irbesartan
BNF entry for Irbesartan · Stand-alone drug page
Mechanism
Angiotensin II receptor blocker.
Uses
Hypertension, diabetic nephropathy.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Dizziness, hyperkalaemia, renal impairment; angioedema rare.
Interactions
NSAIDs, ACE inhibitors, potassium-sparing diuretics, lithium.
Special advice
U&E after initiation; avoid in pregnancy.
More from the textbook: uses, cautions and other points
- ACE inhibitors (ramipril, lisinopril, perindopril, enalapril) block angiotensin II production; ARBs (losartan, candesartan, irbesartan, valsartan) block its receptor.
Renal: Anatomy, Physiology and Pharmacology
Where it is discussed
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
Isosorbide mononitrate
BNF entry for Isosorbide mononitrate · Stand-alone drug page
Mechanism
Organic nitrate releasing nitric oxide to relax vascular smooth muscle.
Uses
Angina prophylaxis, heart failure (with hydralazine).
Dosing
- Isosorbide mononitrate 10 mg twice daily initially, usually 20–40 mg twice daily, given asymmetrically (e.g. 8 am and 2 pm).
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina - Isosorbide mononitrate | 20–40 mg twice daily (asymmetric), or MR 25–60 mg each morning (max 120 mg).
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table
Side effects
Headache, flushing, hypotension, tolerance.
Interactions
PDE5 inhibitors contraindicated; antihypertensives additive.
Special advice
Use a nitrate-free interval to avoid tolerance; avoid if hypertrophic obstructive cardiomyopathy or hypotension.
More from the textbook: uses, cautions and other points
- Tolerance - needs a nitrate-free period (asymmetric dosing of isosorbide mononitrate, or once-daily modified-release).
Cardiology: Anatomy Physiology and Pharmacology - GTN / isosorbide mononitrate | Nitric oxide donors; headache; nitrate-free period; never with sildenafil.
Cardiology: Anatomy Physiology and Pharmacology - Tolerance - reduced effect with repeated doses, needing higher doses for the same effect - e.g. opioids , benzodiazepines , alcohol, nitrates (prevented by a nitrate-free period - asymmetric dosing of isosorbide mononitrate, patch off overnight).
Clinical pharmacology and prescribing: Principles of clinical pharmacology - Use generic names , no abbreviations of drug names | ISOSORBIDE MONONITRATE | ISMN, MST, HCT, AZT
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law - Collapse after sildenafil in a man taking isosorbide mononitrate | Severe hypotension - nitrate interaction
Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Integrated cardiology chapter (2 mentions)
Isotretinoin
BNF entry for Isotretinoin · Stand-alone drug page
Mechanism
Retinoid modulating sebum production, keratinisation and inflammation.
Uses
Severe acne unresponsive to other treatment (specialist).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Dry skin and lips, photosensitivity, raised lipids and liver enzymes, mood changes; teratogenic.
Interactions
Tetracyclines (raised intracranial pressure); vitamin A supplements; methotrexate.
Special advice
Pregnancy prevention programme; monthly pregnancy tests; monitor lipids, LFT and mood.
More from the textbook: uses, cautions and other points
- Raised intracranial pressure (IIH) | Tetracyclines (doxycycline, minocycline), isotretinoin and vitamin A, steroid withdrawal, lithium, growth hormone
Neurology: Anatomy, Physiology and Pharmacology - Drugs - tetracyclines (doxycycline, minocycline), retinoids (isotretinoin), lithium, growth hormone, steroid withdrawal.
Neurology: Headache and Facial Pain - Pregnancy prevention programmes — valproate , isotretinoin and oral retinoids, topiramate (MHRA 2024), thalidomide-type drugs — highly effective contraception and annual review.
Obstetrics - Isotretinoin and oral retinoids (acitretin) | Severe craniofacial, cardiac and CNS defects — pregnancy prevention programme
Obstetrics - Review medicines - stop or switch teratogenic drugs (e.g. valproate, isotretinoin, warfarin, ACE inhibitors, methotrexate, mycophenolate); don't stop essential drugs suddenly without advice.
Obstetrics: Antenatal Care - Isotretinoin , acitretin | Severe malformations; pregnancy prevention programme.
Obstetrics: Medical Problems
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Headache and Facial Pain (1 mention)
- Obstetrics (3 mentions)
- Obstetrics: Antenatal Care (1 mention)
- Obstetrics: Medical Problems (2 mentions)
- Ophthalmology: Anatomy Physiology and Pharmacology (2 mentions)
- Ophthalmology Basics Cataract Glaucoma (1 mention)
- Ophthalmology: Neuro-ophthalmology (1 mention)
- Psychiatry: assessment, treatment and the law (1 mention)
- Psychiatry: Mood disorders (1 mention)
- Psychiatry: Psychosis and schizophrenia (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (3 mentions)
- General Practice: Child health, women's health and men's health in primary care (1 mention)
- Anatomy: Embryology and development (1 mention)
- Biochemistry: Metabolism of carbohydrates, lipids and proteins (1 mention)
- Biochemistry: Enzymes, vitamins and trace elements (1 mention)
- Embryology and Congenital Anatomy (1 mention)
Itraconazole
BNF entry for Itraconazole · Stand-alone drug page
Mechanism
Triazole antifungal inhibiting ergosterol synthesis.
Uses
Aspergillosis, histoplasmosis, nail and skin fungal infection.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, rash, heart failure exacerbation, hepatotoxicity, QT prolongation.
Interactions
Potent CYP3A4 inhibitor; PPIs reduce absorption of capsules.
Special advice
Take capsules with food and acid; avoid in heart failure; monitor LFT.
More from the textbook: uses, cautions and other points
- Interactions - CYP3A4 inhibitors ( clarithromycin , erythromycin, itraconazole, grapefruit juice with simvastatin), amiodarone and diltiazem (simvastatin dose limits), fibrates (gemfibrozil - avoid).
Cardiology: Anatomy Physiology and Pharmacology - Antifungals - voriconazole (aspergillosis - visual disturbance, photosensitivity, skin cancer risk, many interactions); itraconazole (ABPA, chronic aspergillosis).
Respiratory: Anatomy, Physiology and Pharmacology - Itraconazole (antifungal) to reduce the fungal load and steroid needs - check levels and watch for interactions (including steroid interactions causing Cushing's).
Respiratory: Airways Disease - Itraconazole | ABPA; check levels and interactions (including with inhaled budesonide - risk of Cushing's).
Respiratory: Airways Disease - Long courses of oral antifungals (itraconazole or voriconazole) for at least 6 months.
Respiratory: Infections - Itraconazole / voriconazole | Chronic pulmonary aspergillosis (and ABPA); voriconazole for invasive aspergillosis. Level monitoring; many interactions; voriconazole causes visual disturbance and photosensitivity.
Respiratory: Infections
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Respiratory: Airways Disease (3 mentions)
- Respiratory: Infections (2 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: Adrenal Disease (2 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Dermatology: Skin infections and infestations (6 mentions)
- ID: How Infection Happens (1 mention)
- ID: Viral, fungal and parasitic infections (4 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical Immunology: Primary immunodeficiency (3 mentions)
- Integrated respiratory chapter (5 mentions)
- Microbiology: Fungi, parasites and travel-related infection (2 mentions)
K
Ketamine
BNF entry for Ketamine · Stand-alone drug page
Mechanism
NMDA receptor antagonist producing dissociative anaesthesia.
Uses
Procedural sedation and anaesthesia induction, analgesia, refractory depression (specialist).
Dosing
- Ketamine at sub-dissociative doses (e.g. 0.1–0.3 mg/kg IV) — for severe pain, opioid-tolerant patients.
Emergency Medicine: ED procedures - Ketamine sedation | 1–1.5 mg/kg IV; airway reflexes kept | Laryngospasm, emergence, vomiting
Emergency Medicine: ED procedures - Induction — ketamine (1–2 mg/kg — haemodynamically safer in shock), propofol (1–2.5 mg/kg — reduced doses in unstable patients), thiopental (traditional for obstetric RSI), etomidate (adrenal suppression — not routinely in UK); often with fentanyl.
Anaesthesia: Airway management and anaesthetic drugs - Ketamine | NMDA antagonist; 1–2 mg/kg IV, 5–10 mg/kg IM | Maintains BP (sympathomimetic), bronchodilator (asthma), analgesia, airway reflexes partly kept — shock, trauma, prehospital | Emergence phenomena, hypersalivation, raised BP and heart rate (IHD), possibly raised ICP (not clinically important — now used in head injury)
Anaesthesia: Airway management and anaesthetic drugs
Side effects
Hallucinations, emergence reactions, hypertension, tachycardia, raised intracranial pressure, urological toxicity with chronic use.
Interactions
CNS depressants additive; theophylline lowers seizure threshold.
Special advice
Maintains airway reflexes better than other agents; caution in severe hypertension and psychosis.
More from the textbook: uses, cautions and other points
- Glutamate | Main excitatory transmitter; learning and memory (NMDA and AMPA receptors) | Excitotoxic cell death in stroke and trauma; memantine and ketamine block NMDA; perampanel blocks AMPA; riluzole reduces release (MND)
Neurology: Anatomy, Physiology and Pharmacology - Recreational drugs - boosters raise levels of MDMA, ketamine, GHB and some opioids (dangerous toxicity).
ID: HIV, viral hepatitis and blood-borne viruses - Esketamine nasal spray - licensed for treatment-resistant depression but not recommended by NICE; ketamine used in some specialist services.
Psychiatry: assessment, treatment and the law - Early sedation - IM or IV benzodiazepines; ketamine (IM) by experienced clinicians in some departments.
Psychiatric emergencies - Ketamine (IM) | Severe acute behavioural disturbance by experienced emergency clinicians.
Psychiatric emergencies - Substance use - alcohol, cannabis, vaping, nitrous oxide, ketamine (bladder damage); brief interventions, young people's substance misuse services; think about exploitation and safeguarding.
Psychiatry: Safeguarding
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- ID: HIV, viral hepatitis and blood-borne viruses (1 mention)
- Psychiatry: assessment, treatment and the law (1 mention)
- Psychiatric emergencies (2 mentions)
- Psychiatry: Safeguarding (1 mention)
- Psychiatry: Alcohol, drugs and addiction (3 mentions)
- Psychiatry: Psychosis and schizophrenia (2 mentions)
- Surgery: Surgical principles and perioperative care (1 mention)
- Emergency Medicine: Paediatric emergency medicine (1 mention)
- Emergency Medicine: ED procedures (9 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (2 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
- Critical care: Admission and organ support (1 mention)
- Anaesthesia: Airway management and anaesthetic drugs (5 mentions)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (2 mentions)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (2 mentions)
- Cell Biology: Cell structure, organelles and membrane transport (1 mention)
Ketoconazole
BNF entry for Ketoconazole · Stand-alone drug page
Mechanism
Imidazole antifungal inhibiting ergosterol and steroid synthesis.
Uses
Cushing syndrome (off-label), topical seborrhoeic dermatitis and dandruff.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hepatotoxicity, adrenal suppression, QT prolongation, nausea.
Interactions
Potent CYP3A4 inhibitor; QT-prolonging drugs; PPIs reduce absorption.
Special advice
Oral systemic use restricted for fungal infection because of liver toxicity; monitor LFT.
More from the textbook: uses, cautions and other points
- Cushing's syndrome (before surgery or if surgery isn't possible) - metyrapone and osilodrostat (block cortisol synthesis - risk of adrenal insufficiency and low potassium/high blood pressure from precursor build-up), ketoconazole (liver toxicity - specialist), etomidate IV in severe cases.
Endocrine: Anatomy Physiology and Pharmacology - Etomidate , ketoconazole, metyrapone | Adrenal suppression
Endocrine: Anatomy Physiology and Pharmacology - … adrenal haemorrhage (anticoagulants, meningococcal sepsis, antiphospholipid syndrome); metastases (lung, breast, melanoma); bilateral adrenalectomy; drugs (ketoconazole, metyrapone, osilodrostat, etomidate, mitotane); adrenoleukodystrophy (young men); congenital adrenal hyperplasia; HIV-related infections; infiltration …
Endocrinology: Adrenal Disease - Urgent medical control of cortisol: Metyrapone, osilodrostat or ketoconazole; IV etomidate in severe cases.
Endocrinology: Adrenal Disease - Reduced absorption of drugs needing acid - itraconazole, ketoconazole, iron, levothyroxine, some HIV drugs (atazanavir, rilpivirine - avoid).
Gastroenterology: Anatomy Physiology Pharmacology - Hepatocellular (ALT up) | Paracetamol (overdose), isoniazid , rifampicin, pyrazinamide, valproate , methotrexate, statins (usually mild), amiodarone, nitrofurantoin , ketoconazole, NSAIDs (diclofenac), herbal supplements (green tea extract, kava, turmeric), checkpoint inhibitors
Gastroenterology: Anatomy Physiology Pharmacology
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Adrenal Disease (5 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Liver disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Dermatology: Skin basics, eczema and psoriasis (4 mentions)
- Dermatology: Skin infections and infestations (4 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Microbiology: Fungi, parasites and travel-related infection (1 mention)
L
Labetalol
BNF entry for Labetalol · Stand-alone drug page
Mechanism
Combined alpha-1 and non-selective beta blocker.
Uses
Hypertension in pregnancy, hypertensive emergencies, acute aortic dissection (adjunct).
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Hypertensive emergency | 20–80 mg IV bolus every 10 min prn | Caution in asthma, bradycardia, heart failure. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
- IV labetalol - bolus (e.g. 20 mg, repeated) then infusion.
Obstetrics: Obstetrics: Emergencies
Side effects
Postural hypotension, bradycardia, bronchospasm, fatigue, tingling scalp, hepatotoxicity.
Interactions
Verapamil and diltiazem; halothane; additive hypotension.
Special advice
Avoid in asthma and heart block; rapid IV bolus can cause severe hypotension; first-line oral agent in pregnancy.
More from the textbook: uses, cautions and other points
- Non-selective - propranolol (also used for thyrotoxicosis, migraine, varices, anxiety), sotalol (also class III), carvedilol (also alpha-blocking), labetalol (pregnancy hypertension).
Cardiology: Anatomy Physiology and Pharmacology - Analgesia; control heart rate and BP (IV labetalol — target systolic 100–120 mmHg).
Cardiology: Presentations - Aortic dissection | CT aortogram; IV labetalol or esmolol to HR below 60, SBP 100–120; cardiothoracic surgery for type A
Cardiology: Cardiology Emergencies - IV labetalol or esmolol first , aiming for heart rate below 60 and systolic BP 100–120 mmHg .
Cardiology: Cardiology Emergencies - BP must be below 185/110 before treatment, and kept below 180/105 for the first 24 hours (e.g. IV labetalol).
Neurology: Stroke Emergencies - Labetalol IV BP in stroke | Before thrombolysis: below 185/110. Intracerebral haemorrhage: systolic 130–139 within 1 hour.
Neurology: Stroke Emergencies
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: Presentations (1 mention)
- Cardiology: Cardiology Emergencies (6 mentions)
- Neurology: Stroke Emergencies (3 mentions)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Tubular Inherited Stones (2 mentions)
- Paediatrics: Neonatology (1 mention)
- Obstetrics (6 mentions)
- Obstetrics: Obstetrics: Emergencies (5 mentions)
- Obstetrics: Medical Problems (7 mentions)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
- Surgery: Vascular surgery (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (5 mentions)
- Acute Medicine: Acute chest pain, breathlessness, collapse and blood gases (1 mention)
- Clinical imaging: Chest X-ray and cardiothoracic imaging (1 mention)
- Integrated paediatrics chapter (1 mention)
Lacosamide
BNF entry for Lacosamide · Stand-alone drug page
Mechanism
Enhances slow inactivation of voltage-gated sodium channels.
Uses
Focal seizures (monotherapy or adjunct).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Dizziness, diplopia, headache, nausea, PR prolongation.
Interactions
Other sodium-channel blockers; PR-prolonging drugs.
Special advice
ECG in cardiac conduction disease; avoid abrupt withdrawal.
More from the textbook: uses, cautions and other points
- Drugs that block sodium channels - carbamazepine , phenytoin , lamotrigine , lacosamide (epilepsy), lidocaine and other local anaesthetics, class I antiarrhythmics, tricyclic antidepressants in overdose.
Neurology: Anatomy, Physiology and Pharmacology - How they work - block sodium channels (carbamazepine, lamotrigine, phenytoin, lacosamide, oxcarbazepine), block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate …
Neurology: Anatomy, Physiology and Pharmacology - Focal seizures | Lamotrigine or levetiracetam . Alternatives: carbamazepine, oxcarbazepine, zonisamide, lacosamide
Neurology: Epilepsy - Lacosamide: Dizziness, PR prolongation (check ECG).
Neurology: Epilepsy
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Epilepsy (3 mentions)
Lamotrigine
BNF entry for Lamotrigine · Stand-alone drug page
Mechanism
Blocks voltage-gated sodium channels and glutamate release.
Uses
Epilepsy (focal and generalised), bipolar disorder maintenance.
Dosing
- Folic acid 5 mg if she might become pregnant; discuss contraception (lamotrigine levels fall with the combined pill); DVLA advice.
Neurology: Anatomy, Physiology and Pharmacology - If pregnancy is planned, consider switching to lamotrigine or levetiracetam and start folic acid 5 mg.
Neurology: Epilepsy - Pregnancy: folic acid 5 mg; lamotrigine and levetiracetam are the safest; don't stop drugs suddenly.
Neurology: Epilepsy - Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
Obstetrics
3 more dose entries from the chapters
- Epilepsy — lamotrigine and levetiracetam preferred; folic acid 5 mg; never stop AEDs abruptly; vitamin K is no longer routinely given to mothers.
Obstetrics - Epilepsy | Lamotrigine or levetiracetam ; folic acid 5 mg; avoid valproate
Clinical pharmacology and prescribing: Prescribing in special groups - … risk of neurodevelopmental disorders. Under the Pregnancy Prevention Programme, she should have urgent specialist review to switch to a safer antiepileptic (e.g. lamotrigine or levetiracetam) before conception, and take folic acid 5 mg daily.
Anatomy: Embryology and development
Side effects
Rash (including Stevens-Johnson), dizziness, headache, diplopia, tremor.
Interactions
Valproate more than doubles levels (halve dose); enzyme inducers halve levels; oestrogen contraceptives lower levels.
Special advice
Titrate slowly to reduce rash risk; stop at any rash with fever; restart titration if missed for more than 5 half-lives.
More from the textbook: uses, cautions and other points
- Combined pill (oestrogen raises binding proteins) - falsely raises total T4 and cortisol; interacts with enzyme inducers (rifampicin, carbamazepine, St John's wort) and lamotrigine.
Endocrine: Anatomy Physiology and Pharmacology - Drugs that block sodium channels - carbamazepine , phenytoin , lamotrigine , lacosamide (epilepsy), lidocaine and other local anaesthetics, class I antiarrhythmics, tricyclic antidepressants in overdose.
Neurology: Anatomy, Physiology and Pharmacology - How they work - block sodium channels (carbamazepine, lamotrigine, phenytoin, lacosamide, oxcarbazepine), block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate …
Neurology: Anatomy, Physiology and Pharmacology - Juvenile myoclonic epilepsy | Teenagers; morning myoclonic jerks , tonic-clonic seizures (often after sleep deprivation or alcohol), sometimes absences. Lifelong. Valproate (men), levetiracetam or lamotrigine. Carbamazepine, phenytoin and gabapentin worsen it
Neurology: Epilepsy - Dravet syndrome | SCN1A gene; prolonged fever-related seizures in infancy. Avoid sodium-channel blockers (carbamazepine, lamotrigine). Cannabidiol and fenfluramine
Neurology: Epilepsy - SUNCT / SUNA | Very brief stabbing attacks (seconds to minutes), up to hundreds a day, with eye watering and redness. Lamotrigine first line; MRI to look for nerve compression
Neurology: Headache and Facial Pain
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (17 mentions)
- Neurology: Epilepsy (21 mentions)
- Neurology: Headache and Facial Pain (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Paediatrics: Neurology, bones and joints in children (8 mentions)
- Obstetrics (5 mentions)
- Obstetrics: Medical Problems (5 mentions)
- Gynaecology: Fertility Contraception Menopause (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (4 mentions)
- Psychiatry: Mood disorders (4 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (5 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (7 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (1 mention)
- Integrated paediatrics chapter (8 mentions)
- Anatomy: Embryology and development (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (2 mentions)
- Cell Biology: Cell structure, organelles and membrane transport (1 mention)
- Embryology and Congenital Anatomy (1 mention)
Lansoprazole
BNF entry for Lansoprazole · Stand-alone drug page
Mechanism
Proton pump inhibitor.
Uses
GORD, peptic ulcer, H. pylori regimens, NSAID gastroprotection.
Dosing
- Clopidogrel (75 mg) - prodrug activated by CYP2C19 (poor metabolisers respond less; omeprazole may reduce effect - use lansoprazole or pantoprazole); irreversible.
Cardiology: Anatomy Physiology and Pharmacology - Full-dose PPI for 4–8 weeks (e.g. omeprazole 20 mg once daily, lansoprazole 30 mg once daily) - take 30–60 minutes before breakfast.
Gastroenterology: Oesophagus and Stomach - Lansoprazole 30 mg once daily | Alternative full-dose PPI; preferred with clopidogrel (with pantoprazole). Linked to microscopic colitis.
Gastroenterology: Oesophagus and Stomach
Side effects
Headache, diarrhoea, hypomagnesaemia, B12 deficiency, fracture risk, C. difficile.
Interactions
Reduces absorption of iron and levothyroxine; methotrexate levels rise.
Special advice
Review long-term need; take 30 minutes before food.
More from the textbook: uses, cautions and other points
- Omeprazole and esomeprazole inhibit CYP2C19 → less activation of clopidogrel (avoid the combination - use lansoprazole or pantoprazole).
Gastroenterology: Anatomy Physiology Pharmacology - Microscopic colitis | NSAIDs, PPIs (lansoprazole), SSRIs, statins
Gastroenterology: Anatomy Physiology Pharmacology - Microscopic colitis (especially lansoprazole).
Gastroenterology: Oesophagus and Stomach - Clopidogrel: Omeprazole and esomeprazole reduce its activation - use lansoprazole or pantoprazole instead.
Gastroenterology: Oesophagus and Stomach - Drug triggers: PPIs (especially lansoprazole), NSAIDs, SSRIs (e.g. sertraline) , statins, beta-blockers, acarbose.
Gastroenterology: Inflammatory Bowel Disease - Woman of 65 on lansoprazole with watery diarrhoea and a normal-looking colon | Microscopic colitis
Gastroenterology: Inflammatory Bowel Disease
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (5 mentions)
- Gastroenterology: Oesophagus and Stomach (5 mentions)
- Gastroenterology: Inflammatory Bowel Disease (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Haemostasis and Thrombosis (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (2 mentions)
Latanoprost
BNF entry for Latanoprost · Stand-alone drug page
Mechanism
Prostaglandin F2-alpha analogue increasing uveoscleral outflow.
Uses
Open-angle glaucoma and ocular hypertension.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Eye redness, iris and eyelash changes, periocular pigmentation, stinging.
Interactions
Few; other prostaglandin analogues avoided.
Special advice
Once daily in the evening; warn about permanent iris colour change; remove contact lenses before use.
More from the textbook: uses, cautions and other points
- Prostaglandin analogues (latanoprost, bimatoprost, travoprost) — once daily at night; first-line drops | Increase uveoscleral outflow | Darkening of the iris (permanent, brown), eyelash growth , periocular skin darkening, periorbital fat loss, red eye; caution in uveitis and after complicated cataract surgery (macular oedema)
Ophthalmology: Anatomy Physiology and Pharmacology - Prostaglandin analogues (latanoprost, bimatoprost, travoprost) - first-line drops , once at night. Increase outflow. Side effects: darker iris colour , longer eyelashes, red eyes, darkened eyelid skin.
Ophthalmology Basics Cataract Glaucoma - Latanoprost (prostaglandin analogue) | First-line glaucoma drop, once at night. Darker iris, long lashes, red eye.
Ophthalmology Basics Cataract Glaucoma
Where it is discussed
- Ophthalmology: Anatomy Physiology and Pharmacology (1 mention)
- Ophthalmology Basics Cataract Glaucoma (2 mentions)
Levetiracetam
BNF entry for Levetiracetam · Stand-alone drug page
Mechanism
Binds synaptic vesicle protein SV2A.
Uses
Focal and generalised seizures, status epilepticus (second line), myoclonic seizures.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Second-line status epilepticus / seizures | Usually 1–3 g IV load | Dose-adjust in renal impairment. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
- IV levetiracetam (about 60 mg/kg, maximum 4.5 g) over about 10 minutes.
Neurology: Anatomy, Physiology and Pharmacology - Status epilepticus | Benzodiazepine (IV lorazepam 4 mg or buccal midazolam 10 mg), repeat at 5–10 minutes; then levetiracetam, phenytoin or valproate; ICU
Neurology: Emergencies - Levetiracetam IV (e.g. 60 mg/kg, maximum 4.5 g, over about 10–15 minutes) - quick to give, with fewer side effects.
Neurology: Emergencies - If pregnancy is planned, consider switching to lamotrigine or levetiracetam and start folic acid 5 mg.
Neurology: Epilepsy
4 more dose entries from the chapters
- Pregnancy: folic acid 5 mg; lamotrigine and levetiracetam are the safest; don't stop drugs suddenly.
Neurology: Epilepsy - Seizures (e.g. brain tumours): Continue antiepileptics by a non-oral route (SC levetiracetam via pump or midazolam in the pump). Buccal or SC midazolam 10 mg for a seizure.
Palliative: End of Life Care - Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
Obstetrics - Epilepsy — lamotrigine and levetiracetam preferred; folic acid 5 mg; never stop AEDs abruptly; vitamin K is no longer routinely given to mothers.
Obstetrics
Side effects
Drowsiness, irritability, depression and behavioural change, fatigue.
Interactions
Few pharmacokinetic interactions.
Special advice
Adjust dose in renal impairment; mood and behaviour changes may need dose change or switch.
More from the textbook: uses, cautions and other points
- Vesicles release neurotransmitter (vesicle protein SV2A is the target of levetiracetam ; botulinum toxin blocks release; tetanus toxin blocks inhibitory release in the spinal cord).
Neurology: Anatomy, Physiology and Pharmacology - … block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate (perampanel, topiramate). Several act in more than one way.
Neurology: Anatomy, Physiology and Pharmacology - If still fitting: IV levetiracetam (or phenytoin or valproate).
Neurology: Emergencies - Status epilepticus: benzodiazepine twice, then levetiracetam, phenytoin or valproate, then ICU.
Neurology: Emergencies - Juvenile myoclonic epilepsy | Teenagers; morning myoclonic jerks , tonic-clonic seizures (often after sleep deprivation or alcohol), sometimes absences. Lifelong. Valproate (men), levetiracetam or lamotrigine. Carbamazepine, phenytoin and gabapentin worsen it
Neurology: Epilepsy - Focal seizures | Lamotrigine or levetiracetam . Alternatives: carbamazepine, oxcarbazepine, zonisamide, lacosamide
Neurology: Epilepsy
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (13 mentions)
- Neurology: Emergencies (5 mentions)
- Neurology: Epilepsy (17 mentions)
- Neurology: Movement Disorders (1 mention)
- Neurology: Spine and Sleep Disorders (1 mention)
- Neurology: Oncology and Hydrocephalus (2 mentions)
- Oncology: Emergencies (3 mentions)
- Palliative: End of Life Care (2 mentions)
- Paediatrics: Neurology, bones and joints in children (10 mentions)
- Obstetrics (4 mentions)
- Obstetrics: Medical Problems (3 mentions)
- Psychiatry: Mood disorders (1 mention)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Emergency Medicine: Paediatric emergency medicine (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (5 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (5 mentions)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (1 mention)
- Critical care: common problems, ethics and recovery (2 mentions)
- Integrated paediatrics chapter (10 mentions)
- Anatomy: Embryology and development (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)
Levothyroxine
BNF entry for Levothyroxine · Stand-alone drug page
Mechanism
Synthetic T4, converted to active T3.
Uses
Hypothyroidism, TSH suppression in thyroid cancer.
Dosing
- Thyroid hormone: IV liothyronine (T3), e.g. 5–20 micrograms slowly, repeated every 4–12 hours, or IV/oral levothyroxine according to local protocol. Use cautious doses in older people and those with heart disease.
Endocrinology: Thyroid disease - Block-and-replace: Carbimazole 40 mg daily plus levothyroxine, usually for about 6 months. It gives more stable levels but higher drug exposure. Not used in pregnancy.
Endocrinology: Thyroid disease - Hypothyroidism | Increase levothyroxine (often 25–50 micrograms) as soon as pregnancy is confirmed
Clinical pharmacology and prescribing: Prescribing in special groups - Hypothyroidism: levothyroxine 1.6 micrograms/kg/day in younger adults; start 25–50 micrograms in older people or those with heart disease. Check TSH 6–8 weeks after a dose change, then annually. Target TSH within the reference range.
General Practice: Long-term conditions, multimorbidity and polypharmacy
Side effects
With over-replacement: palpitations, AF, weight loss, tremor, osteoporosis, anxiety.
Interactions
Iron, calcium, PPIs and cholestyramine reduce absorption; enzyme inducers increase requirement; warfarin effect rises as thyroid function normalises.
Special advice
Take on an empty stomach 30–60 minutes before food, separate from iron and calcium by 4 hours; check TSH 6–8 weeks after dose change; start low in older people and cardiac disease.
More from the textbook: uses, cautions and other points
- Ask about - thyroid symptoms, anaemia, caffeine, energy drinks, alcohol, recreational drugs (cocaine, amphetamines), medicines (salbutamol, levothyroxine, QT-prolonging drugs), family history of sudden death.
Cardiology: History and Examination - Drugs that cause or worsen heart problems - NSAIDs (heart failure, hypertension), steroids, calcium channel blockers (oedema), QT-prolonging drugs, thyroxine, decongestants, anthracyclines and trastuzumab.
Cardiology: History and Examination - Duration, frequency, triggers (exercise, caffeine, alcohol, drugs — salbutamol, thyroxine, stimulants).
Cardiology: Presentations - Hypothyroidism: Bradycardia, pericardial effusion, reduced contractility; reversible with levothyroxine (start low in heart disease).
Cardiology: Cardiomyopathies › 3.46 Endocrine and Nutritional Cardiomyopathy - Exogenous hormones suppress the axis - e.g. long-term steroids suppress ACTH (adrenal atrophy), testosterone suppresses LH/FSH (infertility), too much levothyroxine suppresses TSH.
Endocrine: Anatomy Physiology and Pharmacology - Pregnancy - hCG stimulates the TSH receptor (TSH can be low in the first trimester; hyperemesis can cause transient hyperthyroidism); TBG rises; needs for levothyroxine increase.
Endocrine: Anatomy Physiology and Pharmacology
Where it is discussed
- Cardiology: History and Examination (2 mentions)
- Cardiology: Presentations (1 mention)
- Cardiology: Cardiomyopathies (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (7 mentions)
- Endocrinology: Emergencies (1 mention)
- Endocrinology: Pituitary Disease (8 mentions)
- Endocrinology: Adrenal Disease (3 mentions)
- Endocrinology: Thyroid disease (45 mentions)
- Endocrinology: Bone Medicine (2 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Investigations (2 mentions)
- Gastroenterology: Bowel Disorders (1 mention)
- Neurology: Movement Disorders (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Glomerular Disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Oncology: Principles (1 mention)
- Paediatrics: Kidneys, urinary tract and hormones in children (4 mentions)
- Obstetrics (5 mentions)
- Obstetrics: Medical Problems (5 mentions)
- ENT: Neck lumps and cancer (2 mentions)
- Psychiatry: Anxiety, stress and somatic disorders (1 mention)
- Psychiatry: Mood disorders (1 mention)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Surgey: Breast and endocrine surgery (2 mentions)
Lidocaine
BNF entry for Lidocaine · Stand-alone drug page
Mechanism
Class Ib sodium-channel blocker; local anaesthetic.
Uses
Local and regional anaesthesia, ventricular arrhythmia (when amiodarone unavailable), topical analgesia.
Dosing
- After the 5th shock: A further amiodarone 150 mg . Lidocaine 100 mg is an alternative.
Cardiology: Cardiology Emergencies - Amiodarone VF/pulseless VT | 300 mg IV after the 3rd shock; 150 mg after the 5th. Lidocaine 100 mg is an alternative.
Cardiology: Cardiology Emergencies - Amiodarone: 300 mg IV/IO after three shocks; 150 mg after five shocks for recurrent/persistent VF/pVT. Lidocaine is an alternative where specified.
Cardiology: Cardiac Arrhythmias › 5.23 Ventricular Fibrillation and Pulseless VT - First episode - aciclovir 400 mg three times daily for 5 days (or valaciclovir 500 mg twice daily), started within 5 days or while new lesions are forming; saline bathing, analgesia, topical lidocaine; catheter (suprapubic) for retention.
Gynaecology: Sexual health
4 more dose entries from the chapters
- Lidocaine (plain) | 3 mg/kg (maximum 200 mg) | Fast onset, short action; 1% = 10 mg/mL
Surgery: Surgical principles and perioperative care - Lidocaine with adrenaline | 7 mg/kg (maximum 500 mg) | Adrenaline slows absorption and reduces bleeding
Surgery: Surgical principles and perioperative care - Example — a 70 kg adult can have up to about 21 mL of 1% plain lidocaine.
Emergency Medicine: Minor injuries wounds, bites, minor burns, hands and foreign bodies - Lidocaine | Max about 3 mg/kg plain, 7 mg/kg with adrenaline; LAST — Intralipid
Emergency Medicine: Minor injuries wounds, bites, minor burns, hands and foreign bodies
Side effects
Perioral numbness, dizziness, confusion, seizures, bradycardia, hypotension; toxicity if intravascular or excess.
Interactions
Beta-blockers and cimetidine reduce clearance; additive with other antiarrhythmics.
Special advice
Check maximum dose by weight with and without adrenaline; have lipid emulsion available for local anaesthetic toxicity; reduce in liver failure and heart failure.
More from the textbook: uses, cautions and other points
- Phase 0 - rapid depolarisation: fast sodium channels open (blocked by class I antiarrhythmics - flecainide, lidocaine).
Cardiology: Anatomy Physiology and Pharmacology - Ib | Sodium channel block, shorten repolarisation - lidocaine , mexiletine | Ventricular arrhythmias (ischaemic VT); local anaesthetic toxicity
Cardiology: Anatomy Physiology and Pharmacology - Stool softeners , fibre and fluids; topical lidocaine.
Gastroenterology: Bowel Disorders - Drugs that block sodium channels - carbamazepine , phenytoin , lamotrigine , lacosamide (epilepsy), lidocaine and other local anaesthetics, class I antiarrhythmics, tricyclic antidepressants in overdose.
Neurology: Anatomy, Physiology and Pharmacology - Lidocaine plasters - post-herpetic neuralgia (limited NHS use).
Neurology: Anatomy, Physiology and Pharmacology - Bowel - constipation (use lidocaine gel before rectal examination).
Neurology: Emergencies
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Cardiology Emergencies (2 mentions)
- Cardiology: Cardiac Arrhythmias (1 mention)
- Gastroenterology: Bowel Disorders (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Emergencies (1 mention)
- Neurology: Headache and Facial Pain (2 mentions)
- Neurology: Neuromuscular disease (2 mentions)
- Gynaecology: Pelvic floor ovary and vulva (2 mentions)
- Gynaecology: Sexual health (1 mention)
- Dermatology: Skin infections and infestations (1 mention)
- Dermatology: Skin lesions and skin cancer (1 mention)
- ENT Anatomy Physiology (3 mentions)
- ENT: Common Ear disorders (2 mentions)
- ENT: Emergencies (1 mention)
- ID: Viral, fungal and parasitic infections (1 mention)
- Surgery: Surgical principles and perioperative care (6 mentions)
- Surgery: Colorectal and anal surgery (2 mentions)
- Surgey: Urology (1 mention)
- Emergency Medicine: Minor injuries wounds, bites, minor burns, hands and foreign bodies (5 mentions)
- Emergency Medicine: ED procedures (10 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Acute Medicine: Cardiac arrest, advanced life support and peri-arrest arrhythmias (1 mention)
Linagliptin
BNF entry for Linagliptin · Stand-alone drug page
Mechanism
DPP-4 inhibitor raising incretin levels.
Uses
Type 2 diabetes.
Dosing
- Linagliptin 5 mg daily (no renal dose adjustment - useful in CKD).
Endocrinology: Diabetes - Sitagliptin / linagliptin Type 2 | Sitagliptin 100 mg daily (reduce in CKD). Linagliptin 5 mg daily (no renal adjustment). Not with GLP-1 agonists.
Endocrinology: Diabetes
Side effects
Nasopharyngitis, pancreatitis (rare), arthralgia, bullous pemphigoid.
Interactions
Rifampicin reduces effect; sulfonylureas increase hypoglycaemia.
Special advice
No renal dose adjustment; stop if pancreatitis suspected.
More from the textbook: uses, cautions and other points
- Linagliptin needs no dose change in kidney disease.
Endocrine: Anatomy Physiology and Pharmacology - Sitagliptin / linagliptin | DPP-4; weight neutral, few hypos; pancreatitis, bullous pemphigoid.
Endocrine: Anatomy Physiology and Pharmacology - DPP-4 inhibitors - dose-adjust (linagliptin needs no adjustment).
Renal: Chronic Kidney Disease - DPP-4 inhibitors (gliptins - linagliptin needs no kidney dose change) - safe, well tolerated.
Medicine of the older adult: .Prescribing and deprescribing in older people
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (3 mentions)
- Endocrinology: Diabetes (2 mentions)
- Renal: Chronic Kidney Disease (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
Lithium
BNF entry for Lithium · Stand-alone drug page
Mechanism
Mood stabiliser; inhibits inositol monophosphatase and GSK-3.
Uses
Bipolar disorder prophylaxis, resistant depression, cluster headache (specialist).
Dosing
- 5. A 70-year-old man on lithium was started on bendroflumethiazide for hypertension 2 weeks ago. He is confused and unsteady with a coarse tremor. Lithium level 2.1 mmol/L. Answer: Chronic lithium toxicity (thiazide interaction).
Psychiatric emergencies - Lithium | First-line long-term in bipolar; level 0.6–0.8 mmol/L at 12 hours; thyroid, kidneys, calcium; NSAIDs/ACEi/thiazides raise levels.
Psychiatry: Mood disorders - 4. A 52-year-old man on lithium has had diarrhoea for 3 days. He is unsteady, has a coarse tremor and is confused. Lithium level 2.4 mmol/L, creatinine raised. Answer: Lithium toxicity with AKI.
Psychiatry: Mood disorders - Lithium | 0.4–1.0 mmol/L (lower in older people; often 0.6–0.8) | 12 hours post-dose | Tremor, diarrhoea, ataxia, confusion
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing
3 more dose entries from the chapters
- 4. A 75-year-old woman on lithium for 20 years is admitted with diarrhoea and vomiting for 3 days. She is confused with a coarse tremor and ataxia. Creatinine 210 (baseline 110). Lithium level 2.4 mmol/L. She takes ramipril and bendroflumethiazide. Answer: Lithium toxicity precipitated by dehydration, AKI and interacting drugs.
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing - Lithium | Level 12 h post-dose every 3 months (target usually 0.4–1.0 mmol/L); U&E, eGFR, calcium, TFTs every 6 months
General Practice: Long-term conditions, multimorbidity and polypharmacy - Lithium | 0.4–1.0 mmol/L (lower in older people), 12 h post-dose | Coarse tremor, vomiting, diarrhoea, ataxia, confusion, seizures; nephrogenic DI, hypothyroidism, hypercalcaemia long term
Biochemistry: Clinical biochemistry - interpreting laboratory tests
Side effects
Tremor, polyuria, hypothyroidism, hypercalcaemia, weight gain, renal impairment; toxicity causes ataxia, confusion, seizures.
Interactions
NSAIDs, ACE inhibitors, ARBs, thiazides and loop diuretics raise levels; dehydration.
Special advice
Narrow therapeutic index; level 12 hours post-dose; monitor U&E, TFT and calcium; stop in vomiting or diarrhoea; carry lithium card.
More from the textbook: uses, cautions and other points
- Side effects - hyponatraemia (especially older women), low potassium, raised calcium , raised urate (gout), raised glucose, erectile dysfunction; increase lithium levels.
Cardiology: Anatomy Physiology and Pharmacology - Indapamide / bendroflumethiazide | Thiazide-like; hyponatraemia, hypercalcaemia, gout; raise lithium.
Cardiology: Anatomy Physiology and Pharmacology - Lithium: Ebstein anomaly (a weak association).
Cardiology: Congenital heart disease › 6.03 Causes and Associations - Maternal lithium (weak association).
Cardiology: Congenital heart disease › 6.29 Ebstein Anomaly - Nephrogenic - lithium , hypercalcaemia , hypokalaemia , genetic - doesn't respond to desmopressin.
Endocrine: Anatomy Physiology and Pharmacology - Lithium | Hypothyroidism and goitre; nephrogenic diabetes insipidus ; hyperparathyroidism and hypercalcaemia
Endocrine: Anatomy Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Congenital heart disease (4 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (4 mentions)
- Endocrinology: Emergencies (1 mention)
- Endocrinology: Sodium and Water disorders (4 mentions)
- Endocrinology: Pituitary Disease (6 mentions)
- Endocrinology: Thyroid disease (7 mentions)
- Endocrinology: Bone Medicine (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (9 mentions)
- Neurology: Localisation and Investigation (2 mentions)
- Neurology: Headache and Facial Pain (3 mentions)
- Neurology: Movement Disorders (7 mentions)
- Neurology: Dementia and Cognition Disorders (Complete) (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (13 mentions)
- Renal: Emergencies (3 mentions)
- Renal: Chronic Kidney Disease (5 mentions)
- Renal: Tubular Inherited Stones (6 mentions)
- Renal: Glomerular Disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Oncology: Emergencies (1 mention)
- Paediatrics: Kidneys, urinary tract and hormones in children (1 mention)
- Obstetrics (5 mentions)
- Obstetrics: Medical Problems (2 mentions)
- Obstetrics: Post Natal Care (2 mentions)
- Dermatology: Skin basics, eczema and psoriasis (2 mentions)
Loperamide
BNF entry for Loperamide · Stand-alone drug page
Mechanism
Opioid agonist at gut mu receptors reducing motility.
Uses
Acute non-infective diarrhoea, chronic diarrhoea, ileostomy output.
Dosing
- Loperamide 2 mg after each loose stool (max 16 mg/day) | IBS-D, bile acid diarrhoea, incontinence; avoid in colitis and C. difficile.
Gastroenterology: Bowel Disorders - High-dose loperamide (4 mg, then 2 mg every 2 hours).
Oncology: Emergencies - Restrict hypotonic oral fluids (about 500–1,000 mL a day) and give an oral rehydration solution (St Mark's); loperamide 30–60 minutes before meals (high doses may be needed), ± codeine and a PPI.
Surgery: Colorectal and anal surgery
Side effects
Constipation, abdominal cramps, ileus, toxic megacolon; cardiac toxicity in overdose.
Interactions
CYP3A4 and P-gp inhibitors raise systemic exposure.
Special advice
Avoid in bloody diarrhoea, fever, C. difficile and acute colitis.
More from the textbook: uses, cautions and other points
- Nintedanib (tyrosine kinase inhibitor) - side effects: diarrhoea (very common - loperamide), nausea, raised LFTs; bleeding risk (care with anticoagulants); teratogenic.
Respiratory: Anatomy, Physiology and Pharmacology - Loperamide for IBS with diarrhoea.
Gastroenterology: Anatomy Physiology Pharmacology - Loperamide | Avoid in bloody diarrhoea, C. difficile, IBD flares; arrhythmias in overdose.
Gastroenterology: Anatomy Physiology Pharmacology - Avoid antimotility drugs (loperamide) and opioids.
Gastroenterology: Gastroenterology Emergencies (Complete) - Loperamide in high doses (taken 30–60 minutes before meals; can be opened from capsules), with codeine if needed.
Gastroenterology: Investigations - Loperamide (high dose) | High-output stoma; take before meals.
Gastroenterology: Investigations
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (4 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Investigations (4 mentions)
- Gastroenterology: Bowel Disorders (3 mentions)
- Gastroenterology: Inflammatory Bowel Disease (1 mention)
- Oncology: Principles (3 mentions)
- Oncology: Emergencies (3 mentions)
- Paediatrics: Infections in children (1 mention)
- ID: Sepsis, fever and serious bacterial infections (3 mentions)
- ID: Tropical and travel medicine (1 mention)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Surgery: Colorectal and anal surgery (6 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (1 mention)
- Integrated paediatrics chapter (1 mention)
Loratadine
BNF entry for Loratadine · Stand-alone drug page
Mechanism
Non-sedating H1 antihistamine.
Uses
Allergic rhinitis, urticaria.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Headache, dry mouth, drowsiness uncommon.
Interactions
Few; CYP3A4 and 2D6 inhibitors modest effect.
Special advice
Once daily; reduced dose in severe liver impairment.
More from the textbook: uses, cautions and other points
- Antihistamines — chlorphenamine, loratadine, cetirizine.
Obstetrics - Non-sedating antihistamine (cetirizine, loratadine, fexofenadine) daily; if not controlled, increase up to four times the standard dose (off-label, specialist advice).
Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies - Cetirizine / loratadine / fexofenadine | Urticaria - daily; up to four times standard dose for chronic urticaria (specialist advice).
Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies - Antihistamines — oral non-sedating (cetirizine, loratadine, fexofenadine) or intranasal (azelastine) — sneezing, itch, rhinorrhoea; less effect on blockage.
ENT Anatomy Physiology - Oral non-sedating antihistamines - cetirizine, loratadine, fexofenadine - for mild or intermittent symptoms.
ENT: Common Nose and Throat disorders - Cetirizine / loratadine / fexofenadine | Non-sedating oral antihistamines for allergic rhinitis.
ENT: Common Nose and Throat disorders
Where it is discussed
- Obstetrics (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Nose and Throat disorders (2 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (2 mentions)
Lorazepam
BNF entry for Lorazepam · Stand-alone drug page
Mechanism
Benzodiazepine enhancing GABA-A activity.
Uses
Status epilepticus, acute agitation, anxiety, sedation, alcohol withdrawal.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Status epilepticus | 2–4 mg IV, may repeat once | Be airway-ready; check glucose early. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
- IV lorazepam 4 mg (0.1 mg/kg), repeated once after 5–10 minutes if seizures continue.
Neurology: Anatomy, Physiology and Pharmacology - ABC, oxygen, glucose; give one dose of IV lorazepam 4 mg (the buccal midazolam counts as the first benzodiazepine dose).
Neurology: Anatomy, Physiology and Pharmacology - Status epilepticus | Benzodiazepine (IV lorazepam 4 mg or buccal midazolam 10 mg), repeat at 5–10 minutes; then levetiracetam, phenytoin or valproate; ICU
Neurology: Emergencies - IV lorazepam 4 mg (0.1 mg/kg, maximum 4 mg) if IV access and resuscitation facilities are available, or
Neurology: Emergencies
4 more dose entries from the chapters
- Anxiety and anticipatory nausea | Lorazepam 0.5–1 mg sublingually
Palliative: Symptoms Management - Benzodiazepines for associated panic and anxiety - lorazepam 0.5 mg sublingually as needed; midazolam SC near the end of life.
Palliative: Symptoms Management - First benzodiazepine (5 minutes) - IV lorazepam 0.1 mg/kg (max 4 mg), or if no IV access buccal midazolam (about 0.3 mg/kg, max 10 mg) or rectal diazepam.
Paediatrics: Neurology, bones and joints in children - Lorazepam IV 0.1 mg/kg (max 4 mg) | First-line in hospital for status epilepticus; can repeat once.
Paediatrics: Neurology, bones and joints in children
Side effects
Drowsiness, respiratory depression, ataxia, dependence, confusion in older adults.
Interactions
Opioids, alcohol, CNS depressants; valproate raises levels.
Special advice
Short-acting; avoid long-term use; refrigerate injection; monitor airway and breathing with IV doses.
More from the textbook: uses, cautions and other points
- In significant liver impairment, lorazepam or oxazepam (short-acting, not dependent on liver oxidation) - avoid oversedation, which can mimic or precipitate encephalopathy.
Gastroenterology: Anatomy Physiology Pharmacology - Withdrawal seizures - lorazepam; delirium tremens - benzodiazepines, ITU if severe.
Gastroenterology: Anatomy Physiology Pharmacology - Benzodiazepine: Usually chlordiazepoxide , symptom-triggered using a validated scale (e.g. CIWA-Ar), or a fixed reducing regimen. In liver failure, a shorter-acting drug (e.g. lorazepam or oxazepam) at lower doses may be safer.
Gastroenterology: Gastroenterology Emergencies (Complete) - Seizures: A quick-acting benzodiazepine (e.g. lorazepam).
Gastroenterology: Gastroenterology Emergencies (Complete) - Lorazepam / buccal midazolam | First-line in status; maximum two benzodiazepine doses.
Neurology: Anatomy, Physiology and Pharmacology - Seizure lasting 7 minutes, not responding to one dose of lorazepam | Status epilepticus
Neurology: Emergencies
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (4 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (3 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Emergencies (5 mentions)
- Neurology: Epilepsy (1 mention)
- Neurology: Movement Disorders (1 mention)
- Oncology: Principles (1 mention)
- Palliative: Symptoms Management (6 mentions)
- Paediatrics: Neurology, bones and joints in children (3 mentions)
- Psychiatric emergencies (12 mentions)
- Psychiatry: Mood disorders (1 mention)
- Psychiatry: Alcohol, drugs and addiction (6 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (2 mentions)
- Psychiatry: Psychosis and schizophrenia (4 mentions)
- Medicine of the older adult: Delirium, dementia and mood in older people (3 mentions)
- Emergency Medicine: Paediatric emergency medicine (3 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (9 mentions)
- Integrated paediatrics chapter (3 mentions)
- OSCEs II: Practical procedures, prescribing and acute care stations (1 mention)
Losartan
BNF entry for Losartan · Stand-alone drug page
Mechanism
Angiotensin II receptor blocker.
Uses
Hypertension, heart failure, diabetic nephropathy, stroke prevention in LVH.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Dizziness, hyperkalaemia, renal impairment, angioedema rare.
Interactions
NSAIDs, potassium-sparing diuretics, ACE inhibitors, lithium.
Special advice
Check U&E after starting; avoid in pregnancy and bilateral renal artery stenosis.
More from the textbook: uses, cautions and other points
- Angiotensin receptor blockers (ARBs) (losartan, candesartan, valsartan) - block the AT1 receptor; same uses; no cough (used when ACE inhibitors cause it); angioedema much less common.
Cardiology: Anatomy Physiology and Pharmacology - Candesartan / losartan | ARB; no cough; don't combine with ACE inhibitor.
Cardiology: Anatomy Physiology and Pharmacology - Urate - filtered and partly reabsorbed in the proximal tubule; reduced excretion with CKD, thiazides, loop diuretics, low-dose aspirin, alcohol, ciclosporin → gout; losartan and SGLT2 inhibitors slightly increase excretion.
Renal: Anatomy, Physiology and Pharmacology - ACE inhibitors (ramipril, lisinopril, perindopril, enalapril) block angiotensin II production; ARBs (losartan, candesartan, irbesartan, valsartan) block its receptor.
Renal: Anatomy, Physiology and Pharmacology - ACE inhibitor (e.g. ramipril) or ARB (e.g. losartan) | Diabetes with ACR over 3; hypertension with ACR over 30; any ACR 70 or more. Check K and eGFR at 1–2 weeks; accept an eGFR fall under 25%. Never combine.
Renal: Chronic Kidney Disease - Lifestyle — weight loss, reduce alcohol (especially beer and spirits) and sugary drinks; review diuretics (losartan has a mild uricosuric effect).
Rheumatology Anatomy Physiology Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (3 mentions)
- Renal: Chronic Kidney Disease (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (2 mentions)
- Rheumatology: Connective tissue diseases (1 mention)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (2 mentions)
- Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders (1 mention)
M
Magnesium sulfate
BNF entry for Magnesium sulfate · Stand-alone drug page
Mechanism
Calcium antagonist and NMDA blocker; cofactor for ATP-dependent enzymes.
Uses
Pre-eclampsia seizure prophylaxis and treatment, torsades de pointes, severe asthma (selected), hypomagnesaemia.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Torsades / eclampsia / severe asthma | 2 g IV over 10–15 min | Caution in renal failure; watch reflexes and respiratory rate. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
Check: the Resuscitation Council UK tachycardia algorithm gives 2 g over 10 minutes for torsades.
- Magnesium sulfate | Torsades de pointes; 2 g IV over 10 minutes (adults).
Cardiology: Anatomy Physiology and Pharmacology - Torsades de pointes | Magnesium sulfate 2 g IV over 10 minutes; stop QT-prolonging drugs
Cardiology: Cardiology Emergencies - Magnesium sulfate 2 g IV over 10 minutes - even if magnesium is normal.
Cardiology: Cardiology Emergencies - RCUK 2026 torsades regimen: Magnesium sulfate 8 mmol IV over 10 min; consider isoprenaline or temporary overdrive pacing for pause-dependent recurrent torsades with expert input.
Cardiology: Cardiac Arrhythmias › 5.22 Polymorphic VT and Torsades de Pointes
4 more dose entries from the chapters
- Magnesium sulfate Torsades | 8 mmol IV over 10 min per RCUK 2026 tachyarrhythmia algorithm; correct K/Mg and remove QT-prolonging agents.
Cardiology: Cardiac Arrhythmias › 5.42 Two-Column Drug and Dose Table - Magnesium sulfate - smooth muscle relaxant; IV 1.2–2 g over 20 minutes in acute severe or life-threatening asthma not responding to initial treatment (single dose); also used in some COPD exacerbations. Watch for hypotension and flushing.
Respiratory: Anatomy, Physiology and Pharmacology - Magnesium sulfate (IV) | Acute severe asthma -1.2–2 g over 20 minutes.
Respiratory: Anatomy, Physiology and Pharmacology - Life-threatening asthma | As above plus magnesium sulfate 1.2–2 g IV over 20 minutes; back-to-back salbutamol; senior and ICU now
Respiratory: Emergencies
Side effects
Flushing, hypotension, loss of tendon reflexes, respiratory depression, muscle weakness.
Interactions
Calcium channel blockers, neuromuscular blockers potentiated; aminoglycosides.
Special advice
Monitor reflexes, respiratory rate and urine output; calcium gluconate as antidote; reduce dose in renal impairment.
More from the textbook: uses, cautions and other points
- Severe pre-eclampsia / eclampsia | Below 160/105 (and 150/100 maintenance); labetalol, nifedipine or hydralazine; magnesium sulfate for seizures
Cardiology: Cardiology Emergencies - Alternatives - IV nicardipine, magnesium sulfate, sodium nitroprusside.
Endocrinology: Emergencies - Treatment: delivery , BP control, magnesium sulfate.
Gastroenterology: Liver disease - Start - ABC, high-flow oxygen, check glucose (treat hypoglycaemia), IV access; thiamine (Pabrinex) if alcohol misuse or malnutrition is possible; think of eclampsia in pregnancy (magnesium sulfate).
Neurology: Anatomy, Physiology and Pharmacology - Eclampsia (pregnancy or postpartum - give magnesium sulfate ).
Neurology: Emergencies - Pregnancy: MG can worsen, especially postpartum. Babies can have temporary neonatal myasthenia (feeding and breathing problems). Avoid magnesium sulfate for pre-eclampsia.
Neurology: Neuromuscular disease
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: Cardiology Emergencies (4 mentions)
- Cardiology: Cardiac Arrhythmias (2 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (2 mentions)
- Respiratory: Emergencies (4 mentions)
- Endocrinology: Emergencies (1 mention)
- Endocrinology: Bone Medicine (2 mentions)
- Gastroenterology: Liver disease (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Emergencies (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Tubular Inherited Stones (4 mentions)
- Paediatrics: Respiratory and heart problems in children (2 mentions)
- Obstetrics (4 mentions)
- Obstetrics: Obstetrics: Emergencies (5 mentions)
- Obstetrics: Complications (6 mentions)
- Obstetrics: Medical Problems (5 mentions)
- Emergency Medicine: Paediatric emergency medicine (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (1 mention)
- Acute Medicine: Acute chest pain, breathlessness, collapse and blood gases (1 mention)
- Acute Medicine: Electrolytes, acid–base, AKI and metabolic emergencies (2 mentions)
- Integrated cardiology chapter (2 mentions)
- Integrated respiratory chapter (5 mentions)
Melatonin
BNF entry for Melatonin · Stand-alone drug page
Mechanism
Hormone acting at MT1 and MT2 receptors regulating circadian rhythm.
Uses
Insomnia in people aged 55 and over (short term), sleep disorders in neurodevelopmental conditions.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Headache, drowsiness, nausea, nightmares.
Interactions
Fluvoxamine raises levels; smoking and carbamazepine reduce levels.
Special advice
Take 1–2 hours before bedtime; prescribed modified-release licensed for short courses.
More from the textbook: uses, cautions and other points
- REM sleep behaviour disorder - melatonin or clonazepam; bed safety.
Neurology: Movement Disorders - Bed safety; melatonin or clonazepam.
Neurology: Spine and Sleep Disorders - RBD - bed safety; melatonin or clonazepam.
Neurology: Dementia and Cognition Disorders (Complete) - Sleep - sleep hygiene, daylight, daytime activity. Avoid hypnotics where possible. Melatonin is not recommended by NICE for sleep in dementia.
Neurology: Dementia and Cognition Disorders (Complete) - Melatonin (modified-release) - licensed for adults 55 and over (short term).
Psychiatry: Anxiety, stress and somatic disorders - REM sleep behaviour disorder - acting out dreams (punching, kicking); strongly linked to later Parkinson's disease and dementia with Lewy bodies; clonazepam or melatonin; bedroom safety.
Psychiatry: Anxiety, stress and somatic disorders
Where it is discussed
- Neurology: Movement Disorders (1 mention)
- Neurology: Spine and Sleep Disorders (1 mention)
- Neurology: Dementia and Cognition Disorders (Complete) (2 mentions)
- Psychiatry: Anxiety, stress and somatic disorders (4 mentions)
- Psychiatry: Safeguarding (2 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Medicine of the older adult: Delirium, dementia and mood in older people (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (1 mention)
- Clinical Genetics: Chromosomal and imprinting disorders (1 mention)
- Biochemistry: Metabolism of carbohydrates, lipids and proteins (1 mention)
Memantine
BNF entry for Memantine · Stand-alone drug page
Mechanism
NMDA receptor antagonist.
Uses
Moderate to severe Alzheimer disease.
Dosing
- Memantine 5 mg, up to 20 mg daily | Moderate AD if AChEI unsuitable; severe AD; add-on; reduce to 10 mg if CrCl under 30 mL/min.
Neurology: Dementia and Cognition Disorders (Complete)
Side effects
Dizziness, headache, constipation, hypertension, confusion.
Interactions
Other NMDA antagonists (amantadine, ketamine, dextromethorphan).
Special advice
Titrate slowly; reduce dose in renal impairment; caution in epilepsy.
More from the textbook: uses, cautions and other points
- Glutamate | Main excitatory transmitter; learning and memory (NMDA and AMPA receptors) | Excitotoxic cell death in stroke and trauma; memantine and ketamine block NMDA; perampanel blocks AMPA; riluzole reduces release (MND)
Neurology: Anatomy, Physiology and Pharmacology - Memantine - NMDA receptor antagonist ; moderate to severe Alzheimer's (alone, or added to an AChE inhibitor); dizziness, headache, constipation, drowsiness; reduce dose in CKD.
Neurology: Anatomy, Physiology and Pharmacology - Memantine if these are not tolerated.
Neurology: Movement Disorders - Oscillopsia (shaky vision from nystagmus): Gabapentin or memantine.
Neurology: Multiple Sclerosis and inflammatory disease - AChEIs and memantine are not recommended for pure vascular dementia - offer them only if Alzheimer's disease, DLB or PDD is suspected to coexist ( mixed dementia ).
Neurology: Dementia and Cognition Disorders (Complete) - AChEIs - donepezil or rivastigmine (NICE) - often help cognition, fluctuations and hallucinations. Galantamine if these aren't tolerated; memantine if AChEIs are unsuitable.
Neurology: Dementia and Cognition Disorders (Complete)
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Movement Disorders (1 mention)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Neurology: Dementia and Cognition Disorders (Complete) (5 mentions)
- Medicine of the older adult: Delirium, dementia and mood in older people (5 mentions)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (2 mentions)
Meropenem
BNF entry for Meropenem · Stand-alone drug page
Mechanism
Carbapenem inhibiting cell-wall synthesis; broad spectrum.
Uses
Severe sepsis, nosocomial infection, meningitis, febrile neutropenia, ESBL infection.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Diarrhoea, nausea, rash, seizures, C. difficile.
Interactions
Valproate levels fall markedly (avoid combination); probenecid raises levels.
Special advice
Reduce dose in renal impairment; cross-reactivity with penicillin allergy is low but check history.
More from the textbook: uses, cautions and other points
- Severe or higher risk of resistance (e.g. recent antibiotics, ICU, known resistant organisms): IV piperacillin-tazobactam , a cephalosporin or meropenem, guided by local microbiology.
Respiratory: Emergencies - Interactions - enzyme inhibitor : doubles lamotrigine levels (rash risk - use a lower, slower lamotrigine titration); carbapenems (meropenem) cause a rapid, large fall in valproate levels (avoid - seizures).
Neurology: Anatomy, Physiology and Pharmacology - Seizures return when a patient on valproate gets meropenem | Carbapenem interaction - valproate levels crash
Neurology: Anatomy, Physiology and Pharmacology - Penicillin allergy: Follow local policy (e.g. meropenem for non-severe allergy; other combinations for severe allergy).
Oncology: Emergencies - Pseudomonas - naturally resistant to many drugs; options include piperacillin–tazobactam, ceftazidime, meropenem, ciprofloxacin, aminoglycosides.
ID: How Infection Happens - Meropenem / ertapenem | ESBL and severe sepsis; reserve; seizures; lowers valproate.
ID: How Infection Happens
Where it is discussed
- Respiratory: Emergencies (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Oncology: Emergencies (1 mention)
- ID: How Infection Happens (4 mentions)
- ID: Sepsis, fever and serious bacterial infections (1 mention)
- ID: Tropical and travel medicine (6 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
- Critical care: common problems, ethics and recovery (1 mention)
- Integrated respiratory chapter (1 mention)
- Microbiology: Bacteriology - structure, classification and important pathogens (1 mention)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (2 mentions)
Mesalazine
BNF entry for Mesalazine · Stand-alone drug page
Mechanism
5-aminosalicylate with local anti-inflammatory action in gut mucosa.
Uses
Ulcerative colitis induction and maintenance, mild Crohn colitis.
Dosing
- Mesalazine suppository 1 g daily - topical treatment works best here.
Gastroenterology: Inflammatory Bowel Disease - High-dose oral mesalazine (e.g. 2.4–4.8 g once daily) plus mesalazine enemas .
Gastroenterology: Inflammatory Bowel Disease - Idiopathic, trauma, steroids, mumps and other viruses, autoimmune, scorpion venom, hypercalcaemia , hypertriglyceridaemia (often over 10 mmol/L), hypothermia, ERCP , drugs (azathioprine, valproate, thiazides, mesalazine, GLP-1 agonists and others), pancreatic cancer.
Surgery: Acute abdomen and emergency general surgery
Side effects
Headache, nausea, abdominal pain; rarely interstitial nephritis, pancreatitis, blood dyscrasias.
Interactions
Azathioprine may increase myelosuppression; nephrotoxic drugs.
Special advice
Monitor renal function at baseline and periodically; choose formulation by site of disease.
More from the textbook: uses, cautions and other points
- Brands of oral mesalazine are not interchangeable (prescribe by brand).
Gastroenterology: Anatomy Physiology Pharmacology - Pancreatitis | Azathioprine , mesalazine, valproate, thiazides and furosemide, GLP-1 agonists and gliptins, steroids, oestrogens (via triglycerides), some HIV drugs
Gastroenterology: Anatomy Physiology Pharmacology - Add oral mesalazine if not enough.
Gastroenterology: Inflammatory Bowel Disease - Topical steroids if mesalazine is not tolerated.
Gastroenterology: Inflammatory Bowel Disease - Acute interstitial nephritis | PPIs , NSAIDs , penicillins and cephalosporins, rifampicin, allopurinol, mesalazine, co-trimoxazole, diuretics, immune checkpoint inhibitors - may cause rash, fever and eosinophilia (often not); white cells in urine
Renal: Anatomy, Physiology and Pharmacology - UC - aminosalicylates (mesalazine); steroids for flares; azathioprine; biologics; colectomy for severe disease.
Paediatrics: Gastroenterology and surgery in children
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Inflammatory Bowel Disease (13 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Paediatrics: Gastroenterology and surgery in children (2 mentions)
- Surgery: Acute abdomen and emergency general surgery (1 mention)
- Integrated paediatrics chapter (2 mentions)
Metformin
BNF entry for Metformin · Stand-alone drug page
Mechanism
Biguanide reducing hepatic gluconeogenesis and improving insulin sensitivity.
Uses
Type 2 diabetes, polycystic ovary syndrome (off-label).
Dosing
- Established atherosclerotic cardiovascular disease: Triple therapy - metformin MR, an SGLT2 inhibitor and subcutaneous semaglutide - added in sequence, titrating semaglutide to 1 mg weekly.
Endocrinology: Diabetes - Metformin MR Type 2 first-line | 500 mg daily with the evening meal, titrated to max 2 g daily. Max 1 g/day if eGFR below 45; stop if below 30. GI upset; B12 deficiency.
Endocrinology: Diabetes - 1. A 62-year-old with type 2 diabetes has eGFR 41 and ACR 58 mg/mmol (confirmed). She takes metformin 1 g twice daily and amlodipine. BP 148/88. Answer: Diabetic kidney disease, CKD G3b A3.
Renal: Chronic Kidney Disease - Reduce metformin (eGFR under 45); atorvastatin 20 mg; BP target under 140/90 (under 130/80 if ACR 70 or more).
Renal: Chronic Kidney Disease
4 more dose entries from the chapters
- Lactate - marker of tissue hypoperfusion in sepsis (over 2 mmol/L abnormal; 4 or more is high risk); also raised by metformin, liver failure, seizures, salbutamol.
ID: How Infection Happens - 5. A 58-year-old man with type 2 diabetes is having a morning laparoscopic cholecystectomy as a day case. He takes metformin twice daily, gliclazide twice daily, dapagliflozin and insulin glargine at night. HbA1c is 62 mmol/mol. Answer: CPOC peri-operative diabetes plan.
Surgery: Surgical principles and perioperative care - Take with food - NSAIDs, metformin, prednisolone (reduce GI upset), rivaroxaban 15/20 mg (better absorption).
Clinical pharmacology and prescribing: Principles of clinical pharmacology - 1. A 76-year-old woman (55 kg) is admitted with AKI (creatinine 210, baseline 90) after diarrhoea. Her medicines are ramipril, furosemide, metformin, gliclazide, apixaban 5 mg twice daily and naproxen. Answer: Medicines review in AKI.
Clinical pharmacology and prescribing: Prescribing in special groups
Side effects
Gastrointestinal upset, metallic taste, B12 deficiency, rarely lactic acidosis.
Interactions
Iodinated contrast, alcohol excess, cimetidine; hold with acute kidney injury.
Special advice
Titrate slowly with meals; review if eGFR below 45 and stop if below 30; sick-day rules; check B12 periodically.
More from the textbook: uses, cautions and other points
- Sick-day rules — temporarily stop ACE inhibitors, ARBs, diuretics, SGLT2 inhibitors and metformin during dehydrating illness — give individualised advice, not blanket instructions.
Cardiology: Presentations - Hold metformin around the procedure if kidney function is impaired.
Cardiology Investigations - Metformin - usually continued if eGFR is 30 or more; withhold for 48 hours after contrast if eGFR is below 30 or there is AKI (follow local radiology guidance).
Cardiology Investigations - Iodinated contrast (CT with contrast, CTPA) - check kidney function, allergy history and metformin (follow local radiology guidance).
Respiratory: Investigations - NICE NG28 - offer an SGLT2 inhibitor with metformin in type 2 diabetes if there is heart failure, established cardiovascular disease or high cardiovascular risk (check the current version - recent updates widen early use).
Endocrine: Anatomy Physiology and Pharmacology - Metformin | First-line type 2; GI upset, B12 deficiency; stop if eGFR under 30 and during dehydrating illness.
Endocrine: Anatomy Physiology and Pharmacology
Where it is discussed
- Cardiology: Presentations (1 mention)
- Cardiology Investigations (2 mentions)
- Respiratory: Investigations (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (8 mentions)
- Endocrinology: Diabetes (22 mentions)
- Endocrinology: Reproductive (2 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Investigations (2 mentions)
- Gastroenterology: Bowel Disorders (1 mention)
- Gastroenterology: Pancreas and Biliary (1 mention)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (5 mentions)
- Renal: Emergencies (8 mentions)
- Renal: Chronic Kidney Disease (4 mentions)
- Renal: Tubular Inherited Stones (1 mention)
- Renal: Dialysis and Transplant (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Haematology: History and Examination (3 mentions)
- Haematology: Anaemia (2 mentions)
- Paediatrics: Kidneys, urinary tract and hormones in children (2 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Medical Problems (9 mentions)
- Gynaecology: Menstrual Disorders (1 mention)
- Gynaecology: Fertility Contraception Menopause (1 mention)
Methadone
BNF entry for Methadone · Stand-alone drug page
Mechanism
Long-acting mu-opioid agonist and NMDA antagonist.
Uses
Opioid dependence substitution, chronic and neuropathic pain (specialist).
Dosing
- 3. A 31-year-old man on methadone 80 mg daily is admitted with a groin abscess. He says he missed today's dose. Answer: Continue opioid substitution safely in hospital.
Psychiatry: Alcohol, drugs and addiction - 5. A 62-year-old man with a heroin overdose wakes after IV naloxone 400 micrograms and wants to leave. He used long-acting methadone as well. Answer: Risk of re-sedation after naloxone wears off.
Clinical pharmacology and prescribing: Principles of clinical pharmacology
Side effects
Respiratory depression, constipation, QT prolongation, sedation, sweating.
Interactions
CYP3A4 inhibitors and inducers, QT-prolonging drugs, benzodiazepines.
Special advice
Long variable half-life; accumulation causes late overdose; supervised dosing; ECG if cardiac risk; do not restart at previous dose after a break.
More from the textbook: uses, cautions and other points
- Antipsychotics (haloperidol), citalopram, escitalopram, methadone, ondansetron, domperidone.
Cardiology: Cardiology Emergencies - QT-prolonging medications: Some macrolides, fluoroquinolones, antipsychotics, antiemetics, methadone and class Ia/III antiarrhythmics; assess combinations and patient-specific risk.
Cardiology: Cardiac Arrhythmias › 5.35 Drug-Induced Arrhythmias and Electrolytes - Rifampicin - orange-red urine, tears and sweat (stains contact lenses); potent enzyme inducer (reduces the effect of the combined pill, warfarin, DOACs, antiretrovirals, steroids, methadone); hepatitis; flu-like symptoms.
Respiratory: Anatomy, Physiology and Pharmacology - Naloxone wears off in 30–90 minutes, sooner than many opioids - observe closely and use an infusion for long-acting opioids (methadone, modified-release).
Respiratory: Emergencies - Powerful enzyme inducer - it reduces the effect of the contraceptive pill , warfarin, DOACs, steroids, HIV drugs, methadone and many others.
Respiratory: Infections - Methadone - complex, long and variable half-life; specialist use only.
Palliative: Symptoms Management
Where it is discussed
- Cardiology: Cardiology Emergencies (1 mention)
- Cardiology: Cardiac Arrhythmias (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Respiratory: Emergencies (1 mention)
- Respiratory: Infections (1 mention)
- Palliative: Symptoms Management (1 mention)
- Paediatrics: Neonatology (3 mentions)
- Obstetrics: Medical Problems (1 mention)
- Psychiatric emergencies (1 mention)
- Psychiatry: Alcohol, drugs and addiction (10 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (5 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (4 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (6 mentions)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (1 mention)
- Integrated cardiology chapter (1 mention)
- Integrated respiratory chapter (2 mentions)
- Integrated paediatrics chapter (3 mentions)
- General Practice: Mental health, safeguarding, certification and the law (1 mention)
- Public Health: Prevention, health promotion and behaviour change (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (2 mentions)
Methotrexate
BNF entry for Methotrexate · Stand-alone drug page
Mechanism
Folate antagonist inhibiting dihydrofolate reductase.
Uses
Rheumatoid arthritis, psoriasis, Crohn disease, malignancy, ectopic pregnancy.
Dosing
- Treatment: Corticosteroids (e.g. prednisolone 30–40 mg daily, tapered) for active disease, with methotrexate as a steroid-sparing agent and anti-TNF therapy for refractory cases.
Cardiology: Cardiomyopathies › 3.30 Cardiac Sarcoidosis - Methotrexate 25 mg weekly, then 15 mg weekly | Crohn's; folic acid 5 mg weekly; teratogenic; once WEEKLY.
Gastroenterology: Inflammatory Bowel Disease - Treatment toxicity checks: baseline echo and cumulative anthracycline dose (usually kept below 450 mg/m²); rituximab infusion reactions (slow first infusion, premedicate); vincristine neuropathy and constipation; methotrexate clearance (avoid NSAIDs, PPIs and co-trimoxazole during high-dose methotrexate).
Haematology: Myeloma and Lymphoma - Methotrexate 50 mg/m² IM | Stable ectopic meeting criteria; hCG days 4 and 7; avoid pregnancy for 3 months.
Obstetrics: Antenatal Care
4 more dose entries from the chapters
- 2. A 24-year-old at 6 weeks has left iliac fossa pain and light bleeding. She is stable. Scan shows a 25 mm left adnexal mass, no heartbeat, empty womb. hCG is 1,200 IU/L. Answer: Unruptured tubal ectopic pregnancy suitable for methotrexate (or expectant management if hCG falling and pain-free).
Obstetrics: Antenatal Care - 3. A 52-year-old woman with RA on methotrexate 15 mg weekly is prescribed trimethoprim for a UTI. She develops mouth ulcers and a sore throat. Answer: Methotrexate toxicity (myelosuppression) from an antifolate interaction.
Rheumatology Anatomy Physiology Pharmacology - 2. A 58-year-old woman on methotrexate 15 mg weekly for RA is prescribed trimethoprim for a UTI. A week later she has mouth ulcers, fever and bruising. Neutrophils 0.3, platelets 35. Answer: Methotrexate toxicity (marrow suppression) from a trimethoprim interaction.
Rheumatology: assessment, investigations and drugs - Stop methotrexate (1–3 months before conception per BSR); continue sulfasalazine (with folic acid 5 mg daily) and consider adding hydroxychloroquine to keep disease controlled.
Rheumatology: assessment, investigations and drugs
Side effects
Nausea, mucositis, marrow suppression, hepatotoxicity, pneumonitis, teratogenic.
Interactions
Trimethoprim and co-trimoxazole (severe marrow suppression), NSAIDs, PPIs, penicillins reduce clearance.
Special advice
Once-weekly dosing for autoimmune disease; error causes fatalities; folic acid weekly; FBC, LFT and U&E monitoring; avoid in pregnancy.
More from the textbook: uses, cautions and other points
- Methotrexate | Acute hypersensitivity pneumonitis (cough, fever, breathlessness - stop and seek advice)
Respiratory: Anatomy, Physiology and Pharmacology - Drugs damaging lungs: amiodarone, methotrexate, nitrofurantoin, bleomycin, checkpoint inhibitors.
Respiratory: Anatomy, Physiology and Pharmacology - 2. A 65-year-old woman with rheumatoid arthritis has a dry cough. FEV1 2.0 L (80%), FVC 2.2 L (70%), ratio 0.91; TLC 68%, TLCO 50%. Answer: Restrictive pattern with low gas transfer - interstitial lung disease (possibly RA-ILD, or drug-induced, e.g. methotrexate).
Respiratory: Investigations - Drugs - past and present (methotrexate, amiodarone, nitrofurantoin, chemotherapy, immunotherapy).
Respiratory: Interstitial Lung Disease - Drug toxicity - methotrexate, and infection risk with biologics.
Respiratory: Interstitial Lung Disease - Drugs (methotrexate, amiodarone, dasatinib).
Respiratory: Lung Cancer
Where it is discussed
- Cardiology: Cardiomyopathies (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (2 mentions)
- Respiratory: Investigations (1 mention)
- Respiratory: Interstitial Lung Disease (8 mentions)
- Respiratory: Lung Cancer (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (9 mentions)
- Gastroenterology: Investigations (1 mention)
- Gastroenterology: Inflammatory Bowel Disease (6 mentions)
- Gastroenterology: Liver disease (2 mentions)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Neurology: Neuromuscular disease (3 mentions)
- Renal: Anatomy, Physiology and Pharmacology (10 mentions)
- Renal: Glomerular Disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (5 mentions)
- Haematology: History and Examination (3 mentions)
- Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia (1 mention)
- Haematology: Anaemia (3 mentions)
- Haematology: Myeloma and Lymphoma (4 mentions)
- Oncology: Principles (1 mention)
- Oncology: Emergencies (1 mention)
- Oncology: Breast and Gynae Cancers (2 mentions)
- Paediatrics: Gastroenterology and surgery in children (1 mention)
- Paediatrics: Neurology, bones and joints in children (2 mentions)
Methylphenidate
BNF entry for Methylphenidate · Stand-alone drug page
Mechanism
Dopamine and noradrenaline reuptake inhibitor.
Uses
ADHD, narcolepsy.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Reduced appetite, insomnia, tachycardia, hypertension, anxiety, tics, growth effects in children.
Interactions
MAOIs contraindicated; antihypertensives antagonised.
Special advice
Monitor BP, pulse, weight and height; controlled drug; misuse potential; take earlier in the day.
More from the textbook: uses, cautions and other points
- Modafinil , pitolisant, solriamfetol, methylphenidate.
Neurology: Spine and Sleep Disorders - Methylphenidate first-line (short or long-acting).
Psychiatry: Safeguarding - Lisdexamfetamine if methylphenidate fails after a 6-week trial.
Psychiatry: Safeguarding - Medication first-line in adults with significant impairment - lisdexamfetamine or methylphenidate ; then the other; then atomoxetine if stimulants aren't tolerated.
Psychiatry: Personality, eating and neurodevelopmental disorders - Lisdexamfetamine / methylphenidate | First-line ADHD medication in adults; BP, pulse, weight every 6 months; controlled drugs.
Psychiatry: Personality, eating and neurodevelopmental disorders - 2 | Morphine , diamorphine , oxycodone , fentanyl , methadone , pethidine, alfentanil, cocaine , amphetamines (dexamfetamine, lisdexamfetamine), methylphenidate , ketamine , cannabis-based medicines (prescribed) | Full CD prescription requirements ; safe custody (CD cupboard); CD register ; destruction witnessed
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law
Where it is discussed
Metoclopramide
BNF entry for Metoclopramide · Stand-alone drug page
Mechanism
Dopamine D2 antagonist and 5-HT4 agonist.
Uses
Nausea and vomiting, gastroparesis, migraine adjunct.
Dosing
- Analgesia: IV morphine 2.5–5 mg slowly, titrated to effect, with an antiemetic (e.g. metoclopramide 10 mg IV). Opioids can delay absorption of oral P2Y12 inhibitors, so use the lowest effective dose.
Cardiology: Ischaemic Heart Disease (ACS) › 1.19 Immediate Management - Metoclopramide | D2 antagonist (also speeds gastric emptying) | Gastric stasis, migraine, post-operative, drug-induced | Extrapyramidal effects - acute dystonia (young women), tardive dyskinesia; maximum 5 days , 10 mg up to 3 times a day (MHRA); avoid in Parkinson's, bowel obstruction, under 1 year
Gastroenterology: Anatomy Physiology Pharmacology - Stop metoclopramide; give procyclidine 5–10 mg IV or IM (or benzatropine).
Gastroenterology: Anatomy Physiology Pharmacology - Metoclopramide - MHRA advises up to 10 mg three times daily for a maximum of 5 days (risk of tardive dyskinesia), although specialists sometimes use it longer.
Gastroenterology: Oesophagus and Stomach
4 more dose entries from the chapters
- Metoclopramide 10 mg up to three times daily | Gastroparesis and nausea; MHRA limit 5 days; extrapyramidal effects and tardive dyskinesia; avoid in Parkinson's.
Gastroenterology: Oesophagus and Stomach - Antiemetics: Metoclopramide 10 mg or prochlorperazine - they help nausea and also absorption of other drugs.
Neurology: Headache and Facial Pain - Gastric stasis - "squashed stomach" (liver enlargement, ascites), autonomic failure, opioids | Early fullness, large-volume vomits soon after eating, relief after vomiting. Metoclopramide 10 mg three times daily (or domperidone). Avoid in complete bowel obstruction
Palliative: Symptoms Management - Metoclopramide 10 mg three times daily | Gastric stasis; hiccups; avoid in complete obstruction with colic and in Parkinson's.
Palliative: Symptoms Management
Side effects
Extrapyramidal effects (especially in young women), drowsiness, tardive dyskinesia, hyperprolactinaemia.
Interactions
Antipsychotics increase extrapyramidal risk; opioids and antimuscarinics antagonise effect.
Special advice
Maximum 5 days; avoid in Parkinson disease, bowel obstruction and age under 20 for acute dystonia risk.
More from the textbook: uses, cautions and other points
- Causes of high prolactin - pregnancy and breastfeeding, drugs (antipsychotics, metoclopramide, domperidone, some antidepressants), prolactinoma, stalk compression, primary hypothyroidism (high TRH stimulates prolactin), kidney failure, stress (including a difficult blood test), seizures, chest wall injury, macroprolactin …
Endocrine: Anatomy Physiology and Pharmacology - Antipsychotics , metoclopramide, domperidone | Hyperprolactinaemia ; olanzapine and clozapine - weight gain and diabetes
Endocrine: Anatomy Physiology and Pharmacology - Gastroparesis - early fullness, vomiting, bloating and erratic glucose (food absorbed unpredictably, causing post-meal hypoglycaemia). Manage with small, low-fat, low-fibre meals; prokinetics (metoclopramide or domperidone short-term, erythromycin); adjust insulin timing; gastric electrical stimulation in severe cases.
Endocrinology: Diabetes - Triggers: Surgery, anaesthesia, tumour manipulation, contrast, beta-blockers given alone , glucocorticoids, metoclopramide, tricyclics, pregnancy and labour.
Endocrinology: Emergencies - BP 260/140 after metoclopramide, known adrenal mass | Phaeochromocytoma crisis
Endocrinology: Emergencies - Metoclopramide and domperidone .
Endocrinology: Pituitary Disease
Where it is discussed
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Diabetes (1 mention)
- Endocrinology: Emergencies (2 mentions)
- Endocrinology: Pituitary Disease (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (9 mentions)
- Gastroenterology: Oesophagus and Stomach (4 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (7 mentions)
- Neurology: Emergencies (3 mentions)
- Neurology: Headache and Facial Pain (2 mentions)
- Neurology: Movement Disorders (8 mentions)
- Renal: Chronic Kidney Disease (1 mention)
- Oncology: Principles (1 mention)
- Palliative: Symptoms Management (12 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Antenatal Care (3 mentions)
- Obstetrics: Medical Problems (1 mention)
- Obstetrics: Post Natal Care (1 mention)
- Gynaecology: Menstrual Disorders (1 mention)
- Rheumatology: Connective tissue diseases (1 mention)
- Psychiatric emergencies (1 mention)
- Surgery: Surgical principles and perioperative care (1 mention)
- Surgey: Breast and endocrine surgery (1 mention)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (1 mention)
- Medicine of the older adult: Delirium, dementia and mood in older people (1 mention)
Metoprolol
BNF entry for Metoprolol · Stand-alone drug page
Mechanism
Cardioselective beta-1 blocker.
Uses
Angina, hypertension, heart failure, post-MI, arrhythmia, migraine prophylaxis.
Dosing
- Metoprolol: 50–100 mg two to three times daily.
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina
Side effects
Bradycardia, fatigue, cold extremities, bronchospasm, sleep disturbance.
Interactions
Verapamil and diltiazem (heart block); clonidine rebound; insulin masks hypoglycaemia.
Special advice
Do not stop abruptly; avoid in severe asthma and heart block.
More from the textbook: uses, cautions and other points
- Beta-1 | Heart - faster rate (chronotropy), stronger contraction (inotropy), faster AV conduction; kidney - renin release | Agonist: dobutamine. Blockers: bisoprolol, metoprolol, atenolol
Cardiology: Anatomy Physiology and Pharmacology - Cardioselective (beta-1) - bisoprolol, metoprolol, atenolol, nebivolol.
Cardiology: Anatomy Physiology and Pharmacology - Beta-blocker (e.g. bisoprolol orally, or IV metoprolol in increments) or rate-limiting calcium channel blocker (diltiazem, verapamil) - avoid calcium channel blockers in heart failure with reduced EF.
Cardiology: Cardiology Emergencies - Evidence-based agents : Bisoprolol. Carvedilol. Metoprolol succinate modified-release. Nebivolol in selected patients.
Cardiology: Heart Failure › 2.19 💊 Beta Blockers - Treatment before delivery: Beta blocker (e.g. metoprolol), loop diuretic for congestion, hydralazine and nitrates for afterload reduction; avoid ACE inhibitors, ARBs, ARNIs, MRAs and SGLT2 inhibitors. Urgent pregnancy heart team input for timing and mode of delivery.
Cardiology: Cardiomyopathies › 3.42 Peripartum Cardiomyopathy (PPCM) - … postpartum and breastfeeding, is breathless with an LVEF of 28%. Answer: Peripartum cardiomyopathy - HFrEF therapy compatible with breastfeeding (e.g. enalapril, metoprolol), diuretics, consider bromocriptine with anticoagulation (stops lactation), wearable defibrillator, and counselling against further pregnancy unless EF …
Cardiology: Cardiomyopathies › 3.59 Exam-style Scenarios
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (4 mentions)
- Cardiology: Cardiology Emergencies (1 mention)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Cardiology: Heart Failure (1 mention)
- Cardiology: Cardiomyopathies (2 mentions)
- Integrated cardiology chapter (4 mentions)
Metronidazole
BNF entry for Metronidazole · Stand-alone drug page
Mechanism
Nitroimidazole forming DNA-damaging radicals in anaerobes and protozoa.
Uses
Anaerobic infection, C. difficile (alternative), amoebiasis, giardiasis, bacterial vaginosis, trichomoniasis.
Dosing
- Life-threatening C. difficile | Oral vancomycin 500 mg four times daily plus IV metronidazole; surgical review
Gastroenterology: Gastroenterology Emergencies (Complete) - Life-threatening: Oral vancomycin 500 mg four times daily plus IV metronidazole 500 mg three times daily . Urgent specialist microbiology and surgical review (colectomy may be life-saving).
Gastroenterology: Gastroenterology Emergencies (Complete) - First line: PPI + amoxicillin 1 g + clarithromycin 500 mg or metronidazole 400 mg .
Gastroenterology: Oesophagus and Stomach - Penicillin allergy: PPI + clarithromycin 250 mg + metronidazole 400 mg.
Gastroenterology: Oesophagus and Stomach
4 more dose entries from the chapters
- Metronidazole (e.g. 400 mg three times daily for 5 days) or tinidazole.
Gastroenterology: Bowel Disorders - Systemically unwell, immunosuppressed or significant comorbidity: Co-amoxiclav (500/125 mg three times daily for 5 days) - or cefalexin plus metronidazole, or trimethoprim plus metronidazole, if allergic to penicillin.
Gastroenterology: Bowel Disorders - Metronidazole 400 mg twice daily for 7 days (or 2 g single dose); avoid alcohol during and 48 hours after.
Gynaecology: Sexual health - Treatment - metronidazole 400 mg twice daily for 7 days (preferred over a single 2 g dose); treat partners ; avoid sex until both treated; test for other STIs.
Gynaecology: Sexual health
Side effects
Metallic taste, nausea, peripheral neuropathy with prolonged use, disulfiram-like reaction.
Interactions
Alcohol; warfarin effect rises; lithium levels rise.
Special advice
Avoid alcohol during and 48 hours after; limit prolonged courses because of neuropathy.
More from the textbook: uses, cautions and other points
- Many interactions - enzyme inhibitors raise INR (amiodarone, clarithromycin, erythromycin, fluconazole, metronidazole, ciprofloxacin, alcohol binges); inducers lower it (rifampicin, carbamazepine, phenytoin, St John's wort); diet (vitamin K-rich foods).
Cardiology: Anatomy Physiology and Pharmacology - PPI + amoxicillin + either clarithromycin or metronidazole .
Gastroenterology: Anatomy Physiology Pharmacology - Penicillin allergy - PPI + clarithromycin + metronidazole.
Gastroenterology: Anatomy Physiology Pharmacology - 💡 Clinical Pearl: Adherence is the main reason eradication fails. Warn patients about a metallic taste (metronidazole), diarrhoea, and no alcohol with metronidazole.
Gastroenterology: Oesophagus and Stomach - H. pylori first line: PPI + amoxicillin + clarithromycin or metronidazole, twice daily for 7 days.
Gastroenterology: Oesophagus and Stomach - Antibiotics - metronidazole or ciprofloxacin.
Gastroenterology: Inflammatory Bowel Disease
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (6 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (3 mentions)
- Gastroenterology: Oesophagus and Stomach (9 mentions)
- Gastroenterology: Bowel Disorders (5 mentions)
- Gastroenterology: Inflammatory Bowel Disease (3 mentions)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Spine and Sleep Disorders (2 mentions)
- Neurology: Neuromuscular disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Palliative: Symptoms Management (3 mentions)
- Paediatrics: Infections in children (1 mention)
- Obstetrics (1 mention)
- Gynaecology: Sexual health (11 mentions)
- Dermatology: Skin infections and infestations (1 mention)
- ENT Anatomy Physiology (2 mentions)
- ENT: Emergencies (7 mentions)
- Ophthalmology: Red emergencies (2 mentions)
- ID: How Infection Happens (9 mentions)
- ID: Sepsis, fever and serious bacterial infections (5 mentions)
- ID: Viral, fungal and parasitic infections (3 mentions)
- ID: Tropical and travel medicine (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Psychiatry: Mood disorders (1 mention)
Miconazole
BNF entry for Miconazole · Stand-alone drug page
Mechanism
Imidazole antifungal inhibiting ergosterol synthesis.
Uses
Oral and skin candidiasis, tinea.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Local irritation; oral gel absorbed systemically with interactions.
Interactions
Oral gel inhibits warfarin metabolism (raised INR); CYP3A4 substrates.
Special advice
Check INR if on warfarin; apply after food.
More from the textbook: uses, cautions and other points
- Enzyme inhibitors - amiodarone , fluconazole and miconazole (including oral gel ), metronidazole , clarithromycin and erythromycin, ciprofloxacin , co-trimoxazole , allopurinol, cimetidine, SSRIs (fluoxetine, fluvoxamine).
Haematology: Anatomy Physiology and Pharmacology - Warfarin interactions: amiodarone, azoles (including miconazole gel), macrolides, metronidazole raise INR; rifampicin, carbamazepine, St John's wort lower it.
Haematology: Anatomy Physiology and Pharmacology - Nipple thrush - burning, shooting pain after feeds, shiny skin; baby has oral thrush: treat both (miconazole for mother's nipples, miconazole or nystatin for the baby).
Obstetrics: Post Natal Care - Topical - terbinafine cream (1–2 weeks) or an imidazole (clotrimazole, miconazole -2–4 weeks, continue 1–2 weeks after clearing).
Dermatology: Skin infections and infestations - Treatment - keep skin folds dry; topical imidazole (clotrimazole, miconazole) for 2 weeks (with mild steroid if inflamed); oral fluconazole for extensive or resistant infection; check glucose or HbA1c if recurrent.
Dermatology: Skin infections and infestations - Treatment - miconazole oral gel (avoid with warfarin - raises INR), nystatin, or oral fluconazole; denture hygiene; rinse after inhalers.
ENT: Common Nose and Throat disorders
Where it is discussed
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Obstetrics: Post Natal Care (1 mention)
- Dermatology: Skin infections and infestations (4 mentions)
- ENT: Common Nose and Throat disorders (2 mentions)
- ID: How Infection Happens (2 mentions)
- ID: Viral, fungal and parasitic infections (2 mentions)
- Microbiology: Fungi, parasites and travel-related infection (1 mention)
Midazolam
BNF entry for Midazolam · Stand-alone drug page
Mechanism
Short-acting benzodiazepine.
Uses
Procedural sedation, status epilepticus (buccal), palliative care seizures and agitation, anaesthesia premedication.
Dosing
- No IV access (or in the community) - buccal midazolam 10 mg (or rectal diazepam 10–20 mg).
Neurology: Anatomy, Physiology and Pharmacology - ABC, oxygen, glucose; give one dose of IV lorazepam 4 mg (the buccal midazolam counts as the first benzodiazepine dose).
Neurology: Anatomy, Physiology and Pharmacology - Status epilepticus | Benzodiazepine (IV lorazepam 4 mg or buccal midazolam 10 mg), repeat at 5–10 minutes; then levetiracetam, phenytoin or valproate; ICU
Neurology: Emergencies - Buccal midazolam 10 mg (or rectal diazepam 10–20 mg) in the community or without IV access.
Neurology: Emergencies
4 more dose entries from the chapters
- Buccal midazolam 10 mg (adults).
Neurology: Epilepsy - Buccal midazolam 10 mg (adults) | Rescue for seizures lasting 5 minutes or more; written care plan.
Neurology: Epilepsy - Benzodiazepines for associated panic and anxiety - lorazepam 0.5 mg sublingually as needed; midazolam SC near the end of life.
Palliative: Symptoms Management - Midazolam 2.5–5 mg SC if there is also distress or agitation near the end of life.
Palliative: Symptoms Management
Side effects
Respiratory depression, hypotension, paradoxical agitation, amnesia.
Interactions
CYP3A4 inhibitors raise levels; opioids synergistic.
Special advice
Monitor oxygen saturation and airway; reduce dose in older people; flumazenil reverses sedation.
More from the textbook: uses, cautions and other points
- Bronchoscopy and EBUS - sedation (midazolam, opioids - respiratory depression in type 2 respiratory failure); risks of bleeding (stop anticoagulants and clopidogrel per protocol before biopsy), pneumothorax after transbronchial biopsy, hypoxia, infection; fast beforehand; check platelets and clotting.
Respiratory: Investigations - Sedation: Throat spray alone, or IV sedation (midazolam with or without an opioid).
Gastroenterology: Investigations - Midazolam | Conscious sedation; lower doses in older people; reverse with flumazenil.
Gastroenterology: Investigations - Bleeding near the end of life: Agree a plan in advance (dark towels, midazolam).
Gastroenterology: Cirrhosis and Transplantation - Third-line (refractory status) - about 30–45 minutes after onset: anaesthetist and ITU - rapid sequence induction with propofol, thiopental or midazolam, with EEG monitoring.
Neurology: Anatomy, Physiology and Pharmacology - ⚠️ Safety Pearl: Count every benzodiazepine dose given before arrival (buccal midazolam by family or paramedics counts). Two doses total, then move to a second-line drug - more benzodiazepines mostly add respiratory depression.
Neurology: Anatomy, Physiology and Pharmacology
Where it is discussed
- Respiratory: Investigations (1 mention)
- Gastroenterology: Investigations (2 mentions)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (6 mentions)
- Neurology: Emergencies (4 mentions)
- Neurology: Epilepsy (3 mentions)
- Oncology: Emergencies (1 mention)
- Palliative: Symptoms Management (3 mentions)
- Palliative: End of Life Care (17 mentions)
- Paediatrics: Neurology, bones and joints in children (6 mentions)
- ID: HIV, viral hepatitis and blood-borne viruses (1 mention)
- Surgery: Surgical principles and perioperative care (1 mention)
- Medicine of the older adult. Discharge, capacity, advance care planning and end of life (1 mention)
- Emergency Medicine: Paediatric emergency medicine (4 mentions)
- Emergency Medicine: ED procedures (3 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (3 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (4 mentions)
- Critical care: Admission and organ support (1 mention)
- Critical care: common problems, ethics and recovery (2 mentions)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Anaesthesia: Airway management and anaesthetic drugs (2 mentions)
- Integrated paediatrics chapter (6 mentions)
- General Practice: Mental health, safeguarding, certification and the law (1 mention)
Minoxidil
BNF entry for Minoxidil · Stand-alone drug page
Mechanism
Direct arterial vasodilator opening potassium channels.
Uses
Resistant hypertension (oral), alopecia (topical).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Fluid retention, tachycardia, hypertrichosis, pericardial effusion.
Interactions
Combine with beta-blocker and loop diuretic to limit side effects.
Special advice
Specialist use for hypertension; pericardial effusion risk.
More from the textbook: uses, cautions and other points
- Drugs acting on potassium channels — amiodarone and sotalol (class III — prolong repolarisation and QT), sulfonylureas (close K ATP channels in beta cells → insulin release), nicorandil and minoxidil (open K + channels — vasodilate).
Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing › Neural, muscular and autonomic physiology
Where it is discussed
Mirtazapine
BNF entry for Mirtazapine · Stand-alone drug page
Mechanism
Alpha-2 antagonist increasing noradrenaline and serotonin release; H1 antagonist.
Uses
Depression, particularly with insomnia and poor appetite.
Dosing
- Lorazepam 0.5–1 mg sublingually for acute anxiety or panic; an SSRI or mirtazapine for ongoing anxiety.
Palliative: Symptoms Management - Antidepressants - SSRIs (sertraline) - hyponatraemia (check sodium), bleeding (with NSAIDs, anticoagulants), falls; citalopram max 20 mg over 65 (QT); avoid tricyclics ; mirtazapine (sedation, weight gain).
Medicine of the older adult: .Prescribing and deprescribing in older people
Side effects
Sedation, weight gain, increased appetite, dizziness; neutropenia rare.
Interactions
MAOIs; alcohol and sedatives additive; carbamazepine reduces levels.
Special advice
Take at night; useful in older people with weight loss; report fever or sore throat.
More from the textbook: uses, cautions and other points
- Depression and anxiety - common. SSRIs (watch for serotonin syndrome with MAO-B inhibitors at high doses), mirtazapine, CBT.
Neurology: Movement Disorders - Drugs - antihistamines, antidepressants (SSRIs, mirtazapine), antipsychotics, metoclopramide.
Neurology: Movement Disorders - Depression - psychological approaches; antidepressants have little evidence in moderate to severe dementia (sertraline, mirtazapine are used; citalopram - QT limit). Avoid tricyclics (anticholinergic).
Neurology: Dementia and Cognition Disorders (Complete) - Sertraline / mirtazapine | Depression in dementia (limited evidence); avoid tricyclics.
Neurology: Dementia and Cognition Disorders (Complete) - Agranulocytosis / aplastic anaemia | Carbimazole , propylthiouracil, clozapine (mandatory FBC monitoring), sulfasalazine, carbamazepine , co-trimoxazole, chloramphenicol, deferiprone , methotrexate, azathioprine (TPMT), mirtazapine (rare), NSAIDs (rare) - warn about sore throat and fever
Haematology: Anatomy Physiology and Pharmacology - Mirtazapine (also helps sleep and appetite) or sertraline . They take 2–4 weeks to work.
Palliative: Symptoms Management
Where it is discussed
- Neurology: Movement Disorders (2 mentions)
- Neurology: Dementia and Cognition Disorders (Complete) (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Palliative: Symptoms Management (3 mentions)
- Psychiatric emergencies (2 mentions)
- Psychiatry: Mood disorders (7 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Psychiatry: Psychosis and schizophrenia (1 mention)
- Medicine of the older adult: Delirium, dementia and mood in older people (2 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
Morphine
BNF entry for Morphine · Stand-alone drug page
Mechanism
Mu-opioid receptor agonist.
Uses
Severe pain, acute pulmonary oedema (selected), palliative breathlessness, MI analgesia.
Dosing
- Analgesia: IV morphine 2.5–5 mg slowly, titrated to effect, with an antiemetic (e.g. metoclopramide 10 mg IV). Opioids can delay absorption of oral P2Y12 inhibitors, so use the lowest effective dose.
Cardiology: Ischaemic Heart Disease (ACS) › 1.19 Immediate Management - Morphine | 2.5–5 mg IV slowly, titrated, with an antiemetic.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - Morphine Hypercyanotic spell | Around 100 micrograms/kg IV/IM/SC, or intranasal diamorphine per protocol. Together with knee–chest position, oxygen and fluid bolus.
Cardiology: Congenital heart disease › 6.36 Drug Reference Table - 4. A 76-year-old man with CKD G4 (eGFR 18) is started on morphine sulfate 10 mg four times a day for pain from a hip fracture. Two days later he is drowsy, confused, with pinpoint pupils, twitching and a respiratory rate of 8. Answer: Opioid toxicity due to accumulation of morphine metabolites in CKD.
Renal: Anatomy, Physiology and Pharmacology
4 more dose entries from the chapters
- Immediate-release morphine (e.g. oral solution) 2.5–5 mg every 4 hours as needed , then convert to regular dosing; or
Palliative: Symptoms Management - Modified-release morphine 10–15 mg twice daily , plus immediate-release morphine for breakthrough pain.
Palliative: Symptoms Management - Pain or breathlessness | Morphine 2–5 mg SC hourly as needed (opioid-naive), or 1/6 of the 24-hour SC dose if already on opioids. eGFR under 30 - oxycodone 1–2 mg SC or alfentanil (specialist advice)
Palliative: End of Life Care - From oral morphine: Divide the 24-hour total by 2 for SC morphine (e.g. MR morphine 30 mg twice daily = 60 mg a day oral = 30 mg SC over 24 hours ).
Palliative: End of Life Care
Side effects
Constipation, nausea, drowsiness, respiratory depression, itching, hypotension; metabolites accumulate in renal failure.
Interactions
Benzodiazepines, alcohol and CNS depressants; MAOIs.
Special advice
Co-prescribe laxatives; prefer alternatives (oxycodone) in renal impairment; titrate cautiously; naloxone for toxicity.
More from the textbook: uses, cautions and other points
- Pain relief: GTN sublingual (if systolic above 90 and not RV infarction); IV morphine or diamorphine with an antiemetic if needed.
Cardiology: Cardiology Emergencies - Other considerations : Do not routinely give morphine. Treat ACS, arrhythmia or hypertensive emergency when present. Assess for acute valvular lesions and mechanical complications. Consider critical care when oxygenation or haemodynamics remain unstable.
Cardiology: Heart Failure › 2.15 🚑 Acute Pulmonary Oedema - IV or intranasal opioid (morphine).
Cardiology: Congenital heart disease › 6.22 Tetralogy of Fallot - A 2-year-old with tetralogy awaiting surgery becomes very blue and floppy after crying; the murmur is now quieter. Answer: Hypercyanotic spell. Knee–chest position, oxygen, morphine, IV fluid; propranolol or phenylephrine if persistent; urgent cardiology.
Cardiology: Congenital heart disease › 6.38 Exam-style Scenarios - Low-dose oral morphine for refractory breathlessness (specialist guidance).
Respiratory: Airways Disease - Causes: Overdose, accumulation in renal impairment (morphine, codeine), transdermal patches, combinations with gabapentinoids or benzodiazepines.
Respiratory: Emergencies
Where it is discussed
- Cardiology: Cardiology Emergencies (1 mention)
- Cardiology: Ischaemic Heart Disease (ACS) (2 mentions)
- Cardiology: Heart Failure (1 mention)
- Cardiology: Congenital heart disease (4 mentions)
- Respiratory: Airways Disease (1 mention)
- Respiratory: Emergencies (2 mentions)
- Respiratory: Lung Cancer (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Movement Disorders (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (5 mentions)
- Renal: Emergencies (1 mention)
- Renal: Chronic Kidney Disease (3 mentions)
- Renal: Dialysis and Transplant (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Haemoglobinopathies and Transfusion (2 mentions)
- Palliative: Symptoms Management (27 mentions)
- Palliative: End of Life Care (12 mentions)
- Paediatrics: Respiratory and heart problems in children (1 mention)
- Paediatrics: Neonatology (2 mentions)
- Paediatrics: Gastroenterology and surgery in children (2 mentions)
- Obstetrics (1 mention)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Surgery: Surgical principles and perioperative care (3 mentions)
- Surgey: Trauma and orthopaedics (1 mention)
Moxifloxacin
BNF entry for Moxifloxacin · Stand-alone drug page
Mechanism
Fluoroquinolone inhibiting DNA gyrase and topoisomerase IV.
Uses
Community-acquired pneumonia (second line), TB (second line), pelvic infection (specialist).
Dosing
- Doxycycline 100 mg twice daily for 7 days , then moxifloxacin 400 mg daily for 10 days (if macrolide resistance or status unknown).
Gynaecology: Sexual health - Moxifloxacin 400 mg for 10 days | Mycoplasma genitalium (after doxycycline); QT and tendon risks.
Gynaecology: Sexual health
Side effects
Tendinopathy, QT prolongation, C. difficile, aortic aneurysm, neuropsychiatric effects, hypoglycaemia.
Interactions
QT-prolonging drugs; corticosteroids increase tendon rupture risk; antacids reduce absorption.
Special advice
Restricted to specialist guidance under MHRA warnings; stop at first tendon pain.
More from the textbook: uses, cautions and other points
- All-oral regimens built around newer drugs - bedaquiline , pretomanid and linezolid (with or without moxifloxacin) for 6 months (the "BPaL(M)" regimen) in many cases, or longer individualised regimens.
Respiratory: Infections - Side effects: QT prolongation (bedaquiline, moxifloxacin), and myelosuppression and neuropathy (linezolid).
Respiratory: Infections - Kidney impairment | No dose change usually - ceftriaxone, doxycycline, clindamycin, linezolid, moxifloxacin, metronidazole | Reduce - most penicillins and cephalosporins at low eGFR (seizures), aminoglycosides , vancomycin , aciclovir , co-trimoxazole, fluconazole; avoid nitrofurantoin if eGFR under 45
ID: How Infection Happens - All-oral regimens built around newer drugs — bedaquiline , pretomanid and linezolid (with or without moxifloxacin) for 6 months (the "BPaL(M)" regimen) in many cases, or longer individualised regimens.
Integrated respiratory chapter › 4.13 Drug-resistant TB - Multidrug-resistant TB (resistant to rifampicin and isoniazid) - specialist regimens (e.g. BPaLM: bedaquiline, pretomanid, linezolid ± moxifloxacin).
Microbiology: Bacteriology - structure, classification and important pathogens - DNA gyrase | Fluoroquinolones | Ciprofloxacin, levofloxacin, moxifloxacin | Ciprofloxacin - Gram-negatives including Pseudomonas; levofloxacin and moxifloxacin - respiratory
Microbiology: Diagnostic microbiology, antimicrobials and resistance
Where it is discussed
- Respiratory: Infections (2 mentions)
- Gynaecology: Sexual health (2 mentions)
- ID: How Infection Happens (1 mention)
- Integrated respiratory chapter (2 mentions)
- Microbiology: Bacteriology - structure, classification and important pathogens (1 mention)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (1 mention)
Mycophenolate mofetil
BNF entry for Mycophenolate mofetil · Stand-alone drug page
Mechanism
Inhibits inosine monophosphate dehydrogenase, reducing lymphocyte proliferation.
Uses
Transplant rejection prophylaxis, lupus nephritis, vasculitis.
Dosing
- Treatment: Stop the checkpoint inhibitor; IV methylprednisolone 500–1000 mg daily for 3–5 days, then oral steroid taper; second-line agents (e.g. abatacept, mycophenolate, ruxolitinib) for steroid-refractory disease.
Cardiology: Cardiomyopathies › 3.37 Immune Checkpoint Inhibitor Myocarditis - 4. A 31-year-old woman with SLE (anti-Ro positive, antiphospholipid antibody negative) on hydroxychloroquine, mycophenolate and prednisolone 5 mg wants to become pregnant. Answer: Pre-pregnancy planning in SLE.
Rheumatology: Emergencies, pregnancy and other systemic diseases - 4. A 45-year-old woman with lupus nephritis on prednisolone 30 mg and mycophenolate develops progressive breathlessness and a dry cough over a week. SpO 2 95% at rest, 86% on walking. Answer: Pneumocystis jirovecii pneumonia.
Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination - Grade 2 - prednisolone 0.5–1 mg/kg; grade 3–4 - IV methylprednisolone; infliximab for refractory colitis, mycophenolate for hepatitis.
Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology
Side effects
Diarrhoea, nausea, leucopenia, infection, teratogenicity.
Interactions
Antacids and PPIs reduce absorption; azathioprine increases marrow suppression.
Special advice
Pregnancy prevention programme; monitor FBC; avoid live vaccines.
More from the textbook: uses, cautions and other points
- Treatment: Treat the cause. Immunosuppression (prednisolone, mycophenolate) often helps - unlike IPF.
Respiratory: Interstitial Lung Disease - Prednisolone for significant disease; mycophenolate or azathioprine to spare steroids.
Respiratory: Interstitial Lung Disease - Second-line options: mycophenolate, other immunosuppressants or biologics, orbital radiotherapy.
Endocrinology: Thyroid disease - Drugs also undergo enterohepatic recycling (e.g. some oestrogens, mycophenolate) - interrupted by antibiotics and bile acid binders.
Gastroenterology: Anatomy Physiology Pharmacology - Diarrhoea | Antibiotics (and C. difficile ), metformin, magnesium, colchicine (also an early sign of toxicity), mycophenolate, PPIs, SSRIs, laxative misuse, checkpoint inhibitors (colitis)
Gastroenterology: Anatomy Physiology Pharmacology - Second line: Mycophenolate, tacrolimus.
Gastroenterology: Liver disease
Where it is discussed
- Cardiology: Cardiomyopathies (1 mention)
- Respiratory: Interstitial Lung Disease (6 mentions)
- Endocrinology: Thyroid disease (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Liver disease (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Multiple Sclerosis and inflammatory disease (3 mentions)
- Neurology: Neuromuscular disease (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (5 mentions)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Tubular Inherited Stones (1 mention)
- Renal: Dialysis and Transplant (1 mention)
- Renal: Glomerular Disease (4 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Oncology: Principles (1 mention)
- Paediatrics: Kidneys, urinary tract and hormones in children (1 mention)
- Obstetrics (2 mentions)
- Obstetrics: Antenatal Care (1 mention)
- Obstetrics: Medical Problems (2 mentions)
- Dermatology: Skin basics, eczema and psoriasis (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (4 mentions)
- Rheumatology: Connective tissue diseases (9 mentions)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (1 mention)
N
Naloxone
BNF entry for Naloxone · Stand-alone drug page
Mechanism
Competitive opioid receptor antagonist.
Uses
Opioid overdose reversal, postoperative respiratory depression.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Opioid toxicity | 0.04–0.4 mg IV titrated | Reverse breathing, not full consciousness. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
- Opioid toxicity | Support breathing; naloxone 400 micrograms IV/IM (titrate smaller doses in opioid-dependent or palliative patients)
Respiratory: Emergencies - Naloxone 400 micrograms IV or IM , repeated as needed.
Respiratory: Emergencies - Action: Reduce or stop the dose, hydrate, and switch opioid if needed. Naloxone only for serious respiratory depression (small titrated doses - e.g. 20–40 micrograms IV at a time) to avoid sudden severe pain.
Palliative: Symptoms Management - IV morphine | Titrate 1–2 mg increments | Respiratory depression — naloxone
Emergency Medicine: ED procedures
4 more dose entries from the chapters
- 5. A 62-year-old man with a heroin overdose wakes after IV naloxone 400 micrograms and wants to leave. He used long-acting methadone as well. Answer: Risk of re-sedation after naloxone wears off.
Clinical pharmacology and prescribing: Principles of clinical pharmacology - … - drowsiness, confusion, hallucinations, myoclonus (metabolite accumulation in CKD), pinpoint pupils , respiratory depression - reduce dose or switch opioid; naloxone for life-threatening respiratory depression (in palliative patients, small titrated doses - e.g. 20–100 micrograms - to avoid reversing analgesia and …
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing - Pain crisis after 400 micrograms naloxone in a palliative patient | Naloxone reversed analgesia - titrate small doses
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing - Airway and bag–valve–mask ventilation with oxygen; IV naloxone 400 micrograms , repeat every 2–3 minutes (IM or intranasal if no IV access) aiming for adequate breathing.
Clinical pharmacology and prescribing: Poisoning and overdose
Side effects
Withdrawal in dependent patients (agitation, vomiting, pulmonary oedema), short duration.
Interactions
Reverses opioid analgesia.
Special advice
Short half-life, so re-sedation may occur; observe and repeat or infuse; titrate in postoperative use.
More from the textbook: uses, cautions and other points
- Reversal - naloxone for opioids (titrated in small IV doses in palliative or chronic opioid users to avoid severe pain and withdrawal; short half-life - infusion may be needed); flumazenil for benzodiazepines (rarely used - seizure risk).
Respiratory: Anatomy, Physiology and Pharmacology - Naloxone | Reverses opioid respiratory depression; short-acting - may need repeat or infusion.
Respiratory: Anatomy, Physiology and Pharmacology - Naloxone wears off in 30–90 minutes, sooner than many opioids - observe closely and use an infusion for long-acting opioids (methadone, modified-release).
Respiratory: Emergencies - Reversal agents: flumazenil (benzodiazepines) and naloxone (opioids).
Gastroenterology: Investigations - Naloxone | Reverses opioid sedation.
Gastroenterology: Investigations - Naloxone if opioid toxicity is possible (pinpoint pupils, slow breathing).
Neurology: Emergencies
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (2 mentions)
- Respiratory: Emergencies (4 mentions)
- Gastroenterology: Investigations (2 mentions)
- Neurology: Emergencies (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Palliative: Symptoms Management (1 mention)
- Obstetrics: Post Natal Care (2 mentions)
- ID: Sepsis, fever and serious bacterial infections (1 mention)
- ID: HIV, viral hepatitis and blood-borne viruses (1 mention)
- Psychiatry: Alcohol, drugs and addiction (8 mentions)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Emergency Medicine: ED procedures (3 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (10 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (3 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (11 mentions)
- Acute Medicine: The deteriorating patient (5 mentions)
- Acute Medicine: Cardiac arrest, advanced life support and peri-arrest arrhythmias (2 mentions)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (3 mentions)
- Acute Medicine: The acute medical take (1 mention)
- Anaesthesia: Airway management and anaesthetic drugs (1 mention)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (3 mentions)
- Integrated respiratory chapter (5 mentions)
- General Practice: Mental health, safeguarding, certification and the law (1 mention)
- Public Health: Prevention, health promotion and behaviour change (1 mention)
Naproxen
BNF entry for Naproxen · Stand-alone drug page
Mechanism
Non-selective NSAID.
Uses
Pain and inflammation, gout, inflammatory arthritis, dysmenorrhoea.
Dosing
- 1. A 55-year-old man on naproxen has melaena. HR 110, BP 98/60, Hb 82 g/L, urea 16. Answer: Upper GI bleed - probable peptic ulcer (high Blatchford score).
Gastroenterology: Gastroenterology Emergencies (Complete) - 1. A 76-year-old woman (55 kg) is admitted with AKI (creatinine 210, baseline 90) after diarrhoea. Her medicines are ramipril, furosemide, metformin, gliclazide, apixaban 5 mg twice daily and naproxen. Answer: Medicines review in AKI.
Clinical pharmacology and prescribing: Prescribing in special groups - 1. A 62-year-old man on naproxen has vomited blood twice and has melaena. Pulse 118, BP 96/60, haemoglobin 82 g/L, urea 18. Answer: Upper GI bleed - probable peptic ulcer - high risk (Glasgow–Blatchford well above 1).
Acute Medicine: The acute medical take
Side effects
Dyspepsia, GI bleeding, renal impairment, hypertension; lower cardiovascular risk than diclofenac.
Interactions
Anticoagulants, ACE inhibitors, diuretics, methotrexate, lithium.
Special advice
Take with food and consider PPI; avoid in renal impairment and heart failure.
More from the textbook: uses, cautions and other points
- Melaena, on naproxen, urea 18, normal creatinine | Peptic ulcer bleed
Gastroenterology: Gastroenterology Emergencies (Complete) - Stop naproxen; test for and treat H. pylori .
Gastroenterology: Gastroenterology Emergencies (Complete) - Ibuprofen and naproxen have lower GI risk than others.
Gastroenterology: Oesophagus and Stomach - 4. A 70-year-old on naproxen and sertraline has a gastric ulcer on OGD. Answer: NSAID-related gastric ulcer, with higher risk from the SSRI.
Gastroenterology: Oesophagus and Stomach - Treatment - NSAIDs (ibuprofen, naproxen, mefenamic acid) started at the onset of pain or just before; paracetamol; heat; exercise; combined hormonal contraception (or other hormonal methods) if NSAIDs aren't enough.
Gynaecology: Menstrual Disorders - Ibuprofen / naproxen | Primary dysmenorrhoea, endometriosis pain.
Gynaecology: Menstrual Disorders
Where it is discussed
- Gastroenterology: Gastroenterology Emergencies (Complete) (3 mentions)
- Gastroenterology: Oesophagus and Stomach (3 mentions)
- Gynaecology: Menstrual Disorders (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (2 mentions)
- Rheumatology: assessment, investigations and drugs (2 mentions)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (1 mention)
- Surgery: Acute abdomen and emergency general surgery (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (3 mentions)
- Acute Medicine: The acute medical take (3 mentions)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (1 mention)
Nebivolol
BNF entry for Nebivolol · Stand-alone drug page
Mechanism
Cardioselective beta blocker with nitric oxide-mediated vasodilation.
Uses
Hypertension, heart failure in older people.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Bradycardia, headache, fatigue, dizziness.
Interactions
Verapamil and diltiazem; clonidine; amiodarone.
Special advice
Do not stop abruptly; caution in asthma.
More from the textbook: uses, cautions and other points
- Cardioselective (beta-1) - bisoprolol, metoprolol, atenolol, nebivolol.
Cardiology: Anatomy Physiology and Pharmacology - Uses - angina, after MI, HFrEF (bisoprolol, carvedilol, nebivolol, metoprolol succinate -"start low, go slow"), AF rate control, SVT, hypertension (not first-line alone), thyrotoxicosis.
Cardiology: Anatomy Physiology and Pharmacology - Evidence-based agents : Bisoprolol. Carvedilol. Metoprolol succinate modified-release. Nebivolol in selected patients.
Cardiology: Heart Failure › 2.19 💊 Beta Blockers
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Heart Failure (1 mention)
- Integrated cardiology chapter (1 mention)
Neostigmine
BNF entry for Neostigmine · Stand-alone drug page
Mechanism
Reversible acetylcholinesterase inhibitor.
Uses
Reversal of non-depolarising muscle relaxants, myasthenia gravis, acute colonic pseudo-obstruction (specialist).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Bradycardia, salivation, bronchospasm, abdominal cramps.
Interactions
Given with glycopyrronium or atropine to counter muscarinic effects.
Special advice
Cholinergic crisis if excess; monitor ECG when used for pseudo-obstruction.
More from the textbook: uses, cautions and other points
- If the caecum is very dilated (above about 10–12 cm) or not resolving: IV neostigmine (with cardiac monitoring and atropine available), or colonoscopic decompression.
Gastroenterology: Gastroenterology Emergencies (Complete) - Neostigmine Pseudo-obstruction | IV, with cardiac monitoring and atropine available (specialist).
Gastroenterology: Gastroenterology Emergencies (Complete) - Rocuronium , atracurium (non-depolarising) - reversed by neostigmine (with glycopyrronium) or sugammadex (rocuronium and vecuronium); people with myasthenia are very sensitive to them.
Neurology: Anatomy, Physiology and Pharmacology - Muscle relaxation when needed - neuromuscular blockers (rocuronium, atracurium; suxamethonium for rapid sequence); reversed with neostigmine or sugammadex.
Surgery: Surgical principles and perioperative care - Treatment - correct electrolytes, stop drugs that slow the gut, mobilise, NG and rectal tubes; neostigmine (with cardiac monitoring - bradycardia; atropine available) if not settling; colonoscopic decompression; surgery if perforation or a very large caecum.
Surgery: Acute abdomen and emergency general surgery - Pseudo-obstruction | Post-op, low K, opioids, no mechanical cause | CT | Correct electrolytes, neostigmine, decompression
Surgery: Acute abdomen and emergency general surgery
Where it is discussed
- Gastroenterology: Gastroenterology Emergencies (Complete) (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Surgery: Surgical principles and perioperative care (1 mention)
- Surgery: Acute abdomen and emergency general surgery (3 mentions)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Anaesthesia: Airway management and anaesthetic drugs (4 mentions)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (2 mentions)
Nifedipine
BNF entry for Nifedipine · Stand-alone drug page
Mechanism
Dihydropyridine calcium channel blocker.
Uses
Hypertension, angina, Raynaud phenomenon, preterm labour tocolysis, hypertension in pregnancy.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Ankle oedema, flushing, headache, palpitations, gingival hyperplasia.
Interactions
CYP3A4 inhibitors (clarithromycin) and grapefruit raise levels; beta-blockers hypotension.
Special advice
Avoid short-acting capsules for hypertension; avoid in unstable angina and severe aortic stenosis.
More from the textbook: uses, cautions and other points
- Avoid short-acting nifedipine in angina (reflex tachycardia).
Cardiology: Anatomy Physiology and Pharmacology - Severe pre-eclampsia / eclampsia | Below 160/105 (and 150/100 maintenance); labetalol, nifedipine or hydralazine; magnesium sulfate for seizures
Cardiology: Cardiology Emergencies - Treatment: Descend ; oxygen; nifedipine (lowers pulmonary artery pressure); portable hyperbaric bag.
Respiratory: Sleep and Breathing (Complete) - Nifedipine for people with previous HAPE.
Respiratory: Sleep and Breathing (Complete) - Nifedipine or nitrates - little benefit.
Gastroenterology: Oesophagus and Stomach - If BP stays high: A fast-acting antihypertensive - e.g. sublingual GTN or immediate-release nifedipine, per spinal injuries unit guidance.
Neurology: Emergencies
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: Cardiology Emergencies (1 mention)
- Respiratory: Sleep and Breathing (Complete) (4 mentions)
- Gastroenterology: Oesophagus and Stomach (1 mention)
- Neurology: Emergencies (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Tubular Inherited Stones (1 mention)
- Obstetrics (8 mentions)
- Obstetrics: Obstetrics: Emergencies (4 mentions)
- Obstetrics: Complications (5 mentions)
- Obstetrics: Medical Problems (7 mentions)
- Rheumatology: Connective tissue diseases (3 mentions)
- ENT Anatomy Physiology (1 mention)
- ID: Tropical and travel medicine (1 mention)
- Surgery: Vascular surgery (1 mention)
- Emergency Medicine: Environmental emergencies (6 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (4 mentions)
- Integrated respiratory chapter (4 mentions)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (2 mentions)
- Pathology: Immunopathology, amyloidosis, genetic and environmental disease (1 mention)
Nitrofurantoin
BNF entry for Nitrofurantoin · Stand-alone drug page
Mechanism
Damages bacterial DNA and ribosomes; concentrates in urine.
Uses
Uncomplicated lower urinary tract infection, prophylaxis.
Dosing
- Nitrofurantoin (modified-release 100 mg twice daily) if eGFR is 45 or more (BNF: avoid if under 45, though a short course may be used with caution at 30–44 when no alternative); or
Renal: Anatomy, Physiology and Pharmacology - Nitrofurantoin 100 mg modified-release twice daily for 3 days (if eGFR 45 or more).
Renal: Tubular Inherited Stones - Nitrofurantoin 100 mg MR twice daily | Lower UTI: 3 days (women), 7 days (men, pregnancy); avoid if eGFR under 45 and at term.
Renal: Tubular Inherited Stones
Side effects
Nausea, rash, pulmonary reactions, hepatitis, peripheral neuropathy.
Interactions
Antacids (magnesium trisilicate) reduce absorption; quinolones antagonistic.
Special advice
Avoid if eGFR below 45 (short-course use allowed with caution), at term and in G6PD deficiency; take with food.
More from the textbook: uses, cautions and other points
- Nitrofurantoin | Acute pneumonitis (within days) or chronic fibrosis (long-term use - older women on prophylaxis)
Respiratory: Anatomy, Physiology and Pharmacology - Breathless with lung fibrosis on long-term nitrofurantoin | Drug-induced pulmonary fibrosis
Respiratory: Anatomy, Physiology and Pharmacology - Drugs - past and present (methotrexate, amiodarone, nitrofurantoin, chemotherapy, immunotherapy).
Respiratory: Interstitial Lung Disease - Nitrofurantoin - acute reaction (fever, eosinophilia) or chronic fibrosis with long-term use (e.g. UTI prophylaxis).
Respiratory: Interstitial Lung Disease - Hepatocellular (ALT up) | Paracetamol (overdose), isoniazid , rifampicin, pyrazinamide, valproate , methotrexate, statins (usually mild), amiodarone, nitrofurantoin , ketoconazole, NSAIDs (diclofenac), herbal supplements (green tea extract, kava, turmeric), checkpoint inhibitors
Gastroenterology: Anatomy Physiology Pharmacology - Autoimmune-like hepatitis | Nitrofurantoin, minocycline, methyldopa, anti-TNF drugs
Gastroenterology: Anatomy Physiology Pharmacology
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (3 mentions)
- Respiratory: Interstitial Lung Disease (5 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Liver disease (3 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (10 mentions)
- Renal: Emergencies (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Tubular Inherited Stones (9 mentions)
- Renal: Dialysis and Transplant (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Haematology: History and Examination (1 mention)
- Haematology: Anaemia (3 mentions)
- Paediatrics: Kidneys, urinary tract and hormones in children (3 mentions)
- Obstetrics (3 mentions)
- Obstetrics: Medical Problems (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (1 mention)
- ID: How Infection Happens (8 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (2 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (3 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (3 mentions)
Noradrenaline
BNF entry for Noradrenaline · Stand-alone drug page
Mechanism
Alpha-1 agonist with beta-1 effect; vasopressor.
Uses
Septic and vasodilatory shock, hypotension unresponsive to fluids.
Dosing
- 3. A 60-year-old man with septic shock from cholangitis has a MAP of 55 mmHg despite 30 mL/kg of fluid and noradrenaline at 0.4 micrograms/kg/min. Lactate is 6. Answer: Refractory septic shock.
Critical care: Admission and organ support
Side effects
Hypertension, bradycardia, arrhythmia, peripheral and mesenteric ischaemia, extravasation necrosis.
Interactions
MAOIs, tricyclics and linezolid potentiate; beta-blockers.
Special advice
Central line infusion with invasive BP monitoring; titrate to MAP target; correct hypovolaemia first.
More from the textbook: uses, cautions and other points
- Alpha-1 | Blood vessels - vasoconstriction | Agonists: noradrenaline, phenylephrine, metaraminol. Blockers: doxazosin, tamsulosin (postural hypotension)
Cardiology: Anatomy Physiology and Pharmacology - Noradrenaline | Alpha-1 more than beta-1 - vasoconstriction , raises BP | First-line vasopressor in septic shock ; vasodilatory shock
Cardiology: Anatomy Physiology and Pharmacology - Cardiogenic shock | ICU; echo; revascularise culprit artery; noradrenaline ± dobutamine
Cardiology: Cardiology Emergencies - Mean arterial pressure above 65 mmHg , with fluids, noradrenaline and dobutamine as needed.
Cardiology: Cardiology Emergencies - Noradrenaline for hypotension, with or without dobutamine for low output, under invasive monitoring.
Cardiology: Ischaemic Heart Disease (ACS) › 1.27 Heart Failure and Cardiogenic Shock - Sympathetic nervous system activation : Reduced effective arterial perfusion activates sympathetic responses; Noradrenaline increases heart rate, contractility and peripheral vascular resistance; Persistent activation increases myocardial oxygen demand and promotes arrhythmias; Chronic catecholamine stimulation contributes to …
Cardiology: Heart Failure › 2.04 🔬 Pathophysiology of Heart Failure
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (4 mentions)
- Cardiology: Cardiology Emergencies (5 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Cardiology: Heart Failure (1 mention)
- Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (3 mentions)
- Endocrinology: Adrenal Disease (2 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- ID: Sepsis, fever and serious bacterial infections (1 mention)
- Acute Medicine: The deteriorating patient (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (10 mentions)
- Critical care: Admission and organ support (7 mentions)
- Critical care: common problems, ethics and recovery (2 mentions)
- Anaesthesia: Airway management and anaesthetic drugs (1 mention)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (1 mention)
- Integrated cardiology chapter (2 mentions)
- Physiology: Endocrine control, metabolism and thermoregulation (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (11 mentions)
- Histology: Organ-system histology (1 mention)
- Neurophysiology, neuromuscular transmission and endocrine feedback (1 mention)
Nortriptyline
BNF entry for Nortriptyline · Stand-alone drug page
Mechanism
Tricyclic antidepressant, mainly noradrenaline reuptake inhibitor.
Uses
Depression, neuropathic pain, smoking cessation (off-label).
Dosing
- Amitriptyline (and nortriptyline) - TCA; start low at night (10 mg); side effects - drowsiness, dry mouth, constipation, urinary retention, weight gain, postural hypotension, QT prolongation ; dangerous in overdose (arrhythmias, seizures); caution in older people and heart disease.
Neurology: Anatomy, Physiology and Pharmacology
Side effects
Dry mouth, constipation, sedation, urinary retention, arrhythmia, postural hypotension; toxic in overdose.
Interactions
MAOIs, other serotonergic drugs, QT-prolonging drugs.
Special advice
Lower anticholinergic burden than amitriptyline; limit supplies if overdose risk.
More from the textbook: uses, cautions and other points
- Antidepressants - amitriptyline , nortriptyline, imipramine, paroxetine.
Medicine of the older adult: .Prescribing and deprescribing in older people - Very dangerous in overdose (amitriptyline, dosulepin, nortriptyline, imipramine) - small amounts can kill; rapid deterioration is common in the first hours.
Clinical pharmacology and prescribing: Poisoning and overdose
Where it is discussed
Nystatin
BNF entry for Nystatin · Stand-alone drug page
Mechanism
Polyene antifungal binding fungal membrane ergosterol.
Uses
Oral and intestinal candidiasis.
Dosing
- Oral candida - white plaques, sore red mouth. Nystatin suspension or fluconazole 50 mg daily for 7 days (watch interactions). Clean dentures.
Palliative: Symptoms Management
Side effects
Nausea, diarrhoea at high doses; not absorbed.
Interactions
None significant.
Special advice
Hold in mouth after food; treat dentures; continue 48 hours after clearance.
More from the textbook: uses, cautions and other points
- Nipple thrush - burning, shooting pain after feeds, shiny skin; baby has oral thrush: treat both (miconazole for mother's nipples, miconazole or nystatin for the baby).
Obstetrics: Post Natal Care - Oral thrush - miconazole oral gel (warfarin interaction) or nystatin; fluconazole if severe; rinse mouth after inhaled steroids.
Dermatology: Skin infections and infestations - Treatment - miconazole oral gel (avoid with warfarin - raises INR), nystatin, or oral fluconazole; denture hygiene; rinse after inhalers.
ENT: Common Nose and Throat disorders - Miconazole oral gel / nystatin / fluconazole | Oral candida; miconazole raises INR with warfarin.
ENT: Common Nose and Throat disorders - Nystatin , miconazole, clotrimazole | Topical and oral thrush, vaginal candidiasis | Nystatin not absorbed; miconazole oral gel raises INR with warfarin
ID: How Infection Happens - Oral thrush - white plaques that can be scraped off; dentures, inhaled steroids, antibiotics, diabetes, immunosuppression, frailty - nystatin or miconazole gel ( raises INR with warfarin ), or fluconazole.
ID: Viral, fungal and parasitic infections
Where it is discussed
- Palliative: Symptoms Management (1 mention)
- Obstetrics: Post Natal Care (1 mention)
- Dermatology: Skin infections and infestations (1 mention)
- ENT: Common Nose and Throat disorders (2 mentions)
- ID: How Infection Happens (1 mention)
- ID: Viral, fungal and parasitic infections (2 mentions)
- Microbiology: Fungi, parasites and travel-related infection (1 mention)
O
Olanzapine
BNF entry for Olanzapine · Stand-alone drug page
Mechanism
Atypical antipsychotic blocking dopamine and serotonin receptors.
Uses
Schizophrenia, bipolar mania, agitation, nausea (palliative).
Dosing
- 5. A 30-year-old man with schizophrenia has gained 15 kg on olanzapine. HbA1c is 50 mmol/mol. Answer: Antipsychotic-induced weight gain and type 2 diabetes.
Psychiatry: Psychosis and schizophrenia
Side effects
Weight gain, metabolic syndrome, sedation, sialorrhoea; neuroleptic malignant syndrome.
Interactions
CNS depressants; smoking reduces levels; fluvoxamine raises levels; parenteral IM olanzapine with benzodiazepine caution.
Special advice
Monitor weight, glucose and lipids; avoid in dementia with Lewy bodies.
More from the textbook: uses, cautions and other points
- Antipsychotics , metoclopramide, domperidone | Hyperprolactinaemia ; olanzapine and clozapine - weight gain and diabetes
Endocrine: Anatomy Physiology and Pharmacology - Antipsychotics (olanzapine, clozapine).
Endocrinology: Diabetes - Delirium tremens: Oral lorazepam first-line. Parenteral lorazepam, haloperidol or olanzapine if symptoms persist. Treat in a safe environment, often HDU.
Gastroenterology: Gastroenterology Emergencies (Complete) - Chorea: Tetrabenazine (can cause depression and parkinsonism) or antipsychotics (olanzapine, risperidone).
Neurology: Movement Disorders - Ondansetron / dexamethasone / aprepitant / olanzapine | Chemotherapy-induced nausea prevention, by emetogenic risk.
Oncology: Principles - Varenicline / cytisine / NRT | Stop-smoking treatment - vital in severe mental illness; check clozapine and olanzapine levels when smoking changes.
Psychiatry: assessment, treatment and the law
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: Diabetes (1 mention)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Neurology: Movement Disorders (1 mention)
- Oncology: Principles (1 mention)
- Psychiatry: assessment, treatment and the law (1 mention)
- Psychiatric emergencies (6 mentions)
- Psychiatry: Mood disorders (9 mentions)
- Psychiatry: Alcohol, drugs and addiction (2 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (2 mentions)
- Psychiatry: Psychosis and schizophrenia (10 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
- Public Health: Prevention, health promotion and behaviour change (1 mention)
Omeprazole
BNF entry for Omeprazole · Stand-alone drug page
Mechanism
Proton pump inhibitor.
Uses
GORD, peptic ulcer, H. pylori regimens, gastroprotection with NSAIDs.
Dosing
- Clopidogrel (75 mg) - prodrug activated by CYP2C19 (poor metabolisers respond less; omeprazole may reduce effect - use lansoprazole or pantoprazole); irreversible.
Cardiology: Anatomy Physiology and Pharmacology - Full-dose PPI for 4–8 weeks (e.g. omeprazole 20 mg once daily, lansoprazole 30 mg once daily) - take 30–60 minutes before breakfast.
Gastroenterology: Oesophagus and Stomach - High-dose PPI for 8 weeks (e.g. omeprazole 20–40 mg twice daily) - works in about half.
Gastroenterology: Oesophagus and Stomach - PPI (e.g. omeprazole 20 mg) | Improves enzyme effect when PERT response is poor.
Gastroenterology: Pancreas and Biliary
2 more dose entries from the chapters
- 3. A 72-year-old man has tiredness. Hb 92 g/L, MCV 71 fL, ferritin 6 micrograms/L. He takes omeprazole. He has no GI symptoms. Answer: Iron deficiency anaemia - must be investigated for GI cancer.
Haematology: Anatomy Physiology and Pharmacology - … (CFS 6) is admitted after a fall. She takes: amlodipine 10 mg, ramipril 10 mg, indapamide, doxazosin, atorvastatin, aspirin 75 mg (no history of vascular disease), omeprazole 40 mg (started 6 years ago for dyspepsia), amitriptyline 25 mg (sleep), zopiclone, oxybutynin and gliclazide (HbA1c 49). Standing BP 106/60. Answer: …
Medicine of the older adult: .Prescribing and deprescribing in older people
Side effects
Headache, diarrhoea, hypomagnesaemia, B12 deficiency, fracture risk, C. difficile.
Interactions
Clopidogrel activation reduced; methotrexate levels rise; reduces absorption of iron and levothyroxine.
Special advice
Review long-term need; use the lowest effective dose.
More from the textbook: uses, cautions and other points
- Omeprazole and esomeprazole inhibit CYP2C19 → less activation of clopidogrel (avoid the combination - use lansoprazole or pantoprazole).
Gastroenterology: Anatomy Physiology Pharmacology - Omeprazole / lansoprazole (PPIs) | Before breakfast; C. difficile, low magnesium, fractures, B12; omeprazole reduces clopidogrel activation; stop 2 weeks before H. pylori testing.
Gastroenterology: Anatomy Physiology Pharmacology - Clopidogrel: Omeprazole and esomeprazole reduce its activation - use lansoprazole or pantoprazole instead.
Gastroenterology: Oesophagus and Stomach - Potassium won't rise despite supplements; on omeprazole and furosemide | Low magnesium - replace it
Renal: Anatomy, Physiology and Pharmacology - AKI with rash and white cells in urine 10 days after starting omeprazole | Acute interstitial nephritis
Renal: Anatomy, Physiology and Pharmacology - AKI with sterile pyuria 2 months after starting omeprazole | Drug-induced interstitial nephritis
Renal: Emergencies
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (6 mentions)
- Gastroenterology: Oesophagus and Stomach (4 mentions)
- Gastroenterology: Pancreas and Biliary (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Emergencies (1 mention)
- Renal: Tubular Inherited Stones (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (5 mentions)
- Paediatrics: Gastroenterology and surgery in children (1 mention)
- Obstetrics (1 mention)
- Obstetrics: Post Natal Care (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (3 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Acute Medicine: Electrolytes, acid–base, AKI and metabolic emergencies (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Integrated paediatrics chapter (1 mention)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)
Ondansetron
BNF entry for Ondansetron · Stand-alone drug page
Mechanism
5-HT3 receptor antagonist.
Uses
Chemotherapy and postoperative nausea and vomiting, hyperemesis (selected).
Dosing
- Clinical dehydration - ORS 50 mL/kg over 4 hours (small, frequent sips) plus maintenance fluid; NG tube if not drinking or vomiting; ondansetron (single oral dose) in hospital can reduce vomiting.
Paediatrics: Infections in children - Clinical dehydration — oral rehydration solution (ORS) 50 mL/kg over 4 hours plus maintenance, small frequent amounts; nasogastric ORS if not tolerated orally; ondansetron (single oral dose) can reduce vomiting and IV need.
Emergency Medicine: Paediatric emergency medicine - Gastroenteritis | Diarrhoea and vomiting | ORS 50 mL/kg over 4 hours; NG; ondansetron
Emergency Medicine: Paediatric emergency medicine - Clinical dehydration — ORS 50 mL/kg over 4 hours (small, frequent sips) plus maintenance fluid; NG tube if not drinking or vomiting; ondansetron (single oral dose) in hospital can reduce vomiting.
Integrated paediatrics chapter › Gastroenteritis and Dehydration
Side effects
Constipation, headache, QT prolongation, flushing.
Interactions
QT-prolonging drugs; apomorphine contraindicated.
Special advice
Check electrolytes and ECG in cardiac risk; avoid in congenital long QT.
More from the textbook: uses, cautions and other points
- Antipsychotics (haloperidol), citalopram, escitalopram, methadone, ondansetron, domperidone.
Cardiology: Cardiology Emergencies - Serotonin (5-HT) | Enterochromaffin cells (most of the body's 5-HT) | Motility, secretion, nausea | Carcinoid syndrome; ondansetron; prucalopride
Gastroenterology: Anatomy Physiology Pharmacology - Ondansetron | 5-HT3 antagonist | Chemotherapy, radiotherapy, post-operative, gastroenteritis | Constipation , headache, QT prolongation ; small increased risk of oral clefts if used in the first trimester (MHRA) - not first-line in pregnancy
Gastroenterology: Anatomy Physiology Pharmacology - Hyperemesis gravidarum - see obstetric guidance (thiamine, fluids, antiemetics such as cyclizine and ondansetron).
Gastroenterology: Oesophagus and Stomach - Drugs: Opioids , iron, calcium channel blockers, anticholinergics, antidepressants, antipsychotics, aluminium antacids, ondansetron.
Gastroenterology: Bowel Disorders - Serotonin (5-HT) | Mood, sleep, appetite, pain, nausea, blood vessel tone | Triptans (5-HT1B/1D agonists) in migraine; ondansetron (5-HT3); SSRIs; serotonin syndrome
Neurology: Anatomy, Physiology and Pharmacology
Where it is discussed
- Cardiology: Cardiology Emergencies (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (9 mentions)
- Gastroenterology: Oesophagus and Stomach (1 mention)
- Gastroenterology: Bowel Disorders (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Emergencies (1 mention)
- Neurology: Movement Disorders (1 mention)
- Oncology: Principles (2 mentions)
- Palliative: Symptoms Management (2 mentions)
- Paediatrics: Infections in children (3 mentions)
- Obstetrics (1 mention)
- Obstetrics: Antenatal Care (3 mentions)
- Psychiatric emergencies (1 mention)
- Psychiatry: Mood disorders (1 mention)
- Surgery: Surgical principles and perioperative care (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Emergency Medicine: Paediatric emergency medicine (2 mentions)
- Emergency Medicine: ED procedures (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (4 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Acute Medicine: The acute medical take (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (3 mentions)
- Anaesthesia: Airway management and anaesthetic drugs (1 mention)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (3 mentions)
- Integrated paediatrics chapter (3 mentions)
Oseltamivir
BNF entry for Oseltamivir · Stand-alone drug page
Mechanism
Neuraminidase inhibitor preventing viral release.
Uses
Influenza treatment and prophylaxis.
Dosing
- Oseltamivir Influenza | 75 mg twice daily for 5 days (adjust for renal function); for at-risk patients and all hospital admissions with suspected influenza in season.
Respiratory: Infections
Side effects
Nausea, vomiting, headache, neuropsychiatric events rare.
Interactions
Few; probenecid raises levels.
Special advice
Start within 48 hours of symptoms in at-risk patients; adjust for renal function.
More from the textbook: uses, cautions and other points
- Antivirals - oseltamivir for influenza in at-risk people (within 48 hours); COVID-19 antivirals in eligible high-risk patients.
Respiratory: Anatomy, Physiology and Pharmacology - Influenza in season: Antivirals (e.g. oseltamivir) for hospitalised patients.
Respiratory: Emergencies - Influenza - oseltamivir (oral) within 48 hours of symptoms for people at risk of complications, all hospitalised patients with suspected influenza, and as post-exposure prophylaxis in at-risk groups when flu is circulating (NICE); zanamivir (inhaled - bronchospasm; IV for resistant or severe cases).
ID: How Infection Happens - Oseltamivir | Influenza within 48 hours in at-risk and hospitalised patients.
ID: How Infection Happens - Treatment - oseltamivir (5 days) for at-risk people with influenza-like illness when flu is circulating, ideally within 48 hours of symptoms, and for all hospitalised patients with suspected influenza (even later); zanamivir for resistance or severe illness; treat bacterial complications.
ID: Viral, fungal and parasitic infections - Oseltamivir | Influenza - at-risk within 48 hours, all hospitalised; prophylaxis in outbreaks.
ID: Viral, fungal and parasitic infections
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Respiratory: Emergencies (1 mention)
- Respiratory: Infections (1 mention)
- ID: How Infection Happens (2 mentions)
- ID: Viral, fungal and parasitic infections (3 mentions)
- Integrated respiratory chapter (2 mentions)
- Microbiology: Virology - structure, replication and important viral infections (3 mentions)
Oxybutynin
BNF entry for Oxybutynin · Stand-alone drug page
Mechanism
Antimuscarinic reducing detrusor contractions.
Uses
Overactive bladder, nocturnal enuresis, hyperhidrosis.
Dosing
- … dysfunction, gynaecomastia; halves PSA (double the value when interpreting) Combination Bothersome symptoms with a large prostate Both sets Antimuscarinic (oxybutynin, solifenacin) or mirabegron Storage symptoms (overactive bladder) if persisting Antimuscarinics - dry mouth, constipation, confusion in older people …
Surgey: Urology - 2. A 78-year-old man had a hip replacement 2 days ago. He hasn't passed urine for 10 hours and has lower abdominal pain. A bladder scan shows 950 mL. He takes oxybutynin and morphine. Answer: Acute urinary retention (post-operative, drug-related, likely BPH).
Surgey: Urology - … atorvastatin, aspirin 75 mg (no history of vascular disease), omeprazole 40 mg (started 6 years ago for dyspepsia), amitriptyline 25 mg (sleep), zopiclone, oxybutynin and gliclazide (HbA1c 49). Standing BP 106/60. Answer: Problematic polypharmacy contributing to falls.
Medicine of the older adult: .Prescribing and deprescribing in older people
Side effects
Dry mouth, constipation, blurred vision, confusion, urinary retention.
Interactions
Other anticholinergics additive; acetylcholinesterase inhibitors antagonistic.
Special advice
Avoid in older people with cognitive impairment; consider mirabegron as alternative.
More from the textbook: uses, cautions and other points
- Constipation | Opioids , anticholinergics (oxybutynin, TCAs), iron, calcium, aluminium antacids, verapamil, ondansetron, clozapine (can cause fatal bowel obstruction - MHRA)
Gastroenterology: Anatomy Physiology Pharmacology - Anticholinergic burden - drugs with antimuscarinic effects (oxybutynin, TCAs, chlorphenamine, some antipsychotics) worsen confusion and are linked to dementia risk - review and deprescribe.
Neurology: Anatomy, Physiology and Pharmacology - Anticholinergics - oxybutynin, tolterodine, amitriptyline, chlorphenamine, promethazine, hyoscine, procyclidine, many others. Use an anticholinergic burden score (e.g. ACB).
Neurology: Dementia and Cognition Disorders (Complete) - Confusion and worse memory after starting oxybutynin | Anticholinergic cognitive impairment
Neurology: Dementia and Cognition Disorders (Complete) - Antimuscarinics (oxybutynin, solifenacin, tolterodine, trospium, fesoterodine) - dry mouth, constipation, blurred vision, urinary retention; confusion and possible dementia risk in older people (avoid immediate-release oxybutynin in frail older women; trospium crosses into the brain less).
Renal: Anatomy, Physiology and Pharmacology - Oxybutynin / solifenacin / mirabegron | Overactive bladder; anticholinergic confusion / raised BP (mirabegron).
Renal: Anatomy, Physiology and Pharmacology
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Dementia and Cognition Disorders (Complete) (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Palliative: Symptoms Management (2 mentions)
- Paediatrics: Kidneys, urinary tract and hormones in children (1 mention)
- Gynaecology: Pelvic floor ovary and vulva (5 mentions)
- Ophthalmology Basics Cataract Glaucoma (1 mention)
- Psychiatric emergencies (1 mention)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Surgey: Urology (5 mentions)
- Medicine of the older adult: Delirium, dementia and mood in older people (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (10 mentions)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (6 mentions)
- Integrated paediatrics chapter (1 mention)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (2 mentions)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (2 mentions)
Oxycodone
BNF entry for Oxycodone · Stand-alone drug page
Mechanism
Mu-opioid receptor agonist.
Uses
Moderate to severe pain, breakthrough pain, palliative care.
Dosing
- Pain or breathlessness | Morphine 2–5 mg SC hourly as needed (opioid-naive), or 1/6 of the 24-hour SC dose if already on opioids. eGFR under 30 - oxycodone 1–2 mg SC or alfentanil (specialist advice)
Palliative: End of Life Care - … 25–50% when switching between opioids because of incomplete cross-tolerance): From To (approximate) Oral morphine 10 mg SC morphine 5 mg Oral morphine 10 mg Oral oxycodone 5–7.5 mg (ratio 1.5–2:1) Oral morphine 10 mg SC diamorphine about 3.3 mg Oral codeine 60 mg Oral morphine about 6 mg (codeine is about one-tenth as …
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing - Oral morphine 10 mg | Oral oxycodone 5–7.5 mg (ratio 1.5–2:1)
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing - Strong opioids - oral morphine (e.g. 2.5–5 mg as needed in frail older people); oxycodone or alfentanil if eGFR is low (morphine accumulates in kidney failure); IV titration for severe pain.
Acute Medicine: The acute medical take
1 more dose entries from the chapters
- … pregnancy), weak opioid, then strong opioid (oral morphine 2.5–5 mg PRN in opioid-naïve; regular laxative; antiemetic; lower doses in renal impairment - consider oxycodone or alfentanil per local guidance).
OSCEs II: Practical procedures, prescribing and acute care stations
Side effects
Constipation, nausea, sedation, respiratory depression, dependence.
Interactions
Benzodiazepines, alcohol, CYP3A4 inhibitors (clarithromycin, ritonavir).
Special advice
Co-prescribe laxatives; safer than morphine in renal impairment; avoid abrupt withdrawal.
More from the textbook: uses, cautions and other points
- Opioids: Use cautiously at low doses; they can trigger encephalopathy (through constipation and sedation). Give laxatives. Avoid codeine, and avoid morphine in severe disease (oxycodone in low doses, or fentanyl, is used with specialist advice).
Gastroenterology: Cirrhosis and Transplantation - Morphine and codeine (active metabolites - drowsiness, myoclonus, respiratory depression) - prefer low-dose oxycodone, or fentanyl or alfentanil in advanced CKD and palliative care; tramadol with caution.
Renal: Anatomy, Physiology and Pharmacology - Switch to a safer opioid at a low dose (e.g. oxycodone with caution, or fentanyl or alfentanil with specialist advice); regular paracetamol; consider a nerve block for the hip.
Renal: Anatomy, Physiology and Pharmacology - Opioids - avoid morphine and codeine in advanced CKD (metabolites accumulate); oxycodone with caution; fentanyl, alfentanil and buprenorphine are safer.
Renal: Chronic Kidney Disease - Strong opioid for severe pain - e.g. morphine or diamorphine (IV, SC or intranasal), or oral oxycodone. Avoid pethidine .
Haematology: Haemoglobinopathies and Transfusion - Strong opioid (morphine, diamorphine, oxycodone) | Sickle pain crisis within 30 minutes; reassess every 30 minutes; avoid pethidine; laxative and antiemetic.
Haematology: Haemoglobinopathies and Transfusion
Where it is discussed
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Chronic Kidney Disease (1 mention)
- Haematology: Haemoglobinopathies and Transfusion (2 mentions)
- Palliative: Symptoms Management (6 mentions)
- Palliative: End of Life Care (5 mentions)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Surgery: Surgical principles and perioperative care (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (3 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (3 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (3 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
- Acute Medicine: The acute medical take (2 mentions)
- Anaesthesia: Airway management and anaesthetic drugs (1 mention)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (4 mentions)
- General Practice: Mental health, safeguarding, certification and the law (1 mention)
- OSCEs II: Practical procedures, prescribing and acute care stations (1 mention)
P
Pantoprazole
BNF entry for Pantoprazole · Stand-alone drug page
Mechanism
Proton pump inhibitor.
Uses
GORD, peptic ulcer, gastroprotection with NSAIDs.
Dosing
- Clopidogrel (75 mg) - prodrug activated by CYP2C19 (poor metabolisers respond less; omeprazole may reduce effect - use lansoprazole or pantoprazole); irreversible.
Cardiology: Anatomy Physiology and Pharmacology - Lansoprazole 30 mg once daily | Alternative full-dose PPI; preferred with clopidogrel (with pantoprazole). Linked to microscopic colitis.
Gastroenterology: Oesophagus and Stomach
Side effects
Headache, diarrhoea, hypomagnesaemia, B12 deficiency, fracture risk, C. difficile.
Interactions
Lower CYP2C19 inhibition so less effect on clopidogrel; reduces iron and levothyroxine absorption.
Special advice
Review long-term need; IV form available.
More from the textbook: uses, cautions and other points
- Omeprazole and esomeprazole inhibit CYP2C19 → less activation of clopidogrel (avoid the combination - use lansoprazole or pantoprazole).
Gastroenterology: Anatomy Physiology Pharmacology - Recurrent stent thrombosis in a patient on clopidogrel and omeprazole | CYP2C19 interaction - switch to lansoprazole or pantoprazole
Gastroenterology: Anatomy Physiology Pharmacology - Clopidogrel: Omeprazole and esomeprazole reduce its activation - use lansoprazole or pantoprazole instead.
Gastroenterology: Oesophagus and Stomach - Give PPI protection to high-risk NSAID or aspirin users; use lansoprazole or pantoprazole with clopidogrel.
Gastroenterology: Oesophagus and Stomach - Clopidogrel - a prodrug activated by CYP2C19 (poor metabolisers and omeprazole or esomeprazole reduce its effect - use lansoprazole or pantoprazole); used after stroke, in peripheral arterial disease and with aspirin after ACS or stents.
Haematology: Anatomy Physiology and Pharmacology - Gastroprotection - PPI for people on antiplatelets with GI risk factors (lansoprazole or pantoprazole with clopidogrel).
Haematology: Haemostasis and Thrombosis
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Oesophagus and Stomach (3 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Haemostasis and Thrombosis (1 mention)
Paracetamol
BNF entry for Paracetamol · Stand-alone drug page
Mechanism
Analgesic and antipyretic acting centrally (COX inhibition and other pathways).
Uses
Pain, fever.
Dosing
- Paracetamol - the preferred painkiller in liver disease at a reduced dose (e.g. maximum 2–3 g a day in cirrhosis, low weight, malnutrition or alcohol excess) - safer than NSAIDs or opioids.
Gastroenterology: Anatomy Physiology Pharmacology - Acetylcysteine | Paracetamol overdose - replenishes glutathione; UK nomogram line 100 mg/L at 4 hours.
Gastroenterology: Anatomy Physiology Pharmacology - Single acute ingestion: Take a paracetamol level at 4 hours or later after ingestion (levels before 4 hours cannot be interpreted). Plot it on the UK nomogram - the treatment line starts at 100 mg/L at 4 hours .
Gastroenterology: Gastroenterology Emergencies (Complete) - Stop at 12 hours if INR is 1.3 or less, ALT is normal, paracetamol is below 10 mg/L and there are no symptoms of liver injury. Otherwise continue (further bags) and discuss with NPIS and the liver unit.
Gastroenterology: Gastroenterology Emergencies (Complete)
4 more dose entries from the chapters
- Paracetamol is the preferred painkiller. Usual doses are generally safe, but use a reduced maximum (e.g. 2–3 g a day) in people who weigh under 50 kg, are malnourished, or drink heavily (check local guidance).
Gastroenterology: Cirrhosis and Transplantation - Simple painkillers - aspirin 900 mg , ibuprofen or paracetamol - taken early .
Neurology: Anatomy, Physiology and Pharmacology - Or for mild attacks: NSAID (e.g. ibuprofen 400–600 mg, aspirin 900 mg) or paracetamol 1 g.
Neurology: Headache and Facial Pain - 240 mg codeine a day ≈ 24 mg oral morphine a day: start MR morphine 10–15 mg twice daily (keep paracetamol).
Palliative: Symptoms Management
Side effects
Rare at therapeutic dose; hepatotoxicity in overdose.
Interactions
Warfarin effect may rise with regular use; flucloxacillin with paracetamol and acidosis risk.
Special advice
Dose by weight if under 50 kg or at risk of hepatotoxicity; overdose treated with acetylcysteine by protocol.
More from the textbook: uses, cautions and other points
- Drugs and the duct - prostaglandin E1 (alprostadil) keeps the duct open in duct-dependent heart lesions; NSAIDs (ibuprofen, indomethacin) or paracetamol close a PDA in preterm babies; NSAIDs late in pregnancy can close the fetal duct early.
Cardiology: Anatomy Physiology and Pharmacology - Preterm babies: Drugs that inhibit prostaglandin can close the duct - ibuprofen, indometacin or paracetamol . Surgical ligation if this fails.
Cardiology: Congenital heart disease › 6.18 Patent Ductus Arteriosus (PDA) - Paracetamol / indometacin PDA closure (preterm) | Alternatives to ibuprofen per neonatal protocol.
Cardiology: Congenital heart disease › 6.36 Drug Reference Table - Avoid NSAIDs (paracetamol is usually tolerated).
Respiratory: Airways Disease - Supportive: Cooling, paracetamol ( avoid aspirin , which displaces thyroid hormone from binding proteins), fluids, treat the trigger.
Endocrinology: Emergencies - Cooling with paracetamol (not aspirin); treat the trigger.
Endocrinology: Emergencies
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: Congenital heart disease (2 mentions)
- Respiratory: Airways Disease (1 mention)
- Endocrinology: Emergencies (2 mentions)
- Endocrinology: Thyroid disease (3 mentions)
- Endocrinology: Bone Medicine (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (9 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (16 mentions)
- Gastroenterology: Bowel Disorders (2 mentions)
- Gastroenterology: Liver disease (2 mentions)
- Gastroenterology: Cirrhosis and Transplantation (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Emergencies (1 mention)
- Neurology: Headache and Facial Pain (9 mentions)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Neurology: Dementia and Cognition Disorders (Complete) (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Tubular Inherited Stones (3 mentions)
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Haematology: Haemoglobinopathies and Transfusion (3 mentions)
- Haematology: Myeloma and Lymphoma (1 mention)
- Oncology: Emergencies (1 mention)
- Palliative: Symptoms Management (3 mentions)
- Palliative: End of Life Care (2 mentions)
- Paediatrics: Respiratory and heart problems in children (1 mention)
Phenobarbital
BNF entry for Phenobarbital · Stand-alone drug page
Mechanism
Barbiturate enhancing GABA-A activity.
Uses
Seizures (including neonatal), status epilepticus (later line), alcohol withdrawal (selected).
Dosing
- Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
Obstetrics
Side effects
Sedation, cognitive slowing, respiratory depression, rash, osteomalacia, dependence.
Interactions
Strong CYP inducer reducing levels of warfarin, contraceptives, DOACs, many drugs.
Special advice
Long half-life; levels useful; avoid abrupt withdrawal.
More from the textbook: uses, cautions and other points
- Crigler–Najjar syndrome: Severe lack of the same enzyme - high unconjugated bilirubin in infants. Type 1 risks kernicterus (phototherapy, transplant). Type 2 responds to phenobarbital.
Gastroenterology: Liver disease - … phenytoin, lacosamide, oxcarbazepine), block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate (perampanel, topiramate). Several act in more than one way.
Neurology: Anatomy, Physiology and Pharmacology - Brand consistency (MHRA categories) - keep patients on the same manufacturer for category 1 drugs ( phenytoin, carbamazepine, phenobarbital, primidone ); use clinical judgement for category 2 (valproate, lamotrigine, topiramate, oxcarbazepine, clobazam, others).
Neurology: Anatomy, Physiology and Pharmacology - Third line (refractory status, usually at about 30–60 minutes): General anaesthesia in ICU (e.g. propofol or midazolam infusion) with EEG monitoring, or phenobarbital.
Neurology: Emergencies - Prescribe by brand for some drugs (category 1 - carbamazepine, phenytoin, phenobarbital, primidone ) to avoid switching between products.
Neurology: Epilepsy - Enzyme-inducing drugs (carbamazepine, oxcarbazepine, phenytoin, phenobarbital, topiramate, eslicarbazepine) make the combined pill, progestogen-only pill and implant unreliable.
Neurology: Epilepsy
Where it is discussed
- Gastroenterology: Liver disease (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (4 mentions)
- Neurology: Emergencies (1 mention)
- Neurology: Epilepsy (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Palliative: End of Life Care (1 mention)
- Paediatrics: Neonatology (2 mentions)
- Obstetrics (1 mention)
- Gynaecology: Fertility Contraception Menopause (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (3 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (3 mentions)
- Critical care: common problems, ethics and recovery (1 mention)
- Integrated paediatrics chapter (2 mentions)
Phenytoin
BNF entry for Phenytoin · Stand-alone drug page
Mechanism
Blocks voltage-gated sodium channels.
Uses
Focal and generalised tonic-clonic seizures, status epilepticus (second line).
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Second-line status epilepticus | 15–20 mg/kg IV at ≤50 mg/min | ECG and BP monitoring needed. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
- Increased dose needs - pregnancy (increase as soon as pregnancy is confirmed - often by 25–50 micrograms - and check TFTs each trimester), oral oestrogen, enzyme inducers (rifampicin, carbamazepine, phenytoin), weight gain.
Endocrine: Anatomy Physiology and Pharmacology - Phenytoin level | About 10–20 mg/L (correct for low albumin)
Neurology: Anatomy, Physiology and Pharmacology - IV phenytoin - hypotension , arrhythmias and heart block (give no faster than 50 mg/min with ECG and blood pressure monitoring ), "purple glove" tissue damage.
Neurology: Anatomy, Physiology and Pharmacology - Status epilepticus | Benzodiazepine (IV lorazepam 4 mg or buccal midazolam 10 mg), repeat at 5–10 minutes; then levetiracetam, phenytoin or valproate; ICU
Neurology: Emergencies
4 more dose entries from the chapters
- Phenytoin IV (20 mg/kg, no faster than 50 mg/minute, with ECG and BP monitoring).
Neurology: Emergencies - Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
Obstetrics - Second line — levetiracetam (40–60 mg/kg), phenytoin (20 mg/kg) or sodium valproate (40 mg/kg) over 5–20 minutes.
Emergency Medicine: Paediatric emergency medicine - Loading dose - a larger first dose to reach the target level quickly, when waiting 4–5 half-lives would be too slow: digoxin , amiodarone , phenytoin (and levetiracetam in status), vancomycin , teicoplanin, aminophylline , warfarin (in some regimens), clopidogrel (300–600 mg in ACS), ticagrelor.
Clinical pharmacology and prescribing: Principles of clinical pharmacology
Side effects
Nystagmus, ataxia, gingival hyperplasia, hirsutism, rash, osteomalacia; IV causes hypotension and arrhythmia.
Interactions
Strong enzyme inducer; many interactions including warfarin and contraceptives; amiodarone and fluconazole raise levels.
Special advice
Non-linear kinetics; monitor levels; IV must be slow with ECG and BP monitoring; avoid extravasation.
More from the textbook: uses, cautions and other points
- Many interactions - enzyme inhibitors raise INR (amiodarone, clarithromycin, erythromycin, fluconazole, metronidazole, ciprofloxacin, alcohol binges); inducers lower it (rifampicin, carbamazepine, phenytoin, St John's wort); diet (vitamin K-rich foods).
Cardiology: Anatomy Physiology and Pharmacology - Metabolised by CYP1A2 - levels raised by ciprofloxacin , clarithromycin , erythromycin, fluvoxamine, cimetidine, heart failure, liver disease, viral infection, stopping smoking; lowered by smoking , rifampicin, carbamazepine, phenytoin, alcohol.
Respiratory: Anatomy, Physiology and Pharmacology - Interactions - CYP3A4 inhibitors (ritonavir and cobicistat, itraconazole, clarithromycin) block breakdown of inhaled or nasal fluticasone and budesonide → Cushing's syndrome and adrenal suppression; enzyme inducers (rifampicin, carbamazepine, phenytoin) reduce steroid effect - double replacement doses may be needed.
Endocrine: Anatomy Physiology and Pharmacology - Enzyme inducers (rifampicin, carbamazepine, phenytoin) increase steroid requirements.
Endocrinology: Adrenal Disease - Enzyme inducers (rifampicin, phenytoin, carbamazepine): Speed up steroid breakdown, which can precipitate crisis in treated patients. They may need higher doses.
Endocrinology: Adrenal Disease - Enzyme inducers (carbamazepine, phenytoin, rifampicin) speed up breakdown.
Endocrinology: Thyroid disease
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Adrenal Disease (2 mentions)
- Endocrinology: Thyroid disease (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Investigations (2 mentions)
- Gastroenterology: Liver disease (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (18 mentions)
- Neurology: Emergencies (5 mentions)
- Neurology: Localisation and Investigation (1 mention)
- Neurology: Epilepsy (6 mentions)
- Neurology: Movement Disorders (2 mentions)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Dialysis and Transplant (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (6 mentions)
- Haematology: History and Examination (3 mentions)
- Haematology: Anaemia (1 mention)
- Haematology: Haemostasis and Thrombosis (1 mention)
- Paediatrics: Neonatology (1 mention)
- Paediatrics: Neurology, bones and joints in children (4 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Medical Problems (1 mention)
- Gynaecology: Fertility Contraception Menopause (1 mention)
Pioglitazone
BNF entry for Pioglitazone · Stand-alone drug page
Mechanism
Thiazolidinedione PPAR-gamma agonist improving insulin sensitivity.
Uses
Type 2 diabetes.
Dosing
- Pioglitazone Type 2 | 15–30 mg daily (max 45 mg). Contraindicated in heart failure; fluid retention, fractures, bladder cancer caution.
Endocrinology: Diabetes
Side effects
Fluid retention, weight gain, fractures, heart failure, bladder cancer risk.
Interactions
Gemfibrozil raises levels; insulin increases oedema.
Special advice
Contraindicated in heart failure; stop if macular oedema or haematuria without cause.
More from the textbook: uses, cautions and other points
- Drugs — calcium channel blockers (amlodipine), NSAIDs, steroids, pioglitazone.
Cardiology: Presentations - Pioglitazone: Can cause fluid retention and aggravate heart failure.
Cardiology: Heart Failure › 2.34 🚫 Medications That Can Worsen Heart Failure - Pioglitazone | Insulin sensitiser; avoid in heart failure and bladder cancer; fractures, weight gain.
Endocrine: Anatomy Physiology and Pharmacology - Pioglitazone - avoid in heart failure and bladder cancer.
Endocrine: Anatomy Physiology and Pharmacology - Heart failure: Continue SGLT2 inhibitors for heart and kidney benefit. Avoid pioglitazone .
Endocrinology: Diabetes - Further glucose lowering: Options are a GLP-1 agonist or tirzepatide (preferred where recommended), a DPP-4 inhibitor, pioglitazone (not in heart failure), a sulfonylurea (if eGFR is above 30), or insulin. Do not combine a GLP-1 agonist or tirzepatide with a DPP-4 inhibitor (same pathway).
Endocrinology: Diabetes
Where it is discussed
- Cardiology: Presentations (1 mention)
- Cardiology: Heart Failure (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Diabetes (5 mentions)
- Gastroenterology: Liver disease (1 mention)
- Oncology: Urology and Genital cancers (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Integrated cardiology chapter (1 mention)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)
Piperacillin and tazobactam
BNF entry for Piperacillin and tazobactam · Stand-alone drug page
Mechanism
Broad-spectrum penicillin with beta-lactamase inhibitor.
Uses
Severe sepsis, hospital-acquired pneumonia, intra-abdominal infection, febrile neutropenia.
Dosing
- Piperacillin–tazobactam 4.5 g IV (NICE) - don't routinely add an aminoglycoside unless there is shock or local policy says so.
Oncology: Emergencies - Piperacillin–tazobactam 4.5 g IV | Neutropenic sepsis within 1 hour; add glycopeptide for line infection.
Oncology: Emergencies
Side effects
Diarrhoea, rash, nausea, C. difficile, neutropenia with prolonged use.
Interactions
Methotrexate levels rise; aminoglycosides inactivated if mixed; warfarin.
Special advice
Penicillin allergy contraindication; adjust in renal impairment; extended infusion in some protocols.
More from the textbook: uses, cautions and other points
- Severe or higher risk of resistance (e.g. recent antibiotics, ICU, known resistant organisms): IV piperacillin-tazobactam , a cephalosporin or meropenem, guided by local microbiology.
Respiratory: Emergencies - IV antibiotics per local policy - e.g. a third-generation cephalosporin or piperacillin-tazobactam (wider cover if hospital-acquired).
Gastroenterology: Gastroenterology Emergencies (Complete) - IV antibiotics per local policy (e.g. piperacillin-tazobactam).
Gastroenterology: Gastroenterology Emergencies (Complete) - Acute tubular necrosis | Aminoglycosides (gentamicin), vancomycin (especially with piperacillin–tazobactam), amphotericin , cisplatin , iodinated contrast , IV bisphosphonates (zoledronic acid), colistin, high-dose methotrexate, rhabdomyolysis (statins with fibrates or macrolides, cocaine, prolonged lie)
Renal: Anatomy, Physiology and Pharmacology - Neutropenic sepsis - temperature over 38°C or signs of sepsis with neutrophils 0.5 × 10⁹/L or less (usually after chemotherapy) - IV broad-spectrum antibiotics within 1 hour (e.g. piperacillin–tazobactam) without waiting for the count if chemotherapy is recent (NICE).
Haematology: Anatomy Physiology and Pharmacology - IV piperacillin–tazobactam within 1 hour; consider G-CSF.
Haematology: Emergencies
Where it is discussed
- Respiratory: Emergencies (1 mention)
- Gastroenterology: Gastroenterology Emergencies (Complete) (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Emergencies (1 mention)
- Oncology: Emergencies (5 mentions)
- Obstetrics: Obstetrics: Emergencies (2 mentions)
- ENT: Emergencies (2 mentions)
- ID: How Infection Happens (7 mentions)
- ID: Sepsis, fever and serious bacterial infections (4 mentions)
- ID: Viral, fungal and parasitic infections (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (6 mentions)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (2 mentions)
- Surgery: Upper GI, hepatobiliary and bariatric surgery (2 mentions)
- Surgery: Acute abdomen and emergency general surgery (1 mention)
- Surgey: Urology (2 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (4 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (6 mentions)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (4 mentions)
- Integrated respiratory chapter (1 mention)
- Microbiology: Bacteriology - structure, classification and important pathogens (1 mention)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (2 mentions)
Prednisolone
BNF entry for Prednisolone · Stand-alone drug page
Mechanism
Glucocorticoid with anti-inflammatory and immunosuppressive effects.
Uses
Asthma and COPD exacerbation, giant cell arteritis, polymyalgia, inflammatory bowel disease, vasculitis, nephrotic syndrome.
Dosing
- Treatment: Corticosteroids (e.g. prednisolone 30–40 mg daily, tapered) for active disease, with methotrexate as a steroid-sparing agent and anti-TNF therapy for refractory cases.
Cardiology: Cardiomyopathies › 3.30 Cardiac Sarcoidosis - Methylprednisolone | Checkpoint-inhibitor or severe immune myocarditis (specialist): 500–1000 mg IV daily for 3–5 days, then oral prednisolone taper.
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses - Acute asthma - prednisolone 40–50 mg once daily for at least 5 days (IV hydrocortisone if unable to swallow); no need to taper short courses.
Respiratory: Anatomy, Physiology and Pharmacology - COPD exacerbation - prednisolone 30 mg daily for 5 days (NICE NG115).
Respiratory: Anatomy, Physiology and Pharmacology
4 more dose entries from the chapters
- Prednisolone | Asthma attack: 40–50 mg for at least 5 days. COPD exacerbation: 30 mg for 5 days. ABPA: tapering course.
Respiratory: Airways Disease - Acute severe asthma | Oxygen to 94–98%; salbutamol 5 mg and ipratropium 0.5 mg nebulised (oxygen-driven); prednisolone 40–50 mg
Respiratory: Emergencies - COPD with hypercapnic acidosis | Controlled oxygen to 88–92%; nebulisers; prednisolone 30 mg; NIV if pH below 7.35 and PaCO2 above 6.5 kPa persist
Respiratory: Emergencies - First line: Oral prednisolone (e.g. 20–40 mg daily for pulmonary disease), tapered to the lowest effective dose over 6–12 months or more. Give bone protection.
Respiratory: Interstitial Lung Disease
Side effects
Hyperglycaemia, insomnia, mood change, weight gain, osteoporosis, adrenal suppression, infection, gastric irritation.
Interactions
NSAIDs raise GI bleed risk; enzyme inducers reduce effect; warfarin and antidiabetic drug effects change.
Special advice
Steroid card and sick-day rules when long term; bone protection with prolonged courses; taper if more than 3 weeks.
More from the textbook: uses, cautions and other points
- Severe eosinophilic asthma on maintenance prednisolone | Refer for biologic (e.g. mepolizumab, benralizumab)
Respiratory: Anatomy, Physiology and Pharmacology - Self-management plan and a "rescue pack" (prednisolone and antibiotics) for those who can use it safely.
Respiratory: Airways Disease - Oral prednisolone (tapering course).
Respiratory: Airways Disease - Prednisolone to complete at least 5 days, plus inhaled steroid.
Respiratory: Emergencies - CNS TB (meningitis): 12 months of treatment, plus dexamethasone (or prednisolone) at the start.
Respiratory: Infections - Add prednisolone if hypoxic (e.g. PaO2 below 9.3 kPa on air) - this reduces mortality in HIV.
Respiratory: Infections
Where it is discussed
- Cardiology: Cardiomyopathies (2 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (5 mentions)
- Respiratory: Airways Disease (4 mentions)
- Respiratory: Emergencies (8 mentions)
- Respiratory: Infections (4 mentions)
- Respiratory: Interstitial Lung Disease (7 mentions)
- Respiratory: Lung Cancer (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (6 mentions)
- Endocrinology: Diabetes (2 mentions)
- Endocrinology: Emergencies (1 mention)
- Endocrinology: Adrenal Disease (12 mentions)
- Endocrinology: Thyroid disease (5 mentions)
- Endocrinology: Bone Medicine (7 mentions)
- Endocrinology: NETS and Hypoglycaemia (2 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (4 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Inflammatory Bowel Disease (7 mentions)
- Gastroenterology: Pancreas and Biliary (2 mentions)
- Gastroenterology: Liver disease (4 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (5 mentions)
- Neurology: Emergencies (4 mentions)
- Neurology: Headache and Facial Pain (2 mentions)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Neurology: Neuromuscular disease (10 mentions)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
Pregabalin
BNF entry for Pregabalin · Stand-alone drug page
Mechanism
Binds alpha-2-delta subunit of calcium channels.
Uses
Neuropathic pain, focal seizures adjunct, generalised anxiety.
Dosing
- Amitriptyline / duloxetine / pregabalin / gabapentin Painful neuropathy | E.g. amitriptyline 10 mg at night, titrated; duloxetine 60 mg daily; pregabalin 75 mg twice daily, titrated. Adjust for renal function and frailty.
Endocrinology: Diabetes
Side effects
Drowsiness, dizziness, weight gain, oedema, blurred vision; misuse potential; respiratory depression with opioids.
Interactions
Opioids and CNS depressants; ACE inhibitors may increase angioedema.
Special advice
Controlled drug in the UK; reduce in renal impairment; taper on stopping.
More from the textbook: uses, cautions and other points
- Ankle swelling - both legs (heart failure, nephrotic syndrome, liver disease, drugs - amlodipine and other calcium channel blockers, NSAIDs, steroids, pregabalin) versus one leg (DVT, cellulitis, Baker's cyst, venous obstruction). Ask about weight gain (fluid), abdominal swelling (ascites), and swelling of the sacrum in …
Cardiology: History and Examination - Respiratory depressants - opioids , benzodiazepines , Z-drugs, gabapentin and pregabalin , alcohol, barbiturates, anaesthetic agents. Combinations are especially dangerous (MHRA warnings on opioids with benzodiazepines or gabapentinoids). Highest risk - COPD, sleep apnoea, obesity hypoventilation, neuromuscular disease, older …
Respiratory: Anatomy, Physiology and Pharmacology - Offer amitriptyline, duloxetine, gabapentin or pregabalin ; switch to another if one is ineffective or not tolerated.
Endocrinology: Diabetes - The action potential reaches the nerve ending → voltage-gated calcium channels open (target of gabapentin and pregabalin , and of antibodies in Lambert–Eaton syndrome) → calcium enters.
Neurology: Anatomy, Physiology and Pharmacology - Neuropathic - nerve damage: burning, shooting, electric shock-like , pins and needles, allodynia (pain from light touch) - responds poorly to standard painkillers; use amitriptyline, duloxetine, gabapentin or pregabalin.
Neurology: Anatomy, Physiology and Pharmacology - Myoclonic | Levetiracetam or valproate (males). Avoid carbamazepine, oxcarbazepine, phenytoin, gabapentin, pregabalin, vigabatrin (they can worsen it)
Neurology: Epilepsy
Where it is discussed
- Cardiology: History and Examination (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Endocrinology: Diabetes (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (7 mentions)
- Neurology: Epilepsy (2 mentions)
- Neurology: Headache and Facial Pain (1 mention)
- Neurology: Movement Disorders (3 mentions)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Neurology: Neuromuscular disease (4 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Emergencies (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Palliative: Symptoms Management (2 mentions)
- Dermatology: Skin infections and infestations (2 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (2 mentions)
- ID: Viral, fungal and parasitic infections (1 mention)
- Psychiatric emergencies (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (2 mentions)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (3 mentions)
Primidone
BNF entry for Primidone · Stand-alone drug page
Mechanism
Metabolised to phenobarbital and PEMA; anticonvulsant.
Uses
Seizures, essential tremor.
Dosing
- Primidone (start very low - 25 mg at night; sedation).
Neurology: Movement Disorders - Propranolol / primidone | Essential tremor; start primidone at 25 mg at night.
Neurology: Movement Disorders
Side effects
Sedation, ataxia, nausea, rash, megaloblastic anaemia.
Interactions
Strong enzyme inducer through phenobarbital.
Special advice
Start at low dose to avoid initial sedation; folate supplementation.
More from the textbook: uses, cautions and other points
- Brand consistency (MHRA categories) - keep patients on the same manufacturer for category 1 drugs ( phenytoin, carbamazepine, phenobarbital, primidone ); use clinical judgement for category 2 (valproate, lamotrigine, topiramate, oxcarbazepine, clobazam, others).
Neurology: Anatomy, Physiology and Pharmacology - Essential tremor - propranolol or primidone (sedation; enzyme inducer); topiramate or gabapentin second-line; deep brain stimulation or focused ultrasound.
Neurology: Anatomy, Physiology and Pharmacology - Prescribe by brand for some drugs (category 1 - carbamazepine, phenytoin, phenobarbital, primidone ) to avoid switching between products.
Neurology: Epilepsy - Propranolol or primidone if it affects function.
Neurology: Movement Disorders - Essential tremor: bilateral postural tremor, family history, better with alcohol - propranolol or primidone.
Neurology: Movement Disorders - Essential tremor - bilateral postural and action tremor of the hands (and head, voice), family history, improves with alcohol; propranolol or primidone.
Clinical Examination III: Neurological, eye, ENT and musculoskeletal
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Epilepsy (1 mention)
- Neurology: Movement Disorders (4 mentions)
- Clinical Examination III: Neurological, eye, ENT and musculoskeletal (1 mention)
Propranolol
BNF entry for Propranolol · Stand-alone drug page
Mechanism
Non-selective beta blocker.
Uses
Hypertension, angina, migraine prophylaxis, essential tremor, anxiety (somatic), thyrotoxicosis, variceal prophylaxis.
Dosing
- Block the adrenergic effects: Propranolol (e.g. 60–80 mg orally 4-hourly, or IV in small increments). Also reduces T4-to-T3 conversion. Use caution, or short-acting esmolol, in heart failure.
Endocrinology: Thyroid disease - Propranolol Thyrotoxic symptoms | 10–40 mg three to four times daily. Storm: e.g. 60–80 mg orally 4-hourly. Avoid in asthma (use a cardioselective beta blocker or diltiazem).
Endocrinology: Thyroid disease - Propranolol 40 mg twice daily, titrated | Alternative non-selective beta-blocker; target heart rate 55–60.
Gastroenterology: Cirrhosis and Transplantation - Propranolol 80–160 mg daily (modified-release). Avoid in asthma.
Neurology: Headache and Facial Pain
3 more dose entries from the chapters
- Propranolol 80–160 mg daily | Migraine prevention; avoid in asthma.
Neurology: Headache and Facial Pain - Propranolol (e.g. 40–160 mg daily, or as needed before events).
Neurology: Movement Disorders - Propranolol / primidone | Essential tremor; start primidone at 25 mg at night.
Neurology: Movement Disorders
Side effects
Bradycardia, fatigue, bronchospasm, cold extremities, sleep disturbance.
Interactions
Verapamil and diltiazem; insulin masks hypoglycaemia; clonidine rebound.
Special advice
Avoid in asthma and heart block; do not stop abruptly.
More from the textbook: uses, cautions and other points
- Beta-2 | Bronchi and blood vessels (muscle) - dilatation; some heart effect | Agonist: salbutamol. Non-selective blockers (propranolol) cause bronchospasm
Cardiology: Anatomy Physiology and Pharmacology - Non-selective - propranolol (also used for thyrotoxicosis, migraine, varices, anxiety), sotalol (also class III), carvedilol (also alpha-blocking), labetalol (pregnancy hypertension).
Cardiology: Anatomy Physiology and Pharmacology - Beta-blocker (e.g. propranolol), amiodarone .
Cardiology: Cardiology Emergencies - Bradycardia, hypotension, hypoglycaemia, seizures (propranolol).
Cardiology: Cardiology Emergencies - Avoid non-selective beta blockers (e.g. propranolol) because unopposed alpha-receptor activity can worsen spasm.
Cardiology: Ischaemic Heart Disease (ACS) › 1.10 Vasospastic Angina - Management: Stop QT-prolonging drugs, replace electrolytes, specialist beta-blocker therapy (often nadolol/propranolol in congenital disease), exercise/trigger advice and ICD in selected high-risk patients.
Cardiology: Cardiac Arrhythmias › 5.32 Long QT Syndrome
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Cardiology Emergencies (2 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Cardiology: Cardiac Arrhythmias (1 mention)
- Cardiology: Cardiomyopathies (1 mention)
- Cardiology: Congenital heart disease (3 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: Emergencies (4 mentions)
- Endocrinology: Adrenal Disease (2 mentions)
- Endocrinology: Thyroid disease (5 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (5 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Cirrhosis and Transplantation (3 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Headache and Facial Pain (5 mentions)
- Neurology: Movement Disorders (5 mentions)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Paediatrics: Respiratory and heart problems in children (3 mentions)
- Paediatrics: Neurology, bones and joints in children (2 mentions)
- Obstetrics: Medical Problems (1 mention)
- Dermatology: Skin lesions and skin cancer (4 mentions)
- ENT: Common Ear disorders (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (2 mentions)
- Psychiatry: Psychosis and schizophrenia (2 mentions)
Propylthiouracil
BNF entry for Propylthiouracil · Stand-alone drug page
Mechanism
Inhibits thyroid peroxidase and peripheral T4 to T3 conversion.
Uses
Hyperthyroidism, thyroid storm, first trimester of pregnancy.
Dosing
- Propylthiouracil First trimester / thyroid storm | 200–400 mg daily in divided doses, then a lower maintenance dose. Storm: e.g. 500–1000 mg loading, then 250 mg 4-hourly. Risk of severe hepatotoxicity.
Endocrinology: Thyroid disease
Side effects
Rash, agranulocytosis, severe hepatotoxicity.
Interactions
Warfarin effect reduces as thyroid function normalises.
Special advice
Report sore throat or fever; monitor LFT; carbimazole preferred except in specific settings.
More from the textbook: uses, cautions and other points
- Thyroid peroxidase (TPO) attaches iodine to tyrosines on thyroglobulin and couples them into T4 and T3 (the step blocked by carbimazole and propylthiouracil ; TPO antibodies mark autoimmune thyroid disease).
Endocrine: Anatomy Physiology and Pharmacology - 3. A 32-year-old woman with Graves' disease on carbimazole finds out she is 6 weeks pregnant. Answer: Switch from carbimazole to propylthiouracil for the first trimester.
Endocrine: Anatomy Physiology and Pharmacology - Thyroid storm | Propranolol; propylthiouracil; iodine 1 hour later; hydrocortisone; cooling; ICU
Endocrinology: Emergencies - Thionamide: Propylthiouracil preferred, or high-dose carbimazole, to block new hormone synthesis.
Endocrinology: Emergencies - How they work: Thionamides - carbimazole and propylthiouracil (PTU) - block TPO and so stop new hormone synthesis. Stored hormone is still released, so it takes 4–6 weeks to see an effect. PTU also reduces conversion of T4 to T3.
Endocrinology: Thyroid disease - Glomerular disease | NSAIDs (minimal change, membranous), penicillamine and gold (membranous), hydralazine and propylthiouracil (ANCA vasculitis), pamidronate (FSGS), VEGF inhibitors such as bevacizumab (proteinuria, hypertension)
Renal: Anatomy, Physiology and Pharmacology
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Emergencies (5 mentions)
- Endocrinology: Thyroid disease (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Glomerular Disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Emergencies (1 mention)
- Obstetrics (3 mentions)
- Obstetrics: Medical Problems (3 mentions)
- Rheumatology: assessment, investigations and drugs (1 mention)
- Rheumatology: Vasculitis, GCA and PMR (2 mentions)
- Surgey: Breast and endocrine surgery (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Acute Medicine: Electrolytes, acid–base, AKI and metabolic emergencies (1 mention)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (1 mention)
- Clinical Immunology: Autoimmunity, autoantibodies and complement (4 mentions)
- Physiology: Endocrine control, metabolism and thermoregulation (1 mention)
Q
Quetiapine
BNF entry for Quetiapine · Stand-alone drug page
Mechanism
Atypical antipsychotic with antihistamine and alpha-1 blocking effects.
Uses
Schizophrenia, bipolar depression and mania, adjunct for depression.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Sedation, postural hypotension, weight gain, dry mouth, metabolic effects, QT prolongation.
Interactions
CYP3A4 inhibitors raise levels; QT-prolonging drugs; antihypertensives.
Special advice
Monitor weight, glucose and lipids; avoid in dementia unless risk assessed.
More from the textbook: uses, cautions and other points
- Non-motor symptoms - Parkinson's psychosis (reduce drugs in reverse order of benefit; quetiapine or clozapine - clozapine needs blood monitoring); dementia ( rivastigmine ); depression; constipation; postural hypotension (fludrocortisone, midodrine); drooling (glycopyrronium).
Neurology: Anatomy, Physiology and Pharmacology - If treatment is needed: quetiapine (off-label, low dose) or clozapine (with blood monitoring).
Neurology: Movement Disorders - Antipsychotics: Haloperidol, risperidone - use low-dose quetiapine if needed, or lorazepam for acute agitation.
Neurology: Movement Disorders - Avoid antipsychotics where possible - they can cause severe rigidity, falls, confusion, NMS-like reactions and death. If essential for severe distress, use low-dose quetiapine or clozapine with specialist advice. Never haloperidol .
Neurology: Dementia and Cognition Disorders (Complete) - Quetiapine / clozapine | Severe psychosis in DLB or PDD (specialist, low dose).
Neurology: Dementia and Cognition Disorders (Complete) - Antipsychotics | Sedation, hypotension, QT prolongation and arrhythmias, dystonia, seizures, anticholinergic effects (quetiapine, olanzapine).
Psychiatric emergencies
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Movement Disorders (6 mentions)
- Neurology: Dementia and Cognition Disorders (Complete) (3 mentions)
- Psychiatric emergencies (1 mention)
- Psychiatry: Mood disorders (7 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Psychiatry: Psychosis and schizophrenia (7 mentions)
- Medicine of the older adult: Delirium, dementia and mood in older people (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
R
Ramipril
BNF entry for Ramipril · Stand-alone drug page
Mechanism
ACE inhibitor prodrug (ramiprilat).
Uses
Hypertension, heart failure, post-MI, cardiovascular prevention, diabetic nephropathy.
Dosing
- 5. A 70-year-old woman with HFrEF on ramipril, bisoprolol and spironolactone has potassium 6.2 mmol/L and creatinine up 40% from baseline after a diarrhoeal illness. Answer: Hyperkalaemia and AKI from RAAS blockade during dehydrating illness.
Cardiology: Presentations - Dose: Ramipril 2.5 mg twice daily once stable, titrated to 5 mg twice daily.
Cardiology: Ischaemic Heart Disease (ACS) › 1.31 Secondary Prevention - Ramipril | Post-MI: 2.5 mg twice daily once stable, titrated to 5 mg twice daily.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - Ramipril | Hypertension or HFrEF: 1.25–2.5 mg daily initially, titrated to 5 mg twice daily; check BP, potassium and creatinine.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table
4 more dose entries from the chapters
- Ramipril | Start 1.25–2.5 mg daily in suitable patients, with lower doses for vulnerability. Titrate towards an evidence-based target such as 5 mg twice daily.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Ramipril | HFrEF: 1.25–2.5 mg daily, titrated to 10 mg daily (or 5 mg twice daily).
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses - 1. A 72-year-old man with AF on apixaban 5 mg twice daily (creatinine clearance 55 mL/min) is listed for an elective total hip replacement under spinal anaesthesia. He also takes ramipril and gliclazide. Answer: Peri-operative medicines plan.
Surgery: Surgical principles and perioperative care - 1. An 86-year-old woman (CFS 6) is admitted after a fall. She takes: amlodipine 10 mg, ramipril 10 mg, indapamide, doxazosin, atorvastatin, aspirin 75 mg (no history of vascular disease), omeprazole 40 mg (started 6 years ago for dyspepsia), amitriptyline 25 mg (sleep), zopiclone, oxybutynin and gliclazide (HbA1c 49). Standing …
Medicine of the older adult: .Prescribing and deprescribing in older people
Side effects
Dry cough, hypotension, hyperkalaemia, renal impairment, angioedema.
Interactions
NSAIDs, potassium-sparing diuretics, ARBs, lithium.
Special advice
Check U&E 1–2 weeks after starting; stop in pregnancy or angioedema.
More from the textbook: uses, cautions and other points
- Ramipril | ACE inhibitor; cough, angioedema, hyperkalaemia; check U&E; not in pregnancy.
Cardiology: Anatomy Physiology and Pharmacology - Dry cough on ramipril | Switch to an ARB (e.g. candesartan)
Cardiology: Anatomy Physiology and Pharmacology - Withhold spironolactone and ramipril (and diuretics) temporarily; review drug interactions.
Cardiology: Presentations - Common drugs : Ramipril. Enalapril. Lisinopril. Candesartan, an ARB alternative.
Cardiology: Heart Failure › 2.18 💊 ACE Inhibitors and ARBs - Step 3: A + C + D at optimal tolerated doses. Common options are ramipril, amlodipine and indapamide; monitor renal function, sodium and potassium.
Cardiology: Hypertension, Blood Pressure and Prevention › 7.06 Stepwise Drug Treatment for Hypertension - Night cough on ramipril with a normal chest X-ray | ACE inhibitor cough - stop the drug first
Respiratory: Investigations
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (4 mentions)
- Cardiology: Presentations (2 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (2 mentions)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Heart Failure (2 mentions)
- Cardiology: Hypertension, Blood Pressure and Prevention (1 mention)
- Cardiology: Cardiomyopathies (1 mention)
- Respiratory: Investigations (1 mention)
- Respiratory: Emergencies (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (9 mentions)
- Renal: Emergencies (3 mentions)
- Renal: Chronic Kidney Disease (5 mentions)
- Renal: Tubular Inherited Stones (1 mention)
- Obstetrics (2 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (3 mentions)
- ENT: Emergencies (1 mention)
- ID: How Infection Happens (1 mention)
- Psychiatric emergencies (1 mention)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Surgery: Vascular surgery (1 mention)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (3 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (3 mentions)
Rifampicin
BNF entry for Rifampicin · Stand-alone drug page
Mechanism
Inhibits bacterial DNA-dependent RNA polymerase.
Uses
Tuberculosis, meningococcal prophylaxis, staphylococcal infection (combination), brucellosis.
Dosing
- Increased dose needs - pregnancy (increase as soon as pregnancy is confirmed - often by 25–50 micrograms - and check TFTs each trimester), oral oestrogen, enzyme inducers (rifampicin, carbamazepine, phenytoin), weight gain.
Endocrine: Anatomy Physiology and Pharmacology - Hospital - ABC, blood cultures, then IV ceftriaxone 2 g every 12 hours within 1 hour; add IV amoxicillin 2 g every 4 hours if Listeria is possible (over 60, immunosuppressed, pregnant, alcohol excess); add vancomycin (± rifampicin) if penicillin-resistant pneumococcus is possible (recent travel to areas of high resistance).
ID: Sepsis, fever and serious bacterial infections
Side effects
Orange body fluids, hepatotoxicity, rash, flu-like syndrome, thrombocytopenia.
Interactions
Potent CYP inducer: reduces warfarin, DOACs, contraceptives, steroids, methadone, many others.
Special advice
Monitor LFT; warn about contact-lens staining; review all interacting drugs.
More from the textbook: uses, cautions and other points
- Many interactions - enzyme inhibitors raise INR (amiodarone, clarithromycin, erythromycin, fluconazole, metronidazole, ciprofloxacin, alcohol binges); inducers lower it (rifampicin, carbamazepine, phenytoin, St John's wort); diet (vitamin K-rich foods).
Cardiology: Anatomy Physiology and Pharmacology - Metabolised by CYP1A2 - levels raised by ciprofloxacin , clarithromycin , erythromycin, fluvoxamine, cimetidine, heart failure, liver disease, viral infection, stopping smoking; lowered by smoking , rifampicin, carbamazepine, phenytoin, alcohol.
Respiratory: Anatomy, Physiology and Pharmacology - Monitoring - LFTs (raised transaminases), eye checks in children (cataracts), mood; many CYP3A4 interactions (e.g. rifampicin, clarithromycin, azole antifungals).
Respiratory: Anatomy, Physiology and Pharmacology - Rapid molecular test (NAAT) - e.g. GeneXpert - detects TB DNA and rifampicin resistance within hours.
Respiratory: Infections - Continuation phase - 4 months of rifampicin and isoniazid.
Respiratory: Infections - Interactions - CYP3A4 inhibitors (ritonavir and cobicistat, itraconazole, clarithromycin) block breakdown of inhaled or nasal fluticasone and budesonide → Cushing's syndrome and adrenal suppression; enzyme inducers (rifampicin, carbamazepine, phenytoin) reduce steroid effect - double replacement doses may be needed.
Endocrine: Anatomy Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (7 mentions)
- Respiratory: Infections (17 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (3 mentions)
- Endocrinology: Adrenal Disease (2 mentions)
- Endocrinology: Thyroid disease (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Liver disease (3 mentions)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (5 mentions)
- Renal: Emergencies (1 mention)
- Renal: Dialysis and Transplant (3 mentions)
- Haematology: Anatomy Physiology and Pharmacology (4 mentions)
- Haematology: Haemostasis and Thrombosis (1 mention)
- Palliative: Symptoms Management (1 mention)
- Paediatrics: Kidneys, urinary tract and hormones in children (1 mention)
- Paediatrics: Infections in children (3 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- Rheumatology: assessment, investigations and drugs (2 mentions)
- ENT: Emergencies (1 mention)
- ID: How Infection Happens (6 mentions)
- ID: Sepsis, fever and serious bacterial infections (3 mentions)
- ID: HIV, viral hepatitis and blood-borne viruses (3 mentions)
- ID: Tropical and travel medicine (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (4 mentions)
Risperidone
BNF entry for Risperidone · Stand-alone drug page
Mechanism
Atypical antipsychotic with D2 and 5-HT2A antagonism.
Uses
Schizophrenia, bipolar mania, behavioural symptoms in dementia (short term).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Extrapyramidal symptoms, hyperprolactinaemia, weight gain, postural hypotension, QT prolongation.
Interactions
CYP2D6 inhibitors (fluoxetine, paroxetine) raise levels; QT-prolonging drugs.
Special advice
Increased stroke risk in dementia; monitor prolactin and metabolic parameters.
More from the textbook: uses, cautions and other points
- Antipsychotics - especially risperidone, amisulpride and haloperidol.
Endocrinology: Pituitary Disease - Raised prolactin in a patient on risperidone | Drug-induced hyperprolactinaemia
Endocrinology: Pituitary Disease - Antipsychotics increase the risk of stroke and death in dementia - use only for severe distress or risk, at the lowest dose, for the shortest time (e.g. risperidone, reviewed within 6 weeks).
Neurology: Anatomy, Physiology and Pharmacology - Avoid typical antipsychotics (haloperidol) and risperidone - they worsen parkinsonism.
Neurology: Movement Disorders - Antipsychotics: Haloperidol, risperidone - use low-dose quetiapine if needed, or lorazepam for acute agitation.
Neurology: Movement Disorders - Risperidone is licensed for up to 6 weeks for persistent aggression in Alzheimer's disease that causes risk of harm.
Neurology: Dementia and Cognition Disorders (Complete)
Where it is discussed
- Endocrinology: Pituitary Disease (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Movement Disorders (6 mentions)
- Neurology: Dementia and Cognition Disorders (Complete) (4 mentions)
- Gynaecology: Menstrual Disorders (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (3 mentions)
- Psychiatry: Safeguarding (2 mentions)
- Psychiatry: Mood disorders (3 mentions)
- Psychiatry: Psychosis and schizophrenia (9 mentions)
- Surgey: Breast and endocrine surgery (1 mention)
- Medicine of the older adult: Delirium, dementia and mood in older people (4 mentions)
- Physiology: Endocrine control, metabolism and thermoregulation (1 mention)
Rivaroxaban
BNF entry for Rivaroxaban · Stand-alone drug page
Mechanism
Direct factor Xa inhibitor.
Uses
Stroke prevention in non-valvular AF, VTE treatment and prophylaxis, secondary prevention in coronary and peripheral artery disease.
Dosing
- Rivaroxaban AF stroke prevention | Usually 20 mg orally daily with food; 15 mg daily with food in relevant renal impairment by CrCl.
Cardiology: Cardiac Arrhythmias › 5.42 Two-Column Drug and Dose Table - Rivaroxaban 15 mg twice daily for 21 days, then 20 mg once daily.
Respiratory: Emergencies - Rivaroxaban PE | 15 mg twice daily for 21 days, then 20 mg once daily with food.
Respiratory: Emergencies - Rivaroxaban VTE treatment | 15 mg twice daily for 21 days, then 20 mg daily with food; 10 mg daily option for extended prevention.
Respiratory: Pulmonary Vascular Disease
4 more dose entries from the chapters
- Factor Xa inhibitors - apixaban (twice daily), rivaroxaban (once daily for AF - with food at 15 mg and 20 mg doses), edoxaban (once daily).
Haematology: Anatomy Physiology and Pharmacology - Rivaroxaban 15 mg twice daily for 21 days, then 20 mg once daily (with food).
Haematology: Haemostasis and Thrombosis - Rivaroxaban (Xa inhibitor) | AF: 20 mg once daily with food (15 mg if CrCl 15–49). VTE: 15 mg twice daily for 21 days, then 20 mg daily
Haematology: Haemostasis and Thrombosis - Statin (atorvastatin 80 mg) and antiplatelet ( clopidogrel 75 mg is first choice); in selected patients, low-dose rivaroxaban 2.5 mg twice daily with aspirin (COMPASS regimen).
Surgery: Vascular surgery
Side effects
Bleeding, anaemia, nausea, abnormal LFT.
Interactions
Strong CYP3A4 and P-gp inhibitors or inducers; avoid other anticoagulants.
Special advice
Take with food for 15 and 20 mg doses; reduce or avoid in renal impairment; andexanet alfa reversal.
More from the textbook: uses, cautions and other points
- Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
Cardiology: Anatomy Physiology and Pharmacology - Factor Xa inhibitors - apixaban (twice daily), rivaroxaban (once daily with food in AF), edoxaban (once daily).
Cardiology: Anatomy Physiology and Pharmacology - Lifelong warfarin (VKA) . DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) must never be used - they caused excess valve thrombosis and stroke in trials.
Cardiology: Valvular heart disease › 4.34 Anticoagulation and Valves - First line (NICE NG158) for confirmed proximal DVT or PE — apixaban or rivaroxaban (no LMWH lead-in needed).
Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease - First-line treatment | Apixaban or rivaroxaban
Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease - Most patients: A DOAC - apixaban or rivaroxaban (no heparin lead-in needed), or LMWH then dabigatran or edoxaban.
Respiratory: Pulmonary Vascular Disease
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Cardiac Arrhythmias (1 mention)
- Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease (4 mentions)
- Respiratory: Emergencies (2 mentions)
- Respiratory: Pulmonary Vascular Disease (2 mentions)
- Respiratory: Sleep and Breathing (Complete) (1 mention)
- Gastroenterology: Gastroenterology Emergencies (Complete) (4 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Stroke Emergencies (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (3 mentions)
- Haematology: Emergencies (1 mention)
- Haematology: Haemostasis and Thrombosis (8 mentions)
- Oncology: Emergencies (2 mentions)
- Rheumatology: Connective tissue diseases (1 mention)
- Surgery: Surgical principles and perioperative care (3 mentions)
- Surgery: Vascular surgery (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (2 mentions)
- Acute Medicine: Acute chest pain, breathlessness, collapse and blood gases (1 mention)
- Acute Medicine: The acute medical take (3 mentions)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Integrated cardiology chapter (4 mentions)
- Integrated respiratory chapter (4 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)
Rivastigmine
BNF entry for Rivastigmine · Stand-alone drug page
Mechanism
Acetylcholinesterase and butyrylcholinesterase inhibitor.
Uses
Alzheimer and Parkinson disease dementia.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, vomiting, weight loss, bradycardia, skin reaction with patch.
Interactions
Anticholinergics antagonistic; beta-blockers bradycardia.
Special advice
Rotate patch site and remove old patch; do not use if previous severe skin reaction; monitor weight.
More from the textbook: uses, cautions and other points
- Non-motor symptoms - Parkinson's psychosis (reduce drugs in reverse order of benefit; quetiapine or clozapine - clozapine needs blood monitoring); dementia ( rivastigmine ); depression; constipation; postural hypotension (fludrocortisone, midodrine); drooling (glycopyrronium).
Neurology: Anatomy, Physiology and Pharmacology - Donepezil / rivastigmine | Alzheimer's, Lewy body and Parkinson's dementia; bradycardia, syncope, GI effects.
Neurology: Anatomy, Physiology and Pharmacology - Rivastigmine or another cholinesterase inhibitor.
Neurology: Movement Disorders - Rivastigmine | PD dementia and DLB.
Neurology: Movement Disorders - Rivastigmine (capsules or patch - useful if swallowing is difficult).
Neurology: Dementia and Cognition Disorders (Complete) - AChEIs - donepezil or rivastigmine (NICE) - often help cognition, fluctuations and hallucinations. Galantamine if these aren't tolerated; memantine if AChEIs are unsuitable.
Neurology: Dementia and Cognition Disorders (Complete)
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Movement Disorders (2 mentions)
- Neurology: Dementia and Cognition Disorders (Complete) (6 mentions)
- Medicine of the older adult: Delirium, dementia and mood in older people (2 mentions)
Rosuvastatin
BNF entry for Rosuvastatin · Stand-alone drug page
Mechanism
HMG-CoA reductase inhibitor.
Uses
Hypercholesterolaemia, cardiovascular prevention.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Myalgia, raised ALT, proteinuria at high dose, new-onset diabetes.
Interactions
Ciclosporin, gemfibrozil raise levels; warfarin effect increased.
Special advice
Lower dose in Asian patients and renal impairment; check CK if muscle symptoms.
More from the textbook: uses, cautions and other points
- Try a lower dose, a different statin (e.g. rosuvastatin), or alternate-day dosing.
Endocrinology: Lipids and obesity - Simvastatin - contraindicated (rhabdomyolysis); use low-dose atorvastatin, rosuvastatin or pravastatin with advice.
ID: HIV, viral hepatitis and blood-borne viruses - Stop simvastatin (check CK); use a statin with fewer interactions at low dose (e.g. rosuvastatin or atorvastatin with advice).
ID: HIV, viral hepatitis and blood-borne viruses
Where it is discussed
- Endocrinology: Lipids and obesity (1 mention)
- ID: HIV, viral hepatitis and blood-borne viruses (2 mentions)
S
Salbutamol
BNF entry for Salbutamol · Stand-alone drug page
Mechanism
Short-acting beta-2 agonist.
Uses
Asthma and COPD relief, acute severe asthma, hyperkalaemia.
Dosing
- Severe hyperkalaemia | IV calcium if ECG changes; insulin 10 units with 25 g glucose; salbutamol; SZC
Cardiology: Cardiology Emergencies - Nebulised salbutamol 10–20 mg as an add-on (not alone).
Cardiology: Cardiology Emergencies - Bronchodilator reversibility: Repeat spirometry 15–20 minutes after salbutamol. An FEV1 rise of 12% or more and 200 mL or more supports asthma. Large reversibility is unusual in COPD.
Respiratory: Investigations - FEV1/FVC 0.55, FEV1 rises 450 mL after salbutamol, FeNO 72 ppb | Asthma
Respiratory: Investigations
4 more dose entries from the chapters
- Acute severe asthma | Oxygen to 94–98%; salbutamol 5 mg and ipratropium 0.5 mg nebulised (oxygen-driven); prednisolone 40–50 mg
Respiratory: Emergencies - Life-threatening asthma | As above plus magnesium sulfate 1.2–2 g IV over 20 minutes; back-to-back salbutamol; senior and ICU now
Respiratory: Emergencies - Nebulised salbutamol 10–20 mg - an add-on (not alone); avoid with tachyarrhythmias or ischaemic heart disease; causes tremor and tachycardia.
Renal: Anatomy, Physiology and Pharmacology - Salbutamol (nebulised) | Add-on for hyperkalaemia; 10–20 mg; tachycardia.
Renal: Anatomy, Physiology and Pharmacology
Side effects
Tremor, tachycardia, palpitations, hypokalaemia, headache.
Interactions
Beta-blockers antagonise; corticosteroids and diuretics worsen hypokalaemia.
Special advice
Monitor potassium with high or repeated doses; check inhaler technique and use of spacer.
More from the textbook: uses, cautions and other points
- Beta-2 | Bronchi and blood vessels (muscle) - dilatation; some heart effect | Agonist: salbutamol. Non-selective blockers (propranolol) cause bronchospasm
Cardiology: Anatomy Physiology and Pharmacology - Ask about - thyroid symptoms, anaemia, caffeine, energy drinks, alcohol, recreational drugs (cocaine, amphetamines), medicines (salbutamol, levothyroxine, QT-prolonging drugs), family history of sudden death.
Cardiology: History and Examination - Duration, frequency, triggers (exercise, caffeine, alcohol, drugs — salbutamol, thyroxine, stimulants).
Cardiology: Presentations - SABA (short-acting) - salbutamol , terbutaline: work in minutes, last 4–6 hours; reliever.
Respiratory: Anatomy, Physiology and Pharmacology - Side effects - tremor , tachycardia and palpitations, hypokalaemia (high doses), lactic acidosis (high-dose nebulised or IV salbutamol), headache, muscle cramps.
Respiratory: Anatomy, Physiology and Pharmacology - The big change (BTS/NICE/SIGN 2024): People aged 12 and over should not use a salbutamol (SABA) inhaler alone. Relying on SABA without inhaled steroid is linked to severe attacks and asthma deaths. Treatment is now built around a combined inhaled steroid plus formoterol inhaler (e.g. budesonide/formoterol). Formoterol works …
Respiratory: Airways Disease
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: History and Examination (1 mention)
- Cardiology: Presentations (1 mention)
- Cardiology: Cardiology Emergencies (3 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (5 mentions)
- Respiratory: Investigations (2 mentions)
- Respiratory: Airways Disease (5 mentions)
- Respiratory: Emergencies (8 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Movement Disorders (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (6 mentions)
- Renal: Emergencies (4 mentions)
- Renal: Tubular Inherited Stones (1 mention)
- Renal: Dialysis and Transplant (1 mention)
- Haematology: Myeloma and Lymphoma (2 mentions)
- Paediatrics: Respiratory and heart problems in children (13 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Medical Problems (1 mention)
- Ophthalmology: Anatomy Physiology and Pharmacology (1 mention)
- Ophthalmology Basics Cataract Glaucoma (1 mention)
- ID: How Infection Happens (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (1 mention)
- Medicine of the older adult: Delirium, dementia and mood in older people (1 mention)
- Emergency Medicine: Paediatric emergency medicine (7 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
Salmeterol
BNF entry for Salmeterol · Stand-alone drug page
Mechanism
Long-acting beta-2 agonist.
Uses
Asthma (with inhaled corticosteroid), COPD.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Tremor, palpitations, headache, cramps.
Interactions
Beta-blockers, ketoconazole increases levels.
Special advice
Never use alone in asthma; not for acute relief.
More from the textbook: uses, cautions and other points
- LABA (long-acting) - salmeterol (slow onset, 12 hours), formoterol ( fast onset , 12 hours - allows use as a reliever in MART/AIR), vilanterol, olodaterol, indacaterol (24 hours).
Respiratory: Anatomy, Physiology and Pharmacology - ICS + LABA - budesonide–formoterol, beclometasone–formoterol, fluticasone–salmeterol, fluticasone furoate–vilanterol.
Respiratory: Anatomy, Physiology and Pharmacology - Nirmatrelvir–ritonavir (Paxlovid) - oral, within 5 days of symptoms; ritonavir is a strong CYP3A4 inhibitor - major interactions with statins, DOACs, amiodarone, tacrolimus and ciclosporin, some antiseizure drugs, sildenafil, salmeterol, many others - always check (e.g. the Liverpool COVID-19 interaction checker).
ID: How Infection Happens - β2 | Gs | Bronchodilatation, vasodilatation (muscle), uterine relaxation, K + into cells, glycogenolysis, tremor | Salbutamol , salmeterol; non-selective beta-blockers (propranolol) cause bronchospasm
Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing › Neural, muscular and autonomic physiology
Where it is discussed
Semaglutide
BNF entry for Semaglutide · Stand-alone drug page
Mechanism
GLP-1 receptor agonist slowing gastric emptying and reducing appetite.
Uses
Type 2 diabetes, obesity, cardiovascular risk reduction.
Dosing
- Established atherosclerotic cardiovascular disease: Triple therapy - metformin MR, an SGLT2 inhibitor and subcutaneous semaglutide - added in sequence, titrating semaglutide to 1 mg weekly.
Endocrinology: Diabetes - Semaglutide SC weekly: 0.25 mg, then 0.5 mg, up to 1 mg for type 2 diabetes.
Endocrinology: Diabetes - Semaglutide 2.4 mg Obesity | Weekly SC, titrated over 16 weeks. NICE TA875; specialist service; maximum 2 years.
Endocrinology: Lipids and obesity
Side effects
Nausea, vomiting, diarrhoea, pancreatitis, gallstones, retinopathy complications.
Interactions
Slows absorption of oral drugs; insulin and sulfonylureas increase hypoglycaemia.
Special advice
Titrate slowly; stop in suspected pancreatitis; avoid in pregnancy; monitor retinopathy.
More from the textbook: uses, cautions and other points
- GLP-1 - from the small bowel after eating; boosts insulin, reduces glucagon, slows stomach emptying and reduces appetite - the basis of semaglutide and tirzepatide for weight loss.
Endocrine: Anatomy Physiology and Pharmacology - Uses - type 2 diabetes (especially with obesity or cardiovascular disease - reduce cardiovascular events); weight management (semaglutide, liraglutide - NICE TAs, specialist weight services).
Endocrine: Anatomy Physiology and Pharmacology - Oral semaglutide : Daily; dose depends on the formulation.
Endocrinology: Diabetes - Semaglutide, liraglutide and dulaglutide reduce cardiovascular events in people with cardiovascular disease.
Endocrinology: Diabetes - Worsening of diabetic retinopathy with rapid glucose lowering (semaglutide).
Endocrinology: Lipids and obesity - Use effective contraception; stop semaglutide at least 2 months before trying to conceive.
Endocrinology: Lipids and obesity
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (4 mentions)
- Endocrinology: Diabetes (10 mentions)
- Endocrinology: Lipids and obesity (4 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Liver disease (3 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Glomerular Disease (1 mention)
- Ophthalmology: Retinal Visual Loss (1 mention)
- Ophthalmology: Neuro-ophthalmology (1 mention)
- Public Health: Prevention, health promotion and behaviour change (1 mention)
- Pathology: Immunopathology, amyloidosis, genetic and environmental disease (1 mention)
Sertraline
BNF entry for Sertraline · Stand-alone drug page
Mechanism
SSRI inhibiting serotonin reuptake.
Uses
Depression, anxiety disorders, OCD, PTSD, panic.
Dosing
- SSRIs - sertraline, citalopram, escitalopram, fluoxetine, paroxetine | Usual first choice - safer in overdose. Sertraline - preferred after MI or with heart disease. Citalopram/escitalopram - QT prolongation (citalopram max 20 mg over 65). Fluoxetine - long half-life (fewer withdrawal effects), many interactions; first-line in …
Psychiatry: Mood disorders - SSRIs - sertraline is often first choice in older people (fewer interactions); citalopram (max 20 mg over 65 - QT); watch for hyponatraemia (check sodium at baseline and 2–4 weeks), GI bleeding (add PPI with NSAIDs or anticoagulants), falls.
Medicine of the older adult: Delirium, dementia and mood in older people - Antidepressants - SSRIs (sertraline) - hyponatraemia (check sodium), bleeding (with NSAIDs, anticoagulants), falls; citalopram max 20 mg over 65 (QT); avoid tricyclics ; mirtazapine (sedation, weight gain).
Medicine of the older adult: .Prescribing and deprescribing in older people - 3. A 40-year-old woman on sertraline 100 mg takes tramadol for back pain. Twelve hours later she is agitated, sweaty and tremulous, with temperature 38.6°C, HR 120, dilated pupils, hyperreflexia and inducible ankle clonus. Answer: Serotonin syndrome.
Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy
Side effects
Nausea, diarrhoea, insomnia, sexual dysfunction, hyponatraemia, bleeding risk.
Interactions
MAOIs, other serotonergic drugs, NSAIDs and anticoagulants bleeding.
Special advice
Safer in cardiac disease; taper on stopping; check sodium in older adults.
More from the textbook: uses, cautions and other points
- Euvolaemic low sodium, urine osm 450, urine Na 60, on sertraline | SIADH (drug-induced)
Endocrinology: Sodium and Water disorders - Itch in cholestasis - colestyramine first-line, then rifampicin (watch LFTs), naltrexone, sertraline.
Gastroenterology: Anatomy Physiology Pharmacology - 4. A 70-year-old on naproxen and sertraline has a gastric ulcer on OGD. Answer: NSAID-related gastric ulcer, with higher risk from the SSRI.
Gastroenterology: Oesophagus and Stomach - Drug triggers: PPIs (especially lansoprazole), NSAIDs, SSRIs (e.g. sertraline) , statins, beta-blockers, acarbose.
Gastroenterology: Inflammatory Bowel Disease - Then rifampicin (monitor LFTs), naltrexone, or sertraline.
Gastroenterology: Liver disease - Rifampicin / naltrexone / sertraline | Second-line cholestatic itch; monitor LFTs with rifampicin.
Gastroenterology: Liver disease
Where it is discussed
- Endocrinology: Sodium and Water disorders (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Oesophagus and Stomach (1 mention)
- Gastroenterology: Inflammatory Bowel Disease (1 mention)
- Gastroenterology: Liver disease (2 mentions)
- Neurology: Emergencies (1 mention)
- Neurology: Dementia and Cognition Disorders (Complete) (2 mentions)
- Renal: Chronic Kidney Disease (1 mention)
- Oncology: Principles (1 mention)
- Palliative: Symptoms Management (3 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Medical Problems (1 mention)
- Obstetrics: Post Natal Care (2 mentions)
- Gynaecology: Menstrual Disorders (2 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- ID: How Infection Happens (1 mention)
- Psychiatric emergencies (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (9 mentions)
- Psychiatry: Safeguarding (2 mentions)
- Psychiatry: Mood disorders (7 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (9 mentions)
- Medicine of the older adult: Delirium, dementia and mood in older people (5 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (3 mentions)
- Emergency Medicine: Environmental emergencies (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (3 mentions)
Sildenafil
BNF entry for Sildenafil · Stand-alone drug page
Mechanism
PDE5 inhibitor enhancing cGMP.
Uses
Erectile dysfunction, pulmonary arterial hypertension.
Dosing
- Sildenafil Pulmonary arterial hypertension (adult) | 20 mg three times daily (specialist). Never with nitrates.
Cardiology: Congenital heart disease › 6.36 Drug Reference Table
Side effects
Headache, flushing, dyspepsia, visual disturbance, hypotension.
Interactions
Nitrates and nicorandil contraindicated; CYP3A4 inhibitors raise levels.
Special advice
Avoid in recent MI or stroke, severe hypotension; seek help for priapism.
More from the textbook: uses, cautions and other points
- Contraindicated with PDE5 inhibitors (sildenafil, tadalafil - severe hypotension), severe aortic stenosis, HCM with obstruction, hypotension, RV infarction (preload-dependent).
Cardiology: Anatomy Physiology and Pharmacology - GTN / isosorbide mononitrate | Nitric oxide donors; headache; nitrate-free period; never with sildenafil.
Cardiology: Anatomy Physiology and Pharmacology - Contraindication: Do not give within 24–48 hours of a PDE-5 inhibitor (e.g. sildenafil) because of the risk of profound hypotension.
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina - Advanced pulmonary vasodilators: E.g. bosentan (an endothelin receptor antagonist), sildenafil.
Cardiology: Congenital heart disease › 6.30 Eisenmenger Syndrome - Nitric oxide pathway - PDE5 inhibitors (sildenafil, tadalafil - never with nitrates ; headache, flushing); riociguat (soluble guanylate cyclase stimulator - also for CTEPH; don't combine with PDE5 inhibitors).
Respiratory: Anatomy, Physiology and Pharmacology - Sildenafil / bosentan / epoprostenol | Pulmonary arterial hypertension (specialist); no nitrates with sildenafil; bosentan - liver, teratogenic.
Respiratory: Anatomy, Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Cardiology: Congenital heart disease (2 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (2 mentions)
- Respiratory: Pulmonary Vascular Disease (2 mentions)
- Respiratory: Sleep and Breathing (Complete) (1 mention)
- Endocrinology: Diabetes (1 mention)
- Rheumatology: Connective tissue diseases (3 mentions)
- ENT Anatomy Physiology (1 mention)
- Ophthalmology: Anatomy Physiology and Pharmacology (1 mention)
- Ophthalmology: Retinal Visual Loss (1 mention)
- Ophthalmology: Neuro-ophthalmology (1 mention)
- ID: How Infection Happens (1 mention)
- ID: HIV, viral hepatitis and blood-borne viruses (1 mention)
- Surgery: Vascular surgery (1 mention)
- Surgey: Urology (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (4 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
- Integrated cardiology chapter (3 mentions)
- Integrated respiratory chapter (2 mentions)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)
Simvastatin
BNF entry for Simvastatin · Stand-alone drug page
Mechanism
HMG-CoA reductase inhibitor.
Uses
Hypercholesterolaemia, cardiovascular prevention.
Dosing
- Amlodipine, diltiazem, verapamil - maximum simvastatin dose 20 mg.
Endocrinology: Lipids and obesity - High doses (especially simvastatin 80 mg).
Neurology: Neuromuscular disease - 4. A 52-year-old man with HIV, well controlled on darunavir with cobicistat plus two NRTIs, is started on simvastatin 40 mg by his GP and uses a fluticasone nasal spray for rhinitis. Two months later he has muscle pain, weight gain and a round face. Answer: CYP3A4 interactions - statin myopathy and iatrogenic Cushing's syndrome …
ID: HIV, viral hepatitis and blood-borne viruses - Clarithromycin added for a patient on simvastatin 40 mg | Interaction - rhabdomyolysis; suspend statin
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law
1 more dose entries from the chapters
- … (5 days) and review date; VTE prophylaxis; paracetamol PRN; oxygen prescription with target saturations; check interactions (statins with clarithromycin - suspend simvastatin).
OSCEs II: Practical procedures, prescribing and acute care stations
Side effects
Myalgia, myopathy, raised ALT, rarely rhabdomyolysis.
Interactions
Amlodipine, diltiazem, verapamil limit dose; clarithromycin, azole antifungals contraindicated; ciclosporin.
Special advice
Take at night; avoid large amounts of grapefruit; check CK if muscle symptoms.
More from the textbook: uses, cautions and other points
- Interactions - CYP3A4 inhibitors ( clarithromycin , erythromycin, itraconazole, grapefruit juice with simvastatin), amiodarone and diltiazem (simvastatin dose limits), fibrates (gemfibrozil - avoid).
Cardiology: Anatomy Physiology and Pharmacology - Inhibit CYP3A4 - raise levels of simvastatin, ciclosporin and others; raise digoxin levels.
Cardiology: Anatomy Physiology and Pharmacology - Clarithromycin and erythromycin - pause simvastatin and atorvastatin during the course.
Endocrinology: Lipids and obesity - Grapefruit juice - simvastatin and atorvastatin.
Endocrinology: Lipids and obesity - Side effects to warn about - diarrhoea and C. difficile, taste disturbance; metronidazole with alcohol (disulfiram-like reaction - flushing, vomiting); clarithromycin - QT prolongation and CYP3A4 interactions (statins - pause simvastatin; warfarin; colchicine).
Gastroenterology: Anatomy Physiology Pharmacology - Ticagrelor - reversible, twice daily; breathlessness , bradycardia, raised urate; CYP3A4 interactions (avoid strong inhibitors and inducers; simvastatin dose limit).
Haematology: Anatomy Physiology and Pharmacology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Endocrinology: Lipids and obesity (3 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- ID: How Infection Happens (2 mentions)
- ID: HIV, viral hepatitis and blood-borne viruses (5 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (2 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (5 mentions)
- Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics (1 mention)
- Microbiology: Fungi, parasites and travel-related infection (1 mention)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (1 mention)
- OSCEs II: Practical procedures, prescribing and acute care stations (1 mention)
Sodium valproate
BNF entry for Sodium valproate · Stand-alone drug page
Mechanism
Increases GABA, blocks sodium channels and T-type calcium channels.
Uses
Generalised and focal epilepsy, bipolar disorder (valproate semisodium), migraine prophylaxis.
Dosing
- IV sodium valproate (about 40 mg/kg) - avoid in women who could become pregnant where possible, and in liver disease.
Neurology: Anatomy, Physiology and Pharmacology - Status epilepticus | Benzodiazepine (IV lorazepam 4 mg or buccal midazolam 10 mg), repeat at 5–10 minutes; then levetiracetam, phenytoin or valproate; ICU
Neurology: Emergencies - Sodium valproate IV (40 mg/kg, maximum 3 g). Avoid in women and girls of childbearing potential unless there is no alternative (MHRA).
Neurology: Emergencies - Prevention - folic acid 400 micrograms daily from before conception to 12 weeks; 5 mg for higher risk (previous NTD, family history, antiepileptic drugs, diabetes, BMI 30 or more, sickle cell disease). Avoid valproate in pregnancy. Folic acid fortification of non-wholemeal flour in the UK is being introduced.
Paediatrics: Neurology, bones and joints in children
4 more dose entries from the chapters
- Idiopathic, trauma, steroids, mumps and other viruses, autoimmune, scorpion venom, hypercalcaemia , hypertriglyceridaemia (often over 10 mmol/L), hypothermia, ERCP , drugs (azathioprine, valproate, thiazides, mesalazine, GLP-1 agonists and others), pancreatic cancer.
Surgery: Acute abdomen and emergency general surgery - Second line — levetiracetam (40–60 mg/kg), phenytoin (20 mg/kg) or sodium valproate (40 mg/kg) over 5–20 minutes.
Emergency Medicine: Paediatric emergency medicine - Epilepsy | Lamotrigine or levetiracetam ; folic acid 5 mg; avoid valproate
Clinical pharmacology and prescribing: Prescribing in special groups - … glucose if hypoglycaemic About 20–25 minutes - second-line (if seizures continue after 2 doses of benzodiazepine) IV levetiracetam (60 mg/kg, max 4,500 mg) or sodium valproate (40 mg/kg, max 3,000 mg - avoid in pregnancy and liver disease) or phenytoin (20 mg/kg with cardiac monitoring) About 45 minutes - refractory …
Acute Medicine: Reduced consciousness, seizures, headache and acute confusion
Side effects
Weight gain, tremor, hair loss, thrombocytopenia, hepatotoxicity, pancreatitis, hyperammonaemia, teratogenic.
Interactions
Lamotrigine levels double; carbapenems reduce levels; enzyme inducers.
Special advice
Not for women of childbearing potential without Pregnancy Prevention Programme; check LFT and FBC.
More from the textbook: uses, cautions and other points
- SSRIs , SNRIs, tricyclics. Carbamazepine , oxcarbazepine, sodium valproate.
Endocrinology: Sodium and Water disorders - Hepatocellular (ALT up) | Paracetamol (overdose), isoniazid , rifampicin, pyrazinamide, valproate , methotrexate, statins (usually mild), amiodarone, nitrofurantoin , ketoconazole, NSAIDs (diclofenac), herbal supplements (green tea extract, kava, turmeric), checkpoint inhibitors
Gastroenterology: Anatomy Physiology Pharmacology - Fatty liver | Amiodarone, methotrexate, steroids, tamoxifen, valproate (microvesicular), tetracyclines (IV)
Gastroenterology: Anatomy Physiology Pharmacology - Drugs - azathioprine, valproate, thiazides, GLP-1 receptor agonists, steroids, oestrogens.
Gastroenterology: Gastroenterology Emergencies (Complete) - Hepatocellular | Paracetamol (dose-related), isoniazid, rifampicin, pyrazinamide , NSAIDs (diclofenac), statins (rarely serious), valproate, ketoconazole, nitrofurantoin, herbal products (green tea extract, ashwagandha, turmeric)
Gastroenterology: Liver disease - Fatty liver | Amiodarone, methotrexate, steroids, tamoxifen, valproate, tetracyclines
Gastroenterology: Liver disease
Where it is discussed
- Endocrinology: Sodium and Water disorders (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Liver disease (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (24 mentions)
- Neurology: Emergencies (5 mentions)
- Neurology: Epilepsy (21 mentions)
- Neurology: Headache and Facial Pain (1 mention)
- Neurology: Movement Disorders (5 mentions)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Haematology: Haemostasis and Thrombosis (1 mention)
- Paediatrics: Neonatology (1 mention)
- Paediatrics: Neurology, bones and joints in children (13 mentions)
- Obstetrics (7 mentions)
- Obstetrics: Antenatal Care (1 mention)
- Obstetrics: Medical Problems (3 mentions)
- Obstetrics: Post Natal Care (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- ID: How Infection Happens (6 mentions)
- Psychiatry: Mood disorders (9 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (2 mentions)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
- Surgery: Acute abdomen and emergency general surgery (1 mention)
Solifenacin
BNF entry for Solifenacin · Stand-alone drug page
Mechanism
Antimuscarinic selective for M3 receptors.
Uses
Overactive bladder.
Dosing
- … gynaecomastia; halves PSA (double the value when interpreting) Combination Bothersome symptoms with a large prostate Both sets Antimuscarinic (oxybutynin, solifenacin) or mirabegron Storage symptoms (overactive bladder) if persisting Antimuscarinics - dry mouth, constipation, confusion in older people (anticholinergic …
Surgey: Urology
Side effects
Dry mouth, constipation, blurred vision, urinary retention, QT prolongation.
Interactions
CYP3A4 inhibitors raise levels; other anticholinergics additive.
Special advice
Avoid in older people with cognitive impairment; consider mirabegron.
More from the textbook: uses, cautions and other points
- Antimuscarinics (oxybutynin, solifenacin, tolterodine, trospium, fesoterodine) - dry mouth, constipation, blurred vision, urinary retention; confusion and possible dementia risk in older people (avoid immediate-release oxybutynin in frail older women; trospium crosses into the brain less).
Renal: Anatomy, Physiology and Pharmacology - Oxybutynin / solifenacin / mirabegron | Overactive bladder; anticholinergic confusion / raised BP (mirabegron).
Renal: Anatomy, Physiology and Pharmacology - Solifenacin / tolterodine / fesoterodine | Antimuscarinics for overactive bladder; dry mouth, constipation; anticholinergic burden in older people.
Gynaecology: Pelvic floor ovary and vulva - Antimuscarinic (oxybutynin, solifenacin) or mirabegron | Storage symptoms (overactive bladder) if persisting | Antimuscarinics - dry mouth, constipation, confusion in older people (anticholinergic burden), retention; mirabegron - raises BP
Surgey: Urology - Bladder - oxybutynin (worst - crosses into the brain), tolterodine, solifenacin (mirabegron is not anticholinergic).
Medicine of the older adult: .Prescribing and deprescribing in older people - Drugs for urge incontinence - mirabegron (not anticholinergic - check BP) or antimuscarinics with low brain penetration (e.g. trospium, solifenacin) - avoid oxybutynin in frail older people (confusion).
Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes
Where it is discussed
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Gynaecology: Pelvic floor ovary and vulva (1 mention)
- Surgey: Urology (2 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)
Spironolactone
BNF entry for Spironolactone · Stand-alone drug page
Mechanism
Aldosterone receptor antagonist.
Uses
Heart failure, ascites, resistant hypertension, primary hyperaldosteronism, hirsutism and acne.
Dosing
- 5. A 70-year-old woman with HFrEF on ramipril, bisoprolol and spironolactone has potassium 6.2 mmol/L and creatinine up 40% from baseline after a diarrhoeal illness. Answer: Hyperkalaemia and AKI from RAAS blockade during dehydrating illness.
Cardiology: Presentations - Spironolactone | 12.5–25 mg daily for HFrEF or congestion; check potassium and renal function.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table - Spironolactone | 25 mg daily commonly; sometimes 12.5 mg initially. Up to 50 mg daily in selected patients.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Resistant hypertension: Confirm adherence and out-of-office readings; consider low-dose spironolactone if potassium ≤4.5 mmol/L or an alpha-/beta-blocker if higher, with specialist advice where appropriate.
Cardiology: Hypertension, Blood Pressure and Prevention › 7.06 Stepwise Drug Treatment for Hypertension
4 more dose entries from the chapters
- Spironolactone | HFrEF: 25 mg once daily (12.5 mg if renal or potassium concerns), up to 50 mg daily; monitor potassium and eGFR.
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses - Spironolactone Infant heart failure | Commonly 1–2 mg/kg daily (BNFc), with furosemide. Monitor potassium.
Cardiology: Congenital heart disease › 6.36 Drug Reference Table - Spironolactone , e.g. 25–100 mg daily. Side effects include gynaecomastia , breast tenderness, erectile dysfunction and menstrual upset.
Endocrinology: Adrenal Disease - Spironolactone Primary aldosteronism | 25–100 mg daily (higher doses sometimes used). Gynaecomastia; monitor potassium and creatinine. Avoid in pregnancy.
Endocrinology: Adrenal Disease
Side effects
Hyperkalaemia, gynaecomastia, menstrual irregularity, renal impairment.
Interactions
ACE inhibitors, ARBs, potassium supplements, NSAIDs, digoxin levels rise.
Special advice
Check potassium and creatinine at baseline, 1 week and regularly; use eplerenone if breast symptoms.
More from the textbook: uses, cautions and other points
- Side effects - hyperkalaemia (check U&E regularly; caution with ACE inhibitors, ARBs, potassium supplements, CKD), gynaecomastia and breast pain with spironolactone (less with eplerenone).
Cardiology: Anatomy Physiology and Pharmacology - Spironolactone / eplerenone | MRAs; HFrEF survival; hyperkalaemia; gynaecomastia (spironolactone).
Cardiology: Anatomy Physiology and Pharmacology - ACE inhibitors, ARBs, MRAs (spironolactone) — check K + and creatinine before and 1–2 weeks after starting or increasing (accept a creatinine rise up to 30%).
Cardiology: Presentations - Withhold spironolactone and ramipril (and diuretics) temporarily; review drug interactions.
Cardiology: Presentations - Find and stop the cause: AKI, CKD, ACE inhibitors, ARBs, spironolactone, trimethoprim, potassium supplements, rhabdomyolysis, DKA, adrenal insufficiency.
Cardiology: Cardiology Emergencies - Drugs : Spironolactone. Eplerenone.
Cardiology: Heart Failure › 2.20 💊 Mineralocorticoid Receptor Antagonists
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (4 mentions)
- Cardiology: Presentations (3 mentions)
- Cardiology: Cardiology Emergencies (1 mention)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Heart Failure (3 mentions)
- Cardiology: Hypertension, Blood Pressure and Prevention (1 mention)
- Cardiology: Cardiomyopathies (1 mention)
- Cardiology: Congenital heart disease (2 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (4 mentions)
- Endocrinology: Adrenal Disease (5 mentions)
- Endocrinology: Reproductive (3 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Cirrhosis and Transplantation (6 mentions)
- Renal: Anatomy, Physiology and Pharmacology (11 mentions)
- Renal: Emergencies (2 mentions)
- Renal: Chronic Kidney Disease (3 mentions)
- Renal: Tubular Inherited Stones (2 mentions)
- Oncology: Breast and Gynae Cancers (1 mention)
- Palliative: Symptoms Management (1 mention)
- Paediatrics: Respiratory and heart problems in children (3 mentions)
- Gynaecology: Menstrual Disorders (1 mention)
- Surgey: Breast and endocrine surgery (3 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (4 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
Sulfasalazine
BNF entry for Sulfasalazine · Stand-alone drug page
Mechanism
Prodrug cleaved to 5-ASA and sulfapyridine; anti-inflammatory.
Uses
Ulcerative colitis, rheumatoid arthritis.
Dosing
- Sulfasalazine (with folic acid 5 mg ).
Gastroenterology: Inflammatory Bowel Disease - Folic acid 400 mcg (5 mg if on sulfasalazine).
Gastroenterology: Inflammatory Bowel Disease - Immunosuppressants compatible with pregnancy — prednisolone (mostly inactivated by the placenta), hydroxychloroquine , azathioprine , sulfasalazine (with folic acid 5 mg), ciclosporin, tacrolimus, most anti-TNF drugs (certolizumab minimal transfer).
Obstetrics - Sulfasalazine | Sulfapyridine plus 5-aminosalicylic acid — reduces cytokines and leucocyte function | GI upset, rash, marrow suppression , hepatitis, orange urine and tears , reversible oligospermia; safe in pregnancy (with folic acid 5 mg)
Rheumatology Anatomy Physiology Pharmacology
3 more dose entries from the chapters
- Sulfasalazine - RA, peripheral spondyloarthritis, enteropathic arthritis; side effects - nausea, rash, orange urine and tears (stains contact lenses), reversible low sperm count , marrow suppression, hepatitis, haemolysis in G6PD deficiency. Safe in pregnancy (with folic acid 5 mg daily).
Rheumatology: assessment, investigations and drugs - Sulfasalazine | Orange urine, oligospermia, marrow | Safe (folic acid 5 mg)
Rheumatology: assessment, investigations and drugs - Sulfasalazine | Compatible - with folic acid 5 mg daily | Compatible (healthy term babies)
Rheumatology: Emergencies, pregnancy and other systemic diseases
Side effects
Nausea, rash, headache, oligospermia, agranulocytosis, orange urine.
Interactions
Digoxin and folate absorption reduced.
Special advice
FBC and LFT monitoring; avoid in sulfonamide allergy; male fertility reversible.
More from the textbook: uses, cautions and other points
- Biologics and others - anti-TNF, rituximab, leflunomide, sulfasalazine.
Respiratory: Interstitial Lung Disease - Folate | Jejunum | Stores last only about 4 months. Deficiency - poor diet, alcohol, coeliac disease, pregnancy, haemolysis, drugs ( methotrexate , trimethoprim, phenytoin, sulfasalazine).
Gastroenterology: Anatomy Physiology Pharmacology - Sulfasalazine - also orange urine and tears, reversible male infertility (low sperm count), folate deficiency, rash, hepatitis; avoid with sulfonamide allergy.
Gastroenterology: Anatomy Physiology Pharmacology - 5-aminosalicylates (5-ASA) - mesalazine (also sulfasalazine, balsalazide, olsalazine):
Gastroenterology: Inflammatory Bowel Disease - Sulfasalazine: More side effects - rash, low sperm count (reversible), blood disorders, orange urine. Used if joint disease is present too.
Gastroenterology: Inflammatory Bowel Disease - Agranulocytosis / aplastic anaemia | Carbimazole , propylthiouracil, clozapine (mandatory FBC monitoring), sulfasalazine, carbamazepine , co-trimoxazole, chloramphenicol, deferiprone , methotrexate, azathioprine (TPMT), mirtazapine (rare), NSAIDs (rare) - warn about sore throat and fever
Haematology: Anatomy Physiology and Pharmacology
Where it is discussed
- Respiratory: Interstitial Lung Disease (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Inflammatory Bowel Disease (4 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: History and Examination (1 mention)
- Haematology: Emergencies (1 mention)
- Haematology: Anaemia (1 mention)
- Obstetrics (2 mentions)
- Gynaecology: Fertility Contraception Menopause (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (6 mentions)
- Rheumatology: Inflammatory arthritis (7 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (5 mentions)
- ENT: Common Nose and Throat disorders (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (1 mention)
- Integrated respiratory chapter (1 mention)
- Biochemistry: Enzymes, vitamins and trace elements (1 mention)
Sumatriptan
BNF entry for Sumatriptan · Stand-alone drug page
Mechanism
5-HT1B/1D agonist causing cranial vasoconstriction.
Uses
Acute migraine, cluster headache.
Dosing
- Acute - high-flow 100% oxygen (12–15 L/min via non-rebreathe mask for 15–20 minutes) and subcutaneous sumatriptan 6 mg or nasal triptan.
Neurology: Anatomy, Physiology and Pharmacology - Sumatriptan | 5-HT1B/1D agonist; avoid in IHD, stroke, PVD; SC 6 mg for cluster headache.
Neurology: Anatomy, Physiology and Pharmacology - E.g. sumatriptan 50–100 mg , rizatriptan, zolmitriptan.
Neurology: Headache and Facial Pain - Vomiting: Nasal sumatriptan or zolmitriptan, or subcutaneous sumatriptan 6 mg .
Neurology: Headache and Facial Pain
Side effects
Chest tightness, flushing, dizziness, tingling, rarely coronary vasospasm.
Interactions
MAOIs, SSRIs (serotonin syndrome risk), ergot drugs.
Special advice
Avoid in ischaemic heart disease, uncontrolled hypertension and stroke; limit medication-overuse headache.
More from the textbook: uses, cautions and other points
- Triptans (sumatriptan, zolmitriptan, rizatriptan, others) - 5-HT1B/1D agonists - narrow cranial vessels and reduce CGRP release; often combined with an NSAID or paracetamol; take at the start of the headache (not during the aura). Side effects - tingling, tightness in the chest, throat or jaw, flushing. Avoid in ischaemic heart …
Neurology: Anatomy, Physiology and Pharmacology - Paracetamol first; sumatriptan can be used if needed (reassuring safety data); avoid NSAIDs in the third trimester.
Neurology: Headache and Facial Pain - Cluster headache | 15–180 minutes, up to 8 a day, men, restless. Oxygen and subcutaneous sumatriptan; verapamil
Neurology: Headache and Facial Pain - Treatment - ibuprofen or paracetamol early; nasal triptan (sumatriptan or zolmitriptan) for ages 12–17 ; antiemetic.
Paediatrics: Neurology, bones and joints in children - Sumatriptan or zolmitriptan (nasal) | Acute migraine age 12–17.
Paediatrics: Neurology, bones and joints in children - Migraine - often improves; paracetamol, metoclopramide; sumatriptan acceptable; low-dose aspirin or propranolol for prevention.
Obstetrics: Medical Problems
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Headache and Facial Pain (8 mentions)
- Paediatrics: Neurology, bones and joints in children (2 mentions)
- Obstetrics: Medical Problems (1 mention)
- Integrated paediatrics chapter (2 mentions)
T
Tacrolimus
BNF entry for Tacrolimus · Stand-alone drug page
Mechanism
Calcineurin inhibitor suppressing T-cell activation.
Uses
Transplant rejection prophylaxis, atopic dermatitis (topical).
Dosing
- Immunosuppressants compatible with pregnancy — prednisolone (mostly inactivated by the placenta), hydroxychloroquine , azathioprine , sulfasalazine (with folic acid 5 mg), ciclosporin, tacrolimus, most anti-TNF drugs (certolizumab minimal transfer).
Obstetrics
Side effects
Nephrotoxicity, tremor, hyperglycaemia, hypertension, hyperkalaemia, infection.
Interactions
CYP3A4 inhibitors and inducers markedly alter levels; nephrotoxic drugs; grapefruit.
Special advice
Trough level monitoring; avoid live vaccines; skin cancer surveillance.
More from the textbook: uses, cautions and other points
- Treatment: Combined immunosuppression (high-dose corticosteroid plus ciclosporin or tacrolimus, ± anti-thymocyte globulin) improves survival.
Cardiology: Cardiomyopathies › 3.36 Giant-cell Myocarditis - Tacrolimus and ciclosporin - post-transplant diabetes.
Endocrinology: Diabetes - Drugs: ACE inhibitors, ARBs, spironolactone and eplerenone, heparin (which inhibits aldosterone production), NSAIDs, ciclosporin and tacrolimus. Trimethoprim and amiloride cause a similar picture by blocking the sodium channel.
Endocrinology: Adrenal Disease - Ciclosporin and tacrolimus, cisplatin.
Endocrinology: Bone Medicine - Second line: Mycophenolate, tacrolimus.
Gastroenterology: Liver disease - Tacrolimus | Post-transplant immunosuppression; nephrotoxicity, diabetes, tremor; many interactions.
Gastroenterology: Cirrhosis and Transplantation
Where it is discussed
- Cardiology: Cardiomyopathies (1 mention)
- Endocrinology: Diabetes (1 mention)
- Endocrinology: Adrenal Disease (1 mention)
- Endocrinology: Bone Medicine (1 mention)
- Gastroenterology: Liver disease (1 mention)
- Gastroenterology: Cirrhosis and Transplantation (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Movement Disorders (1 mention)
- Neurology: Spine and Sleep Disorders (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (10 mentions)
- Renal: Emergencies (1 mention)
- Renal: Dialysis and Transplant (13 mentions)
- Renal: Glomerular Disease (2 mentions)
- Paediatrics: Kidneys, urinary tract and hormones in children (1 mention)
- Obstetrics (1 mention)
- Dermatology: Skin basics, eczema and psoriasis (5 mentions)
- Dermatology: Skin lesions and skin cancer (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Rheumatology: assessment, investigations and drugs (1 mention)
- Rheumatology: Connective tissue diseases (2 mentions)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (2 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (2 mentions)
- ID: How Infection Happens (5 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (2 mentions)
- Surgery: Upper GI, hepatobiliary and bariatric surgery (1 mention)
Tadalafil
BNF entry for Tadalafil · Stand-alone drug page
Mechanism
PDE5 inhibitor with long half-life.
Uses
Erectile dysfunction, benign prostatic hyperplasia, pulmonary arterial hypertension.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Headache, flushing, back pain, myalgia, dyspepsia.
Interactions
Nitrates and nicorandil contraindicated; alpha-blockers hypotension.
Special advice
Effect lasts up to 36 hours; avoid within recent MI or stroke periods.
More from the textbook: uses, cautions and other points
- Contraindicated with PDE5 inhibitors (sildenafil, tadalafil - severe hypotension), severe aortic stenosis, HCM with obstruction, hypotension, RV infarction (preload-dependent).
Cardiology: Anatomy Physiology and Pharmacology - Nitric oxide pathway - PDE5 inhibitors (sildenafil, tadalafil - never with nitrates ; headache, flushing); riociguat (soluble guanylate cyclase stimulator - also for CTEPH; don't combine with PDE5 inhibitors).
Respiratory: Anatomy, Physiology and Pharmacology - PDE5 inhibitors - sildenafil, tadalafil. Do not combine with nitrates (severe hypotension).
Respiratory: Pulmonary Vascular Disease - PDE5 inhibitors (sildenafil, tadalafil) | PAH (specialist); never with nitrates.
Respiratory: Pulmonary Vascular Disease - Pulmonary arterial hypertension - endothelin receptor antagonists (bosentan, ambrisentan, macitentan), PDE5 inhibitors (sildenafil, tadalafil), riociguat, prostacyclin analogues (iloprost, epoprostenol, selexipag); oxygen, diuretics, anticoagulation in some (see the Respiratory chapters).
Rheumatology: Connective tissue diseases - Erectile dysfunction - often an early sign of cardiovascular disease (check BP, lipids, HbA1c); also neurological, hormonal (testosterone), drugs (beta-blockers, thiazides, SSRIs, finasteride), psychological; PDE5 inhibitors (sildenafil, tadalafil) - never with nitrates (severe hypotension).
Surgey: Urology
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Respiratory: Pulmonary Vascular Disease (2 mentions)
- Respiratory: Sleep and Breathing (Complete) (1 mention)
- Rheumatology: Connective tissue diseases (1 mention)
- Surgey: Urology (1 mention)
- Integrated respiratory chapter (2 mentions)
Tamoxifen
BNF entry for Tamoxifen · Stand-alone drug page
Mechanism
Selective oestrogen receptor modulator.
Uses
ER-positive breast cancer treatment and prevention.
Dosing
- Retinal toxicity - dose no more than 5 mg/kg/day; baseline eye check within 1 year and annual retinal screening after 5 years of use (earlier - after 1 year - with risk factors such as kidney impairment, tamoxifen or higher doses) (RCOphth).
Rheumatology: assessment, investigations and drugs - Hydroxychloroquine (and chloroquine) | Retinal toxicity ("bull's-eye" maculopathy) — irreversible; risk with dose over 5 mg/kg/day (actual body weight), long duration, renal impairment, tamoxifen — annual screening (OCT and fields) after 5 years of use (after 1 year if additional risk factors — RCOphth 2020)
Ophthalmology: Anatomy Physiology and Pharmacology - Hydroxychloroquine | Retinal toxicity (bull's-eye maculopathy, permanent). Keep dose at 5 mg/kg/day or less (actual body weight). RCOphth : yearly screening (OCT and fields) after 5 years , or after 1 year if extra risk (eGFR under 60, tamoxifen, higher doses).
Ophthalmology: Neuro-ophthalmology
Side effects
Hot flushes, VTE, endometrial hyperplasia and cancer, visual disturbance.
Interactions
CYP2D6 inhibitors (paroxetine, fluoxetine) reduce activation; warfarin effect rises.
Special advice
Report abnormal vaginal bleeding; avoid in VTE history; review duration with oncology.
More from the textbook: uses, cautions and other points
- Management: Corticosteroids, tamoxifen or rituximab; surgery to relieve compression.
Endocrinology: Thyroid disease - Drugs - oral oestrogens, retinoids, thiazides, beta-blockers, steroids, antipsychotics, antiretrovirals, tamoxifen.
Endocrinology: Lipids and obesity - SSRIs or SNRIs - avoid paroxetine and fluoxetine with tamoxifen.
Endocrinology: Reproductive - Tamoxifen (specialist) for painful, recent gynaecomastia.
Endocrinology: Reproductive - Fatty liver | Amiodarone, methotrexate, steroids, tamoxifen, valproate (microvesicular), tetracyclines (IV)
Gastroenterology: Anatomy Physiology Pharmacology - Fatty liver | Amiodarone, methotrexate, steroids, tamoxifen, valproate, tetracyclines
Gastroenterology: Liver disease
Where it is discussed
- Endocrinology: Thyroid disease (1 mention)
- Endocrinology: Lipids and obesity (1 mention)
- Endocrinology: Reproductive (2 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Liver disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: History and Examination (1 mention)
- Oncology: Principles (5 mentions)
- Oncology: Breast and Gynae Cancers (4 mentions)
- Gynaecology: Menstrual Disorders (5 mentions)
- Gynaecology: Fertility Contraception Menopause (2 mentions)
- Rheumatology: assessment, investigations and drugs (1 mention)
- Ophthalmology: Anatomy Physiology and Pharmacology (1 mention)
- Ophthalmology: Neuro-ophthalmology (1 mention)
- Surgey: Breast and endocrine surgery (3 mentions)
- Clinical Genetics: Cancer genetics and inherited cardiovascular conditions (1 mention)
- Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics (2 mentions)
- Histology: Organ-system histology (1 mention)
Tamsulosin
BNF entry for Tamsulosin · Stand-alone drug page
Mechanism
Alpha-1A adrenoceptor antagonist.
Uses
Lower urinary tract symptoms in benign prostatic hyperplasia.
Dosing
- Medicines : Drug Use Side effects Alpha-blocker (tamsulosin, alfuzosin) First-line for moderate to severe voiding symptoms; works in days Postural hypotension , dizziness, retrograde ejaculation, floppy iris syndrome (tell the eye surgeon before cataract surgery) 5-alpha reductase inhibitor (finasteride, dutasteride) Enlarged …
Surgey: Urology - … hesitancy, poor stream; examine abdomen and prostate, urinalysis, U&E, PSA after counselling; frequency–volume chart. Treatment: lifestyle, alpha-blocker (tamsulosin) for moderate–severe voiding symptoms, 5-alpha reductase inhibitor (finasteride) if prostate is estimated >30 g or PSA >1.4; antimuscarinic or mirabegron …
General Practice: Child health, women's health and men's health in primary care
Side effects
Postural hypotension, dizziness, retrograde ejaculation, floppy iris syndrome.
Interactions
Other antihypertensives and PDE5 inhibitors additive; CYP3A4 and 2D6 inhibitors.
Special advice
Take after food; tell ophthalmologist before cataract surgery.
More from the textbook: uses, cautions and other points
- Alpha-1 | Blood vessels - vasoconstriction | Agonists: noradrenaline, phenylephrine, metaraminol. Blockers: doxazosin, tamsulosin (postural hypotension)
Cardiology: Anatomy Physiology and Pharmacology - Collapse on standing from bed in a man on tamsulosin | Orthostatic hypotension
Cardiology: History and Examination - Alpha-blocker (tamsulosin) - helps pass distal ureteric stones under 10 mm (medical expulsive therapy).
Renal: Anatomy, Physiology and Pharmacology - Alpha-blockers (tamsulosin, alfuzosin, doxazosin) - relax prostate and bladder-neck muscle; work in days; postural hypotension (first dose, falls), dizziness, retrograde ejaculation , floppy iris syndrome during cataract surgery (tell the eye surgeon).
Renal: Anatomy, Physiology and Pharmacology - Alpha-blocker (tamsulosin) before a trial without catheter.
Renal: Emergencies - Tamsulosin | Before trial without catheter in BPH-related retention.
Renal: Emergencies
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: History and Examination (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (3 mentions)
- Renal: Emergencies (2 mentions)
- Renal: Tubular Inherited Stones (2 mentions)
- Ophthalmology: Anatomy Physiology and Pharmacology (3 mentions)
- Ophthalmology Basics Cataract Glaucoma (2 mentions)
- Ophthalmology: Neuro-ophthalmology (2 mentions)
- Ophthalmology: Paediatrics (1 mention)
- Surgey: Urology (8 mentions)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (2 mentions)
- Clinical imaging: Abdominal imaging — AXR, ultrasound, CT and MRI (1 mention)
- General Practice: Child health, women's health and men's health in primary care (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (3 mentions)
Teicoplanin
BNF entry for Teicoplanin · Stand-alone drug page
Mechanism
Glycopeptide inhibiting cell-wall synthesis.
Uses
MRSA and resistant Gram-positive infection, endocarditis, bone and joint infection.
Dosing
- Loading dose - a larger first dose to reach the target level quickly, when waiting 4–5 half-lives would be too slow: digoxin , amiodarone , phenytoin (and levetiracetam in status), vancomycin , teicoplanin, aminophylline , warfarin (in some regimens), clopidogrel (300–600 mg in ACS), ticagrelor.
Clinical pharmacology and prescribing: Principles of clinical pharmacology
Side effects
Rash, fever, thrombocytopenia, injection-site reactions; less nephrotoxic than vancomycin.
Interactions
Aminoglycosides increase nephrotoxicity and ototoxicity.
Special advice
Loading doses needed; trough level monitoring in serious infection.
More from the textbook: uses, cautions and other points
- MRSA suspected: Add vancomycin or teicoplanin.
Respiratory: Emergencies - Add vancomycin or teicoplanin for suspected line infection, MRSA or skin infection; antifungals for persistent fever (after 4–7 days).
Oncology: Emergencies - Severe or systemically unwell - IV flucloxacillin (or co-amoxiclav, cefuroxime, ceftriaxone, clindamycin per local policy); MRSA - vancomycin, teicoplanin or linezolid.
Dermatology: Skin infections and infestations - Cell wall | Beta-lactams (penicillins, cephalosporins, carbapenems, aztreonam) - bind penicillin-binding proteins; glycopeptides (vancomycin, teicoplanin)
ID: How Infection Happens - MRSA (meticillin-resistant S. aureus) - resistant to flucloxacillin and most beta-lactams; treat with vancomycin, teicoplanin, linezolid, daptomycin, or doxycycline or co-trimoxazole for milder infections (depending on sensitivities); decolonise (nasal mupirocin and chlorhexidine body wash) before some surgery.
ID: How Infection Happens - Line infection | Staphylococci (including CoNS, MRSA), Gram-negatives, Candida | Vancomycin or teicoplanin ± Gram-negative cover; remove the line in many cases
ID: Sepsis, fever and serious bacterial infections
Where it is discussed
- Respiratory: Emergencies (1 mention)
- Oncology: Emergencies (1 mention)
- Dermatology: Skin infections and infestations (1 mention)
- ID: How Infection Happens (5 mentions)
- ID: Sepsis, fever and serious bacterial infections (2 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Acute Medicine: The acute medical take (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (4 mentions)
- Anaesthesia: Airway management and anaesthetic drugs (2 mentions)
- Integrated respiratory chapter (1 mention)
- Microbiology: Bacteriology - structure, classification and important pathogens (1 mention)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (1 mention)
Temazepam
BNF entry for Temazepam · Stand-alone drug page
Mechanism
Short-acting benzodiazepine.
Uses
Short-term insomnia.
Dosing
- 5. A 77-year-old man has taken temazepam 20 mg nightly for 15 years. He has had two falls and wants to stop. Answer: Benzodiazepine deprescribing.
Medicine of the older adult: .Prescribing and deprescribing in older people
Side effects
Drowsiness, hangover effect, falls, confusion, dependence.
Interactions
Opioids, alcohol, CNS depressants.
Special advice
Controlled drug; maximum 2–4 weeks; avoid in older adults; withdraw gradually.
More from the textbook: uses, cautions and other points
- 5. A 72-year-old woman has taken temazepam nightly for 10 years. She has had two falls and wants to stop. Answer: Long-term benzodiazepine dependence with falls.
Psychiatry: Anxiety, stress and somatic disorders - Rebound insomnia and anxiety after stopping long-term temazepam suddenly | Benzodiazepine withdrawal - taper
Medicine of the older adult: .Prescribing and deprescribing in older people - 3 | Buprenorphine , tramadol , temazepam , midazolam , phenobarbital, gabapentin , pregabalin | CD prescription requirements; safe custody for some (buprenorphine, temazepam); usually no register
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law - Schedule 3 examples | Buprenorphine, tramadol, temazepam, midazolam, gabapentin, pregabalin
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law
Where it is discussed
Terbinafine
BNF entry for Terbinafine · Stand-alone drug page
Mechanism
Allylamine inhibiting squalene epoxidase.
Uses
Onychomycosis, tinea infections.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, taste disturbance, rash, hepatotoxicity.
Interactions
CYP2D6 inhibitor raising tricyclics, beta-blockers, SSRIs; rifampicin reduces levels.
Special advice
Baseline LFT before oral use; stop if jaundice or liver symptoms.
More from the textbook: uses, cautions and other points
- Cholestatic (ALP up) | Co-amoxiclav (may start up to 6 weeks after the course), flucloxacillin (older people; may be delayed), chlorpromazine, combined pill , anabolic steroids , carbimazole, sulfonylureas, erythromycin, terbinafine
Gastroenterology: Anatomy Physiology Pharmacology - Cholestatic | Co-amoxiclav (often weeks after the course ends; older men), flucloxacillin , chlorpromazine, anabolic steroids , the combined pill, erythromycin, terbinafine
Gastroenterology: Liver disease - Tinea capitis (scalp ringworm) - scaly patches with hair loss; kerion (boggy, inflamed swelling); needs oral antifungals (terbinafine or griseofulvin) - topical alone won't work.
Paediatrics: Infections in children - Topical - terbinafine cream (1–2 weeks) or an imidazole (clotrimazole, miconazole -2–4 weeks, continue 1–2 weeks after clearing).
Dermatology: Skin infections and infestations - Oral - terbinafine (or itraconazole) for extensive, severe or resistant infection, or if topical treatment fails.
Dermatology: Skin infections and infestations - Drugs - beta-lactam antibiotics , macrolides, hydroxychloroquine, diltiazem, terbinafine.
Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies
Where it is discussed
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Liver disease (1 mention)
- Paediatrics: Infections in children (1 mention)
- Dermatology: Skin infections and infestations (11 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- Rheumatology: Connective tissue diseases (2 mentions)
- ENT Anatomy Physiology (1 mention)
- ID: How Infection Happens (1 mention)
- Integrated paediatrics chapter (1 mention)
- Microbiology: Fungi, parasites and travel-related infection (2 mentions)
Testosterone
BNF entry for Testosterone · Stand-alone drug page
Mechanism
Androgen receptor agonist.
Uses
Male hypogonadism, gender-affirming therapy.
Dosing
- Testosterone Male hypogonadism | E.g. daily transdermal gel, or testosterone undecanoate 1 g IM every 10–14 weeks. Monitor haematocrit and PSA.
Endocrinology: Pituitary Disease - Testosterone undecanoate 1 g IM , every 10–14 weeks after a loading dose at 6 weeks. Long-acting.
Endocrinology: Reproductive - Testosterone esters (e.g. Sustanon 250 mg IM), every 2–4 weeks. Peaks and troughs cause mood swings.
Endocrinology: Reproductive
Side effects
Acne, polycythaemia, fluid retention, mood change, hepatic effects, prostate stimulation.
Interactions
Warfarin effect rises; insulin requirements change.
Special advice
Monitor haematocrit, PSA and lipids; avoid in prostate or breast cancer.
More from the textbook: uses, cautions and other points
- Binding proteins - most cortisol, thyroid hormone and testosterone is bound (to CBG, TBG and SHBG); only the free fraction is active. Oestrogen (pregnancy, the pill) raises binding proteins, so total levels rise but free levels may be normal - measure free hormone where possible.
Endocrine: Anatomy Physiology and Pharmacology - GnRH (pulsatile) | LH and FSH | Gonads → testosterone, oestrogen, progesterone, inhibin | Sex steroids and inhibin suppress (oestrogen can also trigger the mid-cycle LH surge)
Endocrine: Anatomy Physiology and Pharmacology - Gonadal axis: LH, FSH and oestradiol (women) or 9 am testosterone (men). Low sex hormones with low or normal gonadotrophins means pituitary failure. In post-menopausal women, "normal" gonadotrophins are abnormally low.
Endocrinology: Pituitary Disease - 💡 Clinical Pearl: An older patient with hyponatraemia, fatigue and low libido may have a non-functioning macroadenoma with hypopituitarism, not SIADH. Check 9 am cortisol, FT4, gonadotrophins and testosterone.
Endocrinology: Pituitary Disease - Men: Testosterone, SHBG, LH and FSH.
Endocrinology: Bone Medicine - Testosterone in hypogonadal men improves bone density, but is not a substitute for bone treatment when the fracture risk is high.
Endocrinology: Bone Medicine
Where it is discussed
- Endocrine: Anatomy Physiology and Pharmacology (12 mentions)
- Endocrinology: Pituitary Disease (4 mentions)
- Endocrinology: Bone Medicine (4 mentions)
- Endocrinology: Reproductive (35 mentions)
- Gastroenterology: Liver disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (3 mentions)
- Haematology: History and Examination (2 mentions)
- Haematology: Anaemia (5 mentions)
- Oncology: Principles (2 mentions)
- Oncology: Urology and Genital cancers (1 mention)
- Oncology: Breast and Gynae Cancers (1 mention)
- Paediatrics: Growth, development and nutrition (3 mentions)
- Obstetrics (1 mention)
- Gynaecology: Menstrual Disorders (7 mentions)
- Gynaecology: Fertility Contraception Menopause (4 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Surgey: Breast and endocrine surgery (1 mention)
- Surgey: Urology (1 mention)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical Genetics: Chromosomal and imprinting disorders (6 mentions)
- Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders (1 mention)
- Integrated paediatrics chapter (3 mentions)
Thiamine
BNF entry for Thiamine · Stand-alone drug page
Mechanism
Vitamin B1, cofactor in carbohydrate metabolism.
Uses
Prevention and treatment of Wernicke encephalopathy, alcohol dependence, malnutrition.
Dosing
- Thiamine before and during feeding - e.g. oral thiamine 200–300 mg daily, or IV Pabrinex - plus vitamin B compound strong and a multivitamin.
Gastroenterology: Investigations - Thiamine 200–300 mg oral daily, or IV Pabrinex | Before and during refeeding; before glucose in at-risk patients.
Gastroenterology: Investigations - Thiamine for everyone at risk (oral 100 mg three times daily for long-term use).
Gastroenterology: Liver disease - … IV lorazepam (0.1 mg/kg, usually 4 mg) - or if no IV access, buccal midazolam 10 mg (or rectal diazepam 10–20 mg); repeat once after 5–10 minutes if still seizing Thiamine and glucose IV Pabrinex if alcohol excess or malnutrition; glucose if hypoglycaemic About 20–25 minutes - second-line (if seizures continue after 2 doses …
Acute Medicine: Reduced consciousness, seizures, headache and acute confusion
1 more dose entries from the chapters
- … breathless, weak, phosphate 0.3 mmol/L. Answer: Refeeding syndrome - IV phosphate replacement, check potassium and magnesium, reduce feeding rate temporarily, thiamine and vitamin B, cardiac monitoring, fluid balance; involve dietitians and follow MEED guidance (Medical Emergencies in Eating Disorders, RCPsych 2022).
Pathology: Immunopathology, amyloidosis, genetic and environmental disease
Side effects
Rare anaphylaxis with IV preparations; local reactions.
Interactions
Few; glucose before thiamine may precipitate Wernicke encephalopathy.
Special advice
Give before or with glucose in at-risk patients; use IV high-dose preparation when Wernicke suspected.
More from the textbook: uses, cautions and other points
- Toxic, endocrine and metabolic causes : Excess alcohol consumption; Anthracycline chemotherapy; Trastuzumab-associated cardiac dysfunction; Thyrotoxicosis or severe hypothyroidism; Thiamine deficiency; Severe chronic anaemia.
Cardiology: Heart Failure › 2.05 🧬 Causes of Heart Failure - Endocrine/nutritional/neuromuscular: Thyroid disease, acromegaly, phaeochromocytoma, thiamine deficiency; Duchenne/Becker, myotonic dystrophy, Friedreich's ataxia.
Cardiology: Cardiomyopathies › 3.05 Causes and Aetiological Clues - Alcohol treatment: Complete abstinence (or marked reduction), thiamine supplementation, nutritional correction and HFrEF therapy; EF frequently improves within months.
Cardiology: Cardiomyopathies › 3.43 Alcohol- and Drug-related Cardiomyopathy - Alcohol excess or malnutrition: Give IV thiamine (Pabrinex) with glucose.
Endocrinology: Emergencies - Hypoglycaemia: fast carbohydrate, IV 10% glucose or IM glucagon; thiamine if alcohol or malnutrition.
Endocrinology: Emergencies - Thiamine deficiency - Wernicke's encephalopathy with persistent vomiting. Give IV Pabrinex urgently.
Endocrinology: Lipids and obesity
Where it is discussed
- Cardiology: Heart Failure (1 mention)
- Cardiology: Cardiomyopathies (4 mentions)
- Endocrinology: Emergencies (2 mentions)
- Endocrinology: Lipids and obesity (1 mention)
- Endocrinology: Bone Medicine (2 mentions)
- Endocrinology: NETS and Hypoglycaemia (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (5 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (8 mentions)
- Gastroenterology: Investigations (8 mentions)
- Gastroenterology: Oesophagus and Stomach (3 mentions)
- Gastroenterology: Liver disease (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Emergencies (3 mentions)
- Neurology: Localisation and Investigation (1 mention)
- Neurology: Spine and Sleep Disorders (1 mention)
- Neurology: Dementia and Cognition Disorders (Complete) (3 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Antenatal Care (5 mentions)
- Ophthalmology: Retinal Visual Loss (1 mention)
- Ophthalmology: Neuro-ophthalmology (2 mentions)
- Ophthalmology: Paediatrics (1 mention)
- Psychiatry: assessment, treatment and the law (1 mention)
- Psychiatry: Safeguarding (3 mentions)
- Psychiatry: Alcohol, drugs and addiction (12 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (3 mentions)
Ticagrelor
BNF entry for Ticagrelor · Stand-alone drug page
Mechanism
Reversible P2Y12 receptor antagonist.
Uses
Acute coronary syndrome, post-MI secondary prevention.
Dosing
- Ticagrelor (90 mg twice daily) - reversible, more potent; side effects - breathlessness , bradyarrhythmias; interacts with strong CYP3A4 drugs.
Cardiology: Anatomy Physiology and Pharmacology - Second antiplatelet (per local PPCI protocol): prasugrel (60 mg loading, then 10 mg daily; 5 mg if aged 75 or over or under 60 kg) if not on an oral anticoagulant, or ticagrelor (180 mg loading, then 90 mg twice daily). Clopidogrel if high bleeding risk or on an anticoagulant.
Cardiology: Cardiology Emergencies - Ticagrelor ACS | 180 mg loading, then 90 mg twice daily.
Cardiology: Cardiology Emergencies - Clopidogrel: 300 mg loading if aged 75 or under; 75 mg (no loading) if over 75; then 75 mg daily. Ticagrelor and prasugrel are not used with fibrinolysis.
Cardiology: Ischaemic Heart Disease (ACS) › 1.21 STEMI: Fibrinolysis
2 more dose entries from the chapters
- Ticagrelor | 180 mg loading, then 90 mg twice daily for 12 months; 60 mg twice daily thereafter in selected patients.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - Loading dose - a larger first dose to reach the target level quickly, when waiting 4–5 half-lives would be too slow: digoxin , amiodarone , phenytoin (and levetiracetam in status), vancomycin , teicoplanin, aminophylline , warfarin (in some regimens), clopidogrel (300–600 mg in ACS), ticagrelor.
Clinical pharmacology and prescribing: Principles of clinical pharmacology
Side effects
Bleeding, dyspnoea, bradycardia, raised uric acid and creatinine.
Interactions
Strong CYP3A4 inhibitors and inducers; simvastatin dose limit.
Special advice
Dyspnoea is usually benign; avoid in prior intracranial haemorrhage; hold before surgery per guidance.
More from the textbook: uses, cautions and other points
- Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
Cardiology: Anatomy Physiology and Pharmacology - Before surgery - clopidogrel and ticagrelor usually stopped 5 days, prasugrel 7 days before (balance against stent thrombosis - discuss with cardiology).
Cardiology: Anatomy Physiology and Pharmacology - PCI planned: Prasugrel or ticagrelor.
Cardiology: Cardiology Emergencies - Conservative management: Ticagrelor (or clopidogrel if high bleeding risk).
Cardiology: Cardiology Emergencies - STEMI with primary PCI: Prasugrel with aspirin if not on an oral anticoagulant; ticagrelor or clopidogrel as alternatives depending on bleeding risk.
Cardiology: Ischaemic Heart Disease (ACS) › 1.23 Antiplatelet Therapy - NSTEMI or unstable angina having angiography: Prasugrel or ticagrelor. Give prasugrel only once the anatomy is known and PCI is planned.
Cardiology: Ischaemic Heart Disease (ACS) › 1.23 Antiplatelet Therapy
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (5 mentions)
- Cardiology: Cardiology Emergencies (4 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (5 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Investigations (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (6 mentions)
- Haematology: Haemostasis and Thrombosis (1 mention)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical imaging: Imaging pathways and interventional radiology (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (3 mentions)
- Integrated cardiology chapter (5 mentions)
- Pathology: Haemodynamic disorders, thrombosis, embolism and atherosclerosis (1 mention)
Timolol
BNF entry for Timolol · Stand-alone drug page
Mechanism
Non-selective beta blocker.
Uses
Glaucoma (eye drops), hypertension, angina, migraine.
Dosing
- Emergency ophthalmology; IV acetazolamide 500 mg , topical timolol, apraclonidine and steroid; pilocarpine once IOP starts to fall; analgesia and antiemetic; lie supine.
Ophthalmology: Anatomy Physiology and Pharmacology - Acetazolamide 500 mg IV; timolol and apraclonidine drops; pilocarpine; analgesia and antiemetic.
Ophthalmology: Red emergencies
Side effects
Eye drops: ocular irritation; systemic absorption can cause bradycardia and bronchospasm.
Interactions
Verapamil and other beta-blockers; CYP2D6 inhibitors.
Special advice
Avoid eye drops in asthma and heart block; press the tear duct after instillation.
More from the textbook: uses, cautions and other points
- Drugs that cause bronchospasm - beta-blockers (especially non-selective - propranolol, timolol eye drops), NSAIDs and aspirin (aspirin-exacerbated respiratory disease - asthma with nasal polyps), adenosine, some contrast agents and anaesthetic drugs.
Respiratory: Anatomy, Physiology and Pharmacology - Treatment - most need no treatment; oral propranolol (specialist - hypoglycaemia, bradycardia, bronchospasm) for problematic lesions; topical timolol for small superficial ones.
Dermatology: Skin lesions and skin cancer - Timolol (topical) | Small superficial infantile haemangiomas.
Dermatology: Skin lesions and skin cancer - Beta-blockers (timolol, betaxolol) | Reduce aqueous production | Systemic — bronchospasm (avoid in asthma , caution COPD), bradycardia, heart block, hypotension, fatigue; masking hypoglycaemia
Ophthalmology: Anatomy Physiology and Pharmacology - Topical beta-blocker (timolol), alpha-agonist (apraclonidine), steroid ; pilocarpine once IOP starts to fall (the ischaemic iris doesn't respond at very high pressure).
Ophthalmology: Anatomy Physiology and Pharmacology - Systemic absorption - drops drain to the nose and are absorbed, so timolol can cause bradycardia and bronchospasm (asthma). Teach patients to press on the inner corner of the eye for 1–2 minutes after the drop.
Ophthalmology Basics Cataract Glaucoma
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Dermatology: Skin lesions and skin cancer (2 mentions)
- Ophthalmology: Anatomy Physiology and Pharmacology (7 mentions)
- Ophthalmology Basics Cataract Glaucoma (5 mentions)
- Ophthalmology: Red emergencies (3 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
Tiotropium
BNF entry for Tiotropium · Stand-alone drug page
Mechanism
Long-acting muscarinic antagonist.
Uses
COPD, asthma add-on.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Dry mouth, urinary retention, constipation, blurred vision.
Interactions
Other anticholinergics additive.
Special advice
Check inhaler technique; caution in glaucoma and prostatic hypertrophy.
More from the textbook: uses, cautions and other points
- LAMA - tiotropium , umeclidinium, glycopyrronium, aclidinium - once or twice daily; mainly COPD; also add-on in severe asthma.
Respiratory: Anatomy, Physiology and Pharmacology - LABA + LAMA (e.g. umeclidinium–vilanterol, tiotropium–olodaterol) - first-line regular treatment for most people with COPD who remain breathless (NICE NG115).
Respiratory: Anatomy, Physiology and Pharmacology - LAMA (e.g. tiotropium) | COPD maintenance; add-on in asthma; dry mouth, urinary retention.
Respiratory: Airways Disease - M3 | Gq | Smooth muscle contraction (bronchi, gut, detrusor), glands (saliva, sweat), pupil constriction and accommodation | Antagonists — tiotropium, ipratropium (COPD), oxybutynin and solifenacin (bladder), hyoscine; agonist — pilocarpine
Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing › Neural, muscular and autonomic physiology
Where it is discussed
- Respiratory: Anatomy, Physiology and Pharmacology (3 mentions)
- Respiratory: Airways Disease (1 mention)
- Integrated respiratory chapter (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)
Tirzepatide
BNF entry for Tirzepatide · Stand-alone drug page
Mechanism
Dual GIP and GLP-1 receptor agonist.
Uses
Type 2 diabetes, obesity.
Dosing
- Tirzepatide weekly: A dual GIP/GLP-1 agonist, starting at 2.5 mg and increased in 2.5 mg steps every 4 weeks, to 5–15 mg.
Endocrinology: Diabetes - Tirzepatide Type 2; obesity | 2.5 mg weekly for 4 weeks, increasing by 2.5 mg every 4 weeks to 5–15 mg. Reduces oral contraceptive effectiveness during titration.
Endocrinology: Diabetes - Tirzepatide Obesity | 2.5 mg weekly, increased by 2.5 mg every 4 weeks to 15 mg maximum. NICE TA1026; phased primary care rollout. Reduces oral contraceptive reliability.
Endocrinology: Lipids and obesity
Side effects
Nausea, vomiting, diarrhoea, constipation, pancreatitis, gallstones.
Interactions
Oral contraceptive absorption affected at initiation and dose escalation; insulin and sulfonylureas increase hypoglycaemia.
Special advice
Titrate slowly; use additional contraception at starts and escalations.
More from the textbook: uses, cautions and other points
- Weight loss - this can cure mild OSA. GLP-1 based drugs (e.g. tirzepatide) reduce OSA severity.
Respiratory: Sleep and Breathing (Complete) - GLP-1 - from the small bowel after eating; boosts insulin, reduces glucagon, slows stomach emptying and reduces appetite - the basis of semaglutide and tirzepatide for weight loss.
Endocrine: Anatomy Physiology and Pharmacology - Tirzepatide - dual GIP and GLP-1 agonist , weekly injection; greater weight and glucose reduction; similar side effects.
Endocrine: Anatomy Physiology and Pharmacology - Weight-loss medicines: GLP-1 agonists and tirzepatide (see below).
Endocrinology: Diabetes - Early-onset type 2 diabetes (under 40): Consider triple therapy with metformin MR, an SGLT2 inhibitor and a GLP-1 agonist or tirzepatide.
Endocrinology: Diabetes - How incretin drugs work: GLP-1 is a gut hormone released after eating. GLP-1 receptor agonists act on the brain to reduce appetite and increase fullness , slow gastric emptying, and boost insulin when glucose is high. Tirzepatide also activates the GIP receptor (a "twincretin"), which gives greater weight loss.
Endocrinology: Lipids and obesity
Where it is discussed
- Respiratory: Sleep and Breathing (Complete) (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (6 mentions)
- Endocrinology: Diabetes (7 mentions)
- Endocrinology: Lipids and obesity (7 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Surgery: Upper GI, hepatobiliary and bariatric surgery (1 mention)
- Integrated respiratory chapter (1 mention)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)
- Public Health: Prevention, health promotion and behaviour change (1 mention)
- Pathology: Immunopathology, amyloidosis, genetic and environmental disease (1 mention)
Tobramycin
BNF entry for Tobramycin · Stand-alone drug page
Mechanism
Aminoglycoside inhibiting 30S ribosome.
Uses
Pseudomonas infection, cystic fibrosis exacerbations (IV or inhaled).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nephrotoxicity, ototoxicity, neuromuscular blockade.
Interactions
Loop diuretics, ciclosporin and vancomycin increase toxicity.
Special advice
Level monitoring and renal function checks; avoid in myasthenia gravis.
More from the textbook: uses, cautions and other points
- Antibiotics - prophylactic flucloxacillin (young children, in many centres); treat infections promptly; Pseudomonas eradication and nebulised antibiotics (tobramycin, colistin).
Paediatrics: Respiratory and heart problems in children - Aminoglycosides (gentamicin, amikacin, tobramycin) | Permanent cochlear (high-frequency hearing loss) and vestibular toxicity (gentamicin — oscillopsia, imbalance); risk with high or prolonged levels, renal impairment, loop diuretics; MT-RNR1 m.1555A>G carriers can go deaf after a single dose — monitor levels, shortest course, …
ENT Anatomy Physiology - Aminoglycosides (gentamicin, amikacin, tobramycin) | Permanent hearing loss and balance loss (vestibular toxicity -"oscillopsia" and unsteadiness). Monitor levels; higher risk with the m.1555A>G mitochondrial variant (rapid genetic testing in neonatal units).
ENT: Common Ear disorders - Uses - serious Gram-negative sepsis (often a single empirical dose while cultures are awaited), pyelonephritis, Pseudomonas, synergy in endocarditis; tobramycin nebulised in CF.
ID: How Infection Happens - Treatment - specialist CF centres; airway clearance physiotherapy; nebulised dornase alfa and hypertonic saline; antibiotics (inhaled tobramycin or colistin for Pseudomonas ); pancreatic enzyme replacement and high-calorie diet with vitamins A, D, E, K; CFTR modulators - elexacaftor/tezacaftor/ivacaftor (Kaftrio) for people …
Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders - Antibiotics — prophylactic flucloxacillin (young children, in many centres); treat infections promptly; Pseudomonas eradication and nebulised antibiotics (tobramycin, colistin).
Integrated paediatrics chapter › Cystic Fibrosis
Where it is discussed
- Paediatrics: Respiratory and heart problems in children (1 mention)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Ear disorders (1 mention)
- ID: How Infection Happens (1 mention)
- Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders (1 mention)
- Integrated paediatrics chapter (1 mention)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (1 mention)
Tocilizumab
BNF entry for Tocilizumab · Stand-alone drug page
Mechanism
Interleukin-6 receptor antagonist.
Uses
Rheumatoid arthritis, giant cell arteritis, COVID-19 (selected), cytokine release syndrome.
Dosing
- Hospital patients needing oxygen: Dexamethasone (6 mg daily for up to 10 days) and, in selected patients, an IL-6 inhibitor (tocilizumab). VTE prophylaxis.
Respiratory: Infections - Hospitalised patients needing oxygen - dexamethasone 6 mg daily for up to 10 days ; tocilizumab or baricitinib in severe disease (specialist); VTE prophylaxis; prone positioning and respiratory support.
ID: Viral, fungal and parasitic infections - 3. A patient with rheumatoid arthritis on tocilizumab has fever and confusion. CRP is 6 mg/L. Answer: Possible sepsis masked by IL-6 blockade.
Clinical Immunology: Immune system basics and immunological investigations
Side effects
Infections, raised LFT and lipids, neutropenia, gastrointestinal perforation.
Interactions
Live vaccines contraindicated; CYP-substrate drug levels may fall.
Special advice
Screen for TB; monitor FBC and LFT; may blunt CRP and fever in infection.
More from the textbook: uses, cautions and other points
- Treatment: Mycophenolate (or cyclophosphamide); tocilizumab or rituximab in selected cases; nintedanib for progression.
Respiratory: Interstitial Lung Disease - Tocilizumab for relapsing or refractory disease (NICE TA518).
Neurology: Emergencies - Blinatumomab and other bispecific antibodies; CAR-T cells | ALL, lymphoma, myeloma | Cytokine release syndrome (fever, low BP - tocilizumab), neurotoxicity (ICANS), infections, low antibodies
Haematology: Anatomy Physiology and Pharmacology - Cytokine release syndrome - fever, low BP, hypoxia. Treated with tocilizumab and steroids.
Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia - Tocilizumab | Cytokine release syndrome after CAR-T.
Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia - CAR-T cells / bispecific antibodies | Relapsed lymphoma and myeloma; cytokine release syndrome (tocilizumab) and neurotoxicity (ICANS, dexamethasone); infection and hypogammaglobulinaemia.
Haematology: Myeloma and Lymphoma
Where it is discussed
- Respiratory: Infections (1 mention)
- Respiratory: Interstitial Lung Disease (1 mention)
- Neurology: Emergencies (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia (2 mentions)
- Haematology: Myeloma and Lymphoma (1 mention)
- Oncology: Emergencies (1 mention)
- Paediatrics: Neurology, bones and joints in children (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (5 mentions)
- Rheumatology: Connective tissue diseases (1 mention)
- Rheumatology: Inflammatory arthritis (1 mention)
- Rheumatology: Vasculitis, GCA and PMR (7 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (6 mentions)
- Ophthalmology: Retinal Visual Loss (3 mentions)
- Ophthalmology: Neuro-ophthalmology (1 mention)
- ID: Viral, fungal and parasitic infections (1 mention)
- Clinical Immunology: Immune system basics and immunological investigations (8 mentions)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (1 mention)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (10 mentions)
- Integrated respiratory chapter (2 mentions)
- Integrated paediatrics chapter (2 mentions)
- Cell Biology: Cell cycle, signalling, cell death and stem cells (1 mention)
Topiramate
BNF entry for Topiramate · Stand-alone drug page
Mechanism
Blocks sodium channels, enhances GABA and inhibits carbonic anhydrase.
Uses
Epilepsy, migraine prophylaxis, idiopathic intracranial hypertension.
Dosing
- Topiramate Up to 50 mg twice daily | Migraine prevention, IIH; teratogenic - pregnancy prevention programme; reduces contraceptive effect.
Neurology: Headache and Facial Pain - Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
Obstetrics
Side effects
Cognitive slowing, paraesthesia, weight loss, kidney stones, metabolic acidosis, glaucoma, teratogenic.
Interactions
Enzyme inducers reduce levels; high dose reduces oestrogen contraceptive efficacy.
Special advice
Titrate slowly; pregnancy prevention counselling; report eye pain or visual change.
More from the textbook: uses, cautions and other points
- … pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate (perampanel, topiramate). Several act in more than one way.
Neurology: Anatomy, Physiology and Pharmacology - Brand consistency (MHRA categories) - keep patients on the same manufacturer for category 1 drugs ( phenytoin, carbamazepine, phenobarbital, primidone ); use clinical judgement for category 2 (valproate, lamotrigine, topiramate, oxcarbazepine, clobazam, others).
Neurology: Anatomy, Physiology and Pharmacology - Topiramate: Word-finding difficulty, weight loss, kidney stones, tingling, angle-closure glaucoma. Teratogenic (pregnancy prevention programme).
Neurology: Epilepsy - Enzyme-inducing drugs (carbamazepine, oxcarbazepine, phenytoin, phenobarbital, topiramate, eslicarbazepine) make the combined pill, progestogen-only pill and implant unreliable.
Neurology: Epilepsy - Prevention: Propranolol or amitriptyline. Avoid topiramate, valproate and candesartan .
Neurology: Headache and Facial Pain - Lithium, topiramate (specialist).
Neurology: Headache and Facial Pain
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (8 mentions)
- Neurology: Epilepsy (6 mentions)
- Neurology: Headache and Facial Pain (7 mentions)
- Neurology: Movement Disorders (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Tubular Inherited Stones (1 mention)
- Paediatrics: Neurology, bones and joints in children (2 mentions)
- Obstetrics (3 mentions)
- Obstetrics: Medical Problems (2 mentions)
- Gynaecology: Fertility Contraception Menopause (1 mention)
- ENT: Common Ear disorders (1 mention)
- Ophthalmology: Anatomy Physiology and Pharmacology (6 mentions)
- Ophthalmology Basics Cataract Glaucoma (2 mentions)
- Ophthalmology: Red emergencies (1 mention)
- Ophthalmology: Neuro-ophthalmology (3 mentions)
- Ophthalmology: Paediatrics (2 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (5 mentions)
- Integrated paediatrics chapter (2 mentions)
- General Practice: Undifferentiated presentations, red flags and suspected cancer (1 mention)
- General Practice: Child health, women's health and men's health in primary care (1 mention)
Tramadol
BNF entry for Tramadol · Stand-alone drug page
Mechanism
Weak opioid agonist with serotonin and noradrenaline reuptake inhibition.
Uses
Moderate pain.
Dosing
- 3. A 40-year-old woman on sertraline 100 mg takes tramadol for back pain. Twelve hours later she is agitated, sweaty and tremulous, with temperature 38.6°C, HR 120, dilated pupils, hyperreflexia and inducible ankle clonus. Answer: Serotonin syndrome.
Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy
Side effects
Nausea, dizziness, constipation, seizures, serotonin syndrome, hyponatraemia, hypoglycaemia.
Interactions
SSRIs and other serotonergic drugs; carbamazepine reduces effect; warfarin.
Special advice
Reduce dose in renal impairment; avoid in epilepsy; controlled drug in the UK.
More from the textbook: uses, cautions and other points
- Serotonin syndrome - too much serotonin (SSRIs with tramadol, MAOIs, linezolid, St John's wort, MDMA): agitation, sweating, fever, tremor, clonus and brisk reflexes (legs more than arms), diarrhoea; rapid onset; stop the drugs, cooling, benzodiazepines, cyproheptadine.
Neurology: Anatomy, Physiology and Pharmacology - MAO-B inhibitors - rasagiline, selegiline, safinamide - reduce dopamine breakdown; mild effect; caution with pethidine, tramadol, SSRIs and other serotonergic drugs (serotonin syndrome).
Neurology: Anatomy, Physiology and Pharmacology - Look for provoking causes: Hypoglycaemia, hyponatraemia, hypocalcaemia, alcohol or benzodiazepine withdrawal, drugs (tramadol, bupropion, recreational drugs), head injury, infection.
Neurology: Emergencies - Cause | NMS: Dopamine antagonists (antipsychotics, metoclopramide), or stopping levodopa. Serotonin syndrome: Serotonergic drugs - SSRIs, SNRIs, MAOIs, tramadol, linezolid, triptans, ondansetron, MDMA - especially in combination
Neurology: Emergencies - Drugs (tramadol, bupropion, ciprofloxacin, cocaine).
Neurology: Epilepsy - Tramadol only as short-term rescue.
Neurology: Neuromuscular disease
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (5 mentions)
- Neurology: Emergencies (3 mentions)
- Neurology: Epilepsy (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Palliative: Symptoms Management (2 mentions)
- Obstetrics (2 mentions)
- Psychiatric emergencies (5 mentions)
- Psychiatry: Mood disorders (3 mentions)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (3 mentions)
- Emergency Medicine: Environmental emergencies (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (3 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (6 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (4 mentions)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (1 mention)
- Acute Medicine: The acute medical take (1 mention)
- Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics (1 mention)
- Anaesthesia: Airway management and anaesthetic drugs (2 mentions)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (1 mention)
Tranexamic acid
BNF entry for Tranexamic acid · Stand-alone drug page
Mechanism
Antifibrinolytic blocking lysine binding sites on plasminogen.
Uses
Haemorrhage in trauma, menorrhagia, post-partum haemorrhage, surgical bleeding.
Dosing
- Tranexamic acid - IV (e.g. 1 g) or nebulised.
Respiratory: Emergencies - Tranexamic acid Haemoptysis | e.g. 1 g IV, or nebulised.
Respiratory: Emergencies - Tranexamic acid 1 g IV over 10 minutes (then 1 g over 8 hours) - in trauma within 3 hours and obstetric haemorrhage. Not in GI bleeding (no benefit, more clots).
Haematology: Emergencies - Tranexamic acid 1 g IV over 10 min, then 1 g over 8 h | Trauma (within 3 hours), obstetric haemorrhage, surgery; not GI bleeding.
Haematology: Emergencies
4 more dose entries from the chapters
- Tranexamic acid for surgery with expected blood loss over 500 mL.
Haematology: Haemoglobinopathies and Transfusion - Tranexamic acid 1 g IV | Surgery with expected blood loss over 500 mL; major bleeding.
Haematology: Haemoglobinopathies and Transfusion - Tranexamic acid | Antifibrinolytic — PPH (1 g IV within 3 hours — WOMAN trial) | Seizures at high doses; caution with VTE history
Obstetrics - Tranexamic acid 1 g IV; oxytocin infusion; misoprostol .
Obstetrics
Side effects
Nausea, diarrhoea, seizures at high doses, thrombotic events.
Interactions
Combined oral contraceptives increase thrombosis risk.
Special advice
Early administration is critical in trauma; reduce in renal impairment; avoid in active thromboembolic disease.
More from the textbook: uses, cautions and other points
- Massive haemoptysis | Bleeding side down; oxygen; tranexamic acid; reverse anticoagulation; anaesthetics and interventional radiology
Respiratory: Emergencies - Large-bore access, crossmatch, reverse any anticoagulation; tranexamic acid.
Respiratory: Emergencies - Haemoptysis - palliative radiotherapy, tranexamic acid, bronchial artery embolisation.
Respiratory: Lung Cancer - Tranexamic acid | Haemoptysis (oral or nebulised).
Respiratory: Lung Cancer - Tranexamic acid is not recommended - the HALT-IT trial showed no benefit and more VTE.
Gastroenterology: Gastroenterology Emergencies (Complete) - Upper GI bleed: resuscitate, Blatchford score (0–1 can go home), restrictive transfusion, endoscopy within 24 hours, no PPI before endoscopy, no tranexamic acid.
Gastroenterology: Gastroenterology Emergencies (Complete)
Where it is discussed
- Respiratory: Emergencies (4 mentions)
- Respiratory: Lung Cancer (2 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (7 mentions)
- Haematology: History and Examination (1 mention)
- Haematology: Emergencies (4 mentions)
- Haematology: Haemoglobinopathies and Transfusion (2 mentions)
- Haematology: Haemostasis and Thrombosis (5 mentions)
- Oncology: Emergencies (1 mention)
- Palliative: Symptoms Management (3 mentions)
- Obstetrics (4 mentions)
- Obstetrics: Obstetrics: Emergencies (5 mentions)
- Gynaecology: Menstrual Disorders (6 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Emergencies (5 mentions)
- Surgery: Surgical principles and perioperative care (1 mention)
- Surgery: Major trauma and burns (6 mentions)
- Emergency Medicine: Triage, systems, prehospital care and major incidents (2 mentions)
- Acute Medicine: The deteriorating patient (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Clinical imaging: Musculoskeletal and trauma imaging (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (1 mention)
- Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders (2 mentions)
- Critical care: common problems, ethics and recovery (1 mention)
- Anaesthesia: Airway management and anaesthetic drugs (1 mention)
Trazodone
BNF entry for Trazodone · Stand-alone drug page
Mechanism
Serotonin antagonist and reuptake inhibitor.
Uses
Depression, anxiety, insomnia and agitation in dementia (off-label).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Sedation, postural hypotension, priapism, QT prolongation.
Interactions
MAOIs, serotonergic drugs, CYP3A4 inhibitors.
Special advice
Warn about priapism; caution in cardiac disease.
More from the textbook: uses, cautions and other points
- SSRIs (or trazodone) may help disinhibition and compulsions.
Neurology: Dementia and Cognition Disorders (Complete) - Others - vortioxetine, agomelatine, trazodone, bupropion (smoking) | Vortioxetine - fewer sexual side effects; agomelatine - LFT monitoring; trazodone - sedating.
Psychiatry: Mood disorders - Causes - sickle cell disease , intracavernosal injections for ED, PDE5 inhibitors (rarely), antipsychotics , trazodone, alpha-blockers, cocaine and cannabis, leukaemia, spinal cord injury.
Surgey: Urology - Drugs (commonest) - antihypertensives , diuretics , alpha-blockers (tamsulosin, doxazosin), nitrates , antidepressants (tricyclics, trazodone), antipsychotics, Parkinson's drugs, opioids, PDE5 inhibitors.
Medicine of the older adult.: Falls, syncope, mobility and fragility fractures
Where it is discussed
- Neurology: Dementia and Cognition Disorders (Complete) (1 mention)
- Psychiatry: Mood disorders (1 mention)
- Surgey: Urology (1 mention)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (1 mention)
Trimethoprim
BNF entry for Trimethoprim · Stand-alone drug page
Mechanism
Folate antagonist inhibiting dihydrofolate reductase.
Uses
Urinary tract infection, prophylaxis.
Dosing
- Systemically unwell, immunosuppressed or significant comorbidity: Co-amoxiclav (500/125 mg three times daily for 5 days) - or cefalexin plus metronidazole, or trimethoprim plus metronidazole, if allergic to penicillin.
Gastroenterology: Bowel Disorders - Trimethoprim 200 mg twice daily if low risk of resistance.
Renal: Anatomy, Physiology and Pharmacology - Or trimethoprim 200 mg twice daily for 3 days (if low risk of resistance).
Renal: Tubular Inherited Stones - Trimethoprim 200 mg twice daily | Lower UTI if low resistance risk; avoid in first trimester; raises K and creatinine.
Renal: Tubular Inherited Stones
2 more dose entries from the chapters
- 3. A 52-year-old woman with RA on methotrexate 15 mg weekly is prescribed trimethoprim for a UTI. She develops mouth ulcers and a sore throat. Answer: Methotrexate toxicity (myelosuppression) from an antifolate interaction.
Rheumatology Anatomy Physiology Pharmacology - 2. A 58-year-old woman on methotrexate 15 mg weekly for RA is prescribed trimethoprim for a UTI. A week later she has mouth ulcers, fever and bruising. Neutrophils 0.3, platelets 35. Answer: Methotrexate toxicity (marrow suppression) from a trimethoprim interaction.
Rheumatology: assessment, investigations and drugs
Side effects
Nausea, rash, hyperkalaemia, raised creatinine, folate deficiency.
Interactions
Methotrexate (severe marrow toxicity), ACE inhibitors and spironolactone (hyperkalaemia), warfarin, phenytoin.
Special advice
Avoid in first trimester; check urine culture; adjust in renal impairment.
More from the textbook: uses, cautions and other points
- Find and stop the cause: AKI, CKD, ACE inhibitors, ARBs, spironolactone, trimethoprim, potassium supplements, rhabdomyolysis, DKA, adrenal insufficiency.
Cardiology: Cardiology Emergencies - Heparin , ACE inhibitors, ARBs, spironolactone, trimethoprim | Hyperkalaemia
Endocrine: Anatomy Physiology and Pharmacology - Drugs: ACE inhibitors, ARBs, spironolactone and eplerenone, heparin (which inhibits aldosterone production), NSAIDs, ciclosporin and tacrolimus. Trimethoprim and amiloride cause a similar picture by blocking the sodium channel.
Endocrinology: Adrenal Disease - Folate | Jejunum | Stores last only about 4 months. Deficiency - poor diet, alcohol, coeliac disease, pregnancy, haemolysis, drugs ( methotrexate , trimethoprim, phenytoin, sulfasalazine).
Gastroenterology: Anatomy Physiology Pharmacology - Methotrexate (weekly, oral or subcutaneous) - mainly Crohn's; folic acid on another day; FBC, LFTs and U&E monitoring; teratogenic (effective contraception, for men and women); pneumonitis; avoid trimethoprim and co-trimoxazole (marrow suppression); "once weekly" prescribing errors are a known cause of death.
Gastroenterology: Anatomy Physiology Pharmacology - Some drugs block creatinine secretion by the tubules ( trimethoprim , cimetidine, some HIV drugs such as dolutegravir) → creatinine rises without a true fall in GFR.
Renal: Anatomy, Physiology and Pharmacology
Where it is discussed
- Cardiology: Cardiology Emergencies (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: Adrenal Disease (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Bowel Disorders (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (16 mentions)
- Renal: Emergencies (2 mentions)
- Renal: Chronic Kidney Disease (2 mentions)
- Renal: Tubular Inherited Stones (10 mentions)
- Renal: Dialysis and Transplant (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Haematology: Anaemia (2 mentions)
- Paediatrics: Kidneys, urinary tract and hormones in children (3 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Medical Problems (1 mention)
- Dermatology: Skin basics, eczema and psoriasis (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (4 mentions)
- Rheumatology: assessment, investigations and drugs (7 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (4 mentions)
- ID: How Infection Happens (6 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (3 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (3 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (7 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (6 mentions)
V
Valaciclovir
BNF entry for Valaciclovir · Stand-alone drug page
Mechanism
Prodrug of aciclovir; inhibits viral DNA polymerase.
Uses
Herpes zoster, genital herpes, cold sores, CMV prophylaxis.
Dosing
- First episode - aciclovir 400 mg three times daily for 5 days (or valaciclovir 500 mg twice daily), started within 5 days or while new lesions are forming; saline bathing, analgesia, topical lidocaine; catheter (suprapubic) for retention.
Gynaecology: Sexual health - Oral antiviral within 72 hours of rash onset - aciclovir 800 mg five times a day , valaciclovir or famciclovir for 7 days - for people over 50 , immunocompromised, non-truncal involvement (face, neck, limbs, genitals), moderate or severe pain or rash, or eczema. Ophthalmic and immunocompromised patients - treat even after 72 …
Dermatology: Skin infections and infestations - Aciclovir / valaciclovir / famciclovir | Shingles within 72 hours (aciclovir 800 mg five times daily, 7 days); severe HSV; eczema herpeticum.
Dermatology: Skin infections and infestations - Oral antiviral within 72 hours of rash onset (or later if new lesions are still appearing) - aciclovir 800 mg five times daily or valaciclovir 1 g three times daily for 7 days.
Ophthalmology: Red emergencies
3 more dose entries from the chapters
- Aciclovir 800 mg five times daily or valaciclovir 1 g three times daily | Herpes zoster ophthalmicus for 7 days, within 72 hours.
Ophthalmology: Red emergencies - Treatment - oral aciclovir 800 mg five times daily or valaciclovir 1 g three times daily for 7 days, ideally within 72 hours of the rash (NICE CKS) - for people over 50, immunosuppressed people, non-truncal shingles (face, eyes, limbs, perineum), moderate or severe pain or rash; any time for ophthalmic zoster or …
ID: Viral, fungal and parasitic infections - Valaciclovir | Shingles (1 g three times daily for 7 days within 72 hours), genital herpes; post-exposure prophylaxis for VZV in pregnancy (days 7–14).
ID: Viral, fungal and parasitic infections
Side effects
Nausea, headache, confusion in older adults, renal impairment, thrombotic microangiopathy at high dose.
Interactions
Nephrotoxic drugs; probenecid raises levels.
Special advice
Hydrate well; adjust in renal impairment; start within 72 hours of zoster rash.
More from the textbook: uses, cautions and other points
- Aciclovir or valaciclovir plus prednisolone .
Neurology: Neuromuscular disease - Aciclovir / valaciclovir | Ramsay Hunt syndrome (with prednisolone).
Neurology: Neuromuscular disease - Not immune - oral antiviral prophylaxis (aciclovir or valaciclovir) from day 7 to day 14 after exposure (UKHSA); VZIG is reserved for some cases.
Obstetrics: Medical Problems - Cytomegalovirus (CMV) | The commonest congenital infection ; a leading cause of sensorineural hearing loss in children, also microcephaly, learning disability. Often from young children's saliva and urine - hand hygiene, don't share cutlery. Specialist treatment (valaciclovir) in some first-trimester infections.
Obstetrics: Medical Problems - Ramsay Hunt syndrome (VZV of the geniculate ganglion) — painful ear, vesicles in the ear canal or palate, LMN facial palsy, often hearing loss and vertigo — aciclovir or valaciclovir plus prednisolone ; worse prognosis than Bell's.
ENT Anatomy Physiology - Ramsay Hunt syndrome (herpes zoster oticus) - vesicles in the ear canal or on the palate , severe ear pain, facial palsy, often hearing loss and vertigo. Worse prognosis than Bell's. Treat with prednisolone plus valaciclovir or aciclovir within 72 hours.
ENT: Emergencies
Where it is discussed
- Neurology: Neuromuscular disease (2 mentions)
- Obstetrics: Medical Problems (4 mentions)
- Gynaecology: Sexual health (1 mention)
- Dermatology: Skin infections and infestations (3 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Emergencies (2 mentions)
- Ophthalmology: Anatomy Physiology and Pharmacology (1 mention)
- Ophthalmology: Red emergencies (2 mentions)
- ID: How Infection Happens (1 mention)
- ID: Viral, fungal and parasitic infections (8 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (3 mentions)
- Microbiology: Virology - structure, replication and important viral infections (2 mentions)
Valsartan
BNF entry for Valsartan · Stand-alone drug page
Mechanism
Angiotensin II receptor blocker.
Uses
Hypertension, heart failure, post-MI.
Dosing
- Sacubitril/valsartan | 24/26 mg or 49/51 mg twice daily initially; target 97/103 mg twice daily.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Sacubitril/valsartan | HFrEF: 24/26 mg or 49/51 mg twice daily, titrated to 97/103 mg twice daily; stop ACE inhibitor at least 36 hours before.
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses
Side effects
Dizziness, hyperkalaemia, renal impairment, angioedema rare.
Interactions
NSAIDs, potassium-sparing diuretics, ACE inhibitors, lithium.
Special advice
U&E after starting; avoid in pregnancy; used with sacubitril in heart failure (never with ACE inhibitor).
More from the textbook: uses, cautions and other points
- Angiotensin receptor blockers (ARBs) (losartan, candesartan, valsartan) - block the AT1 receptor; same uses; no cough (used when ACE inhibitors cause it); angioedema much less common.
Cardiology: Anatomy Physiology and Pharmacology - Sacubitril/valsartan | ARNI for HFrEF; 36-hour gap after ACE inhibitor.
Cardiology: Anatomy Physiology and Pharmacology - Sacubitril/valsartan raises BNP (it blocks its breakdown) - use NT-proBNP to monitor.
Cardiology Investigations - Full heart failure therapy for reduced EF: ACE inhibitor/ARB or sacubitril/valsartan, beta blocker, MRA and SGLT2 inhibitor, plus diuretics for congestion.
Cardiology: Ischaemic Heart Disease (ACS) › 1.30 Pericarditis and Late Complications - Optimise heart failure therapy first: ACE inhibitor or sacubitril/valsartan, beta blocker, MRA, SGLT2 inhibitor, and diuretics.
Cardiology: Valvular heart disease › 4.22 Secondary MR - … function, potassium, frailty and clinical stability. If symptoms persist despite maximally tolerated treatment, consider switching the ACE inhibitor to sacubitril/valsartan. When ACE inhibitor intolerance other than angioedema occurs, NICE supports using an ARNI with the other foundational classes. If ACE inhibitor-associated …
Cardiology: Heart Failure › 2.17 💊 Chronic HFrEF - The Four Foundational Drug Classes
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology Investigations (1 mention)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Heart Failure (8 mentions)
- Cardiology: Cardiomyopathies (4 mentions)
- Respiratory: Emergencies (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Emergencies (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- ENT: Emergencies (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (1 mention)
- Integrated cardiology chapter (15 mentions)
- Integrated respiratory chapter (1 mention)
Vancomycin
BNF entry for Vancomycin · Stand-alone drug page
Mechanism
Glycopeptide inhibiting cell-wall synthesis.
Uses
MRSA infection, endocarditis, C. difficile (oral), severe Gram-positive infection with penicillin allergy.
Dosing
- Life-threatening C. difficile | Oral vancomycin 500 mg four times daily plus IV metronidazole; surgical review
Gastroenterology: Gastroenterology Emergencies (Complete) - First episode: Oral vancomycin 125 mg four times daily for 10 days . Fidaxomicin 200 mg twice daily for 10 days is second-line.
Gastroenterology: Gastroenterology Emergencies (Complete) - First episode: Oral vancomycin 125 mg four times daily for 10 days .
Gastroenterology: Bowel Disorders - Vancomycin oral 125 mg four times daily for 10 days | First-episode C. difficile; 500 mg four times daily plus IV metronidazole if life-threatening.
Gastroenterology: Bowel Disorders
4 more dose entries from the chapters
- Hospital - ABC, blood cultures, then IV ceftriaxone 2 g every 12 hours within 1 hour; add IV amoxicillin 2 g every 4 hours if Listeria is possible (over 60, immunosuppressed, pregnant, alcohol excess); add vancomycin (± rifampicin) if penicillin-resistant pneumococcus is possible (recent travel to areas of high resistance).
ID: Sepsis, fever and serious bacterial infections - First episode - oral vancomycin 125 mg four times daily for 10 days ; fidaxomicin 200 mg twice daily for 10 days if vancomycin fails.
ID: Hospital infection, the immunocompromised host, vaccination and public health - Life-threatening - oral vancomycin 500 mg four times daily (plus IV metronidazole), urgent surgical and specialist review (colectomy may be needed); vancomycin by NG tube or rectally in ileus.
ID: Hospital infection, the immunocompromised host, vaccination and public health - Loading dose - a larger first dose to reach the target level quickly, when waiting 4–5 half-lives would be too slow: digoxin , amiodarone , phenytoin (and levetiracetam in status), vancomycin , teicoplanin, aminophylline , warfarin (in some regimens), clopidogrel (300–600 mg in ACS), ticagrelor.
Clinical pharmacology and prescribing: Principles of clinical pharmacology
Side effects
Nephrotoxicity, ototoxicity, red man syndrome, neutropenia.
Interactions
Aminoglycosides, loop diuretics increase toxicity.
Special advice
IV: slow infusion and trough monitoring; oral not absorbed and used only for C. difficile.
More from the textbook: uses, cautions and other points
- MRSA suspected: Add vancomycin or teicoplanin.
Respiratory: Emergencies - C. difficile treatment - stop the causing antibiotic and PPIs if possible; oral vancomycin first-line (fidaxomicin for recurrence or high risk of recurrence - NICE NG199); avoid antidiarrhoeals.
Gastroenterology: Anatomy Physiology Pharmacology - Oral vancomycin / fidaxomicin | C. difficile infection.
Gastroenterology: Anatomy Physiology Pharmacology - After 12 weeks: vancomycin or fidaxomicin.
Gastroenterology: Gastroenterology Emergencies (Complete) - Recurrence within 12 weeks: Fidaxomicin. After 12 weeks: vancomycin or fidaxomicin.
Gastroenterology: Bowel Disorders - C. difficile: isolate, soap and water, oral vancomycin first line, fidaxomicin second line or for recurrence.
Gastroenterology: Bowel Disorders
Where it is discussed
- Respiratory: Emergencies (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (5 mentions)
- Gastroenterology: Bowel Disorders (6 mentions)
- Renal: Anatomy, Physiology and Pharmacology (4 mentions)
- Renal: Emergencies (1 mention)
- Renal: Chronic Kidney Disease (1 mention)
- Renal: Dialysis and Transplant (5 mentions)
- Renal: Glomerular Disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Haematology: Haemostasis and Thrombosis (1 mention)
- Oncology: Emergencies (1 mention)
- Dermatology: Skin infections and infestations (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Ear disorders (1 mention)
- Ophthalmology: Anatomy Physiology and Pharmacology (1 mention)
- Ophthalmology: Red emergencies (1 mention)
- ID: How Infection Happens (18 mentions)
- ID: Sepsis, fever and serious bacterial infections (8 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (7 mentions)
- Surgery: Surgical principles and perioperative care (1 mention)
- Surgey: Trauma and orthopaedics (1 mention)
- Emergency Medicine: ED procedures (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (3 mentions)
Varenicline
BNF entry for Varenicline · Stand-alone drug page
Mechanism
Partial agonist at nicotinic alpha-4 beta-2 receptors.
Uses
Smoking cessation.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, abnormal dreams, insomnia, headache; neuropsychiatric events reported.
Interactions
Few; alcohol tolerance may reduce.
Special advice
Start 1–2 weeks before quit date; take after food; report mood changes.
More from the textbook: uses, cautions and other points
- Stop smoking - the only measure (with oxygen in selected people) proven to slow decline and improve survival. Offer behavioural support plus drugs (NRT, varenicline where available, bupropion). E-cigarettes are a less harmful alternative to smoking.
Respiratory: Airways Disease - Smoking cessation | NRT (combination patch plus short-acting form), varenicline where available, bupropion; with behavioural support.
Respiratory: Airways Disease - Action - stop-smoking support (varenicline, cytisine, NRT, e-cigarettes), statins, diabetes management, healthy lifestyle programmes; consider switching antipsychotics with fewer metabolic effects; metformin can limit antipsychotic weight gain.
Psychiatry: assessment, treatment and the law - Varenicline / cytisine / NRT | Stop-smoking treatment - vital in severe mental illness; check clozapine and olanzapine levels when smoking changes.
Psychiatry: assessment, treatment and the law - Varenicline (partial nicotine receptor agonist) -12 weeks; available again in the UK (reformulated); nausea, vivid dreams.
Psychiatry: Alcohol, drugs and addiction - Varenicline / cytisine | Smoking cessation - most effective single drugs.
Psychiatry: Alcohol, drugs and addiction
Where it is discussed
- Respiratory: Airways Disease (2 mentions)
- Psychiatry: assessment, treatment and the law (2 mentions)
- Psychiatry: Alcohol, drugs and addiction (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Integrated respiratory chapter (2 mentions)
- Public Health: Prevention, health promotion and behaviour change (5 mentions)
- Cell Biology: Cell cycle, signalling, cell death and stem cells (1 mention)
Venlafaxine
BNF entry for Venlafaxine · Stand-alone drug page
Mechanism
Serotonin and noradrenaline reuptake inhibitor.
Uses
Depression, generalised anxiety, panic, social anxiety.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, sweating, hypertension, insomnia, sexual dysfunction, discontinuation symptoms.
Interactions
MAOIs, serotonergic drugs, QT-prolonging drugs; cimetidine raises levels.
Special advice
Monitor BP; taper slowly; dangerous in overdose; avoid in uncontrolled hypertension.
More from the textbook: uses, cautions and other points
- Antidepressants (venlafaxine, clomipramine) for cataplexy.
Neurology: Spine and Sleep Disorders - CYP2D6 inhibitors (fluoxetine, paroxetine) may reduce its effect - use other antidepressants (venlafaxine, citalopram).
Oncology: Principles - Use a different antidepressant (e.g. sertraline, citalopram or venlafaxine).
Oncology: Principles - SSRIs or SNRIs (venlafaxine, citalopram - avoid fluoxetine and paroxetine with tamoxifen ).
Oncology: Breast and Gynae Cancers - SSRIs or SNRIs (e.g. venlafaxine, citalopram) - avoid fluoxetine and paroxetine with tamoxifen (they reduce its effect).
Gynaecology: Fertility Contraception Menopause - Venlafaxine / citalopram / gabapentin / clonidine | Non-hormonal flush treatment; avoid fluoxetine/paroxetine with tamoxifen.
Gynaecology: Fertility Contraception Menopause
Where it is discussed
- Neurology: Spine and Sleep Disorders (1 mention)
- Oncology: Principles (2 mentions)
- Oncology: Breast and Gynae Cancers (1 mention)
- Gynaecology: Fertility Contraception Menopause (2 mentions)
- Psychiatric emergencies (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (5 mentions)
- Psychiatry: Mood disorders (5 mentions)
- Psychiatry: Personality, eating and neurodevelopmental disorders (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
Verapamil
BNF entry for Verapamil · Stand-alone drug page
Mechanism
Non-dihydropyridine calcium channel blocker.
Uses
Angina, SVT, AF rate control, hypertension, cluster headache prophylaxis.
Dosing
- Avoid in severe asthma - use verapamil 2.5–5 mg IV instead (never with a beta-blocker, and avoid in heart failure or broad-complex tachycardia).
Cardiology: Cardiology Emergencies - Verapamil SVT (if adenosine unsuitable) | 2.5–5 mg IV. Never with a beta-blocker; avoid in heart failure and broad-complex tachycardia.
Cardiology: Cardiology Emergencies - Verapamil (rate-limiting): 80–120 mg three times daily.
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina - Verapamil | 80–120 mg three times daily. Never with a beta blocker.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table
4 more dose entries from the chapters
- Stable regular narrow-complex: Vagal manoeuvres, then adenosine 6 mg → 12 mg → 18 mg by rapid IV bolus when no pre-excitation; then specialist-guided beta blocker/verapamil or cardioversion.
Cardiology: Cardiac Arrhythmias › 5.25 RCUK 2026 Tachyarrhythmia Algorithm - Verapamil AF/SVT control | Often 40–80 mg orally three times daily initially. Avoid HFrEF, significant AV block, and combination with beta blockers without specialist oversight.
Cardiology: Cardiac Arrhythmias › 5.42 Two-Column Drug and Dose Table - Verapamil | Selected HCM: 40–80 mg three times daily initially, or modified-release; specialist titration. Avoid with significant LV systolic dysfunction.
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses - Amlodipine, diltiazem, verapamil - maximum simvastatin dose 20 mg.
Endocrinology: Lipids and obesity
Side effects
Constipation, bradycardia, heart block, ankle oedema, hypotension.
Interactions
Beta-blockers (heart block), digoxin levels rise, statins, ciclosporin.
Special advice
Avoid in heart failure with reduced EF, WPW with AF and with IV beta-blockers.
More from the textbook: uses, cautions and other points
- Phase 0 - slower upstroke via L-type calcium channels (blocked by verapamil and diltiazem - slowing AV conduction).
Cardiology: Anatomy Physiology and Pharmacology - Interactions - never give IV verapamil with a beta-blocker (asystole, severe heart block); caution with diltiazem, digoxin, amiodarone.
Cardiology: Anatomy Physiology and Pharmacology - Avoid — verapamil and diltiazem in HFrEF (negatively inotropic) unless a specialist advises; NSAIDs in heart failure; QT-prolonging combinations.
Cardiology: Presentations - Prescribing | Check renal function and K + ; no verapamil or diltiazem in HFrEF
Cardiology: Presentations - Drugs: Beta-blockers, rate-limiting calcium channel blockers (verapamil, diltiazem), digoxin, amiodarone, ivabradine.
Cardiology: Cardiology Emergencies - If it fails or recurs: Beta-blocker or verapamil; DC cardioversion if adverse features develop.
Cardiology: Cardiology Emergencies
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (12 mentions)
- Cardiology: Presentations (2 mentions)
- Cardiology: Cardiology Emergencies (6 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (8 mentions)
- Cardiology: Heart Failure (2 mentions)
- Cardiology: Cardiac Arrhythmias (8 mentions)
- Cardiology: Cardiomyopathies (4 mentions)
- Endocrinology: Pituitary Disease (1 mention)
- Endocrinology: Adrenal Disease (1 mention)
- Endocrinology: Lipids and obesity (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Headache and Facial Pain (6 mentions)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Dialysis and Transplant (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Myeloma and Lymphoma (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (1 mention)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (3 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (7 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
Vigabatrin
BNF entry for Vigabatrin · Stand-alone drug page
Mechanism
Irreversibly inhibits GABA transaminase.
Uses
Refractory focal epilepsy, infantile spasms.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Visual field defects (often permanent), drowsiness, depression, weight gain.
Interactions
Phenytoin levels fall.
Special advice
Visual field monitoring; use specialist guidance; avoid if prior visual field defect.
More from the textbook: uses, cautions and other points
- GABA | Main inhibitory transmitter in the brain | Benzodiazepines , barbiturates, Z-drugs, propofol, alcohol enhance GABA-A; baclofen acts on GABA-B; valproate and vigabatrin raise GABA; withdrawal of these → seizures
Neurology: Anatomy, Physiology and Pharmacology - … oxcarbazepine), block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate (perampanel, topiramate). Several act in more than one way.
Neurology: Anatomy, Physiology and Pharmacology - Infantile spasms (West syndrome) | Babies; clusters of flexion spasms; hypsarrhythmia on EEG; developmental regression. Steroids or vigabatrin (tuberous sclerosis). Urgent
Neurology: Epilepsy - Myoclonic | Levetiracetam or valproate (males). Avoid carbamazepine, oxcarbazepine, phenytoin, gabapentin, pregabalin, vigabatrin (they can worsen it)
Neurology: Epilepsy - Tuberous sclerosis complex (TSC1 or TSC2) | Ash-leaf macules , facial angiofibromas , shagreen patch, nail fibromas; epilepsy (infantile spasms - vigabatrin), learning disability, autism; cortical tubers; renal angiomyolipomas ; cardiac rhabdomyomas (infancy); lung LAM in women. Everolimus (mTOR inhibitor)
Neurology: Spine and Sleep Disorders - … developmental regression ; EEG - hypsarrhythmia . Causes include tuberous sclerosis , HIE, genetic. Urgent (same-week) treatment - prednisolone (or ACTH) with vigabatrin ; vigabatrin first in tuberous sclerosis. Vigabatrin can cause visual field loss.
Paediatrics: Neurology, bones and joints in children
Where it is discussed
- Neurology: Anatomy, Physiology and Pharmacology (4 mentions)
- Neurology: Epilepsy (2 mentions)
- Neurology: Spine and Sleep Disorders (1 mention)
- Paediatrics: Neurology, bones and joints in children (4 mentions)
- Ophthalmology: Anatomy Physiology and Pharmacology (2 mentions)
- Ophthalmology: Neuro-ophthalmology (3 mentions)
- Ophthalmology: Paediatrics (1 mention)
- Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders (1 mention)
- Integrated paediatrics chapter (4 mentions)
W
Warfarin
BNF entry for Warfarin · Stand-alone drug page
Mechanism
Vitamin K antagonist inhibiting synthesis of clotting factors II, VII, IX and X.
Uses
Mechanical heart valves, AF with moderate or severe mitral stenosis, VTE (selected), antiphospholipid syndrome.
Dosing
- Vitamin K + PCC Warfarin with major bleed | Vitamin K 5 mg IV plus prothrombin complex concentrate (dose by weight and INR).
Gastroenterology: Gastroenterology Emergencies (Complete) - 5. An 80-year-old woman started on carbamazepine for trigeminal neuralgia is brought in confused. Sodium 119 mmol/L. She also takes bendroflumethiazide and warfarin; her INR has fallen to 1.4. Answer: Carbamazepine-induced hyponatraemia (worsened by the thiazide) and enzyme induction lowering warfarin effect.
Neurology: Anatomy, Physiology and Pharmacology - Consider prophylactic anticoagulation when albumin is very low (e.g. under 20–25 g/L , or higher in membranous nephropathy) and bleeding risk is low - LMWH or warfarin; DOACs used in some units.
Renal: Glomerular Disease - Major bleeding - stop warfarin; IV vitamin K 5–10 mg ; prothrombin complex concentrate (FFP only if PCC is unavailable).
Haematology: Anatomy Physiology and Pharmacology
4 more dose entries from the chapters
- INR 5–8 with minor bleeding - stop warfarin; IV vitamin K 1–3 mg; restart when INR under 5.
Haematology: Anatomy Physiology and Pharmacology - Warfarin: Prothrombin complex concentrate (PCC, e.g. 25–50 units/kg) plus IV vitamin K 5–10 mg . Recheck the INR after PCC.
Haematology: Emergencies - Prothrombin complex concentrate 25–50 units/kg | Warfarin reversal (with vitamin K 5–10 mg IV); Xa inhibitor bleeding.
Haematology: Emergencies - Fresh frozen plasma (FFP) | Bleeding with abnormal clotting (major haemorrhage, DIC); plasma exchange in TTP. Dose 15 mL/kg. Not for warfarin reversal (use prothrombin complex concentrate) and not routinely before procedures for mildly abnormal clotting
Haematology: Haemoglobinopathies and Transfusion
Side effects
Bleeding, skin necrosis, teratogenicity, purple toe syndrome.
Interactions
Many: antibiotics, azoles, amiodarone, NSAIDs, alcohol raise INR; rifampicin, carbamazepine, St John's wort lower INR.
Special advice
INR monitoring; vitamin K and prothrombin complex concentrate for reversal; consistent vitamin K diet; alert card.
More from the textbook: uses, cautions and other points
- Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
Cardiology: Anatomy Physiology and Pharmacology - Not for mechanical heart valves or moderate–severe mitral stenosis (use warfarin); caution with very low or very high body weight; avoid with antiphospholipid syndrome (triple positive).
Cardiology: Anatomy Physiology and Pharmacology - Complications - AF, stroke (anticoagulation with warfarin in moderate–severe mitral stenosis), pulmonary hypertension.
Cardiology: History and Examination - Anticoagulant prescriptions must state — indication , agent , dose , renal adjustment , interactions , duration and bleeding plan ; take particular care with mechanical valves (warfarin only — DOACs contraindicated), pregnancy (LMWH) and triple-positive antiphospholipid syndrome (warfarin).
Cardiology: Presentations - Warfarin — INR; many interactions (antibiotics, azoles, amiodarone).
Cardiology: Presentations - Invasive procedures and anticoagulation - follow local protocols; radial access often allows warfarin or DOACs to be continued or interrupted for less time.
Cardiology Investigations
Where it is discussed
- Cardiology: Anatomy Physiology and Pharmacology (11 mentions)
- Cardiology: History and Examination (1 mention)
- Cardiology: Presentations (2 mentions)
- Cardiology Investigations (1 mention)
- Cardiology: Ischaemic Heart Disease (ACS) (2 mentions)
- Cardiology: Valvular heart disease (19 mentions)
- Cardiology: Cardiac Arrhythmias (2 mentions)
- Cardiology: Cardiomyopathies (3 mentions)
- Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease (7 mentions)
- Cardiology: Congenital heart disease (2 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (2 mentions)
- Respiratory: Emergencies (2 mentions)
- Respiratory: Infections (2 mentions)
- Respiratory: Pulmonary Vascular Disease (5 mentions)
- Respiratory: Sleep and Breathing (Complete) (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (4 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (2 mentions)
- Gastroenterology: Investigations (4 mentions)
- Gastroenterology: Bowel Disorders (1 mention)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (6 mentions)
- Neurology: Emergencies (1 mention)
- Neurology: Stroke Emergencies (4 mentions)
- Neurology: Epilepsy (1 mention)
- Neurology: Headache and Facial Pain (1 mention)
Z
Zopiclone
BNF entry for Zopiclone · Stand-alone drug page
Mechanism
Non-benzodiazepine hypnotic acting at GABA-A receptors.
Uses
Short-term insomnia.
Dosing
- … doxazosin, atorvastatin, aspirin 75 mg (no history of vascular disease), omeprazole 40 mg (started 6 years ago for dyspepsia), amitriptyline 25 mg (sleep), zopiclone, oxybutynin and gliclazide (HbA1c 49). Standing BP 106/60. Answer: Problematic polypharmacy contributing to falls.
Medicine of the older adult: .Prescribing and deprescribing in older people
Side effects
Bitter taste, drowsiness, next-day impairment, confusion, dependence.
Interactions
Opioids, alcohol, CNS depressants; CYP3A4 inhibitors raise levels.
Special advice
Maximum 2–4 weeks; lower dose in older adults and hepatic impairment; warn about driving.
More from the textbook: uses, cautions and other points
- Z-drugs (zopiclone, zolpidem) or short-acting benzodiazepines - for severe acute insomnia, the lowest dose for the shortest time ( up to 2 weeks , ideally fewer nights).
Psychiatry: Anxiety, stress and somatic disorders - Zopiclone / zolpidem | Short-term insomnia (up to 2 weeks); dependence, falls, next-day impairment.
Psychiatry: Anxiety, stress and somatic disorders - … has had 4 falls in 6 months, usually when getting up from a chair. She takes amlodipine, ramipril, bendroflumethiazide, doxazosin, amitriptyline (for sleep) and zopiclone. Lying BP 152/84, standing BP 118/70 at 3 minutes with dizziness. Answer: Recurrent falls with orthostatic hypotension and falls-risk medicines.
Medicine of the older adult.: Falls, syncope, mobility and fragility fractures - Medication review - stop doxazosin and the thiazide; reduce antihypertensives (relaxed BP targets); taper and stop amitriptyline and zopiclone (anticholinergic and sedative).
Medicine of the older adult.: Falls, syncope, mobility and fragility fractures - Stop or reduce - doxazosin and indapamide (orthostatic hypotension), aspirin (primary prevention), gliclazide (HbA1c low - hypoglycaemia risk), oxybutynin and amitriptyline (anticholinergic), taper zopiclone; step down omeprazole.
Medicine of the older adult: .Prescribing and deprescribing in older people - 4 | Most benzodiazepines (diazepam, lorazepam), Z-drugs (zopiclone, zolpidem); anabolic steroids (part 2) | Prescriptions valid 28 days; no special writing rules
Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law
Where it is discussed
- Psychiatry: Anxiety, stress and somatic disorders (2 mentions)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (2 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)